"CyCSV-Version","1"
"SUID","citation contributors","citation identifier","citation title","citation type","interaction","name","p","selected","shared interaction","shared name","support text"
"java.lang.Long","java.util.List<java.lang.String>","java.lang.String","java.lang.String","java.lang.String","java.lang.String","java.lang.String","java.lang.String","java.lang.Boolean","java.lang.String","java.lang.String","java.lang.String"
"","","","","","","","","","","",""
"18 default edge","public"
"1324","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:positiveCorrelation","false",,,"Oxidation and nitration of macromolecules, such as
proteins, DNA and lipids, are prominent in atherosclerotic
arteries."
"1325","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:positiveCorrelation","false",,,"Oxidation and nitration of macromolecules, such as
proteins, DNA and lipids, are prominent in atherosclerotic
arteries."
"1326","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"Arterial cells are
highly susceptible to oxidative stress, which can induce
both necrosis and apoptosis (programmed cell death) [1,2]."
"1327","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"Arterial cells are
highly susceptible to oxidative stress, which can induce
both necrosis and apoptosis (programmed cell death) [1,2]."
"1328","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"One such risk factor is oxLDL,
which exert pro-apoptotic effects on a variety of cell
lineages, including endothelial cells and VSMCs, both in
cultured cells and in arteries. [19–26]. Increased formation
of oxygen radicals (and other radical species)
facilitates LDL oxidation and influences oxidation-sensitive
mechanisms [15]. It"
"1329","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"One such risk factor is oxLDL,
which exert pro-apoptotic effects on a variety of cell
lineages, including endothelial cells and VSMCs, both in
cultured cells and in arteries. [19–26]. Increased formation
of oxygen radicals (and other radical species)
facilitates LDL oxidation and influences oxidation-sensitive
mechanisms [15]. It"
"1330","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"One such risk factor is oxLDL,
which exert pro-apoptotic effects on a variety of cell
lineages, including endothelial cells and VSMCs, both in
cultured cells and in arteries. [19–26]. Increased formation
of oxygen radicals (and other radical species)
facilitates LDL oxidation and influences oxidation-sensitive
mechanisms [15]. It"
"1331","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"Not surprisingly, high concentrations of exogenous
reactive oxygen species (ROS), generated by enzymatic
reactions or by radiation, also stimulate the apoptosis of
endothelial cells in vitro [29–31]."
"1332","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"The peptide hormone angiotensin II and
pro-inflammatory cytokines also trigger the apoptotic
program in endothelial cells [33,34]."
"1333","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:positiveCorrelation","false",,,"Aging, one of the
major predictors for atherosclerotic lesion formation,
increases the sensitivity of endothelial cells to apoptosis
induced by in vitro and in vivo stimuli [35–37]."
"1334","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"Aging, one of the
major predictors for atherosclerotic lesion formation,
increases the sensitivity of endothelial cells to apoptosis
induced by in vitro and in vivo stimuli [35–37]."
"1335","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"Shear stress
enhances expression of the gene encoding the endothelial
nitric oxide synthase (eNOS) and further stimulates its
enzymatic activity, leading to physiologic low concentrations
of nitric oxide (NO) within endothelial cells
[44–46]. This continuous generation of NO prevents the
apoptosis of endothelial cells, thereby protecting the
endothelial monolayer from injury [47,48]."
"1336","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"Shear stress
enhances expression of the gene encoding the endothelial
nitric oxide synthase (eNOS) and further stimulates its
enzymatic activity, leading to physiologic low concentrations
of nitric oxide (NO) within endothelial cells
[44–46]. This continuous generation of NO prevents the
apoptosis of endothelial cells, thereby protecting the
endothelial monolayer from injury [47,48]."
"1337","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"Shear stress
enhances expression of the gene encoding the endothelial
nitric oxide synthase (eNOS) and further stimulates its
enzymatic activity, leading to physiologic low concentrations
of nitric oxide (NO) within endothelial cells
[44–46]. This continuous generation of NO prevents the
apoptosis of endothelial cells, thereby protecting the
endothelial monolayer from injury [47,48]."
"1338","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:decreases","false",,,"Shear stress
enhances expression of the gene encoding the endothelial
nitric oxide synthase (eNOS) and further stimulates its
enzymatic activity, leading to physiologic low concentrations
of nitric oxide (NO) within endothelial cells
[44–46]. This continuous generation of NO prevents the
apoptosis of endothelial cells, thereby protecting the
endothelial monolayer from injury [47,48]."
"1339","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:decreases","false",,,"More importantly,
intervention with L-arginine has induced beneficial
effects on atherosclerosis in experimental and human
studies [46,49]."
"1340","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"OxLDL induces the generation of ROS in different
vascular cell types [15,58], and might also promote a rise
in ROS levels through a decrease in ROS degradation,
because oxLDL induces a reduction in the antioxidant
enzymes Cu/Zn superoxide dismutase [59] and glutathione
peroxidase [60]."
"1341","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:decreases","false",,,"OxLDL induces the generation of ROS in different
vascular cell types [15,58], and might also promote a rise
in ROS levels through a decrease in ROS degradation,
because oxLDL induces a reduction in the antioxidant
enzymes Cu/Zn superoxide dismutase [59] and glutathione
peroxidase [60]."
"1342","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:decreases","false",,,"OxLDL induces the generation of ROS in different
vascular cell types [15,58], and might also promote a rise
in ROS levels through a decrease in ROS degradation,
because oxLDL induces a reduction in the antioxidant
enzymes Cu/Zn superoxide dismutase [59] and glutathione
peroxidase [60]."
"1343","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"For instance,
during 7-ketocholesterol-induced apoptosis of U937 cells,
the cellular antioxidant content falls rapidly [64], but
administration of two potent antioxidants, the aminothiols
glutathione andN-acetylcysteine, can protect themonocytic
cells from 7-ketocholesterol-induced apoptotic cell death
[64]."
"1344","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:negativeCorrelation","false",,,"For instance,
during 7-ketocholesterol-induced apoptosis of U937 cells,
the cellular antioxidant content falls rapidly [64], but
administration of two potent antioxidants, the aminothiols
glutathione andN-acetylcysteine, can protect themonocytic
cells from 7-ketocholesterol-induced apoptotic cell death
[64]."
"1345","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"In addition, another oxygen-radical scavenger enzyme,
catalase, can prevent VSMC apoptosis triggered by hydrogen
peroxide [27,65]."
"1346","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"The proto-oncogene c-myc can
promote cell death (probably mediated through p53) or
cell proliferation, depending on its expression level. It
functions as a nuclear phosphoprotein with particular
properties of a transcription factor [68,69]. In serumdeprived
cultures, cells overexpressing c-myc readily
undergo apoptosis. In addition, deregulation of c-myc
causes apoptosis of VSMCs deprived of growth factors or
treated with cytokines such as interferon-g [70]."
"1347","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"The proto-oncogene c-myc can
promote cell death (probably mediated through p53) or
cell proliferation, depending on its expression level. It
functions as a nuclear phosphoprotein with particular
properties of a transcription factor [68,69]. In serumdeprived
cultures, cells overexpressing c-myc readily
undergo apoptosis. In addition, deregulation of c-myc
causes apoptosis of VSMCs deprived of growth factors or
treated with cytokines such as interferon-g [70]."
"1348","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"Tissue factor (TF) is a 47 kDa transmembrane glycoprotein
that initiates blood coagulation by binding
coagulation factor VII and its activated form (factor
VIIa), to produce a high-affinity complex [72] that
proteolytically activates factors IX and X, leading to
thrombin generation."
"1349","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"Tissue factor (TF) is a 47 kDa transmembrane glycoprotein
that initiates blood coagulation by binding
coagulation factor VII and its activated form (factor
VIIa), to produce a high-affinity complex [72] that
proteolytically activates factors IX and X, leading to
thrombin generation."
"1350","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"Tissue factor (TF) is a 47 kDa transmembrane glycoprotein
that initiates blood coagulation by binding
coagulation factor VII and its activated form (factor
VIIa), to produce a high-affinity complex [72] that
proteolytically activates factors IX and X, leading to
thrombin generation."
"1351","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"Tissue factor (TF) is a 47 kDa transmembrane glycoprotein
that initiates blood coagulation by binding
coagulation factor VII and its activated form (factor
VIIa), to produce a high-affinity complex [72] that
proteolytically activates factors IX and X, leading to
thrombin generation."
"1352","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"TF works at the surface of cell
membranes, and its activity is highly dependent on the
presence of phosphatidylserine (PS), an anionic phospholipid
that is redistributed on the cell surface during
apoptotic death and confers a potent pro-coagulant activity
to the apoptotic cell [74]."
"1353","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"TF works at the surface of cell
membranes, and its activity is highly dependent on the
presence of phosphatidylserine (PS), an anionic phospholipid
that is redistributed on the cell surface during
apoptotic death and confers a potent pro-coagulant activity
to the apoptotic cell [74]."
"1354","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"TF works at the surface of cell
membranes, and its activity is highly dependent on the
presence of phosphatidylserine (PS), an anionic phospholipid
that is redistributed on the cell surface during
apoptotic death and confers a potent pro-coagulant activity
to the apoptotic cell [74]."
"1355","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:decreases","false",,,"TIMP-3 can be anti-angiogenic by direct binding to vascular
endothelial growth factor (VEGF) receptor 2 in a matrix-metalloproteinase-
independent manner [94]."
"1356","de Nigris FLerman AIgnarro LJWilliams-Ignarro SSica VBaker AHLerman LOGeng YJNapoli C","12928037","Trends in molecular medicine","PubMed",,,"bel:decreases","false",,,"TIMP-3 can be anti-angiogenic by direct binding to vascular
endothelial growth factor (VEGF) receptor 2 in a matrix-metalloproteinase-
independent manner [94]."
"1357","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"Phosphorylation at Ser473, along with Thr308 of its activation loop, is deemed necessary for Akt function, although the regulatory mechanisms and physiological importance of each phosphorylation site remain to be fully understood."
"1358","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"Phosphorylation at Ser473, along with Thr308 of its activation loop, is deemed necessary for Akt function, although the regulatory mechanisms and physiological importance of each phosphorylation site remain to be fully understood."
"1359","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:increases","false",,,"Genetic ablation of sin1 abolished Akt-Ser473 phosphorylation and disrupted rictor-mTOR interaction but maintained Thr308 phosphorylation."
"1360","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:increases","false",,,"We next examined the Akt T-loop Thr308 phosphorylation
in wild-type and SIN1-/- cells. We found that although
Ser473 phosphorylation was completely abolished in the
SIN1-/- cells, Thr308 phosphorylation of Akt was not
blocked (Figure 3A)."
"1361","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:causesNoChange","false",,,"We next examined the Akt T-loop Thr308 phosphorylation
in wild-type and SIN1-/- cells. We found that although
Ser473 phosphorylation was completely abolished in the
SIN1-/- cells, Thr308 phosphorylation of Akt was not
blocked (Figure 3A)."
"1362","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"We also examined phosphorylation of TSC2, another
Akt target (Manning et al., 2002), at the Akt target sites
Ser939 and Thr1462 and found no significant difference
between wild-type and SIN1-/- cells upon serum and
insulin stimulation (Figure 3C)."
"1363","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"We also examined phosphorylation of TSC2, another
Akt target (Manning et al., 2002), at the Akt target sites
Ser939 and Thr1462 and found no significant difference
between wild-type and SIN1-/- cells upon serum and
insulin stimulation (Figure 3C)."
"1364","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:increases","false",,,"To identify a function that could be linked specifically to
Akt-Ser473 phosphorylation, we further examined known
Akt substrates that may have defective phosphorylation in
SIN1-/- cells. We found that phosphorylation of FoxO1/3a
(also called FKHR/FKHRL1) (Greer and Brunet, 2005), was
affected in SIN1-/- cells. In particular, phosphorylation of
FoxO1/3a at Thr24/Thr32 was significantly decreased in
the absence of SIN1 under normal growing and restimulated
conditions (Figure 4A)."
"1365","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:increases","false",,,"To identify a function that could be linked specifically to
Akt-Ser473 phosphorylation, we further examined known
Akt substrates that may have defective phosphorylation in
SIN1-/- cells. We found that phosphorylation of FoxO1/3a
(also called FKHR/FKHRL1) (Greer and Brunet, 2005), was
affected in SIN1-/- cells. In particular, phosphorylation of
FoxO1/3a at Thr24/Thr32 was significantly decreased in
the absence of SIN1 under normal growing and restimulated
conditions (Figure 4A)."
"1366","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"To identify a function that could be linked specifically to
Akt-Ser473 phosphorylation, we further examined known
Akt substrates that may have defective phosphorylation in
SIN1-/- cells. We found that phosphorylation of FoxO1/3a
(also called FKHR/FKHRL1) (Greer and Brunet, 2005), was
affected in SIN1-/- cells. In particular, phosphorylation of
FoxO1/3a at Thr24/Thr32 was significantly decreased in
the absence of SIN1 under normal growing and restimulated
conditions (Figure 4A)."
"1367","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"To identify a function that could be linked specifically to
Akt-Ser473 phosphorylation, we further examined known
Akt substrates that may have defective phosphorylation in
SIN1-/- cells. We found that phosphorylation of FoxO1/3a
(also called FKHR/FKHRL1) (Greer and Brunet, 2005), was
affected in SIN1-/- cells. In particular, phosphorylation of
FoxO1/3a at Thr24/Thr32 was significantly decreased in
the absence of SIN1 under normal growing and restimulated
conditions (Figure 4A)."
"1368","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"We also found that the recombinant FoxO1 could not be phosphorylated at
Thr24/32 in vitro by an Akt mutant harboring an alanine
mutation in either Thr308 or Ser473, whereas a Ser473
to Ala mutated Akt could still phosphorylate recombinant
GSK3 (Figure S2). These results indicate that Akt-Ser473
phosphorylation is required for FoxO1/3a phosphorylation
at Thr24/32."
"1369","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"We also found that the recombinant FoxO1 could not be phosphorylated at
Thr24/32 in vitro by an Akt mutant harboring an alanine
mutation in either Thr308 or Ser473, whereas a Ser473
to Ala mutated Akt could still phosphorylate recombinant
GSK3 (Figure S2). These results indicate that Akt-Ser473
phosphorylation is required for FoxO1/3a phosphorylation
at Thr24/32."
"1370","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"We also found that the recombinant FoxO1 could not be phosphorylated at
Thr24/32 in vitro by an Akt mutant harboring an alanine
mutation in either Thr308 or Ser473, whereas a Ser473
to Ala mutated Akt could still phosphorylate recombinant
GSK3 (Figure S2). These results indicate that Akt-Ser473
phosphorylation is required for FoxO1/3a phosphorylation
at Thr24/32."
"1371","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"We also found that the recombinant FoxO1 could not be phosphorylated at
Thr24/32 in vitro by an Akt mutant harboring an alanine
mutation in either Thr308 or Ser473, whereas a Ser473
to Ala mutated Akt could still phosphorylate recombinant
GSK3 (Figure S2). These results indicate that Akt-Ser473
phosphorylation is required for FoxO1/3a phosphorylation
at Thr24/32."
"1372","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"We also found that the recombinant FoxO1 could not be phosphorylated at
Thr24/32 in vitro by an Akt mutant harboring an alanine
mutation in either Thr308 or Ser473, whereas a Ser473
to Ala mutated Akt could still phosphorylate recombinant
GSK3 (Figure S2). These results indicate that Akt-Ser473
phosphorylation is required for FoxO1/3a phosphorylation
at Thr24/32."
"1373","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:decreases","false",,,"In etoposide-
treated cells, there was a 2-fold increase in the
number of cells that underwent apoptosis after 48 hr in
SIN1 knockouts (Figure 4D). Thus, we find that the
SIN1-/- cells were more sensitive to stress-induced apoptosis,
suggesting that Akt-Ser473 phosphorylation plays
an important role in cell survival (Figures 4C and 4D)."
"1374","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"The phosphorylation of S6K at Thr389,
which is the TORC1-mediated site, was not inhibited in
the SIN1-/- cells (Figure 5A)."
"1375","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"Likewise, phosphorylation of another translational regulator, 4EBP1, at the mTOR target site Thr37/46 (Gingras et al.,1999), was also not impaired in SIN1-/- cells (Figure 5A)."
"1376","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"Likewise, phosphorylation of another translational regulator, 4EBP1, at the mTOR target site Thr37/46 (Gingras et al.,1999), was also not impaired in SIN1-/- cells (Figure 5A)."
"1377","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"Likewise, phosphorylation of another translational regulator, 4EBP1, at the mTOR target site Thr37/46 (Gingras et al.,1999), was also not impaired in SIN1-/- cells (Figure 5A)."
"1378","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyIncreases","false",,,"Likewise, phosphorylation of another translational regulator, 4EBP1, at the mTOR target site Thr37/46 (Gingras et al.,1999), was also not impaired in SIN1-/- cells (Figure 5A)."
"1379","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:increases","false",,,"Akt Ser473 was strongly induced in wild-type cells by different
growth factors such as the platelet-derived growth
factor, epidermal growth factor, and insulin, even in the
absence of amino acids and glucose (Figure 5B). In
SIN1-/- cells, Akt-Ser473 phosphorylation was not induced
by any type of stimulus."
"1380","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:increases","false",,,"Akt Ser473 was strongly induced in wild-type cells by different
growth factors such as the platelet-derived growth
factor, epidermal growth factor, and insulin, even in the
absence of amino acids and glucose (Figure 5B). In
SIN1-/- cells, Akt-Ser473 phosphorylation was not induced
by any type of stimulus."
"1381","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:increases","false",,,"Akt Ser473 was strongly induced in wild-type cells by different
growth factors such as the platelet-derived growth
factor, epidermal growth factor, and insulin, even in the
absence of amino acids and glucose (Figure 5B). In
SIN1-/- cells, Akt-Ser473 phosphorylation was not induced
by any type of stimulus."
"1382","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:increases","false",,,"Akt Ser473 was strongly induced in wild-type cells by different
growth factors such as the platelet-derived growth
factor, epidermal growth factor, and insulin, even in the
absence of amino acids and glucose (Figure 5B). In
SIN1-/- cells, Akt-Ser473 phosphorylation was not induced
by any type of stimulus."
"1383","Jacinto EFacchinetti VLiu DSoto NWei SJung SYHuang QQin JSu B","16962653","Cell","PubMed",,,"bel:directlyDecreases","false",,,"Akt has been well characterized as a prosurvival molecule,
and part of this function is mediated through its suppression
of the activity of the FoxO proteins (Greer and Brunet,
2005)."
"1384","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:negativeCorrelation","false",,,"For example, the inactivation
of VHL has been demonstrated in 70–80% of all
sporadic clear cell RCC, the major form of RCC, which
accounts for w2% of all cancer deaths worldwide [8]."
"1385","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"In
this setting, pVHL targets the a-subunits of hypoxiainducible
factor (HIF) for ubiquitin-mediated proteolysis
under normal oxygen conditions [18]."
"1386","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"In
this setting, pVHL targets the a-subunits of hypoxiainducible
factor (HIF) for ubiquitin-mediated proteolysis
under normal oxygen conditions [18]."
"1387","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"In
this setting, pVHL targets the a-subunits of hypoxiainducible
factor (HIF) for ubiquitin-mediated proteolysis
under normal oxygen conditions [18]."
"1388","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"The stabilization of HIF in response to hypoxia
involves the inactivation of prolylhydroxylases that
modify HIF at specific proline residues in an oxygendependent
manner. Proline hydroxylation marks HIF for
degradation by the VCB–Cul2 E3 ligase complex (Figure 3
and Box 1)."
"1389","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"The stabilization of HIF in response to hypoxia
involves the inactivation of prolylhydroxylases that
modify HIF at specific proline residues in an oxygendependent
manner. Proline hydroxylation marks HIF for
degradation by the VCB–Cul2 E3 ligase complex (Figure 3
and Box 1)."
"1390","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"The VHL-mediated proteolytic degradation of HIF
suppresses a transcription programme that is normally
engaged by HIF as part of the adaptive response of the cell
to hypoxia, such as the activation of vascular endothelial
growth factor (VEGF), which is a potent angiogenic factor
that is involved in the formation and differentiation of
blood vessels."
"1391","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"The VHL-mediated proteolytic degradation of HIF
suppresses a transcription programme that is normally
engaged by HIF as part of the adaptive response of the cell
to hypoxia, such as the activation of vascular endothelial
growth factor (VEGF), which is a potent angiogenic factor
that is involved in the formation and differentiation of
blood vessels."
"1392","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"The VHL-mediated proteolytic degradation of HIF
suppresses a transcription programme that is normally
engaged by HIF as part of the adaptive response of the cell
to hypoxia, such as the activation of vascular endothelial
growth factor (VEGF), which is a potent angiogenic factor
that is involved in the formation and differentiation of
blood vessels."
"1393","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyDecreases","false",,,"Transcriptional control is also maintained by a specific acetylation
(Ac) event at lysine 532 and an additional asparagine hydroxylation (OH) event at
position 863, both of which act as negative regulators of the transcriptional activity
of HIF."
"1394","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyDecreases","false",,,"Transcriptional control is also maintained by a specific acetylation
(Ac) event at lysine 532 and an additional asparagine hydroxylation (OH) event at
position 863, both of which act as negative regulators of the transcriptional activity
of HIF."
"1395","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:negativeCorrelation","false",,,"highly vascular phenotype of
VHL-null tumours."
"1396","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"The inhibition of HIF-2a expression by
siRNA inhibits the growth of VHL-negative tumours [20].
Furthermore, the re-introduction of a degradation-resistant
mutant of HIF-2a into RCC cells ectopically expressing
pVHL abolishes the ability of VHL to suppress the
growth of these cell lines [21]."
"1397","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two proline residues on the HIF polypeptide mediates
interactions between the b-domain of the von Hippel–Lindau protein
(pVHL) and HIF [60]. Each site can interact independently with pVHL,
potentially contributing to the extremely rapid proteolysis of HIF-a that
is observed under normoxic conditions. These sites contain a
conserved LxxLAP motif and are targeted by proline hydroxylases
(PHD) that, in mammalian cells, are provided by three isoforms
termed PHD 1–3 [61]."
"1398","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two proline residues on the HIF polypeptide mediates
interactions between the b-domain of the von Hippel–Lindau protein
(pVHL) and HIF [60]. Each site can interact independently with pVHL,
potentially contributing to the extremely rapid proteolysis of HIF-a that
is observed under normoxic conditions. These sites contain a
conserved LxxLAP motif and are targeted by proline hydroxylases
(PHD) that, in mammalian cells, are provided by three isoforms
termed PHD 1–3 [61]."
"1399","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two proline residues on the HIF polypeptide mediates
interactions between the b-domain of the von Hippel–Lindau protein
(pVHL) and HIF [60]. Each site can interact independently with pVHL,
potentially contributing to the extremely rapid proteolysis of HIF-a that
is observed under normoxic conditions. These sites contain a
conserved LxxLAP motif and are targeted by proline hydroxylases
(PHD) that, in mammalian cells, are provided by three isoforms
termed PHD 1–3 [61]."
"1400","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two proline residues on the HIF polypeptide mediates
interactions between the b-domain of the von Hippel–Lindau protein
(pVHL) and HIF [60]. Each site can interact independently with pVHL,
potentially contributing to the extremely rapid proteolysis of HIF-a that
is observed under normoxic conditions. These sites contain a
conserved LxxLAP motif and are targeted by proline hydroxylases
(PHD) that, in mammalian cells, are provided by three isoforms
termed PHD 1–3 [61]."
"1401","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"Hydroxylation at two proline residues on the HIF polypeptide mediates
interactions between the b-domain of the von Hippel–Lindau protein
(pVHL) and HIF [60]. Each site can interact independently with pVHL,
potentially contributing to the extremely rapid proteolysis of HIF-a that
is observed under normoxic conditions. These sites contain a
conserved LxxLAP motif and are targeted by proline hydroxylases
(PHD) that, in mammalian cells, are provided by three isoforms
termed PHD 1–3 [61]."
"1402","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyDecreases","false",,,"In a second hydroxylation-dependent control,
b-hydroxylation of an asparaginyl residue in the C-terminal activation
domain of HIF-a (N803 in human HIF-1a) is regulated by a HIF
asparaginyl hydroxylase called FIH (factor inhibiting HIF) [62,63].
Hydroxylation at this site prevents the binding of the transcriptional
co-activators p300/CBP (CREB binding protein). Under normoxic
conditions, these hydroxylation reactions provide a dual mechanism
for HIF inactivation that involves proteolytic destruction and the
inhibition of transcriptional activity [64]."
"1403","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyDecreases","false",,,"In a second hydroxylation-dependent control,
b-hydroxylation of an asparaginyl residue in the C-terminal activation
domain of HIF-a (N803 in human HIF-1a) is regulated by a HIF
asparaginyl hydroxylase called FIH (factor inhibiting HIF) [62,63].
Hydroxylation at this site prevents the binding of the transcriptional
co-activators p300/CBP (CREB binding protein). Under normoxic
conditions, these hydroxylation reactions provide a dual mechanism
for HIF inactivation that involves proteolytic destruction and the
inhibition of transcriptional activity [64]."
"1404","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"In a second hydroxylation-dependent control,
b-hydroxylation of an asparaginyl residue in the C-terminal activation
domain of HIF-a (N803 in human HIF-1a) is regulated by a HIF
asparaginyl hydroxylase called FIH (factor inhibiting HIF) [62,63].
Hydroxylation at this site prevents the binding of the transcriptional
co-activators p300/CBP (CREB binding protein). Under normoxic
conditions, these hydroxylation reactions provide a dual mechanism
for HIF inactivation that involves proteolytic destruction and the
inhibition of transcriptional activity [64]."
"1405","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"In a second hydroxylation-dependent control,
b-hydroxylation of an asparaginyl residue in the C-terminal activation
domain of HIF-a (N803 in human HIF-1a) is regulated by a HIF
asparaginyl hydroxylase called FIH (factor inhibiting HIF) [62,63].
Hydroxylation at this site prevents the binding of the transcriptional
co-activators p300/CBP (CREB binding protein). Under normoxic
conditions, these hydroxylation reactions provide a dual mechanism
for HIF inactivation that involves proteolytic destruction and the
inhibition of transcriptional activity [64]."
"1406","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"In a second hydroxylation-dependent control,
b-hydroxylation of an asparaginyl residue in the C-terminal activation
domain of HIF-a (N803 in human HIF-1a) is regulated by a HIF
asparaginyl hydroxylase called FIH (factor inhibiting HIF) [62,63].
Hydroxylation at this site prevents the binding of the transcriptional
co-activators p300/CBP (CREB binding protein). Under normoxic
conditions, these hydroxylation reactions provide a dual mechanism
for HIF inactivation that involves proteolytic destruction and the
inhibition of transcriptional activity [64]."
"1407","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"These hydroxylases are all
Fe(II)- and 2-oxoglutarate-dependent dioxygenases that require molecular
oxygen. Therefore, HIFa becomes stabilized under hypoxic
conditions in which oxygen availability is low."
"1408","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"These hydroxylases are all
Fe(II)- and 2-oxoglutarate-dependent dioxygenases that require molecular
oxygen. Therefore, HIFa becomes stabilized under hypoxic
conditions in which oxygen availability is low."
"1409","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"These hydroxylases are all
Fe(II)- and 2-oxoglutarate-dependent dioxygenases that require molecular
oxygen. Therefore, HIFa becomes stabilized under hypoxic
conditions in which oxygen availability is low."
"1410","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"These hydroxylases are all
Fe(II)- and 2-oxoglutarate-dependent dioxygenases that require molecular
oxygen. Therefore, HIFa becomes stabilized under hypoxic
conditions in which oxygen availability is low."
"1411","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"These hydroxylases are all
Fe(II)- and 2-oxoglutarate-dependent dioxygenases that require molecular
oxygen. Therefore, HIFa becomes stabilized under hypoxic
conditions in which oxygen availability is low."
"1412","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"These hydroxylases are all
Fe(II)- and 2-oxoglutarate-dependent dioxygenases that require molecular
oxygen. Therefore, HIFa becomes stabilized under hypoxic
conditions in which oxygen availability is low."
"1413","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"These hydroxylases are all
Fe(II)- and 2-oxoglutarate-dependent dioxygenases that require molecular
oxygen. Therefore, HIFa becomes stabilized under hypoxic
conditions in which oxygen availability is low."
"1414","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"These hydroxylases are all
Fe(II)- and 2-oxoglutarate-dependent dioxygenases that require molecular
oxygen. Therefore, HIFa becomes stabilized under hypoxic
conditions in which oxygen availability is low."
"1415","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"These hydroxylases are all
Fe(II)- and 2-oxoglutarate-dependent dioxygenases that require molecular
oxygen. Therefore, HIFa becomes stabilized under hypoxic
conditions in which oxygen availability is low."
"1416","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"These hydroxylases are all
Fe(II)- and 2-oxoglutarate-dependent dioxygenases that require molecular
oxygen. Therefore, HIFa becomes stabilized under hypoxic
conditions in which oxygen availability is low."
"1417","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"These hydroxylases are all
Fe(II)- and 2-oxoglutarate-dependent dioxygenases that require molecular
oxygen. Therefore, HIFa becomes stabilized under hypoxic
conditions in which oxygen availability is low."
"1418","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"These hydroxylases are all
Fe(II)- and 2-oxoglutarate-dependent dioxygenases that require molecular
oxygen. Therefore, HIFa becomes stabilized under hypoxic
conditions in which oxygen availability is low."
"1419","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"These hydroxylases are all
Fe(II)- and 2-oxoglutarate-dependent dioxygenases that require molecular
oxygen. Therefore, HIFa becomes stabilized under hypoxic
conditions in which oxygen availability is low."
"1420","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"Furthermore, an
acetyltransferase, ARD1, acetylates K532, a residue previously
shown to result in HIFa stability, thereby negatively regulating it
[65]. Jab1, a transcriptional co-activator, has been shown to positively
regulate HIFa [66]."
"1421","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"Furthermore, an
acetyltransferase, ARD1, acetylates K532, a residue previously
shown to result in HIFa stability, thereby negatively regulating it
[65]. Jab1, a transcriptional co-activator, has been shown to positively
regulate HIFa [66]."
"1422","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"Furthermore, an
acetyltransferase, ARD1, acetylates K532, a residue previously
shown to result in HIFa stability, thereby negatively regulating it
[65]. Jab1, a transcriptional co-activator, has been shown to positively
regulate HIFa [66]."
"1423","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"Furthermore, an
acetyltransferase, ARD1, acetylates K532, a residue previously
shown to result in HIFa stability, thereby negatively regulating it
[65]. Jab1, a transcriptional co-activator, has been shown to positively
regulate HIFa [66]."
"1424","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:negativeCorrelation","false",,,"RCC cells
lacking functional pVHL overexpress various growth
factors, including platelet-derived growth factor b
(PDGFb), VEGF and transforming growth factor
(TGF)-a [25]. The latter is a bona fide renal-cell mitogen
that activates the Ras–Raf–MAP kinase signalling
cascade through its cognate epidermal growth factor
(EGF) cell-surface receptor [26]."
"1425","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:negativeCorrelation","false",,,"RCC cells
lacking functional pVHL overexpress various growth
factors, including platelet-derived growth factor b
(PDGFb), VEGF and transforming growth factor
(TGF)-a [25]. The latter is a bona fide renal-cell mitogen
that activates the Ras–Raf–MAP kinase signalling
cascade through its cognate epidermal growth factor
(EGF) cell-surface receptor [26]."
"1426","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:negativeCorrelation","false",,,"RCC cells
lacking functional pVHL overexpress various growth
factors, including platelet-derived growth factor b
(PDGFb), VEGF and transforming growth factor
(TGF)-a [25]. The latter is a bona fide renal-cell mitogen
that activates the Ras–Raf–MAP kinase signalling
cascade through its cognate epidermal growth factor
(EGF) cell-surface receptor [26]."
"1427","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"RCC cells
lacking functional pVHL overexpress various growth
factors, including platelet-derived growth factor b
(PDGFb), VEGF and transforming growth factor
(TGF)-a [25]. The latter is a bona fide renal-cell mitogen
that activates the Ras–Raf–MAP kinase signalling
cascade through its cognate epidermal growth factor
(EGF) cell-surface receptor [26]."
"1428","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"RCC cells
lacking functional pVHL overexpress various growth
factors, including platelet-derived growth factor b
(PDGFb), VEGF and transforming growth factor
(TGF)-a [25]. The latter is a bona fide renal-cell mitogen
that activates the Ras–Raf–MAP kinase signalling
cascade through its cognate epidermal growth factor
(EGF) cell-surface receptor [26]."
"1429","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"RCC cells
lacking functional pVHL overexpress various growth
factors, including platelet-derived growth factor b
(PDGFb), VEGF and transforming growth factor
(TGF)-a [25]. The latter is a bona fide renal-cell mitogen
that activates the Ras–Raf–MAP kinase signalling
cascade through its cognate epidermal growth factor
(EGF) cell-surface receptor [26]."
"1430","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"The overproduction of
TGF-a in RCC cells is, at least in part, HIF-dependent and
a major contributory event that confers a growth advantage
to these cells [25,27]."
"1431","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"The overproduction of
TGF-a in RCC cells is, at least in part, HIF-dependent and
a major contributory event that confers a growth advantage
to these cells [25,27]."
"1432","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"tumour necrosis factor (TNF)-a has been shown to
promote HIF-1a accumulation, and this might involve a
VHL-dependent step [33,34]."
"1433","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"In particular, it
has been reported that RCC cells can be sensitized to
TNF-a-induced cytotoxicity by re-introducing wild-type
VHL [38]. The authors highlight the fact that TNFreceptor
engagement by TNF-a triggers the activation of
atypical protein kinase C (aPKC), which, through IKKb
phosphorylation, liberates NFkB, thereby initiating the
transcription of genes that are involved in apoptosis"
"1434","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"In particular, it
has been reported that RCC cells can be sensitized to
TNF-a-induced cytotoxicity by re-introducing wild-type
VHL [38]. The authors highlight the fact that TNFreceptor
engagement by TNF-a triggers the activation of
atypical protein kinase C (aPKC), which, through IKKb
phosphorylation, liberates NFkB, thereby initiating the
transcription of genes that are involved in apoptosis"
"1435","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"In particular, it
has been reported that RCC cells can be sensitized to
TNF-a-induced cytotoxicity by re-introducing wild-type
VHL [38]. The authors highlight the fact that TNFreceptor
engagement by TNF-a triggers the activation of
atypical protein kinase C (aPKC), which, through IKKb
phosphorylation, liberates NFkB, thereby initiating the
transcription of genes that are involved in apoptosis"
"1436","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"In particular, it
has been reported that RCC cells can be sensitized to
TNF-a-induced cytotoxicity by re-introducing wild-type
VHL [38]. The authors highlight the fact that TNFreceptor
engagement by TNF-a triggers the activation of
atypical protein kinase C (aPKC), which, through IKKb
phosphorylation, liberates NFkB, thereby initiating the
transcription of genes that are involved in apoptosis"
"1437","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"pVHL
has been shown to bind directly to various aPKC isoforms
and to target aPKCl for ubiquitin-mediated degradation
[39,40]."
"1438","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:association","false",,,"pVHL has also been implicated in tumour invasion and
metastasis, which represent complex multi-step processes
that require the proteolytic degradation of the basement
membrane and tissue matrix, changes in cell polarity and
motility, and the attachment and detachment of cells to
and from the extracellular matrix (ECM) [41]."
"1439","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:association","false",,,"pVHL has also been implicated in tumour invasion and
metastasis, which represent complex multi-step processes
that require the proteolytic degradation of the basement
membrane and tissue matrix, changes in cell polarity and
motility, and the attachment and detachment of cells to
and from the extracellular matrix (ECM) [41]."
"1440","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"Nevertheless, the
restored ability of pVHL-positive transfectants to assemble
extracellular fibronectin was mediated by b1 integrins,
implying that pVHL controls ECM assembly, at least in
part, through integrin signalling [46]. A recent development
has demonstrated that an ubiquitin-like molecule,
NEDD8, covalently modifies pVHL and that a neddylation-
defective pVHL mutant, despite retaining its ability
to degrade HIF, fails to promote the assembly of a
fibronectin matrix [47]."
"1441","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyDecreases","false",,,"The regulation of insulin growth factor (IGF)-I-mediated
cell invasion of RCC cells appears to be dependent upon
PKCd inhibition by pVHL. This inhibition is mediated
through a protein–protein interaction involving a domain
of pVHL that shows similarity to protein kinase inhibitor
(PKI), a natural inhibitor of cAMP-dependent protein
kinase (PKA) [48]"
"1442","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"The regulation of insulin growth factor (IGF)-I-mediated
cell invasion of RCC cells appears to be dependent upon
PKCd inhibition by pVHL. This inhibition is mediated
through a protein–protein interaction involving a domain
of pVHL that shows similarity to protein kinase inhibitor
(PKI), a natural inhibitor of cAMP-dependent protein
kinase (PKA) [48]"
"1443","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"In contrast to protein-binding inhibition,
evidence has shown that pVHL binds to both
atypical PKC isoforms (l and z) through its b-domain, and
in the case of activated aPKCl, mediates its turnover as
part of the E3-ligase function of pVHL [39,40]. Although
the functional significance of this inhibition remains
elusive, given the central role for atypical PKCs
(especially aPKCz) in establishing cell polarity in conjunction
with PAR6 and the GTPase CDC42 [49], one
could envisage a scenario whereby the loss of pVHL leads
to altered cell polarity and, by extension, aberrant cell
migration."
"1444","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"In contrast to protein-binding inhibition,
evidence has shown that pVHL binds to both
atypical PKC isoforms (l and z) through its b-domain, and
in the case of activated aPKCl, mediates its turnover as
part of the E3-ligase function of pVHL [39,40]. Although
the functional significance of this inhibition remains
elusive, given the central role for atypical PKCs
(especially aPKCz) in establishing cell polarity in conjunction
with PAR6 and the GTPase CDC42 [49], one
could envisage a scenario whereby the loss of pVHL leads
to altered cell polarity and, by extension, aberrant cell
migration."
"1445","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"Consistent with this, pVHL30 has been shown to
co-localize with the microtubule network in vivo and to
promote microtubule stabilization [12]. Because microtubule
dynamics have been intimately linked to the
process of directed cell migration [49],"
"1446","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"This same study
demonstrated that the loss of VHL function negatively
regulates tissue inhibitor of metalloproteinase 2 (TIMP-2),
resulting in the upregulation of matrix metalloproteinase
2 (MMP2) and MMP9, thereby implicating pVHL in the
control of these molecules."
"1447","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:decreases","false",,,"This same study
demonstrated that the loss of VHL function negatively
regulates tissue inhibitor of metalloproteinase 2 (TIMP-2),
resulting in the upregulation of matrix metalloproteinase
2 (MMP2) and MMP9, thereby implicating pVHL in the
control of these molecules."
"1448","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:decreases","false",,,"This same study
demonstrated that the loss of VHL function negatively
regulates tissue inhibitor of metalloproteinase 2 (TIMP-2),
resulting in the upregulation of matrix metalloproteinase
2 (MMP2) and MMP9, thereby implicating pVHL in the
control of these molecules."
"1449","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"Importantly, it has been demonstrated that hypoxia
promotes tumour cell invasion by inducing the expression
of the Met receptor [54]. This establishes a mechanism
whereby transformed cells can be spurred to exit a hypoxic
microenvironment and invade the surrounding tissues,
which provide more favourable growth conditions.
Because HIF-1a is involved in Met gene expression, the
constitutive activation of HIF-1a as a consequence of
pVHL deregulation provides a mechanism explaining the
observation that the expression of HGF and Met receptor
is associated with genetic alterations of VHL in primary
RCC."
"1450","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"Importantly, it has been demonstrated that hypoxia
promotes tumour cell invasion by inducing the expression
of the Met receptor [54]. This establishes a mechanism
whereby transformed cells can be spurred to exit a hypoxic
microenvironment and invade the surrounding tissues,
which provide more favourable growth conditions.
Because HIF-1a is involved in Met gene expression, the
constitutive activation of HIF-1a as a consequence of
pVHL deregulation provides a mechanism explaining the
observation that the expression of HGF and Met receptor
is associated with genetic alterations of VHL in primary
RCC."
"1451","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:association","false",,,"Importantly, it has been demonstrated that hypoxia
promotes tumour cell invasion by inducing the expression
of the Met receptor [54]. This establishes a mechanism
whereby transformed cells can be spurred to exit a hypoxic
microenvironment and invade the surrounding tissues,
which provide more favourable growth conditions.
Because HIF-1a is involved in Met gene expression, the
constitutive activation of HIF-1a as a consequence of
pVHL deregulation provides a mechanism explaining the
observation that the expression of HGF and Met receptor
is associated with genetic alterations of VHL in primary
RCC."
"1452","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:association","false",,,"Importantly, it has been demonstrated that hypoxia
promotes tumour cell invasion by inducing the expression
of the Met receptor [54]. This establishes a mechanism
whereby transformed cells can be spurred to exit a hypoxic
microenvironment and invade the surrounding tissues,
which provide more favourable growth conditions.
Because HIF-1a is involved in Met gene expression, the
constitutive activation of HIF-1a as a consequence of
pVHL deregulation provides a mechanism explaining the
observation that the expression of HGF and Met receptor
is associated with genetic alterations of VHL in primary
RCC."
"1453","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:decreases","false",,,"The gene encoding the chemokine receptor CXCR4 has
been discovered as a novel HIF target based on a
microarray comparison of genetic profiles derived from
VHL-null RCC cells and their isogenic wild-type VHLexpressing
counterparts [52]."
"1454","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"The fact that CXCR4 is a hypoxia-inducible gene
provided a potential mechanistic explanation for CXCR4
upregulation during tumour cell evolution. CXCR4-
induced cell-surface expression due to the loss of VHL
function confers enhanced migratory potential to RCC
cells in response to its cognate ligand stromal-derived
factor 1 (SDF1)."
"1455","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:decreases","false",,,"The fact that CXCR4 is a hypoxia-inducible gene
provided a potential mechanistic explanation for CXCR4
upregulation during tumour cell evolution. CXCR4-
induced cell-surface expression due to the loss of VHL
function confers enhanced migratory potential to RCC
cells in response to its cognate ligand stromal-derived
factor 1 (SDF1)."
"1456","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:directlyIncreases","false",,,"The fact that CXCR4 is a hypoxia-inducible gene
provided a potential mechanistic explanation for CXCR4
upregulation during tumour cell evolution. CXCR4-
induced cell-surface expression due to the loss of VHL
function confers enhanced migratory potential to RCC
cells in response to its cognate ligand stromal-derived
factor 1 (SDF1)."
"1457","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:increases","false",,,"The fact that CXCR4 is a hypoxia-inducible gene
provided a potential mechanistic explanation for CXCR4
upregulation during tumour cell evolution. CXCR4-
induced cell-surface expression due to the loss of VHL
function confers enhanced migratory potential to RCC
cells in response to its cognate ligand stromal-derived
factor 1 (SDF1)."
"1458","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:decreases","false",,,"Figure 4. The role of hypoxia-inducible factor (HIF) in conferring tumour growth
potential. In solid tumours, HIFa is stabilised under conditions of low oxygen due to
a lack of vascularisation and the subsequent evolution of a hypoxic microenvironment.
In a VHL-null tumour, HIFa is constitutively active, and can initiate genetic
programmes within the entire population of cells that would normally be activated
only under hypoxic conditions."
"1459","Barry REKrek W","15350900","Trends in molecular medicine","PubMed",,,"bel:decreases","false",,,"Figure 4. The role of hypoxia-inducible factor (HIF) in conferring tumour growth
potential. In solid tumours, HIFa is stabilised under conditions of low oxygen due to
a lack of vascularisation and the subsequent evolution of a hypoxic microenvironment.
In a VHL-null tumour, HIFa is constitutively active, and can initiate genetic
programmes within the entire population of cells that would normally be activated
only under hypoxic conditions."
"1460","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"These modifications render Ras functional and capable of localizing to the lipid-rich inner surface of the cell membrane. The first and most critical modification, farnesylation, which is principally catalyzed by protein FTase, adds a 15-carbon hydrobobic farnesyl isoprenyl tail to the carboxyl terminus of Ras."
"1461","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"These modifications render Ras functional and capable of localizing to the lipid-rich inner surface of the cell membrane. The first and most critical modification, farnesylation, which is principally catalyzed by protein FTase, adds a 15-carbon hydrobobic farnesyl isoprenyl tail to the carboxyl terminus of Ras."
"1462","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:positiveCorrelation","false",,,"The considerable attention paid to targeting Ras as a therapeutic strategy is based on the high incidence of activating ras mutations in human malignancies, including approximately 22% of non–small-cell lung, 50% of colorectal, and 90% of pancreatic cancers.53,60,61 "
"1463","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:positiveCorrelation","false",,,"The considerable attention paid to targeting Ras as a therapeutic strategy is based on the high incidence of activating ras mutations in human malignancies, including approximately 22% of non–small-cell lung, 50% of colorectal, and 90% of pancreatic cancers.53,60,61 "
"1464","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:positiveCorrelation","false",,,"The considerable attention paid to targeting Ras as a therapeutic strategy is based on the high incidence of activating ras mutations in human malignancies, including approximately 22% of non–small-cell lung, 50% of colorectal, and 90% of pancreatic cancers.53,60,61 "
"1465","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Localization of GTP-bound Ras to the inner surface of the cell membrane activates several downstream effectors, most notably the serine/threonine kinase Raf, which is the first signaling element in the MAPK pathway.2,67,68 As shown in Figure 1, other downstream effectors of Ras include the PI3K cell survival pathway, the small GTP-binding proteins Rac and Rho, and the stress-activated protein kinase pathway (also referred to as the c-jun N-terminal kinase [JNK] pathway).69-71 In addition, in response to cellular stress and cytokine stimulation mediated through Ras, the dual-specificity p38MAPK kinases (MKK3 and MKK6) and the JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK and JNK, respectively.72-76"
"1466","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Localization of GTP-bound Ras to the inner surface of the cell membrane activates several downstream effectors, most notably the serine/threonine kinase Raf, which is the first signaling element in the MAPK pathway.2,67,68 As shown in Figure 1, other downstream effectors of Ras include the PI3K cell survival pathway, the small GTP-binding proteins Rac and Rho, and the stress-activated protein kinase pathway (also referred to as the c-jun N-terminal kinase [JNK] pathway).69-71 In addition, in response to cellular stress and cytokine stimulation mediated through Ras, the dual-specificity p38MAPK kinases (MKK3 and MKK6) and the JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK and JNK, respectively.72-76"
"1467","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Localization of GTP-bound Ras to the inner surface of the cell membrane activates several downstream effectors, most notably the serine/threonine kinase Raf, which is the first signaling element in the MAPK pathway.2,67,68 As shown in Figure 1, other downstream effectors of Ras include the PI3K cell survival pathway, the small GTP-binding proteins Rac and Rho, and the stress-activated protein kinase pathway (also referred to as the c-jun N-terminal kinase [JNK] pathway).69-71 In addition, in response to cellular stress and cytokine stimulation mediated through Ras, the dual-specificity p38MAPK kinases (MKK3 and MKK6) and the JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK and JNK, respectively.72-76"
"1468","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Localization of GTP-bound Ras to the inner surface of the cell membrane activates several downstream effectors, most notably the serine/threonine kinase Raf, which is the first signaling element in the MAPK pathway.2,67,68 As shown in Figure 1, other downstream effectors of Ras include the PI3K cell survival pathway, the small GTP-binding proteins Rac and Rho, and the stress-activated protein kinase pathway (also referred to as the c-jun N-terminal kinase [JNK] pathway).69-71 In addition, in response to cellular stress and cytokine stimulation mediated through Ras, the dual-specificity p38MAPK kinases (MKK3 and MKK6) and the JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK and JNK, respectively.72-76"
"1469","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Localization of GTP-bound Ras to the inner surface of the cell membrane activates several downstream effectors, most notably the serine/threonine kinase Raf, which is the first signaling element in the MAPK pathway.2,67,68 As shown in Figure 1, other downstream effectors of Ras include the PI3K cell survival pathway, the small GTP-binding proteins Rac and Rho, and the stress-activated protein kinase pathway (also referred to as the c-jun N-terminal kinase [JNK] pathway).69-71 In addition, in response to cellular stress and cytokine stimulation mediated through Ras, the dual-specificity p38MAPK kinases (MKK3 and MKK6) and the JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK and JNK, respectively.72-76"
"1470","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Localization of GTP-bound Ras to the inner surface of the cell membrane activates several downstream effectors, most notably the serine/threonine kinase Raf, which is the first signaling element in the MAPK pathway.2,67,68 As shown in Figure 1, other downstream effectors of Ras include the PI3K cell survival pathway, the small GTP-binding proteins Rac and Rho, and the stress-activated protein kinase pathway (also referred to as the c-jun N-terminal kinase [JNK] pathway).69-71 In addition, in response to cellular stress and cytokine stimulation mediated through Ras, the dual-specificity p38MAPK kinases (MKK3 and MKK6) and the JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK and JNK, respectively.72-76"
"1471","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Localization of GTP-bound Ras to the inner surface of the cell membrane activates several downstream effectors, most notably the serine/threonine kinase Raf, which is the first signaling element in the MAPK pathway.2,67,68 As shown in Figure 1, other downstream effectors of Ras include the PI3K cell survival pathway, the small GTP-binding proteins Rac and Rho, and the stress-activated protein kinase pathway (also referred to as the c-jun N-terminal kinase [JNK] pathway).69-71 In addition, in response to cellular stress and cytokine stimulation mediated through Ras, the dual-specificity p38MAPK kinases (MKK3 and MKK6) and the JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK and JNK, respectively.72-76"
"1472","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Localization of GTP-bound Ras to the inner surface of the cell membrane activates several downstream effectors, most notably the serine/threonine kinase Raf, which is the first signaling element in the MAPK pathway.2,67,68 As shown in Figure 1, other downstream effectors of Ras include the PI3K cell survival pathway, the small GTP-binding proteins Rac and Rho, and the stress-activated protein kinase pathway (also referred to as the c-jun N-terminal kinase [JNK] pathway).69-71 In addition, in response to cellular stress and cytokine stimulation mediated through Ras, the dual-specificity p38MAPK kinases (MKK3 and MKK6) and the JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK and JNK, respectively.72-76"
"1473","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Localization of GTP-bound Ras to the inner surface of the cell membrane activates several downstream effectors, most notably the serine/threonine kinase Raf, which is the first signaling element in the MAPK pathway.2,67,68 As shown in Figure 1, other downstream effectors of Ras include the PI3K cell survival pathway, the small GTP-binding proteins Rac and Rho, and the stress-activated protein kinase pathway (also referred to as the c-jun N-terminal kinase [JNK] pathway).69-71 In addition, in response to cellular stress and cytokine stimulation mediated through Ras, the dual-specificity p38MAPK kinases (MKK3 and MKK6) and the JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK and JNK, respectively.72-76"
"1474","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Localization of GTP-bound Ras to the inner surface of the cell membrane activates several downstream effectors, most notably the serine/threonine kinase Raf, which is the first signaling element in the MAPK pathway.2,67,68 As shown in Figure 1, other downstream effectors of Ras include the PI3K cell survival pathway, the small GTP-binding proteins Rac and Rho, and the stress-activated protein kinase pathway (also referred to as the c-jun N-terminal kinase [JNK] pathway).69-71 In addition, in response to cellular stress and cytokine stimulation mediated through Ras, the dual-specificity p38MAPK kinases (MKK3 and MKK6) and the JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK and JNK, respectively.72-76"
"1475","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Localization of GTP-bound Ras to the inner surface of the cell membrane activates several downstream effectors, most notably the serine/threonine kinase Raf, which is the first signaling element in the MAPK pathway.2,67,68 As shown in Figure 1, other downstream effectors of Ras include the PI3K cell survival pathway, the small GTP-binding proteins Rac and Rho, and the stress-activated protein kinase pathway (also referred to as the c-jun N-terminal kinase [JNK] pathway).69-71 In addition, in response to cellular stress and cytokine stimulation mediated through Ras, the dual-specificity p38MAPK kinases (MKK3 and MKK6) and the JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK and JNK, respectively.72-76"
"1476","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"GTP-bound Ras interacts directly with Raf and mobilizes the inactive protein from the cytoplasm (Figs 1 and 2). Once the Ras-Raf complex is translocated to the cell membrane, Ras activates the serine/threonine kinase function of Raf through an association between its Ras-binding domain (RBD) in the amino-terminal regulatory region and Ras-GTP."
"1477","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Raf is also activated by Ras-independent activators, including the soluble non-RTK Src and Janus kinase 1, which are involved in cytokine signaling.86 Other Ras-independent activators of Raf include interferon beta, protein kinase C (PKC) alpha, antiapoptotic proteins (eg, Bcl-2), scaffolding proteins (eg, ceramide-activated protein kinase), ultraviolet light, ionizing radiation, retinoids, erythropoietin, and dimerization between Raf isoforms86-94 (Fig 3)."
"1478","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Raf is also activated by Ras-independent activators, including the soluble non-RTK Src and Janus kinase 1, which are involved in cytokine signaling.86 Other Ras-independent activators of Raf include interferon beta, protein kinase C (PKC) alpha, antiapoptotic proteins (eg, Bcl-2), scaffolding proteins (eg, ceramide-activated protein kinase), ultraviolet light, ionizing radiation, retinoids, erythropoietin, and dimerization between Raf isoforms86-94 (Fig 3)."
"1479","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Raf is also activated by Ras-independent activators, including the soluble non-RTK Src and Janus kinase 1, which are involved in cytokine signaling.86 Other Ras-independent activators of Raf include interferon beta, protein kinase C (PKC) alpha, antiapoptotic proteins (eg, Bcl-2), scaffolding proteins (eg, ceramide-activated protein kinase), ultraviolet light, ionizing radiation, retinoids, erythropoietin, and dimerization between Raf isoforms86-94 (Fig 3)."
"1480","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Raf is also activated by Ras-independent activators, including the soluble non-RTK Src and Janus kinase 1, which are involved in cytokine signaling.86 Other Ras-independent activators of Raf include interferon beta, protein kinase C (PKC) alpha, antiapoptotic proteins (eg, Bcl-2), scaffolding proteins (eg, ceramide-activated protein kinase), ultraviolet light, ionizing radiation, retinoids, erythropoietin, and dimerization between Raf isoforms86-94 (Fig 3)."
"1481","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Raf is also activated by Ras-independent activators, including the soluble non-RTK Src and Janus kinase 1, which are involved in cytokine signaling.86 Other Ras-independent activators of Raf include interferon beta, protein kinase C (PKC) alpha, antiapoptotic proteins (eg, Bcl-2), scaffolding proteins (eg, ceramide-activated protein kinase), ultraviolet light, ionizing radiation, retinoids, erythropoietin, and dimerization between Raf isoforms86-94 (Fig 3)."
"1482","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Raf is also activated by Ras-independent activators, including the soluble non-RTK Src and Janus kinase 1, which are involved in cytokine signaling.86 Other Ras-independent activators of Raf include interferon beta, protein kinase C (PKC) alpha, antiapoptotic proteins (eg, Bcl-2), scaffolding proteins (eg, ceramide-activated protein kinase), ultraviolet light, ionizing radiation, retinoids, erythropoietin, and dimerization between Raf isoforms86-94 (Fig 3)."
"1483","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Raf is also activated by Ras-independent activators, including the soluble non-RTK Src and Janus kinase 1, which are involved in cytokine signaling.86 Other Ras-independent activators of Raf include interferon beta, protein kinase C (PKC) alpha, antiapoptotic proteins (eg, Bcl-2), scaffolding proteins (eg, ceramide-activated protein kinase), ultraviolet light, ionizing radiation, retinoids, erythropoietin, and dimerization between Raf isoforms86-94 (Fig 3)."
"1484","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Raf is also activated by Ras-independent activators, including the soluble non-RTK Src and Janus kinase 1, which are involved in cytokine signaling.86 Other Ras-independent activators of Raf include interferon beta, protein kinase C (PKC) alpha, antiapoptotic proteins (eg, Bcl-2), scaffolding proteins (eg, ceramide-activated protein kinase), ultraviolet light, ionizing radiation, retinoids, erythropoietin, and dimerization between Raf isoforms86-94 (Fig 3)."
"1485","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Raf is also activated by Ras-independent activators, including the soluble non-RTK Src and Janus kinase 1, which are involved in cytokine signaling.86 Other Ras-independent activators of Raf include interferon beta, protein kinase C (PKC) alpha, antiapoptotic proteins (eg, Bcl-2), scaffolding proteins (eg, ceramide-activated protein kinase), ultraviolet light, ionizing radiation, retinoids, erythropoietin, and dimerization between Raf isoforms86-94 (Fig 3)."
"1486","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyDecreases","false",,,"Furthermore, the kinase activity of Raf is inhibited by its interactions with cholesterol-rich lipid rafts in the cell membrane and phosphorylation by protein kinases A (PKA) and B (PKB/Akt), as shown in Figure 2.95-98"
"1487","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:decreases","false",,,"Furthermore, the kinase activity of Raf is inhibited by its interactions with cholesterol-rich lipid rafts in the cell membrane and phosphorylation by protein kinases A (PKA) and B (PKB/Akt), as shown in Figure 2.95-98"
"1488","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:decreases","false",,,"Furthermore, the kinase activity of Raf is inhibited by its interactions with cholesterol-rich lipid rafts in the cell membrane and phosphorylation by protein kinases A (PKA) and B (PKB/Akt), as shown in Figure 2.95-98"
"1489","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:hasMembers","false",,,"The mammalian raf family consists of the following three genes: A-raf, B-raf, and C-raf, which are located on chromosomes Xp11, 7q32, and 3p25, respectively. "
"1490","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Additional support for the diverse functionality of Raf family members is provided by the disparate responses of B-Raf and C-Raf to identical stimuli, as well as the distinct messages that each isoform relays downstream to Rap1, which is a small GTPase that functions as both an activator and repressor of Raf.115  Rap1-mediated stimulation of B-Raf by cyclic adenosine monophosphate (cAMP) phosphorylates ERK, whereas stimulation of C-Raf inhibits ERK phosphorylation.115"
"1491","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:decreases","false",,,"Additional support for the diverse functionality of Raf family members is provided by the disparate responses of B-Raf and C-Raf to identical stimuli, as well as the distinct messages that each isoform relays downstream to Rap1, which is a small GTPase that functions as both an activator and repressor of Raf.115  Rap1-mediated stimulation of B-Raf by cyclic adenosine monophosphate (cAMP) phosphorylates ERK, whereas stimulation of C-Raf inhibits ERK phosphorylation.115"
"1492","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:causesNoChange","false",,,"With regard to differences in signaling between the Raf isoforms, A-Raf is a weaker activator of MEK than B-Raf or C-Raf. Furthermore, A-Raf can activate MEK1 only, whereas C-Raf activates both MEK1 and MEK2.123-125  "
"1493","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"With regard to differences in signaling between the Raf isoforms, A-Raf is a weaker activator of MEK than B-Raf or C-Raf. Furthermore, A-Raf can activate MEK1 only, whereas C-Raf activates both MEK1 and MEK2.123-125  "
"1494","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"With regard to differences in signaling between the Raf isoforms, A-Raf is a weaker activator of MEK than B-Raf or C-Raf. Furthermore, A-Raf can activate MEK1 only, whereas C-Raf activates both MEK1 and MEK2.123-125  "
"1495","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"With regard to differences in signaling between the Raf isoforms, A-Raf is a weaker activator of MEK than B-Raf or C-Raf. Furthermore, A-Raf can activate MEK1 only, whereas C-Raf activates both MEK1 and MEK2.123-125  "
"1496","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyDecreases","false",,,"C-Raf exists in the cytoplasm as a 300- to 500-kd protein complex. The complex consists of C-Raf, heat shock protein 90 (Hsp90), and the dimeric protein cofactor 14-3-3. 14-3-3 binds to two specific phosphoserine residues of C-Raf, which masks its kinase domain and inactivates the protein. The binding of Ras to C-Raf displaces the 14-3-3 dimer, rendering C-Raf accessible to dephosphorylation by protein phosphatase 2A.126  "
"1497","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyDecreases","false",,,"C-Raf exists in the cytoplasm as a 300- to 500-kd protein complex. The complex consists of C-Raf, heat shock protein 90 (Hsp90), and the dimeric protein cofactor 14-3-3. 14-3-3 binds to two specific phosphoserine residues of C-Raf, which masks its kinase domain and inactivates the protein. The binding of Ras to C-Raf displaces the 14-3-3 dimer, rendering C-Raf accessible to dephosphorylation by protein phosphatase 2A.126  "
"1498","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyDecreases","false",,,"C-Raf exists in the cytoplasm as a 300- to 500-kd protein complex. The complex consists of C-Raf, heat shock protein 90 (Hsp90), and the dimeric protein cofactor 14-3-3. 14-3-3 binds to two specific phosphoserine residues of C-Raf, which masks its kinase domain and inactivates the protein. The binding of Ras to C-Raf displaces the 14-3-3 dimer, rendering C-Raf accessible to dephosphorylation by protein phosphatase 2A.126  "
"1499","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"The effector domain of GTP-bound Ras binds to C-Raf through the RBD and CRD in the CR1. Although binding to both sites is required for Raf activation, the most critical interaction is between Ras-GTP and the RBD.127  All Ras isoforms are capable of interacting with Raf, but K-Ras is the most potent activator, whereas N-Ras is much more efficient than H-Ras.128  The interaction between Ras and C-Raf alone is insufficient to activate C-Raf, but it serves to translocate C-Raf to the cell membrane where it can be activated. "
"1500","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"The effector domain of GTP-bound Ras binds to C-Raf through the RBD and CRD in the CR1. Although binding to both sites is required for Raf activation, the most critical interaction is between Ras-GTP and the RBD.127  All Ras isoforms are capable of interacting with Raf, but K-Ras is the most potent activator, whereas N-Ras is much more efficient than H-Ras.128  The interaction between Ras and C-Raf alone is insufficient to activate C-Raf, but it serves to translocate C-Raf to the cell membrane where it can be activated. "
"1501","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"The effector domain of GTP-bound Ras binds to C-Raf through the RBD and CRD in the CR1. Although binding to both sites is required for Raf activation, the most critical interaction is between Ras-GTP and the RBD.127  All Ras isoforms are capable of interacting with Raf, but K-Ras is the most potent activator, whereas N-Ras is much more efficient than H-Ras.128  The interaction between Ras and C-Raf alone is insufficient to activate C-Raf, but it serves to translocate C-Raf to the cell membrane where it can be activated. "
"1502","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"The activation of B-Raf by Ras has been less well studied; however, the interacting amino acids in the Ras-Raf interface are identical for B-Raf and C-Raf.129,130  The association of Ras with B-Raf also translocates B-Raf to the cell membrane where it is activated.124  Interestingly, a membrane-free complex of B-Raf and 14-3-3 can be activated in vitro by recombinant Ras. This is in stark contrast to A-Raf and C-Raf, which must undergo a series of phosphorylation reactions on serine and tyrosine residues in the cell membrane and cannot be activated by Ras alone.124,130  Of the Raf isoforms, B-Raf is activated first, and on stimulation by Ras, it heterodimerizes with C-Raf, the significance of which is not known.94"
"1503","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"The activation of B-Raf by Ras has been less well studied; however, the interacting amino acids in the Ras-Raf interface are identical for B-Raf and C-Raf.129,130  The association of Ras with B-Raf also translocates B-Raf to the cell membrane where it is activated.124  Interestingly, a membrane-free complex of B-Raf and 14-3-3 can be activated in vitro by recombinant Ras. This is in stark contrast to A-Raf and C-Raf, which must undergo a series of phosphorylation reactions on serine and tyrosine residues in the cell membrane and cannot be activated by Ras alone.124,130  Of the Raf isoforms, B-Raf is activated first, and on stimulation by Ras, it heterodimerizes with C-Raf, the significance of which is not known.94"
"1504","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"The activation of B-Raf by Ras has been less well studied; however, the interacting amino acids in the Ras-Raf interface are identical for B-Raf and C-Raf.129,130  The association of Ras with B-Raf also translocates B-Raf to the cell membrane where it is activated.124  Interestingly, a membrane-free complex of B-Raf and 14-3-3 can be activated in vitro by recombinant Ras. This is in stark contrast to A-Raf and C-Raf, which must undergo a series of phosphorylation reactions on serine and tyrosine residues in the cell membrane and cannot be activated by Ras alone.124,130  Of the Raf isoforms, B-Raf is activated first, and on stimulation by Ras, it heterodimerizes with C-Raf, the significance of which is not known.94"
"1505","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"Both B-Raf and C-Raf can bind to other small GTPases, most notably Rap1.115,131,132  The effector domains of Rap1 and Ras are nearly identical, but activation of these proteins produces vastly different downstream effects. Furthermore, Rap1 mediates distinct effects after binding to various Raf isoforms. The B-Raf–Rap1 complex activates B-Raf, whereas the C-Raf–Rap1 interaction does not activate C-Raf and, in fact, may be inhibitory.115,132,133  This occurs because Rap1 binds to the CRD of C-Raf with higher affinity than Ras and excludes Ras from binding. "
"1506","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyDecreases","false",,,"Both B-Raf and C-Raf can bind to other small GTPases, most notably Rap1.115,131,132  The effector domains of Rap1 and Ras are nearly identical, but activation of these proteins produces vastly different downstream effects. Furthermore, Rap1 mediates distinct effects after binding to various Raf isoforms. The B-Raf–Rap1 complex activates B-Raf, whereas the C-Raf–Rap1 interaction does not activate C-Raf and, in fact, may be inhibitory.115,132,133  This occurs because Rap1 binds to the CRD of C-Raf with higher affinity than Ras and excludes Ras from binding. "
"1507","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"The Rho family of small GTPases, consisting of Rho, Rac, and cyclin-dependent kinase (Cdc) 42, regulate cytoskeletal organization during the cell cycle and also mediate Ras-induced activation of Raf, especially C-Raf.134-136  These GTPases do not directly bind to Raf but, instead, signal by activating downstream kinases. Rho signals by activating the serine/threonine protein kinases N1 and N2 and Rho-associated kinase 1, whereas Rac and Cdc42 signal through p21-activated kinase (PAK).134-136"
"1508","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"The Rho family of small GTPases, consisting of Rho, Rac, and cyclin-dependent kinase (Cdc) 42, regulate cytoskeletal organization during the cell cycle and also mediate Ras-induced activation of Raf, especially C-Raf.134-136  These GTPases do not directly bind to Raf but, instead, signal by activating downstream kinases. Rho signals by activating the serine/threonine protein kinases N1 and N2 and Rho-associated kinase 1, whereas Rac and Cdc42 signal through p21-activated kinase (PAK).134-136"
"1509","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"The Rho family of small GTPases, consisting of Rho, Rac, and cyclin-dependent kinase (Cdc) 42, regulate cytoskeletal organization during the cell cycle and also mediate Ras-induced activation of Raf, especially C-Raf.134-136  These GTPases do not directly bind to Raf but, instead, signal by activating downstream kinases. Rho signals by activating the serine/threonine protein kinases N1 and N2 and Rho-associated kinase 1, whereas Rac and Cdc42 signal through p21-activated kinase (PAK).134-136"
"1510","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"The Rho family of small GTPases, consisting of Rho, Rac, and cyclin-dependent kinase (Cdc) 42, regulate cytoskeletal organization during the cell cycle and also mediate Ras-induced activation of Raf, especially C-Raf.134-136  These GTPases do not directly bind to Raf but, instead, signal by activating downstream kinases. Rho signals by activating the serine/threonine protein kinases N1 and N2 and Rho-associated kinase 1, whereas Rac and Cdc42 signal through p21-activated kinase (PAK).134-136"
"1511","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"The Rho family of small GTPases, consisting of Rho, Rac, and cyclin-dependent kinase (Cdc) 42, regulate cytoskeletal organization during the cell cycle and also mediate Ras-induced activation of Raf, especially C-Raf.134-136  These GTPases do not directly bind to Raf but, instead, signal by activating downstream kinases. Rho signals by activating the serine/threonine protein kinases N1 and N2 and Rho-associated kinase 1, whereas Rac and Cdc42 signal through p21-activated kinase (PAK).134-136"
"1512","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"The Rho family of small GTPases, consisting of Rho, Rac, and cyclin-dependent kinase (Cdc) 42, regulate cytoskeletal organization during the cell cycle and also mediate Ras-induced activation of Raf, especially C-Raf.134-136  These GTPases do not directly bind to Raf but, instead, signal by activating downstream kinases. Rho signals by activating the serine/threonine protein kinases N1 and N2 and Rho-associated kinase 1, whereas Rac and Cdc42 signal through p21-activated kinase (PAK).134-136"
"1513","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,," Phosphorylation.  Raf is principally activated by phosphorylation of specific amino acid residues as shown for each isoform in Figure 4. From an evolutionary standpoint, the Raf activation sites are highly conserved from yeast to humans. Several amino acids in Raf, particularly serine (S) 259 and S621, which bind 14-3-3 and maintain C-Raf in a closed auto-inhibited conformation, are phosphorylated in the basal state.137  On stimulation, Ras-GTP displaces 14-3-3 from S259, and C-Raf is translocated to the cell membrane, where it can be dephosphorylated at S259 by protein phosphatase 2A or other phosphatases.126  S259 also represents the site of inhibitory phosphorylation by PKB/Akt, PKA, and serum glucocorticoid-inducible kinase.121,138,139  Phosphorylation at S621 seems to have greater significance because mutations at this site inactivate Raf's kinase activity. Hence, a balance of phosphorylation and dephosphorylation is required to prime Raf in the basal state before stimulation by Ras or mitogens.137  "
"1514","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyDecreases","false",,," Phosphorylation.  Raf is principally activated by phosphorylation of specific amino acid residues as shown for each isoform in Figure 4. From an evolutionary standpoint, the Raf activation sites are highly conserved from yeast to humans. Several amino acids in Raf, particularly serine (S) 259 and S621, which bind 14-3-3 and maintain C-Raf in a closed auto-inhibited conformation, are phosphorylated in the basal state.137  On stimulation, Ras-GTP displaces 14-3-3 from S259, and C-Raf is translocated to the cell membrane, where it can be dephosphorylated at S259 by protein phosphatase 2A or other phosphatases.126  S259 also represents the site of inhibitory phosphorylation by PKB/Akt, PKA, and serum glucocorticoid-inducible kinase.121,138,139  Phosphorylation at S621 seems to have greater significance because mutations at this site inactivate Raf's kinase activity. Hence, a balance of phosphorylation and dephosphorylation is required to prime Raf in the basal state before stimulation by Ras or mitogens.137  "
"1515","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyDecreases","false",,," Phosphorylation.  Raf is principally activated by phosphorylation of specific amino acid residues as shown for each isoform in Figure 4. From an evolutionary standpoint, the Raf activation sites are highly conserved from yeast to humans. Several amino acids in Raf, particularly serine (S) 259 and S621, which bind 14-3-3 and maintain C-Raf in a closed auto-inhibited conformation, are phosphorylated in the basal state.137  On stimulation, Ras-GTP displaces 14-3-3 from S259, and C-Raf is translocated to the cell membrane, where it can be dephosphorylated at S259 by protein phosphatase 2A or other phosphatases.126  S259 also represents the site of inhibitory phosphorylation by PKB/Akt, PKA, and serum glucocorticoid-inducible kinase.121,138,139  Phosphorylation at S621 seems to have greater significance because mutations at this site inactivate Raf's kinase activity. Hence, a balance of phosphorylation and dephosphorylation is required to prime Raf in the basal state before stimulation by Ras or mitogens.137  "
"1516","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,," Phosphorylation.  Raf is principally activated by phosphorylation of specific amino acid residues as shown for each isoform in Figure 4. From an evolutionary standpoint, the Raf activation sites are highly conserved from yeast to humans. Several amino acids in Raf, particularly serine (S) 259 and S621, which bind 14-3-3 and maintain C-Raf in a closed auto-inhibited conformation, are phosphorylated in the basal state.137  On stimulation, Ras-GTP displaces 14-3-3 from S259, and C-Raf is translocated to the cell membrane, where it can be dephosphorylated at S259 by protein phosphatase 2A or other phosphatases.126  S259 also represents the site of inhibitory phosphorylation by PKB/Akt, PKA, and serum glucocorticoid-inducible kinase.121,138,139  Phosphorylation at S621 seems to have greater significance because mutations at this site inactivate Raf's kinase activity. Hence, a balance of phosphorylation and dephosphorylation is required to prime Raf in the basal state before stimulation by Ras or mitogens.137  "
"1517","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyDecreases","false",,," Phosphorylation.  Raf is principally activated by phosphorylation of specific amino acid residues as shown for each isoform in Figure 4. From an evolutionary standpoint, the Raf activation sites are highly conserved from yeast to humans. Several amino acids in Raf, particularly serine (S) 259 and S621, which bind 14-3-3 and maintain C-Raf in a closed auto-inhibited conformation, are phosphorylated in the basal state.137  On stimulation, Ras-GTP displaces 14-3-3 from S259, and C-Raf is translocated to the cell membrane, where it can be dephosphorylated at S259 by protein phosphatase 2A or other phosphatases.126  S259 also represents the site of inhibitory phosphorylation by PKB/Akt, PKA, and serum glucocorticoid-inducible kinase.121,138,139  Phosphorylation at S621 seems to have greater significance because mutations at this site inactivate Raf's kinase activity. Hence, a balance of phosphorylation and dephosphorylation is required to prime Raf in the basal state before stimulation by Ras or mitogens.137  "
"1518","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,," Phosphorylation.  Raf is principally activated by phosphorylation of specific amino acid residues as shown for each isoform in Figure 4. From an evolutionary standpoint, the Raf activation sites are highly conserved from yeast to humans. Several amino acids in Raf, particularly serine (S) 259 and S621, which bind 14-3-3 and maintain C-Raf in a closed auto-inhibited conformation, are phosphorylated in the basal state.137  On stimulation, Ras-GTP displaces 14-3-3 from S259, and C-Raf is translocated to the cell membrane, where it can be dephosphorylated at S259 by protein phosphatase 2A or other phosphatases.126  S259 also represents the site of inhibitory phosphorylation by PKB/Akt, PKA, and serum glucocorticoid-inducible kinase.121,138,139  Phosphorylation at S621 seems to have greater significance because mutations at this site inactivate Raf's kinase activity. Hence, a balance of phosphorylation and dephosphorylation is required to prime Raf in the basal state before stimulation by Ras or mitogens.137  "
"1519","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,," Phosphorylation.  Raf is principally activated by phosphorylation of specific amino acid residues as shown for each isoform in Figure 4. From an evolutionary standpoint, the Raf activation sites are highly conserved from yeast to humans. Several amino acids in Raf, particularly serine (S) 259 and S621, which bind 14-3-3 and maintain C-Raf in a closed auto-inhibited conformation, are phosphorylated in the basal state.137  On stimulation, Ras-GTP displaces 14-3-3 from S259, and C-Raf is translocated to the cell membrane, where it can be dephosphorylated at S259 by protein phosphatase 2A or other phosphatases.126  S259 also represents the site of inhibitory phosphorylation by PKB/Akt, PKA, and serum glucocorticoid-inducible kinase.121,138,139  Phosphorylation at S621 seems to have greater significance because mutations at this site inactivate Raf's kinase activity. Hence, a balance of phosphorylation and dephosphorylation is required to prime Raf in the basal state before stimulation by Ras or mitogens.137  "
"1520","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,," Phosphorylation.  Raf is principally activated by phosphorylation of specific amino acid residues as shown for each isoform in Figure 4. From an evolutionary standpoint, the Raf activation sites are highly conserved from yeast to humans. Several amino acids in Raf, particularly serine (S) 259 and S621, which bind 14-3-3 and maintain C-Raf in a closed auto-inhibited conformation, are phosphorylated in the basal state.137  On stimulation, Ras-GTP displaces 14-3-3 from S259, and C-Raf is translocated to the cell membrane, where it can be dephosphorylated at S259 by protein phosphatase 2A or other phosphatases.126  S259 also represents the site of inhibitory phosphorylation by PKB/Akt, PKA, and serum glucocorticoid-inducible kinase.121,138,139  Phosphorylation at S621 seems to have greater significance because mutations at this site inactivate Raf's kinase activity. Hence, a balance of phosphorylation and dephosphorylation is required to prime Raf in the basal state before stimulation by Ras or mitogens.137  "
"1521","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"Raf is also phosphorylated at other serine and threonine residues, the most important of which are S338 and tyrosine (Y) 341, which are situated adjacent to the C-Raf kinase domain.140  Phosphorylation of these residues relieves the inhibitory effects of the regulatory domain on the kinase domain.141  S338, which is the evolutionarily conserved PAK phosphorylation site that resides on the amino-terminal side of the kinase domain, is critical for Raf activation.134-136,140,142  This site is also phosphorylated in response to stimulation by growth factors, integrins, Ras, PAK1, and PAK3.78,136,143"
"1522","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"Raf is also phosphorylated at other serine and threonine residues, the most important of which are S338 and tyrosine (Y) 341, which are situated adjacent to the C-Raf kinase domain.140  Phosphorylation of these residues relieves the inhibitory effects of the regulatory domain on the kinase domain.141  S338, which is the evolutionarily conserved PAK phosphorylation site that resides on the amino-terminal side of the kinase domain, is critical for Raf activation.134-136,140,142  This site is also phosphorylated in response to stimulation by growth factors, integrins, Ras, PAK1, and PAK3.78,136,143"
"1523","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"Raf is also phosphorylated at other serine and threonine residues, the most important of which are S338 and tyrosine (Y) 341, which are situated adjacent to the C-Raf kinase domain.140  Phosphorylation of these residues relieves the inhibitory effects of the regulatory domain on the kinase domain.141  S338, which is the evolutionarily conserved PAK phosphorylation site that resides on the amino-terminal side of the kinase domain, is critical for Raf activation.134-136,140,142  This site is also phosphorylated in response to stimulation by growth factors, integrins, Ras, PAK1, and PAK3.78,136,143"
"1524","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"Raf is also phosphorylated at other serine and threonine residues, the most important of which are S338 and tyrosine (Y) 341, which are situated adjacent to the C-Raf kinase domain.140  Phosphorylation of these residues relieves the inhibitory effects of the regulatory domain on the kinase domain.141  S338, which is the evolutionarily conserved PAK phosphorylation site that resides on the amino-terminal side of the kinase domain, is critical for Raf activation.134-136,140,142  This site is also phosphorylated in response to stimulation by growth factors, integrins, Ras, PAK1, and PAK3.78,136,143"
"1525","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Raf is also phosphorylated at other serine and threonine residues, the most important of which are S338 and tyrosine (Y) 341, which are situated adjacent to the C-Raf kinase domain.140  Phosphorylation of these residues relieves the inhibitory effects of the regulatory domain on the kinase domain.141  S338, which is the evolutionarily conserved PAK phosphorylation site that resides on the amino-terminal side of the kinase domain, is critical for Raf activation.134-136,140,142  This site is also phosphorylated in response to stimulation by growth factors, integrins, Ras, PAK1, and PAK3.78,136,143"
"1526","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Raf is also phosphorylated at other serine and threonine residues, the most important of which are S338 and tyrosine (Y) 341, which are situated adjacent to the C-Raf kinase domain.140  Phosphorylation of these residues relieves the inhibitory effects of the regulatory domain on the kinase domain.141  S338, which is the evolutionarily conserved PAK phosphorylation site that resides on the amino-terminal side of the kinase domain, is critical for Raf activation.134-136,140,142  This site is also phosphorylated in response to stimulation by growth factors, integrins, Ras, PAK1, and PAK3.78,136,143"
"1527","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Raf is also phosphorylated at other serine and threonine residues, the most important of which are S338 and tyrosine (Y) 341, which are situated adjacent to the C-Raf kinase domain.140  Phosphorylation of these residues relieves the inhibitory effects of the regulatory domain on the kinase domain.141  S338, which is the evolutionarily conserved PAK phosphorylation site that resides on the amino-terminal side of the kinase domain, is critical for Raf activation.134-136,140,142  This site is also phosphorylated in response to stimulation by growth factors, integrins, Ras, PAK1, and PAK3.78,136,143"
"1528","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"The homologous site on B-Raf, S445, is constitutively phosphorylated, accounting for the higher basal activity of B-Raf. Ras presumably phosphorylates this site by activating PI3K. "
"1529","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"Y341 is phosphorylated by the Src family of non-RTKs, Janus kinase, and erythropoietin.85,92 "
"1530","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"Y341 is phosphorylated by the Src family of non-RTKs, Janus kinase, and erythropoietin.85,92 "
"1531","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Y341 is phosphorylated by the Src family of non-RTKs, Janus kinase, and erythropoietin.85,92 "
"1532","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"The Raf isoforms are the best characterized MEK1 and MEK2 activators, and all Raf isoforms activate MEK1, whereas only B-Raf and C-Raf activate MEK2. MEK1 and MEK2 contain a proline-rich sequence that enables recognition and activation by Raf."
"1533","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"The Raf isoforms are the best characterized MEK1 and MEK2 activators, and all Raf isoforms activate MEK1, whereas only B-Raf and C-Raf activate MEK2. MEK1 and MEK2 contain a proline-rich sequence that enables recognition and activation by Raf."
"1534","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"The Raf isoforms are the best characterized MEK1 and MEK2 activators, and all Raf isoforms activate MEK1, whereas only B-Raf and C-Raf activate MEK2. MEK1 and MEK2 contain a proline-rich sequence that enables recognition and activation by Raf."
"1535","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"The Raf isoforms are the best characterized MEK1 and MEK2 activators, and all Raf isoforms activate MEK1, whereas only B-Raf and C-Raf activate MEK2. MEK1 and MEK2 contain a proline-rich sequence that enables recognition and activation by Raf."
"1536","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"The Raf isoforms are the best characterized MEK1 and MEK2 activators, and all Raf isoforms activate MEK1, whereas only B-Raf and C-Raf activate MEK2. MEK1 and MEK2 contain a proline-rich sequence that enables recognition and activation by Raf."
"1537","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"the dual-specificity p38MAPK kinases (MKK3 and MKK6) and JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK  and JNK, respectively."
"1538","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"the dual-specificity p38MAPK kinases (MKK3 and MKK6) and JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK  and JNK, respectively."
"1539","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"the dual-specificity p38MAPK kinases (MKK3 and MKK6) and JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK  and JNK, respectively."
"1540","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"the dual-specificity p38MAPK kinases (MKK3 and MKK6) and JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK  and JNK, respectively."
"1541","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Although both A-Raf and C-Raf are capable of activating other signaling elements independent of MAPK pathway activation, such as nuclear factor-kappa B (NF-?B), Rb, and Bcl-2, MEK1 and MEK2 are the only known substrates for B-Raf.154-157 "
"1542","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Although both A-Raf and C-Raf are capable of activating other signaling elements independent of MAPK pathway activation, such as nuclear factor-kappa B (NF-?B), Rb, and Bcl-2, MEK1 and MEK2 are the only known substrates for B-Raf.154-157 "
"1543","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Cell survival signaling is also regulated by C-Raf, which induces phosphorylation of I? B in the NF-?B–I? B complex. This action releases activated NF-?B, which is then translocated to the nucleus where it mediates transcription of antiapoptotic factors.155,166"
"1544","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"Cell survival signaling is also regulated by C-Raf, which induces phosphorylation of I? B in the NF-?B–I? B complex. This action releases activated NF-?B, which is then translocated to the nucleus where it mediates transcription of antiapoptotic factors.155,166"
"1545","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:decreases","false",,,"Other antiapoptotic effects of C-Raf are mediated by a mitochondrial pool of the protein, which, on stimulation, localizes to the mitochondrial membrane where the protein interacts with and phosphorylates Bcl-2, Bcl-2–associated athanogene, and other pro-apoptotic regulators, abrogating their pro-apoptotic effects.157,167 The antiapoptotic effects of C-Raf are also mediated through the ankyrin-repeat protein Tvl-1 and apoptosis signal-regulated kinase-1.166,168,169"
"1546","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"Other antiapoptotic effects of C-Raf are mediated by a mitochondrial pool of the protein, which, on stimulation, localizes to the mitochondrial membrane where the protein interacts with and phosphorylates Bcl-2, Bcl-2–associated athanogene, and other pro-apoptotic regulators, abrogating their pro-apoptotic effects.157,167 The antiapoptotic effects of C-Raf are also mediated through the ankyrin-repeat protein Tvl-1 and apoptosis signal-regulated kinase-1.166,168,169"
"1547","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"Other antiapoptotic effects of C-Raf are mediated by a mitochondrial pool of the protein, which, on stimulation, localizes to the mitochondrial membrane where the protein interacts with and phosphorylates Bcl-2, Bcl-2–associated athanogene, and other pro-apoptotic regulators, abrogating their pro-apoptotic effects.157,167 The antiapoptotic effects of C-Raf are also mediated through the ankyrin-repeat protein Tvl-1 and apoptosis signal-regulated kinase-1.166,168,169"
"1548","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"In addition, C-Raf phosphorylates Rb, p53, Cdc25, and other cell cycle regulatory proteins in metaphase.156,170,171  Lastly, C-Raf induces transcription of the multidrug resistance gene mdr-1,  and its activation has been associated with multidrug resistance.172  "
"1549","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"In addition, C-Raf phosphorylates Rb, p53, Cdc25, and other cell cycle regulatory proteins in metaphase.156,170,171  Lastly, C-Raf induces transcription of the multidrug resistance gene mdr-1,  and its activation has been associated with multidrug resistance.172  "
"1550","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"In addition, C-Raf phosphorylates Rb, p53, Cdc25, and other cell cycle regulatory proteins in metaphase.156,170,171  Lastly, C-Raf induces transcription of the multidrug resistance gene mdr-1,  and its activation has been associated with multidrug resistance.172  "
"1551","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:increases","false",,,"In addition, C-Raf phosphorylates Rb, p53, Cdc25, and other cell cycle regulatory proteins in metaphase.156,170,171  Lastly, C-Raf induces transcription of the multidrug resistance gene mdr-1,  and its activation has been associated with multidrug resistance.172  "
"1552","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:positiveCorrelation","false",,,"Somatic B-raf mutations were demonstrated in 60% to 70% of malignant melanomas and in moderate to high rates in carcinomas of the colon, ovary, and thyroid (papillary), implicating activating oncogenic B-raf mutations as critical promoters of these malignancies.9,14-17 "
"1553","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:positiveCorrelation","false",,,"Somatic B-raf mutations were demonstrated in 60% to 70% of malignant melanomas and in moderate to high rates in carcinomas of the colon, ovary, and thyroid (papillary), implicating activating oncogenic B-raf mutations as critical promoters of these malignancies.9,14-17 "
"1554","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:positiveCorrelation","false",,,"Somatic B-raf mutations were demonstrated in 60% to 70% of malignant melanomas and in moderate to high rates in carcinomas of the colon, ovary, and thyroid (papillary), implicating activating oncogenic B-raf mutations as critical promoters of these malignancies.9,14-17 "
"1555","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:positiveCorrelation","false",,,"Somatic B-raf mutations were demonstrated in 60% to 70% of malignant melanomas and in moderate to high rates in carcinomas of the colon, ovary, and thyroid (papillary), implicating activating oncogenic B-raf mutations as critical promoters of these malignancies.9,14-17 "
"1556","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyIncreases","false",,,"V599EB-Raf possesses the hallmarks of a conventional oncogene because the kinase activity of its encoded protein is greatly elevated;"
"1557","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyDecreases","false",,,"Originally identified by high-throughput screening of small molecules against C-Raf kinase, sorafenib was found to be a potent competitive inhibitor of ATP binding in the catalytic domains of C-Raf, wild-type B-Raf, and V599EB-Raf mutant. "
"1558","Beeram MPatnaik ARowinsky EK","16170185","Journal of clinical oncology : official journal of the American Society of Clinical Oncology","PubMed",,,"bel:directlyDecreases","false",,,"Originally identified by high-throughput screening of small molecules against C-Raf kinase, sorafenib was found to be a potent competitive inhibitor of ATP binding in the catalytic domains of C-Raf, wild-type B-Raf, and V599EB-Raf mutant. "
"1559","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:directlyIncreases","false",,,
"1560","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:directlyIncreases","false",,,"Long PDE4 isoforms from all four subfamilies can be activated through PKA phosphorylation [ 50, 54–57] of a single serine residue [ 50, 56, 58–61] found at the extreme N-terminal end of UCR1, within the PKA consensus, RRESF. "
"1561","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:directlyIncreases","false",,,"Long PDE4 isoforms from all four subfamilies can be activated through PKA phosphorylation [ 50, 54–57] of a single serine residue [ 50, 56, 58–61] found at the extreme N-terminal end of UCR1, within the PKA consensus, RRESF. "
"1562","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:directlyIncreases","false",,,"Once cAMP is generated, the only way to inactivate it is to degrade it to 5´-AMP, through PDE action"
"1563","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:directlyIncreases","false",,,"cAMP is of pivotal importance in determining many aspects of cellular function [ 1, 2]. It is generated at the cytosol surface of the plasma membrane through the action of adenylate cyclases, of which there is a large family. Increased levels of cAMP are translated into cellular responses through the action of cAMP-dependent protein kinase (PKA)"
"1564","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:directlyIncreases","false",,,"cAMP is of pivotal importance in determining many aspects of cellular function [ 1, 2]. It is generated at the cytosol surface of the plasma membrane through the action of adenylate cyclases, of which there is a large family. Increased levels of cAMP are translated into cellular responses through the action of cAMP-dependent protein kinase (PKA)"
"1565","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:directlyIncreases","false",,,"The third subdomain of the catalytic unit of all PDE4 subfamilies, but not that of PDE4A, contains a single, ERK consensus motif (Pro-Xaa-Ser-Pro). The serine residue in this site can be phosphorylated, both in vitro and in vivo , by ERK [ 49, 70, 71]. "
"1566","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:directlyIncreases","false",,,"The third subdomain of the catalytic unit of all PDE4 subfamilies, but not that of PDE4A, contains a single, ERK consensus motif (Pro-Xaa-Ser-Pro). The serine residue in this site can be phosphorylated, both in vitro and in vivo , by ERK [ 49, 70, 71]. "
"1567","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:directlyIncreases","false",,,"The third subdomain of the catalytic unit of all PDE4 subfamilies, but not that of PDE4A, contains a single, ERK consensus motif (Pro-Xaa-Ser-Pro). The serine residue in this site can be phosphorylated, both in vitro and in vivo , by ERK [ 49, 70, 71]. "
"1568","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:directlyDecreases","false",,,"ERK phosphorylation of PDE4 long isoforms leads to inhibition under conditions where the serine target is the sole residue phosphorylated [ 49, 70, 71]. "
"1569","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:increases","false",,,"In these cells ERK causes the autocrine generation of prostaglandin E2  (PGE2) through activation of PKA2 and the production of arachidonic acid. Thus the rapidly generated PGE2 stimulates adenylate cyclase, increasing cAMP levels, "
"1570","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:increases","false",,,"In these cells ERK causes the autocrine generation of prostaglandin E2  (PGE2) through activation of PKA2 and the production of arachidonic acid. Thus the rapidly generated PGE2 stimulates adenylate cyclase, increasing cAMP levels, "
"1571","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:increases","false",,,"In these cells ERK causes the autocrine generation of prostaglandin E2  (PGE2) through activation of PKA2 and the production of arachidonic acid. Thus the rapidly generated PGE2 stimulates adenylate cyclase, increasing cAMP levels, "
"1572","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:increases","false",,,"In these cells ERK causes the autocrine generation of prostaglandin E2  (PGE2) through activation of PKA2 and the production of arachidonic acid. Thus the rapidly generated PGE2 stimulates adenylate cyclase, increasing cAMP levels, "
"1573","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:increases","false",,,"Whether a similar mechanism underpins the ability of interleukin 3 (IL-3) and IL-4 to increase PDE4 activity in myeloid cells through an ERK-mediated process [ 75], or because ERK-activated short forms predominate in such cells (see above), remains to be seen. "
"1574","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:increases","false",,,"Whether a similar mechanism underpins the ability of interleukin 3 (IL-3) and IL-4 to increase PDE4 activity in myeloid cells through an ERK-mediated process [ 75], or because ERK-activated short forms predominate in such cells (see above), remains to be seen. "
"1575","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:directlyIncreases","false",,,"Whether a similar mechanism underpins the ability of interleukin 3 (IL-3) and IL-4 to increase PDE4 activity in myeloid cells through an ERK-mediated process [ 75], or because ERK-activated short forms predominate in such cells (see above), remains to be seen. "
"1576","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:increases","false",,,"PA causes a marked (0.7-3-fold) activation of various long PDE4 isoforms, but fails to affect short and super-short isoforms [ 87, 91]. Similar activation was seen with the acidic phospholipid phosphatidylserine (PS), but not with neutral phospholipids."
"1577","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:increases","false",,,"PA causes a marked (0.7-3-fold) activation of various long PDE4 isoforms, but fails to affect short and super-short isoforms [ 87, 91]. Similar activation was seen with the acidic phospholipid phosphatidylserine (PS), but not with neutral phospholipids."
"1578","Houslay MDAdams DR","12444918","The Biochemical journal","PubMed",,,"bel:directlyIncreases","false",,,"All three categories of PDE4 isoforms from all four subfamilies can interact with b-arrestin1/2, implying that a common region in the PDE4 catalytic unit provides a binding site for b-arrestins [ 65]. Thus challenge of cells with a b-agonist has been shown to cause recruitment of a PDE4–arrestin complex to the b2- AR."
"1579","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Like progesterone receptors (PR), Stat5a and 5b are required for normal mammary gland growth and differentiation. These two proteins are up-regulated during pregnancy, a period dominated by high levels of progesterone. "
"1580","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Like progesterone receptors (PR), Stat5a and 5b are required for normal mammary gland growth and differentiation. These two proteins are up-regulated during pregnancy, a period dominated by high levels of progesterone. "
"1581","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Like progesterone receptors (PR), Stat5a and 5b are required for normal mammary gland growth and differentiation. These two proteins are up-regulated during pregnancy, a period dominated by high levels of progesterone. "
"1582","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:positiveCorrelation","false",,,"Like progesterone receptors (PR), Stat5a and 5b are required for normal mammary gland growth and differentiation. These two proteins are up-regulated during pregnancy, a period dominated by high levels of progesterone. "
"1583","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:positiveCorrelation","false",,,"Like progesterone receptors (PR), Stat5a and 5b are required for normal mammary gland growth and differentiation. These two proteins are up-regulated during pregnancy, a period dominated by high levels of progesterone. "
"1584","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"In addition, progestin treatment induces translocation of Stat5 into the nucleus, possibly mediated by the association of PR and Stat5. Last, progesterone pretreatment enhances the phosphorylation of Stat5 on tyrosine 694 induced by epidermal growth factor. "
"1585","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Stat5 protein levels were elevated by 8 h and remained elevated until 72 h after R5020 treatment with increases of 4–7-fold (Fig. 1  A). To test the PR dependence of this effect, the experiment was repeated using PR-negative T47D-Y cells (28) (Fig. 1  B). In the absence of PR, R5020 did not up-regulate Stat5. "
"1586","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Stat5 protein levels were elevated by 8 h and remained elevated until 72 h after R5020 treatment with increases of 4–7-fold (Fig. 1  A). To test the PR dependence of this effect, the experiment was repeated using PR-negative T47D-Y cells (28) (Fig. 1  B). In the absence of PR, R5020 did not up-regulate Stat5. "
"1587","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"This study shows that both the longer (95 kDa) Stat5a and the shorter (92 kDa) Stat5b isoform are up-regulated by progestin treatment. "
"1588","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"This study shows that both the longer (95 kDa) Stat5a and the shorter (92 kDa) Stat5b isoform are up-regulated by progestin treatment. "
"1589","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Similar studies using anti-Stat3 (Fig. 2  B) and anti-Stat1 (Fig.2  C) antibodies show that these STAT family members are also progestin regulated. While Stat3 is clearly up-regulated by progestin treatment, Stat1 is slightly down-regulated."
"1590","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Similar studies using anti-Stat3 (Fig. 2  B) and anti-Stat1 (Fig.2  C) antibodies show that these STAT family members are also progestin regulated. While Stat3 is clearly up-regulated by progestin treatment, Stat1 is slightly down-regulated."
"1591","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Northern blot analysis demonstrates hormone-dependent induction of Stat5a message at 12 and 24 h following progestin treatment (Fig. 3). "
"1592","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"In contrast, the same Northern blot hybridized with cDNA for two genes known to be PR regulated, fatty acid synthetase (30, 38) or cyclin D1 (18, 39), shows equal induction of these genes by the two PR isoforms. "
"1593","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"In contrast, the same Northern blot hybridized with cDNA for two genes known to be PR regulated, fatty acid synthetase (30, 38) or cyclin D1 (18, 39), shows equal induction of these genes by the two PR isoforms. "
"1594","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"T47Dco cells were treated for 24 h with 10 nm R5020 or vehicle, then with 10 nm EGF or vehicle for 5 min. Nuclear and cytosolic extracts were prepared and equal amounts of protein were probed with antibody recognizing total Stat5 (Fig. 4  A). In untreated cells, Stat5 was exclusively cytoplasmic (lane 1); no Stat5 was found in the nucleus (lane 2). As expected, EGF treatment promoted nuclear translocation of a portion of Stat5 (lanes 5 and 6). Surprisingly, R5020 not only increased total Stat5 levels (lanes 3  and 4; 7and 8), but also promoted extensive nuclear translocation of Stat5 (compare lanes 2 and 4) independent of EGF treatment. "
"1595","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"T47Dco cells were treated for 24 h with 10 nm R5020 or vehicle, then with 10 nm EGF or vehicle for 5 min. Nuclear and cytosolic extracts were prepared and equal amounts of protein were probed with antibody recognizing total Stat5 (Fig. 4  A). In untreated cells, Stat5 was exclusively cytoplasmic (lane 1); no Stat5 was found in the nucleus (lane 2). As expected, EGF treatment promoted nuclear translocation of a portion of Stat5 (lanes 5 and 6). Surprisingly, R5020 not only increased total Stat5 levels (lanes 3  and 4; 7and 8), but also promoted extensive nuclear translocation of Stat5 (compare lanes 2 and 4) independent of EGF treatment. "
"1596","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"T47Dco cells were treated for 24 h with 10 nm R5020 or vehicle, then with 10 nm EGF or vehicle for 5 min. Nuclear and cytosolic extracts were prepared and equal amounts of protein were probed with antibody recognizing total Stat5 (Fig. 4  A). In untreated cells, Stat5 was exclusively cytoplasmic (lane 1); no Stat5 was found in the nucleus (lane 2). As expected, EGF treatment promoted nuclear translocation of a portion of Stat5 (lanes 5 and 6). Surprisingly, R5020 not only increased total Stat5 levels (lanes 3  and 4; 7and 8), but also promoted extensive nuclear translocation of Stat5 (compare lanes 2 and 4) independent of EGF treatment. "
"1597","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"In the absence of R5020 pretreatment, JAK2 is immunoprecipitated with the anti-phosphotyrosine antibody only following EGF treatment (lane 2). Note that JAK2 is not present in phosphotyrosine immunoprecipitates after 1 h of R5020 treatment (lane 1). However, JAK2 is immunoprecipitated with the anti-phosphotyrosine antibody as efficiently after 48 h of R5020 treatment (lane 4) as with EGF treatment (lane 5)."
"1598","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"In the absence of R5020 pretreatment, JAK2 is immunoprecipitated with the anti-phosphotyrosine antibody only following EGF treatment (lane 2). Note that JAK2 is not present in phosphotyrosine immunoprecipitates after 1 h of R5020 treatment (lane 1). However, JAK2 is immunoprecipitated with the anti-phosphotyrosine antibody as efficiently after 48 h of R5020 treatment (lane 4) as with EGF treatment (lane 5)."
"1599","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"However, Stat5 remained unphosphorylated (P-Stat5, lanes 1–5), except in the cells that were pretreated with R5020 for 48 h, prior to the 10-min prolactin treatment (P-Stat5, lane 6). Prolactin alone had no effect (lane 3) nor did transient (1 h) or chronic (48 h) R5020 treatment (lane 2). Thus, in T47Dco cells, Stat5 phosphorylation by prolactin requires progesterone pretreatment. "
"1600","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"The ?-casein promoter, known to be induced by Stat5 when activated by prolactin via prolactin receptors and JAK2, was next used to test the function of the phosphorylated Stat5. T47D-YB cells were pretreated with either R5020 or ethanol vehicle for 48 h. Cells were then washed, transfected with a ?-casein promoter-luciferase reporter, treated with either R5020 or prolactin, and harvested for luciferase assay 24 h after hormone treatment. We found that in T47D-YB breast cancer cells, prolactin alone has minimal to no significant effect on the ?-casein luciferase promoter. However, after R5020 pretreatment, a 6–7-fold induction of the ?-casein luciferase promoter was observed (Fig. 7  B). Thus R5020 sensitized these breast cancer cells to the transcriptional effects of prolactin mediated through Stat5. "
"1601","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"The ?-casein promoter, known to be induced by Stat5 when activated by prolactin via prolactin receptors and JAK2, was next used to test the function of the phosphorylated Stat5. T47D-YB cells were pretreated with either R5020 or ethanol vehicle for 48 h. Cells were then washed, transfected with a ?-casein promoter-luciferase reporter, treated with either R5020 or prolactin, and harvested for luciferase assay 24 h after hormone treatment. We found that in T47D-YB breast cancer cells, prolactin alone has minimal to no significant effect on the ?-casein luciferase promoter. However, after R5020 pretreatment, a 6–7-fold induction of the ?-casein luciferase promoter was observed (Fig. 7  B). Thus R5020 sensitized these breast cancer cells to the transcriptional effects of prolactin mediated through Stat5. "
"1602","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Fig. 8  A shows that the p21WAF1 promoter is induced 4.5-fold by progesterone, 2.4-fold by EGF, and 13.2-fold by both hormones together. The average increase in five experiments was progesterone, 3.5-fold; EGF, 2.2-fold; both hormones, 11-fold. Fig. 8  B demonstrates the corresponding increases in endogenous p21 levels when T47D-YB cells are treated for 24 h with ethanol, progesterone, EGF, or both hormones. Whole cell lysates were probed by immunoblotting with antibody to p21. "
"1603","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Fig. 8  A shows that the p21WAF1 promoter is induced 4.5-fold by progesterone, 2.4-fold by EGF, and 13.2-fold by both hormones together. The average increase in five experiments was progesterone, 3.5-fold; EGF, 2.2-fold; both hormones, 11-fold. Fig. 8  B demonstrates the corresponding increases in endogenous p21 levels when T47D-YB cells are treated for 24 h with ethanol, progesterone, EGF, or both hormones. Whole cell lysates were probed by immunoblotting with antibody to p21. "
"1604","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Fig. 8  A shows that the p21WAF1 promoter is induced 4.5-fold by progesterone, 2.4-fold by EGF, and 13.2-fold by both hormones together. The average increase in five experiments was progesterone, 3.5-fold; EGF, 2.2-fold; both hormones, 11-fold. Fig. 8  B demonstrates the corresponding increases in endogenous p21 levels when T47D-YB cells are treated for 24 h with ethanol, progesterone, EGF, or both hormones. Whole cell lysates were probed by immunoblotting with antibody to p21. "
"1605","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Fig. 8  C shows that the c-fos promoter is induced 19.3-fold by R5020 and 6.2-fold by EGF. Remarkably, together the two hormones produced a 145-fold increase in luciferase activity. "
"1606","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Fig. 8  C shows that the c-fos promoter is induced 19.3-fold by R5020 and 6.2-fold by EGF. Remarkably, together the two hormones produced a 145-fold increase in luciferase activity. "
"1607","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Fig. 8  C shows that the c-fos promoter is induced 19.3-fold by R5020 and 6.2-fold by EGF. Remarkably, together the two hormones produced a 145-fold increase in luciferase activity. "
"1608","Richer JKLange CAManning NGOwen GPowell RHorwitz KB","9813040","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Progesterone enhances the ability of EGF to phosphorylate Stat5 on tyrosine 694."
"1609","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial dysfunction is a major mechanism whereby drugs can induce liver
injury and other serious side effects such as lactic acidosis and rhabdomyolysis in
some patients."
"1610","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial dysfunction is a major mechanism whereby drugs can induce liver
injury and other serious side effects such as lactic acidosis and rhabdomyolysis in
some patients."
"1611","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial dysfunction is a major mechanism whereby drugs can induce liver
injury and other serious side effects such as lactic acidosis and rhabdomyolysis in
some patients."
"1612","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:positiveCorrelation","false",,,"drugs can induce microvesicular steatosis, a potentially severe lesion that can be associated with profound hypoglycaemia and encephalopathy"
"1613","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:positiveCorrelation","false",,,"drugs can induce microvesicular steatosis, a potentially severe lesion that can be associated with profound hypoglycaemia and encephalopathy"
"1614","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:positiveCorrelation","false",,,"drugs can induce microvesicular steatosis, a potentially severe lesion that can be associated with profound hypoglycaemia and encephalopathy"
"1615","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"They can also trigger hepatic necrosis and/or apoptosis, causing cytolytic hepatitis, which can evolve into liver failure."
"1616","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"They can also trigger hepatic necrosis and/or apoptosis, causing cytolytic hepatitis, which can evolve into liver failure."
"1617","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"During the fasting state, fatty acid oxidation
(FAO) in the liver is incomplete; the acetyl-CoA that is
generated is not oxidized in the liver, but condenses into
ketone bodies (mainly acetoacetate and b-hydroxybutyrate)
(Figure 1), which are released into the plasma for
subsequent oxidation in extrahepatic tissues."
"1618","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:directlyIncreases","false",,,"LCFAs are activated into LCFA-coenzyme A (acyl-
CoA) thioesters by long-chain acyl-CoA synthetases (ACS) located in the outer mitochondrial membrane, microsomes and peroxisomes"
"1619","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:directlyIncreases","false",,,"LCFAs are activated into LCFA-coenzyme A (acyl-
CoA) thioesters by long-chain acyl-CoA synthetases (ACS) located in the outer mitochondrial membrane, microsomes and peroxisomes"
"1620","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:directlyIncreases","false",,,"LCFAs are activated into LCFA-coenzyme A (acyl-
CoA) thioesters by long-chain acyl-CoA synthetases (ACS) located in the outer mitochondrial membrane, microsomes and peroxisomes"
"1621","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:directlyIncreases","false",,,"The long-chain acyl-CoA is converted into an acyl-carnitine by carnitine palmitoyltransferase-I (CPT-I) in the outer mitochondrial
membrane."
"1622","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"LCFA-CoA thioesters are then oxidized into acetyl-CoA moieties via
the b-oxidation process."
"1623","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"Acetyl-CoA moieties can then generate ketone bodies (mainly acetoacetate and b-hydroxybutyrate) via ketogenesis,
which is stimulated during fasting."
"1624","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:isA","false",,,"Acetyl-CoA moieties can then generate ketone bodies (mainly acetoacetate and b-hydroxybutyrate) via ketogenesis,
which is stimulated during fasting."
"1625","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Ketone bodies are liberated into the plasma to be used by extrahepatic tissues for energy production."
"1626","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"After
a meal, however, the acetyl-CoA moieties are mainly generated in the liver by the glycolysis of glucose into pyruvate and the oxidative
decarboxylation of pyruvate."
"1627","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:subProcessOf","false",,,"After
a meal, however, the acetyl-CoA moieties are mainly generated in the liver by the glycolysis of glucose into pyruvate and the oxidative
decarboxylation of pyruvate."
"1628","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:subProcessOf","false",,,"The formed acetyl-CoA enters the tricarboxylic acid (TCA) cycle (not shown), to be fully oxidized or to form
citrate, which can leave mitochondria and regenerate acetyl-CoA in the cytosol for subsequent de novo lipogenesis."
"1629","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial fatty acid
b-oxidation (FAO) and the TCA cycle generate NADH and FADH2, which transfer their electrons (e)) to the mitochondrial respiratory chain
(MRC), regenerating NAD+ and FAD used for other b-oxidation (or TCA) cycles"
"1630","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial fatty acid
b-oxidation (FAO) and the TCA cycle generate NADH and FADH2, which transfer their electrons (e)) to the mitochondrial respiratory chain
(MRC), regenerating NAD+ and FAD used for other b-oxidation (or TCA) cycles"
"1631","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial fatty acid
b-oxidation (FAO) and the TCA cycle generate NADH and FADH2, which transfer their electrons (e)) to the mitochondrial respiratory chain
(MRC), regenerating NAD+ and FAD used for other b-oxidation (or TCA) cycles"
"1632","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial fatty acid
b-oxidation (FAO) and the TCA cycle generate NADH and FADH2, which transfer their electrons (e)) to the mitochondrial respiratory chain
(MRC), regenerating NAD+ and FAD used for other b-oxidation (or TCA) cycles"
"1633","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:directlyIncreases","false",,,"When energy is
needed (i.e. when ATP levels are low), these protons re-enter the matrix through ATP synthase (also referred to as complex V), thus liberating
energy that is used to phosphorylate ADP into ATP."
"1634","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"When energy is
needed (i.e. when ATP levels are low), these protons re-enter the matrix through ATP synthase (also referred to as complex V), thus liberating
energy that is used to phosphorylate ADP into ATP."
"1635","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Cytochrome c release induces caspase activation and cell death via
apoptosis or necrosis."
"1636","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Cytochrome c release induces caspase activation and cell death via
apoptosis or necrosis."
"1637","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Cytochrome c release induces caspase activation and cell death via
apoptosis or necrosis."
"1638","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"When cells need energy, the rise in ADP levels
within the mitochondria induces the re-entry of protons
into the mitochondrial matrix through the membranespanning
F0 portion of the ATP synthase complex (also
referred to as the ‘complex V of the MRC’)."
"1639","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"Classically, it is considered that the number of normal
mtDNA copies must fall below 20–40% of basal
levels to induce mitochondrial dysfunction and adverse
events [6]. Below this threshold, hepatic mtDNA
depletion can impair the MRC. This impairment can
hamper the regeneration of NAD+ and FAD, thus
leading to a secondary inhibition of the oxidation of
fatty acids and pyruvate."
"1640","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Classically, it is considered that the number of normal
mtDNA copies must fall below 20–40% of basal
levels to induce mitochondrial dysfunction and adverse
events [6]. Below this threshold, hepatic mtDNA
depletion can impair the MRC. This impairment can
hamper the regeneration of NAD+ and FAD, thus
leading to a secondary inhibition of the oxidation of
fatty acids and pyruvate."
"1641","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Classically, it is considered that the number of normal
mtDNA copies must fall below 20–40% of basal
levels to induce mitochondrial dysfunction and adverse
events [6]. Below this threshold, hepatic mtDNA
depletion can impair the MRC. This impairment can
hamper the regeneration of NAD+ and FAD, thus
leading to a secondary inhibition of the oxidation of
fatty acids and pyruvate."
"1642","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Classically, it is considered that the number of normal
mtDNA copies must fall below 20–40% of basal
levels to induce mitochondrial dysfunction and adverse
events [6]. Below this threshold, hepatic mtDNA
depletion can impair the MRC. This impairment can
hamper the regeneration of NAD+ and FAD, thus
leading to a secondary inhibition of the oxidation of
fatty acids and pyruvate."
"1643","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Classically, it is considered that the number of normal
mtDNA copies must fall below 20–40% of basal
levels to induce mitochondrial dysfunction and adverse
events [6]. Below this threshold, hepatic mtDNA
depletion can impair the MRC. This impairment can
hamper the regeneration of NAD+ and FAD, thus
leading to a secondary inhibition of the oxidation of
fatty acids and pyruvate."
"1644","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Classically, it is considered that the number of normal
mtDNA copies must fall below 20–40% of basal
levels to induce mitochondrial dysfunction and adverse
events [6]. Below this threshold, hepatic mtDNA
depletion can impair the MRC. This impairment can
hamper the regeneration of NAD+ and FAD, thus
leading to a secondary inhibition of the oxidation of
fatty acids and pyruvate."
"1645","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"a key feature of the mitochondrial
genome is its high sensitivity to oxidative damage,
because of its proximity to the inner membrane (the
main cellular source of ROS"
"1646","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"a key feature of the mitochondrial
genome is its high sensitivity to oxidative damage,
because of its proximity to the inner membrane (the
main cellular source of ROS"
"1647","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"However,
at several upstream sites of the MRC (most probably
complexes I and III), a small fraction of these electrons
can directly react with oxygen, to generate the superoxide
anion radical."
"1648","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"to generate the superoxide
anion radical. This radical is then dismutated
by the mitochondrial manganese superoxide dismutase
(MnSOD) into hydrogen peroxide (H2O2), which is
detoxified into water by the mitochondrial glutathione
peroxidase."
"1649","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"to generate the superoxide
anion radical. This radical is then dismutated
by the mitochondrial manganese superoxide dismutase
(MnSOD) into hydrogen peroxide (H2O2), which is
detoxified into water by the mitochondrial glutathione
peroxidase."
"1650","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Hence, in the normal (non-diseased) state,
most of the ROS generated by the MRC is detoxified by
the mitochondrial antioxidant defences."
"1651","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"However, glutathione peroxidase needs
adequate amounts of reduced glutathione in the mitochondrial
matrix to detoxify H2O2."
"1652","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"The depletion of
mitochondrial glutathione below a critical threshold can
impair mitochondrial H2O2 detoxification, which can
trigger mitochondrial dysfunction, mitochondrial permeability
transition (MPT) and cell death [22]."
"1653","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"The depletion of
mitochondrial glutathione below a critical threshold can
impair mitochondrial H2O2 detoxification, which can
trigger mitochondrial dysfunction, mitochondrial permeability
transition (MPT) and cell death [22]."
"1654","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"The depletion of
mitochondrial glutathione below a critical threshold can
impair mitochondrial H2O2 detoxification, which can
trigger mitochondrial dysfunction, mitochondrial permeability
transition (MPT) and cell death [22]."
"1655","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"rupture of the outer membrane and the
release of pro-apoptotic proteins from the intermembrane
space into the cytosol. The release of apoptosis-inducing
factor (AIF) triggers the fragmentation of largesized
nuclear DNA."
"1656","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"The release of a protein called
‘second mitochondria-derived activator of caspase/
direct inhibitor of apoptosis-binding protein with low pI
(Smac/DIABLO)’ inactivates the inhibitor of apoptosis
proteins (IAPs)."
"1657","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"the released cytochrome c binds
in the cytosol to Apaf-1 in an ATP-dependent manner to
activate caspase-9."
"1658","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"the released cytochrome c binds
in the cytosol to Apaf-1 in an ATP-dependent manner to
activate caspase-9."
"1659","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial permeability transition can cause either
apoptosis or necrosis."
"1660","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial permeability transition can cause either
apoptosis or necrosis."
"1661","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"In contrast, when MPT occurs in most
mitochondria in a single cell, ATP generation is compromised
because of the collapse of the Dwm, and the
resulting ATP depletion triggers cell necrosis [2,24]."
"1662","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial permeability transition pore opening,
which is calcium-dependent, can be triggered by a
variety of endogenous compounds such as iron, ROS,
nitric oxide, free fatty acids (and acyl-CoA derivatives),
ceramide and bile salts [25,26]."
"1663","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial permeability transition pore opening,
which is calcium-dependent, can be triggered by a
variety of endogenous compounds such as iron, ROS,
nitric oxide, free fatty acids (and acyl-CoA derivatives),
ceramide and bile salts [25,26]."
"1664","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial permeability transition pore opening,
which is calcium-dependent, can be triggered by a
variety of endogenous compounds such as iron, ROS,
nitric oxide, free fatty acids (and acyl-CoA derivatives),
ceramide and bile salts [25,26]."
"1665","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial permeability transition pore opening,
which is calcium-dependent, can be triggered by a
variety of endogenous compounds such as iron, ROS,
nitric oxide, free fatty acids (and acyl-CoA derivatives),
ceramide and bile salts [25,26]."
"1666","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial permeability transition pore opening,
which is calcium-dependent, can be triggered by a
variety of endogenous compounds such as iron, ROS,
nitric oxide, free fatty acids (and acyl-CoA derivatives),
ceramide and bile salts [25,26]."
"1667","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Mitochondrial permeability transition pore opening,
which is calcium-dependent, can be triggered by a
variety of endogenous compounds such as iron, ROS,
nitric oxide, free fatty acids (and acyl-CoA derivatives),
ceramide and bile salts [25,26]."
"1668","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"MPT can also be
triggered by extracellular cytokines such as tumour
necrosis factor-a (TNF-a) and Fas ligand (Fas-L) acting
through their plasma membrane receptors [27,28]."
"1669","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"MPT can also be
triggered by extracellular cytokines such as tumour
necrosis factor-a (TNF-a) and Fas ligand (Fas-L) acting
through their plasma membrane receptors [27,28]."
"1670","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"troglitazone and
acetaminophen activate c-Jun N-terminal protein kinase
(JNK), thus inducing the cleavage of Bid, the translocation
of this pro-apoptotic protein to the outer mitochondrial
membranes and the release of cytochrome c from
mitochondria [32,33]."
"1671","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"troglitazone and
acetaminophen activate c-Jun N-terminal protein kinase
(JNK), thus inducing the cleavage of Bid, the translocation
of this pro-apoptotic protein to the outer mitochondrial
membranes and the release of cytochrome c from
mitochondria [32,33]."
"1672","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"troglitazone and
acetaminophen activate c-Jun N-terminal protein kinase
(JNK), thus inducing the cleavage of Bid, the translocation
of this pro-apoptotic protein to the outer mitochondrial
membranes and the release of cytochrome c from
mitochondria [32,33]."
"1673","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"Severe inhibition of mitochondrial b-oxidation can
lead to microvesicular steatosis characterized by the
presence of many tiny lipid droplets within the cytoplasm
of hepatocytes."
"1674","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:association","false",,,"Severe inhibition of mitochondrial b-oxidation can
lead to microvesicular steatosis characterized by the
presence of many tiny lipid droplets within the cytoplasm
of hepatocytes."
"1675","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"ROS overproduction may be a key event
in the pathogenesis of drug-induced steatohepatitis by
inducing lipid peroxidation (favoured by lipid accumulation),
and possibly by triggering the generation of proapoptotic
(TNF-a) and pro-fibrotic (TGF-b) cytokines by
Kupffer cells and other inflammatory cells [2,4,40]."
"1676","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"ROS overproduction may be a key event
in the pathogenesis of drug-induced steatohepatitis by
inducing lipid peroxidation (favoured by lipid accumulation),
and possibly by triggering the generation of proapoptotic
(TNF-a) and pro-fibrotic (TGF-b) cytokines by
Kupffer cells and other inflammatory cells [2,4,40]."
"1677","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"ROS overproduction may be a key event
in the pathogenesis of drug-induced steatohepatitis by
inducing lipid peroxidation (favoured by lipid accumulation),
and possibly by triggering the generation of proapoptotic
(TNF-a) and pro-fibrotic (TGF-b) cytokines by
Kupffer cells and other inflammatory cells [2,4,40]."
"1678","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"ROS overproduction may be a key event
in the pathogenesis of drug-induced steatohepatitis by
inducing lipid peroxidation (favoured by lipid accumulation),
and possibly by triggering the generation of proapoptotic
(TNF-a) and pro-fibrotic (TGF-b) cytokines by
Kupffer cells and other inflammatory cells [2,4,40]."
"1679","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"ROS overproduction may be a key event
in the pathogenesis of drug-induced steatohepatitis by
inducing lipid peroxidation (favoured by lipid accumulation),
and possibly by triggering the generation of proapoptotic
(TNF-a) and pro-fibrotic (TGF-b) cytokines by
Kupffer cells and other inflammatory cells [2,4,40]."
"1680","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"tamoxifen directly inhibits the transfer of
electrons within the MRC, and also progressively depletes
hepatic mtDNA through a mechanism that may involve
the inhibition of mitochondrial topoisomerases and the
impairment of mtDNA replication by this DNA-intercalating
drug [41,42]."
"1681","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"tamoxifen directly inhibits the transfer of
electrons within the MRC, and also progressively depletes
hepatic mtDNA through a mechanism that may involve
the inhibition of mitochondrial topoisomerases and the
impairment of mtDNA replication by this DNA-intercalating
drug [41,42]."
"1682","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"tamoxifen directly inhibits the transfer of
electrons within the MRC, and also progressively depletes
hepatic mtDNA through a mechanism that may involve
the inhibition of mitochondrial topoisomerases and the
impairment of mtDNA replication by this DNA-intercalating
drug [41,42]."
"1683","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"some drugs (e.g. amiodarone,
amineptine, pirprofen) also inhibit microsomal
triglyceride transfer protein (MTP), an enzyme playing a
major role in the formation of very-low-density-lipoprotein
(VLDL) particles [43]. Such drugs therefore inhibit
the two main pathways removing fat from the liver,
namely FAO and hepatic VLDL secretion."
"1684","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"some drugs (e.g. amiodarone,
amineptine, pirprofen) also inhibit microsomal
triglyceride transfer protein (MTP), an enzyme playing a
major role in the formation of very-low-density-lipoprotein
(VLDL) particles [43]. Such drugs therefore inhibit
the two main pathways removing fat from the liver,
namely FAO and hepatic VLDL secretion."
"1685","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"some drugs (e.g. amiodarone,
amineptine, pirprofen) also inhibit microsomal
triglyceride transfer protein (MTP), an enzyme playing a
major role in the formation of very-low-density-lipoprotein
(VLDL) particles [43]. Such drugs therefore inhibit
the two main pathways removing fat from the liver,
namely FAO and hepatic VLDL secretion."
"1686","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"some drugs (e.g. amiodarone,
amineptine, pirprofen) also inhibit microsomal
triglyceride transfer protein (MTP), an enzyme playing a
major role in the formation of very-low-density-lipoprotein
(VLDL) particles [43]. Such drugs therefore inhibit
the two main pathways removing fat from the liver,
namely FAO and hepatic VLDL secretion."
"1687","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"some drugs (e.g. amiodarone,
amineptine, pirprofen) also inhibit microsomal
triglyceride transfer protein (MTP), an enzyme playing a
major role in the formation of very-low-density-lipoprotein
(VLDL) particles [43]. Such drugs therefore inhibit
the two main pathways removing fat from the liver,
namely FAO and hepatic VLDL secretion."
"1688","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"some drugs (e.g. amiodarone,
amineptine, pirprofen) also inhibit microsomal
triglyceride transfer protein (MTP), an enzyme playing a
major role in the formation of very-low-density-lipoprotein
(VLDL) particles [43]. Such drugs therefore inhibit
the two main pathways removing fat from the liver,
namely FAO and hepatic VLDL secretion."
"1689","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Cationic amphiphilic drugs such as amiodarone, perhexiline,
diethylaminoethoxyhexestrol (DEAEH) and
tamoxifen can be first protonated in the intermembrane
space of mitochondria, and then electrophoretically
transported into the mitochondrial matrix thanks to
the Dwm [3,4,40,42]....This phenomenon,
which is called ‘OXPHOS uncoupling’, can
also be observed in the case of some mitochondrial
poisons such as the protonophores 2,4-dinitrophenol
(DNP) and carbonylcyanide p-trifluoromethoxyphenylhydrazone
(FCCP)."
"1690","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Cationic amphiphilic drugs such as amiodarone, perhexiline,
diethylaminoethoxyhexestrol (DEAEH) and
tamoxifen can be first protonated in the intermembrane
space of mitochondria, and then electrophoretically
transported into the mitochondrial matrix thanks to
the Dwm [3,4,40,42]....This phenomenon,
which is called ‘OXPHOS uncoupling’, can
also be observed in the case of some mitochondrial
poisons such as the protonophores 2,4-dinitrophenol
(DNP) and carbonylcyanide p-trifluoromethoxyphenylhydrazone
(FCCP)."
"1691","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Cationic amphiphilic drugs such as amiodarone, perhexiline,
diethylaminoethoxyhexestrol (DEAEH) and
tamoxifen can be first protonated in the intermembrane
space of mitochondria, and then electrophoretically
transported into the mitochondrial matrix thanks to
the Dwm [3,4,40,42]....This phenomenon,
which is called ‘OXPHOS uncoupling’, can
also be observed in the case of some mitochondrial
poisons such as the protonophores 2,4-dinitrophenol
(DNP) and carbonylcyanide p-trifluoromethoxyphenylhydrazone
(FCCP)."
"1692","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"Cationic amphiphilic drugs such as amiodarone, perhexiline,
diethylaminoethoxyhexestrol (DEAEH) and
tamoxifen can be first protonated in the intermembrane
space of mitochondria, and then electrophoretically
transported into the mitochondrial matrix thanks to
the Dwm [3,4,40,42]....This phenomenon,
which is called ‘OXPHOS uncoupling’, can
also be observed in the case of some mitochondrial
poisons such as the protonophores 2,4-dinitrophenol
(DNP) and carbonylcyanide p-trifluoromethoxyphenylhydrazone
(FCCP)."
"1693","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"Finally, it must be pointed out that another important
consequence of drug-induced OXPHOS uncoupling is
the reduction of ATP synthesis, as the re-entry of
protons within the mitochondrial matrix bypasses ATP
synthase [3,40]."
"1694","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:decreases","false",,,"valproic acid inhibits mitochondrial FAO through the
sequestration of coenzyme A (a cofactor mandatory for
FAO),"
"1695","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"this antiepileptic drug can induce
MPT (Figure 1) [29], which may explain why valproateinduced
microvesicular steatosis can be associated with
liver cell death [2]."
"1696","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"ethanol intoxication
also increases cytochrome P450 2E1 (CYP2E1)
levels, not only in the endoplasmic reticulum but
also in mitochondria [77]."
"1697","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"ethanol intoxication
also increases cytochrome P450 2E1 (CYP2E1)
levels, not only in the endoplasmic reticulum but
also in mitochondria [77]."
"1698","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"The ectopic localization of
CYP2E1 may enhance the mitochondrial generation of
N-acetyl-p-benzoquinone imine (NAPQI), the toxic
metabolite of acetaminophen."
"1699","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:increases","false",,,"As the reactive NAPQI
has a direct toxicity effect on mitochondria, in particular
by triggering MPT [78,79]"
"1700","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:association","false",,,"An example is the combined role of
aspirin and viral infections in the occurrence of Reye’s
syndrome, a severe post-infectious metabolic disease
characterized by extensive microvesicular steatosis of the
liver, severe hypoglycaemia and a non-inflammatory
encephalopathy [3,83]."
"1701","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:association","false",,,"An example is the combined role of
aspirin and viral infections in the occurrence of Reye’s
syndrome, a severe post-infectious metabolic disease
characterized by extensive microvesicular steatosis of the
liver, severe hypoglycaemia and a non-inflammatory
encephalopathy [3,83]."
"1702","Labbe GPessayre DFromenty B","18705745","Fundamental & clinical pharmacology","PubMed",,,"bel:association","false",,,"An example is the combined role of
aspirin and viral infections in the occurrence of Reye’s
syndrome, a severe post-infectious metabolic disease
characterized by extensive microvesicular steatosis of the
liver, severe hypoglycaemia and a non-inflammatory
encephalopathy [3,83]."
"1703","Dellaire GMakarov EMCowger JJLongman DSutherland HGL??hrmann RTorchia JBickmore WA","12077342","Molecular and cellular biology","PubMed",,,"bel:directlyDecreases","false",,,"The differentially migrating forms of PRP4K detected by Western blot analysis (Fig. 2C) suggest that it is posttranslationally modified. Phosphatase treatment of nuclear extracts reduces most PRP4K to the 147-kDa fast-migrating form (Fig. 5D). Thus, the slower-migrating forms of PRP4K are phosphorylated, and it is only the hypophosphorylated (147 kDa) form that is coimmunoprecipitated by BRG1 and PRP6 antibodies (Fig. 5B and C). "
"1704","Dellaire GMakarov EMCowger JJLongman DSutherland HGL??hrmann RTorchia JBickmore WA","12077342","Molecular and cellular biology","PubMed",,,"bel:directlyDecreases","false",,,"The differentially migrating forms of PRP4K detected by Western blot analysis (Fig. 2C) suggest that it is posttranslationally modified. Phosphatase treatment of nuclear extracts reduces most PRP4K to the 147-kDa fast-migrating form (Fig. 5D). Thus, the slower-migrating forms of PRP4K are phosphorylated, and it is only the hypophosphorylated (147 kDa) form that is coimmunoprecipitated by BRG1 and PRP6 antibodies (Fig. 5B and C). "
"1705","Dellaire GMakarov EMCowger JJLongman DSutherland HGL??hrmann RTorchia JBickmore WA","12077342","Molecular and cellular biology","PubMed",,,"bel:directlyIncreases","false",,,"A strongly labeled doublet (Fig. 6, band B) corresponds to the relative position of PRP4K, a finding consistent with the reported ability of mammalian PRP4K homologues to autophosphorylate (19, 27). Two other prominently labeled proteins correspond in size to BRG1 and PRP6 (Fig. 6, bands A and C, respectively). To confirm that these proteins were indeed BRG1 and PRP6, we carried out kinase assays with BRG1 and PRP6 IP complexes, which also contain coimmunoprecipitated PRP4K (Fig. 5). These immunoprecipitates do exhibit kinase activity, and both phosphorylated PRP6 and BRG1 are much more intense in their respective IP reactions, reflecting the relative increase in each substrate for PRP4K. "
"1706","Dellaire GMakarov EMCowger JJLongman DSutherland HGL??hrmann RTorchia JBickmore WA","12077342","Molecular and cellular biology","PubMed",,,"bel:directlyIncreases","false",,,"A strongly labeled doublet (Fig. 6, band B) corresponds to the relative position of PRP4K, a finding consistent with the reported ability of mammalian PRP4K homologues to autophosphorylate (19, 27). Two other prominently labeled proteins correspond in size to BRG1 and PRP6 (Fig. 6, bands A and C, respectively). To confirm that these proteins were indeed BRG1 and PRP6, we carried out kinase assays with BRG1 and PRP6 IP complexes, which also contain coimmunoprecipitated PRP4K (Fig. 5). These immunoprecipitates do exhibit kinase activity, and both phosphorylated PRP6 and BRG1 are much more intense in their respective IP reactions, reflecting the relative increase in each substrate for PRP4K. "
"1707","Dellaire GMakarov EMCowger JJLongman DSutherland HGL??hrmann RTorchia JBickmore WA","12077342","Molecular and cellular biology","PubMed",,,"bel:directlyIncreases","false",,,"A strongly labeled doublet (Fig. 6, band B) corresponds to the relative position of PRP4K, a finding consistent with the reported ability of mammalian PRP4K homologues to autophosphorylate (19, 27). Two other prominently labeled proteins correspond in size to BRG1 and PRP6 (Fig. 6, bands A and C, respectively). To confirm that these proteins were indeed BRG1 and PRP6, we carried out kinase assays with BRG1 and PRP6 IP complexes, which also contain coimmunoprecipitated PRP4K (Fig. 5). These immunoprecipitates do exhibit kinase activity, and both phosphorylated PRP6 and BRG1 are much more intense in their respective IP reactions, reflecting the relative increase in each substrate for PRP4K. "
"1708","Tagliabue EAgresti RCarcangiu MLGhirelli CMorelli DCampiglio MMartel MGiovanazzi RGreco MBalsari AM??nard S","12932384","Lancet","PubMed",,,"bel:increases","false",,,"Residual breast carcinomas that had been
surgically removed within 48 days after first surgery
showed a significant increase in proliferation if they were
HER2-positive. Wound drainage fluid and postsurgical
serum samples from patients stimulated in-vitro growth of
HER2-overexpressing breast carcinoma cells. Removal of
HER2 from the cell membrane led to a striking reduction of
the induced proliferation."
"1709","Tagliabue EAgresti RCarcangiu MLGhirelli CMorelli DCampiglio MMartel MGiovanazzi RGreco MBalsari AM??nard S","12932384","Lancet","PubMed",,,"bel:increases","false",,,"To determine the potential role
of these growth factors in cell growth induced by
drainage fluid, MDAMB453 cells were treated with
drainage fluids in the presence of neutralising antibodies
against HB-EGF or TGFalpha. Cell proliferation induced
by all drainage fluids was found to decrease by about
50% and 30%, respectively, and no further decrease was
noted in the presence of both antibodies together, as
shown by selected data shown for two drainage fluids
in figure 3."
"1710","Tagliabue EAgresti RCarcangiu MLGhirelli CMorelli DCampiglio MMartel MGiovanazzi RGreco MBalsari AM??nard S","12932384","Lancet","PubMed",,,"bel:increases","false",,,"To determine the potential role
of these growth factors in cell growth induced by
drainage fluid, MDAMB453 cells were treated with
drainage fluids in the presence of neutralising antibodies
against HB-EGF or TGFalpha. Cell proliferation induced
by all drainage fluids was found to decrease by about
50% and 30%, respectively, and no further decrease was
noted in the presence of both antibodies together, as
shown by selected data shown for two drainage fluids
in figure 3."
"1711","Tagliabue EAgresti RCarcangiu MLGhirelli CMorelli DCampiglio MMartel MGiovanazzi RGreco MBalsari AM??nard S","12932384","Lancet","PubMed",,,"bel:positiveCorrelation","false",,,"In the other five cases, the concentrations of
EGF-like factors were below the detection limits in both
presurgical and postsurgical serum samples. A highly
significant direct correlation (r=0·77, 95% CI 0·49–0·92,
p=0·002) was found between EGF in postsurgical serum
and cellular damage induced by surgery, measured on the
basis of creatine phosphokinase concentration in drainage
fluids obtained 1 day after surgery (figure 4). The degree
of drainage-fluid-induced MDAMB453 cell proliferation
also directly correlated with creatine phosphokinase
concentration (r=0·69, 95% CI 0·25–0·91, p=0·009;
figure 4)."
"1712","Tagliabue EAgresti RCarcangiu MLGhirelli CMorelli DCampiglio MMartel MGiovanazzi RGreco MBalsari AM??nard S","12932384","Lancet","PubMed",,,"bel:positiveCorrelation","false",,,"In the other five cases, the concentrations of
EGF-like factors were below the detection limits in both
presurgical and postsurgical serum samples. A highly
significant direct correlation (r=0·77, 95% CI 0·49–0·92,
p=0·002) was found between EGF in postsurgical serum
and cellular damage induced by surgery, measured on the
basis of creatine phosphokinase concentration in drainage
fluids obtained 1 day after surgery (figure 4). The degree
of drainage-fluid-induced MDAMB453 cell proliferation
also directly correlated with creatine phosphokinase
concentration (r=0·69, 95% CI 0·25–0·91, p=0·009;
figure 4)."
"1713","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"We show that protein kinase C (PKC) alpha is translocated to the plasma membrane and activated by adhesion of MM cells to fibronectin and VEGF. We identify beta(1) integrin modulating VEGF-triggered MM cell migration on fibronectin. We show that transient enhancement of MM cell adhesion to fibronectin triggered by VEGF is dependent on the activity of both PKC and beta(1) integrin. Moreover, we demonstrate that PKC alpha is constitutively associated with beta(1) integrin. "
"1714","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"We show that protein kinase C (PKC) alpha is translocated to the plasma membrane and activated by adhesion of MM cells to fibronectin and VEGF. We identify beta(1) integrin modulating VEGF-triggered MM cell migration on fibronectin. We show that transient enhancement of MM cell adhesion to fibronectin triggered by VEGF is dependent on the activity of both PKC and beta(1) integrin. Moreover, we demonstrate that PKC alpha is constitutively associated with beta(1) integrin. "
"1715","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"We show that protein kinase C (PKC) alpha is translocated to the plasma membrane and activated by adhesion of MM cells to fibronectin and VEGF. We identify beta(1) integrin modulating VEGF-triggered MM cell migration on fibronectin. We show that transient enhancement of MM cell adhesion to fibronectin triggered by VEGF is dependent on the activity of both PKC and beta(1) integrin. Moreover, we demonstrate that PKC alpha is constitutively associated with beta(1) integrin. "
"1716","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"We show that protein kinase C (PKC) alpha is translocated to the plasma membrane and activated by adhesion of MM cells to fibronectin and VEGF. We identify beta(1) integrin modulating VEGF-triggered MM cell migration on fibronectin. We show that transient enhancement of MM cell adhesion to fibronectin triggered by VEGF is dependent on the activity of both PKC and beta(1) integrin. Moreover, we demonstrate that PKC alpha is constitutively associated with beta(1) integrin. "
"1717","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"hese data are consistent with PKC alpha-dependent exocytosis of activated beta(1) integrin to the plasma membrane, where its increased surface expression mediates binding to fibronectin; conversely, catalytically active PKC alpha-driven internalization of beta(1) integrin results in MM cell de-adhesion. "
"1718","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"hese data are consistent with PKC alpha-dependent exocytosis of activated beta(1) integrin to the plasma membrane, where its increased surface expression mediates binding to fibronectin; conversely, catalytically active PKC alpha-driven internalization of beta(1) integrin results in MM cell de-adhesion. "
"1719","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"hese data are consistent with PKC alpha-dependent exocytosis of activated beta(1) integrin to the plasma membrane, where its increased surface expression mediates binding to fibronectin; conversely, catalytically active PKC alpha-driven internalization of beta(1) integrin results in MM cell de-adhesion. "
"1720","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"We show that the regulatory subunit of phosphatidylinositol (PI) 3-kinase (p85) is constitutively associated with FMS-like tyrosine kinase-1 (Flt-1). VEGF stimulates activation of PI 3-kinase, and both MM cell adhesion and migration are PI 3-kinase-dependent. Moreover, both VEGF-induced PI 3-kinase activation and beta(1) integrin-mediated binding to fibronectin are required for the recruitment and activation of PKC alpha."
"1721","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"We show that the regulatory subunit of phosphatidylinositol (PI) 3-kinase (p85) is constitutively associated with FMS-like tyrosine kinase-1 (Flt-1). VEGF stimulates activation of PI 3-kinase, and both MM cell adhesion and migration are PI 3-kinase-dependent. Moreover, both VEGF-induced PI 3-kinase activation and beta(1) integrin-mediated binding to fibronectin are required for the recruitment and activation of PKC alpha."
"1722","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"We show that the regulatory subunit of phosphatidylinositol (PI) 3-kinase (p85) is constitutively associated with FMS-like tyrosine kinase-1 (Flt-1). VEGF stimulates activation of PI 3-kinase, and both MM cell adhesion and migration are PI 3-kinase-dependent. Moreover, both VEGF-induced PI 3-kinase activation and beta(1) integrin-mediated binding to fibronectin are required for the recruitment and activation of PKC alpha."
"1723","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"We show that the regulatory subunit of phosphatidylinositol (PI) 3-kinase (p85) is constitutively associated with FMS-like tyrosine kinase-1 (Flt-1). VEGF stimulates activation of PI 3-kinase, and both MM cell adhesion and migration are PI 3-kinase-dependent. Moreover, both VEGF-induced PI 3-kinase activation and beta(1) integrin-mediated binding to fibronectin are required for the recruitment and activation of PKC alpha."
"1724","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"We show that the regulatory subunit of phosphatidylinositol (PI) 3-kinase (p85) is constitutively associated with FMS-like tyrosine kinase-1 (Flt-1). VEGF stimulates activation of PI 3-kinase, and both MM cell adhesion and migration are PI 3-kinase-dependent. Moreover, both VEGF-induced PI 3-kinase activation and beta(1) integrin-mediated binding to fibronectin are required for the recruitment and activation of PKC alpha."
"1725","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"We show that the regulatory subunit of phosphatidylinositol (PI) 3-kinase (p85) is constitutively associated with FMS-like tyrosine kinase-1 (Flt-1). VEGF stimulates activation of PI 3-kinase, and both MM cell adhesion and migration are PI 3-kinase-dependent. Moreover, both VEGF-induced PI 3-kinase activation and beta(1) integrin-mediated binding to fibronectin are required for the recruitment and activation of PKC alpha."
"1726","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"After VEGF stimulation of cells seeded on fibronectin, PKC? translocated into the membrane fraction after 30 min (Fig. 2  a), whereas no significant changes in distribution of PKC isoforms as PKC?, PKC?, and PKC? were observed. "
"1727","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:causesNoChange","false",,,"After VEGF stimulation of cells seeded on fibronectin, PKC? translocated into the membrane fraction after 30 min (Fig. 2  a), whereas no significant changes in distribution of PKC isoforms as PKC?, PKC?, and PKC? were observed. "
"1728","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:causesNoChange","false",,,"After VEGF stimulation of cells seeded on fibronectin, PKC? translocated into the membrane fraction after 30 min (Fig. 2  a), whereas no significant changes in distribution of PKC isoforms as PKC?, PKC?, and PKC? were observed. "
"1729","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:causesNoChange","false",,,"After VEGF stimulation of cells seeded on fibronectin, PKC? translocated into the membrane fraction after 30 min (Fig. 2  a), whereas no significant changes in distribution of PKC isoforms as PKC?, PKC?, and PKC? were observed. "
"1730","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"The activation of PKC? after VEGF treatment of cells attached to fibronectin was further supported by a 2-fold increase in PKC?-IP kinase activity;"
"1731","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"As shown previously, MM cells spontaneously adhered to fibronectin, and this adhesion was increased upon stimulation with VEGF (Fig.3  a)."
"1732","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"As shown in Fig. 3,d–e, incubation with the PKC inhibitor BIM I (as well as with the ?1-neutralizing mAb) blocked dose-dependent VEGF-induced cell adhesion to fibronectin. This involvement of PKC in MM cell adhesion to fibronectin was further confirmed by a dose-dependent increment of adhesion triggered by PMA stimulation (Fig. 3  d) similar to that induced by VEGF. Taken together, our results show that VEGF transiently enhances MM cell adhesion to fibronectin, dependent on both PKC and ?1 integrin activity. "
"1733","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"These data confirm that ?1integrin (CD29) is the integrin primarily associated with VEGF-triggered MM cell migration on fibronectin. "
"1734","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Figure 4

VEGFR-1/Flt-1 associates with ?1 integrin and CADTK and enhances CADTK-phosphorylation, dependent on PKC and ?1 integrin activation. "
"1735","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Figure 4

VEGFR-1/Flt-1 associates with ?1 integrin and CADTK and enhances CADTK-phosphorylation, dependent on PKC and ?1 integrin activation. "
"1736","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Figure 4

VEGFR-1/Flt-1 associates with ?1 integrin and CADTK and enhances CADTK-phosphorylation, dependent on PKC and ?1 integrin activation. "
"1737","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Panel a, co-immunoprecipitation of CADTK and ?1 integrin with PKC?. Panel b, constitutive association of Flt-1 and CADTK. Panel c, activation of CADTK upon treatment with PMA (300 nm), 20 min. Panel d, additional increase of CADTK phosphorylation in the presence of VEGF (100 ng/ml). Panel e, dependence of VEGF-induced CADTK activation on PKC and ?1  integrin. ?1, ?1 integrin; pY, phosphotyrosine; C, IP control "
"1738","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Panel a, co-immunoprecipitation of CADTK and ?1 integrin with PKC?. Panel b, constitutive association of Flt-1 and CADTK. Panel c, activation of CADTK upon treatment with PMA (300 nm), 20 min. Panel d, additional increase of CADTK phosphorylation in the presence of VEGF (100 ng/ml). Panel e, dependence of VEGF-induced CADTK activation on PKC and ?1  integrin. ?1, ?1 integrin; pY, phosphotyrosine; C, IP control "
"1739","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"we have shown previously that CADTK is activated upon dexamethasone treatment, suggesting its role in dexamethasone-induced apoptosis (47)."
"1740","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Our results show that VEGF induces the association of CADTK with the ?1  integrin/PKC? protein complex (Fig. 4  a). "
"1741","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"We have shown recently that Flt-1 VEGFR is expressed in the human MM cell line and patient MM cells and is tyrosine-phosphorylated upon VEGF stimulation (12). Because Flt-1 and the p85 subunit of PI 3-kinase were associated when overexpressed in yeast cells (54), we next determined whether this interaction is biologically significant in MM cells. Flt-1 was immunoprecipitated from VEGF treated and non-treated MM.1S cells followed by immunoblotting with anti-p85 Ab. As illustrated in Fig.5  a, p85 is constitutively associated with Flt-1, suggesting that PI 3-kinase participates in Flt-1-mediated VEGF signal transduction. "
"1742","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"VEGF induced tyrosine phosphorylation of the regulatory p85 subunit of PI 3-kinase, evidenced by immunoblotting of anti-p85 immunoprecipitates with an anti-pY mAb (Fig. 5  b). Moreover, immunoblotting of anti-pY immunoprecipitates with specific p85 mAb showed an increased association of p85 with tyrosine-phosphorylated proteins, which was maximal after 5 min of VEGF treatment (Fig. 5  c). To determine whether VEGF-induced p85 phosphorylation regulates p110, the catalytic counterpart of PI 3-kinase, we performed in vitrokinase assays using PI 4,5-bisphosphate as a substrate. As shown in Fig. 5  d, VEGF induced peak activation (6-fold) of PI 3-kinase activity at 5 min. "
"1743","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"VEGF induced tyrosine phosphorylation of the regulatory p85 subunit of PI 3-kinase, evidenced by immunoblotting of anti-p85 immunoprecipitates with an anti-pY mAb (Fig. 5  b). Moreover, immunoblotting of anti-pY immunoprecipitates with specific p85 mAb showed an increased association of p85 with tyrosine-phosphorylated proteins, which was maximal after 5 min of VEGF treatment (Fig. 5  c). To determine whether VEGF-induced p85 phosphorylation regulates p110, the catalytic counterpart of PI 3-kinase, we performed in vitrokinase assays using PI 4,5-bisphosphate as a substrate. As shown in Fig. 5  d, VEGF induced peak activation (6-fold) of PI 3-kinase activity at 5 min. "
"1744","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"When PI 3-kinase activation in MM cells seeded on fibronectin was inhibited by LY294002, PKC? recruitment to the plasma membrane was also abrogated (Fig. 6). These results indicate that VEGF-induced PI 3-kinase activation along with ?1  integrin binding to fibronectin activate PKC?. "
"1745","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"When PI 3-kinase activation in MM cells seeded on fibronectin was inhibited by LY294002, PKC? recruitment to the plasma membrane was also abrogated (Fig. 6). These results indicate that VEGF-induced PI 3-kinase activation along with ?1  integrin binding to fibronectin activate PKC?. "
"1746","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"When PI 3-kinase activation in MM cells seeded on fibronectin was inhibited by LY294002, PKC? recruitment to the plasma membrane was also abrogated (Fig. 6). These results indicate that VEGF-induced PI 3-kinase activation along with ?1  integrin binding to fibronectin activate PKC?. "
"1747","Podar KTai YTLin BKNarsimhan RPSattler MKijima TSalgia RGupta DChauhan DAnderson KC","11751905","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"s seen in Fig. 7  a, VEGF added to the conditioned medium in the lower chamber induced a dose-dependent migration of growth factor-deprived MM.1S cells seeded on fibronectin in the upper chamber, which was totally inhibited by the PKC inhibitor BIM I. Preincubation with the PI 3-kinase inhibitor LY294002 (20 ?m) at 37?°C for 45 min prior to VEGF stimulation similarly inhibited MM cell migration. "
"1748","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:increases","false",,,"Here, we show that repetitive slow fiber type electrical stimulation, but not fast fiber type stimulation, caused HDAC4-GFP, but not HDAC5-GFP, to translocate from the nucleus to the cytoplasm in cultured adult skeletal muscle fibers. HDAC4-GFP translocation was blocked by calmodulin-dependent protein kinase (CaMK) inhibitor KN-62. "
"1749","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:causesNoChange","false",,,"Here, we show that repetitive slow fiber type electrical stimulation, but not fast fiber type stimulation, caused HDAC4-GFP, but not HDAC5-GFP, to translocate from the nucleus to the cytoplasm in cultured adult skeletal muscle fibers. HDAC4-GFP translocation was blocked by calmodulin-dependent protein kinase (CaMK) inhibitor KN-62. "
"1750","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:directlyDecreases","false",,,"Here, we show that repetitive slow fiber type electrical stimulation, but not fast fiber type stimulation, caused HDAC4-GFP, but not HDAC5-GFP, to translocate from the nucleus to the cytoplasm in cultured adult skeletal muscle fibers. HDAC4-GFP translocation was blocked by calmodulin-dependent protein kinase (CaMK) inhibitor KN-62. "
"1751","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:increases","false",,,"Slow fiber type stimulation increased MEF2 transcriptional activity, nuclear Ca2+ concentration, and nuclear levels of activated CaMKII, but not total nuclear CaMKII or CaM-YFP. Thus, calcium transients for slow, but not fast, fiber stimulation patterns appear to provide sufficient Ca2+-dependent activation of nuclear CaMKII to result in net nuclear efflux of HDAC4. "
"1752","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:increases","false",,,"Slow fiber type stimulation increased MEF2 transcriptional activity, nuclear Ca2+ concentration, and nuclear levels of activated CaMKII, but not total nuclear CaMKII or CaM-YFP. Thus, calcium transients for slow, but not fast, fiber stimulation patterns appear to provide sufficient Ca2+-dependent activation of nuclear CaMKII to result in net nuclear efflux of HDAC4. "
"1753","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:increases","false",,,"Slow fiber type stimulation increased MEF2 transcriptional activity, nuclear Ca2+ concentration, and nuclear levels of activated CaMKII, but not total nuclear CaMKII or CaM-YFP. Thus, calcium transients for slow, but not fast, fiber stimulation patterns appear to provide sufficient Ca2+-dependent activation of nuclear CaMKII to result in net nuclear efflux of HDAC4. "
"1754","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:directlyIncreases","false",,,"Slow fiber type stimulation increased MEF2 transcriptional activity, nuclear Ca2+ concentration, and nuclear levels of activated CaMKII, but not total nuclear CaMKII or CaM-YFP. Thus, calcium transients for slow, but not fast, fiber stimulation patterns appear to provide sufficient Ca2+-dependent activation of nuclear CaMKII to result in net nuclear efflux of HDAC4. "
"1755","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:directlyIncreases","false",,,"It is known that CaMK can phosphorylate class II HDACs (Grozinger and Schreiber, 2000; Wang et al., 2000). Phosphorylated intranuclear HDACs bind to 14-3-3 proteins (McKinsey et al., 2001), exposing a nuclear export signal at the HDAC COOH terminus and thus allowing HDAC translocation to the cytoplasm. "
"1756","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:directlyIncreases","false",,,"It is known that CaMK can phosphorylate class II HDACs (Grozinger and Schreiber, 2000; Wang et al., 2000). Phosphorylated intranuclear HDACs bind to 14-3-3 proteins (McKinsey et al., 2001), exposing a nuclear export signal at the HDAC COOH terminus and thus allowing HDAC translocation to the cytoplasm. "
"1757","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:directlyIncreases","false",,,"It is known that CaMK can phosphorylate class II HDACs (Grozinger and Schreiber, 2000; Wang et al., 2000). Phosphorylated intranuclear HDACs bind to 14-3-3 proteins (McKinsey et al., 2001), exposing a nuclear export signal at the HDAC COOH terminus and thus allowing HDAC translocation to the cytoplasm. "
"1758","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:increases","false",,,"1 h of 10-Hz train stimulation significantly increased (P < 0.01) the mean nuclear stain of activated CaMKII compared with unstimulated fibers, and KN-62 (5 ?M) blocked the increase in activated CaMKII staining after stimulation (Fig. 3 A). In parallel experiments, in which the fibers were stained with antibody directed against total CaMKII, there was no difference in mean nuclear antibody stain between stimulated and unstimulated fibers (P > 0.05; Fig. 3 A). These results are consistent with activation of nuclear CaMKII by fiber electrical stimulation without any appreciable translocation of CaMKII from the cytoplasm to the nucleus. "
"1759","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:increases","false",,,"The same stimulation (5 h, followed by 19 h without stimulation) in the presence of the CaMK inhibitor KN-62 gave the same luciferase activity as control. Thus, KN-62 completely blocked the stimulation-dependent increase in MEF2 reporter activity, just as KN-62 completely blocked the stimulation-dependent efflux of HDAC4 from the nucleus (Fig. 2). "
"1760","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:decreases","false",,,"The same stimulation (5 h, followed by 19 h without stimulation) in the presence of the CaMK inhibitor KN-62 gave the same luciferase activity as control. Thus, KN-62 completely blocked the stimulation-dependent increase in MEF2 reporter activity, just as KN-62 completely blocked the stimulation-dependent efflux of HDAC4 from the nucleus (Fig. 2). "
"1761","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:increases","false",,,"In contrast to the lack of effect of electrical stimulation on the distribution of CaM, prolonged continuous elevation of Ca2+ concentration by addition of ionomycin (2 ?M) to the bathing solution (presumably elevating both cytosolic and nuclear Ca2+ concentration) did give rise to a delayed redistribution of CaM from the cytoplasm to the nucleus,"
"1762","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:increases","false",,,"In contrast to the lack of effect of electrical stimulation on the distribution of CaM, prolonged continuous elevation of Ca2+ concentration by addition of ionomycin (2 ?M) to the bathing solution (presumably elevating both cytosolic and nuclear Ca2+ concentration) did give rise to a delayed redistribution of CaM from the cytoplasm to the nucleus,"
"1763","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:increases","false",,,"Nuclear and cytoplasmic calcium is elevated during electrical stimulation"
"1764","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:directlyDecreases","false",,,"Leptomycin B binds to the nuclear export mediator protein CRM1, thereby blocking the binding of CRM1 to proteins containing the nuclear export signal (Fukuda et al., 1997) and preventing their nuclear export. During exposure to leptomycin B (40 nM), nuclear HDAC4-GFP continuously increased over a 60-min experimental period, whereas the cytoplasmic fluorescence signal was stable (Fig. 8 A). "
"1765","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:increases","false",,,"Leptomycin B binds to the nuclear export mediator protein CRM1, thereby blocking the binding of CRM1 to proteins containing the nuclear export signal (Fukuda et al., 1997) and preventing their nuclear export. During exposure to leptomycin B (40 nM), nuclear HDAC4-GFP continuously increased over a 60-min experimental period, whereas the cytoplasmic fluorescence signal was stable (Fig. 8 A). "
"1766","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:directlyDecreases","false",,,"ver a 60-min period of treatment with 1 ?M calyculin A (a PP1 and PP2A phosphatase inhibitor that does not affect PP2B; Ishihara et al., 1989), the nuclear HDAC4-GFP fluorescence decreased linearly with a mean net export rate of ?0.71 ± 0.07%/min (Fig. 9 A, 13 nuclei from 5 fibers). "
"1767","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:directlyDecreases","false",,,"ver a 60-min period of treatment with 1 ?M calyculin A (a PP1 and PP2A phosphatase inhibitor that does not affect PP2B; Ishihara et al., 1989), the nuclear HDAC4-GFP fluorescence decreased linearly with a mean net export rate of ?0.71 ± 0.07%/min (Fig. 9 A, 13 nuclei from 5 fibers). "
"1768","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:increases","false",,,"ver a 60-min period of treatment with 1 ?M calyculin A (a PP1 and PP2A phosphatase inhibitor that does not affect PP2B; Ishihara et al., 1989), the nuclear HDAC4-GFP fluorescence decreased linearly with a mean net export rate of ?0.71 ± 0.07%/min (Fig. 9 A, 13 nuclei from 5 fibers). "
"1769","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:causesNoChange","false",,,"ver a 60-min period of treatment with 1 ?M calyculin A (a PP1 and PP2A phosphatase inhibitor that does not affect PP2B; Ishihara et al., 1989), the nuclear HDAC4-GFP fluorescence decreased linearly with a mean net export rate of ?0.71 ± 0.07%/min (Fig. 9 A, 13 nuclei from 5 fibers). "
"1770","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:increases","false",,,"Interestingly, calyculin A also caused a similar rate of efflux of HDAC5-GFP (?0.62 ± 0.05, nine nuclei from six fibers) from nuclei as observed for HDAC4, establishing the ability of HDAC5 to move out of the nucleus even though it did not translocate in response to electrical stimulation. "
"1771","Liu YRandall WRSchneider MF","15767461","The Journal of cell biology","PubMed",,,"bel:causesNoChange","false",,,"Interestingly, calyculin A also caused a similar rate of efflux of HDAC5-GFP (?0.62 ± 0.05, nine nuclei from six fibers) from nuclei as observed for HDAC4, establishing the ability of HDAC5 to move out of the nucleus even though it did not translocate in response to electrical stimulation. "
"1772","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"LPS + IFNgamma caused an increase in monolayer permeability, induction of iNOS and NADPH oxidase type 1 (Nox1) proteins, formation of superoxide, nitric oxide and 3-nitrotyrosine, and increase in PP2A activity in endothelial cells. These effects of LPS + IFNgamma were diminished by tripterine (50-200 nM)."
"1773","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"LPS + IFNgamma caused an increase in monolayer permeability, induction of iNOS and NADPH oxidase type 1 (Nox1) proteins, formation of superoxide, nitric oxide and 3-nitrotyrosine, and increase in PP2A activity in endothelial cells. These effects of LPS + IFNgamma were diminished by tripterine (50-200 nM)."
"1774","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"LPS + IFNgamma caused an increase in monolayer permeability, induction of iNOS and NADPH oxidase type 1 (Nox1) proteins, formation of superoxide, nitric oxide and 3-nitrotyrosine, and increase in PP2A activity in endothelial cells. These effects of LPS + IFNgamma were diminished by tripterine (50-200 nM)."
"1775","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"LPS + IFNgamma caused an increase in monolayer permeability, induction of iNOS and NADPH oxidase type 1 (Nox1) proteins, formation of superoxide, nitric oxide and 3-nitrotyrosine, and increase in PP2A activity in endothelial cells. These effects of LPS + IFNgamma were diminished by tripterine (50-200 nM)."
"1776","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"LPS + IFNgamma caused an increase in monolayer permeability, induction of iNOS and NADPH oxidase type 1 (Nox1) proteins, formation of superoxide, nitric oxide and 3-nitrotyrosine, and increase in PP2A activity in endothelial cells. These effects of LPS + IFNgamma were diminished by tripterine (50-200 nM)."
"1777","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"LPS + IFNgamma caused an increase in monolayer permeability, induction of iNOS and NADPH oxidase type 1 (Nox1) proteins, formation of superoxide, nitric oxide and 3-nitrotyrosine, and increase in PP2A activity in endothelial cells. These effects of LPS + IFNgamma were diminished by tripterine (50-200 nM)."
"1778","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"LPS + IFNgamma caused an increase in monolayer permeability, induction of iNOS and NADPH oxidase type 1 (Nox1) proteins, formation of superoxide, nitric oxide and 3-nitrotyrosine, and increase in PP2A activity in endothelial cells. These effects of LPS + IFNgamma were diminished by tripterine (50-200 nM)."
"1779","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:directlyDecreases","false",,,"Further, LPS + IFNgamma-induced expression of iNOS and Nox1 was attenuated by the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor PD98059, the JNK inhibitor SP600125, the Jak2 inhibitor AG490 and the NFkappaB inhibitor MG132, but not by the p38 mitogen-activated protein kinase inhibitor SB203580. LPS + IFNgamma stimulated phosphorylation of ERK, JNK and Jak2, and degradation of IkappaB, but only Jak2 phosphorylation was sensitive to tripterine (50-200 nM). Further, tripterine diminished the increased vascular permeability in inflamed air pouches. "
"1780","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:directlyDecreases","false",,,"Further, LPS + IFNgamma-induced expression of iNOS and Nox1 was attenuated by the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor PD98059, the JNK inhibitor SP600125, the Jak2 inhibitor AG490 and the NFkappaB inhibitor MG132, but not by the p38 mitogen-activated protein kinase inhibitor SB203580. LPS + IFNgamma stimulated phosphorylation of ERK, JNK and Jak2, and degradation of IkappaB, but only Jak2 phosphorylation was sensitive to tripterine (50-200 nM). Further, tripterine diminished the increased vascular permeability in inflamed air pouches. "
"1781","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:directlyDecreases","false",,,"Further, LPS + IFNgamma-induced expression of iNOS and Nox1 was attenuated by the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor PD98059, the JNK inhibitor SP600125, the Jak2 inhibitor AG490 and the NFkappaB inhibitor MG132, but not by the p38 mitogen-activated protein kinase inhibitor SB203580. LPS + IFNgamma stimulated phosphorylation of ERK, JNK and Jak2, and degradation of IkappaB, but only Jak2 phosphorylation was sensitive to tripterine (50-200 nM). Further, tripterine diminished the increased vascular permeability in inflamed air pouches. "
"1782","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:directlyDecreases","false",,,"Further, LPS + IFNgamma-induced expression of iNOS and Nox1 was attenuated by the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor PD98059, the JNK inhibitor SP600125, the Jak2 inhibitor AG490 and the NFkappaB inhibitor MG132, but not by the p38 mitogen-activated protein kinase inhibitor SB203580. LPS + IFNgamma stimulated phosphorylation of ERK, JNK and Jak2, and degradation of IkappaB, but only Jak2 phosphorylation was sensitive to tripterine (50-200 nM). Further, tripterine diminished the increased vascular permeability in inflamed air pouches. "
"1783","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:directlyDecreases","false",,,"Further, LPS + IFNgamma-induced expression of iNOS and Nox1 was attenuated by the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor PD98059, the JNK inhibitor SP600125, the Jak2 inhibitor AG490 and the NFkappaB inhibitor MG132, but not by the p38 mitogen-activated protein kinase inhibitor SB203580. LPS + IFNgamma stimulated phosphorylation of ERK, JNK and Jak2, and degradation of IkappaB, but only Jak2 phosphorylation was sensitive to tripterine (50-200 nM). Further, tripterine diminished the increased vascular permeability in inflamed air pouches. "
"1784","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:decreases","false",,,"Further, LPS + IFNgamma-induced expression of iNOS and Nox1 was attenuated by the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor PD98059, the JNK inhibitor SP600125, the Jak2 inhibitor AG490 and the NFkappaB inhibitor MG132, but not by the p38 mitogen-activated protein kinase inhibitor SB203580. LPS + IFNgamma stimulated phosphorylation of ERK, JNK and Jak2, and degradation of IkappaB, but only Jak2 phosphorylation was sensitive to tripterine (50-200 nM). Further, tripterine diminished the increased vascular permeability in inflamed air pouches. "
"1785","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"Further, LPS + IFNgamma-induced expression of iNOS and Nox1 was attenuated by the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor PD98059, the JNK inhibitor SP600125, the Jak2 inhibitor AG490 and the NFkappaB inhibitor MG132, but not by the p38 mitogen-activated protein kinase inhibitor SB203580. LPS + IFNgamma stimulated phosphorylation of ERK, JNK and Jak2, and degradation of IkappaB, but only Jak2 phosphorylation was sensitive to tripterine (50-200 nM). Further, tripterine diminished the increased vascular permeability in inflamed air pouches. "
"1786","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"Further, LPS + IFNgamma-induced expression of iNOS and Nox1 was attenuated by the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor PD98059, the JNK inhibitor SP600125, the Jak2 inhibitor AG490 and the NFkappaB inhibitor MG132, but not by the p38 mitogen-activated protein kinase inhibitor SB203580. LPS + IFNgamma stimulated phosphorylation of ERK, JNK and Jak2, and degradation of IkappaB, but only Jak2 phosphorylation was sensitive to tripterine (50-200 nM). Further, tripterine diminished the increased vascular permeability in inflamed air pouches. "
"1787","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"Further, LPS + IFNgamma-induced expression of iNOS and Nox1 was attenuated by the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor PD98059, the JNK inhibitor SP600125, the Jak2 inhibitor AG490 and the NFkappaB inhibitor MG132, but not by the p38 mitogen-activated protein kinase inhibitor SB203580. LPS + IFNgamma stimulated phosphorylation of ERK, JNK and Jak2, and degradation of IkappaB, but only Jak2 phosphorylation was sensitive to tripterine (50-200 nM). Further, tripterine diminished the increased vascular permeability in inflamed air pouches. "
"1788","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"Further, LPS + IFNgamma-induced expression of iNOS and Nox1 was attenuated by the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor PD98059, the JNK inhibitor SP600125, the Jak2 inhibitor AG490 and the NFkappaB inhibitor MG132, but not by the p38 mitogen-activated protein kinase inhibitor SB203580. LPS + IFNgamma stimulated phosphorylation of ERK, JNK and Jak2, and degradation of IkappaB, but only Jak2 phosphorylation was sensitive to tripterine (50-200 nM). Further, tripterine diminished the increased vascular permeability in inflamed air pouches. "
"1789","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:decreases","false",,,"Further, LPS + IFNgamma-induced expression of iNOS and Nox1 was attenuated by the mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor PD98059, the JNK inhibitor SP600125, the Jak2 inhibitor AG490 and the NFkappaB inhibitor MG132, but not by the p38 mitogen-activated protein kinase inhibitor SB203580. LPS + IFNgamma stimulated phosphorylation of ERK, JNK and Jak2, and degradation of IkappaB, but only Jak2 phosphorylation was sensitive to tripterine (50-200 nM). Further, tripterine diminished the increased vascular permeability in inflamed air pouches. "
"1790","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:decreases","false",,,"Our results indicate that, by preventing Jak2-dependent induction of iNOS and Nox1, tripterine inhibits peroxynitrite precursor synthesis, attenuates the increased activity of PP2A and consequently protects endothelial barrier function."
"1791","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:directlyDecreases","false",,,"The increased endothelial permeability induced by LPS + IFN? was attenuated by the NADPH oxidase inhibitor apocynin (250 µM; based on Coyle and Kader, 2007), iNOS inhibitor 1400W (50 µM; based on Hortelano et al., 2000), and tripterine (50 nM and 200 nM; based on Allison et al., 2001) (Figure 1B). Neither apocynin, 1400W nor tripterine (50 nM and 200 nM) altered the endothelial permeability in the absence of a pro-inflammatory stimulus (Figure 1B). "
"1792","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"The increased endothelial permeability induced by LPS + IFN? was attenuated by the NADPH oxidase inhibitor apocynin (250 µM; based on Coyle and Kader, 2007), iNOS inhibitor 1400W (50 µM; based on Hortelano et al., 2000), and tripterine (50 nM and 200 nM; based on Allison et al., 2001) (Figure 1B). Neither apocynin, 1400W nor tripterine (50 nM and 200 nM) altered the endothelial permeability in the absence of a pro-inflammatory stimulus (Figure 1B). "
"1793","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"However, tripterine at a concentration of 1 µM (based on Allison et al., 2001), either alone or together with LPS + IFN?, significantly decreased cell viability, which may have caused the permeability increase observed for this high dose (Figure 1B,C)."
"1794","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"LPS + IFN? induces NO and superoxide production in microvascular endothelial cells (Wu et al., 2001; 2002; 2008)."
"1795","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"LPS + IFN? induces NO and superoxide production in microvascular endothelial cells (Wu et al., 2001; 2002; 2008)."
"1796","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"Our previous study identified NADPH oxidase activity as the principal source of superoxide in LPS + IFN?-stimulated microvascular endothelial cells (Wu et al., 2007; 2008). "
"1797","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:directlyIncreases","false",,,"Our previous study identified NADPH oxidase activity as the principal source of superoxide in LPS + IFN?-stimulated microvascular endothelial cells (Wu et al., 2007; 2008). "
"1798","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:hasComponent","false",,,"Nox1 is a catalytic subunit of NADPH oxidase that is expressed in endothelial cells (Sorescu et al., 2004; Wu et al., 2008). "
"1799","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:decreases","false",,,"Tripterine alone also decreased the basal production of NO in endothelial cells, in the absence of LPS + IFN? stimulation (Figure 4D)."
"1800","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:directlyIncreases","false",,,"iNOS-derived NO and NADPH oxidase-derived superoxide react to form peroxynitrite that can nitrate the tyrosine residues of target proteins, leading to the formation of 3-nitrotyrosine. "
"1801","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:directlyIncreases","false",,,"iNOS-derived NO and NADPH oxidase-derived superoxide react to form peroxynitrite that can nitrate the tyrosine residues of target proteins, leading to the formation of 3-nitrotyrosine. "
"1802","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"iNOS-derived NO and NADPH oxidase-derived superoxide react to form peroxynitrite that can nitrate the tyrosine residues of target proteins, leading to the formation of 3-nitrotyrosine. "
"1803","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"Increased production of peroxynitrite is associated with the activation of PP2A; this causes an increase in the permeability of the endothelial cell monolayer (Wu and Wilson, 2009). "
"1804","Wu FHan MWilson JX","19508391","British journal of pharmacology","PubMed",,,"bel:increases","false",,,"Increased production of peroxynitrite is associated with the activation of PP2A; this causes an increase in the permeability of the endothelial cell monolayer (Wu and Wilson, 2009). "
"1805","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:positiveCorrelation","false",,,"Constitutive Akt/protein kinase B (PKB) activity was demonstrated in 16 of 17 cell lines by maintenance of S473 phosphorylation with serum deprivation. Additional analysis of five of 2these NSCLC lines revealed that phosphorylation of S473 and T308 correlated with in vitro kinase activity. "
"1806","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:positiveCorrelation","false",,,"Constitutive Akt/protein kinase B (PKB) activity was demonstrated in 16 of 17 cell lines by maintenance of S473 phosphorylation with serum deprivation. Additional analysis of five of 2these NSCLC lines revealed that phosphorylation of S473 and T308 correlated with in vitro kinase activity. "
"1807","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:positiveCorrelation","false",,,"Constitutive Akt/protein kinase B (PKB) activity was demonstrated in 16 of 17 cell lines by maintenance of S473 phosphorylation with serum deprivation. Additional analysis of five of 2these NSCLC lines revealed that phosphorylation of S473 and T308 correlated with in vitro kinase activity. "
"1808","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:positiveCorrelation","false",,,"Constitutive Akt/protein kinase B (PKB) activity was demonstrated in 16 of 17 cell lines by maintenance of S473 phosphorylation with serum deprivation. Additional analysis of five of 2these NSCLC lines revealed that phosphorylation of S473 and T308 correlated with in vitro kinase activity. "
"1809","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:positiveCorrelation","false",,,"Constitutive Akt/protein kinase B (PKB) activity was demonstrated in 16 of 17 cell lines by maintenance of S473 phosphorylation with serum deprivation. Additional analysis of five of 2these NSCLC lines revealed that phosphorylation of S473 and T308 correlated with in vitro kinase activity. "
"1810","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:increases","false",,,"Akt/PKB activation was phosphatidylinositol 3-kinase-dependent and promoted survival because the phosphatidylinositol 3 inhibitors LY294002 and wortmannin inhibited Akt/PKB phosphorylation, Akt/PKB activity, and increased apoptosis only in cells with active Akt/PKB. "
"1811","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:decreases","false",,,"Akt/PKB activation was phosphatidylinositol 3-kinase-dependent and promoted survival because the phosphatidylinositol 3 inhibitors LY294002 and wortmannin inhibited Akt/PKB phosphorylation, Akt/PKB activity, and increased apoptosis only in cells with active Akt/PKB. "
"1812","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:decreases","false",,,"Akt/PKB activation was phosphatidylinositol 3-kinase-dependent and promoted survival because the phosphatidylinositol 3 inhibitors LY294002 and wortmannin inhibited Akt/PKB phosphorylation, Akt/PKB activity, and increased apoptosis only in cells with active Akt/PKB. "
"1813","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:decreases","false",,,"Akt/PKB activation was phosphatidylinositol 3-kinase-dependent and promoted survival because the phosphatidylinositol 3 inhibitors LY294002 and wortmannin inhibited Akt/PKB phosphorylation, Akt/PKB activity, and increased apoptosis only in cells with active Akt/PKB. "
"1814","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:decreases","false",,,"Akt/PKB activation was phosphatidylinositol 3-kinase-dependent and promoted survival because the phosphatidylinositol 3 inhibitors LY294002 and wortmannin inhibited Akt/PKB phosphorylation, Akt/PKB activity, and increased apoptosis only in cells with active Akt/PKB. "
"1815","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:positiveCorrelation","false",,,"Table 1 ?  shows that under normal growth conditions, 17 of 19 NSCLC cell lines (89%) exhibit phosphorylation of S473. Phosphorylation of S473 was maintained in 16 of 17 positive cell lines (94%) when cells were deprived of serum. "
"1816","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:increases","false",,,"In all 10 cell lines tested, IGF-I increased S473 phosphorylation irrespective of endogenous levels, indicating that NSCLC cell lines phosphorylate Akt/PKB in response to IGF-I, and that the IGF-IR signaling pathway that leads to Akt/PKB activation is intact, even in cells that exhibit no Akt/PKB phosphorylation (H1355). "
"1817","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:decreases","false",,,"Fig. 1A  ?  shows that the H1155, H157, and H1703 cells exhibit S473 phosphorylation under normal growth conditions and serum deprivation, but A549 and H1355 cells show little S473 phosphorylation in low-serum conditions. Levels of phosphorylated S473 were greatest in the H1155 cells. Regulation of S473 phosphorylation by serum withdrawal was only observed with the A549 cells. "
"1818","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:positiveCorrelation","false",,,"Phosphorylation patterns for T308, the PDK1 site (Fig. 1B) ?  , generally correlated with the S473 pattern; only the H1155, H157, and H1703 cells displayed phosphorylation of Akt/PKB at T308. "
"1819","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:directlyIncreases","false",,,"Phosphorylation patterns for T308, the PDK1 site (Fig. 1B) ?  , generally correlated with the S473 pattern; only the H1155, H157, and H1703 cells displayed phosphorylation of Akt/PKB at T308. "
"1820","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:increases","false",,,"Interestingly, both H1703 and H1155 cells increased T308 phosphorylation when transitioned from normal growth conditions to serum deprivation, indicating that increased T308 phosphorylation might be an adaptive response to the stress of serum deprivation in these cells. "
"1821","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:increases","false",,,"Interestingly, both H1703 and H1155 cells increased T308 phosphorylation when transitioned from normal growth conditions to serum deprivation, indicating that increased T308 phosphorylation might be an adaptive response to the stress of serum deprivation in these cells. "
"1822","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:negativeCorrelation","false",,,"In contrast to the low or absent PTEN in cells with phosphorylated Akt/PKB, the cell lines with the lowest levels of phosphorylated Akt had the highest level of PTEN protein expression (A549 and H1355). Both A549 and H1355 cells have wild-type PTEN (Ref. 69  and data not shown, respectively). Taken together, these data show that Akt/PKB phosphorylation and mutations in PTEN are inversely correlated in four of five NSCLC cell lines. "
"1823","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:decreases","false",,,"we tested the ability of two PI3-K inhibitors, LY294002 and wortmannin, to inhibit Akt/PKB phosphorylation. Fig. 2A  ?  shows that both LY294002 and wortmannin completely inhibited phosphorylation of S473 in the three NSCLC cell lines that maintain S473 phosphorylation under serum deprivation. Native Akt/PKB levels did not change. Similar results were obtained for T308 phosphorylation (Fig. 2B) ?  . "
"1824","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:decreases","false",,,"we tested the ability of two PI3-K inhibitors, LY294002 and wortmannin, to inhibit Akt/PKB phosphorylation. Fig. 2A  ?  shows that both LY294002 and wortmannin completely inhibited phosphorylation of S473 in the three NSCLC cell lines that maintain S473 phosphorylation under serum deprivation. Native Akt/PKB levels did not change. Similar results were obtained for T308 phosphorylation (Fig. 2B) ?  . "
"1825","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:decreases","false",,,"we tested the ability of two PI3-K inhibitors, LY294002 and wortmannin, to inhibit Akt/PKB phosphorylation. Fig. 2A  ?  shows that both LY294002 and wortmannin completely inhibited phosphorylation of S473 in the three NSCLC cell lines that maintain S473 phosphorylation under serum deprivation. Native Akt/PKB levels did not change. Similar results were obtained for T308 phosphorylation (Fig. 2B) ?  . "
"1826","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:decreases","false",,,"we tested the ability of two PI3-K inhibitors, LY294002 and wortmannin, to inhibit Akt/PKB phosphorylation. Fig. 2A  ?  shows that both LY294002 and wortmannin completely inhibited phosphorylation of S473 in the three NSCLC cell lines that maintain S473 phosphorylation under serum deprivation. Native Akt/PKB levels did not change. Similar results were obtained for T308 phosphorylation (Fig. 2B) ?  . "
"1827","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:directlyDecreases","false",,,"we tested the ability of two PI3-K inhibitors, LY294002 and wortmannin, to inhibit Akt/PKB phosphorylation. Fig. 2A  ?  shows that both LY294002 and wortmannin completely inhibited phosphorylation of S473 in the three NSCLC cell lines that maintain S473 phosphorylation under serum deprivation. Native Akt/PKB levels did not change. Similar results were obtained for T308 phosphorylation (Fig. 2B) ?  . "
"1828","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:directlyDecreases","false",,,"we tested the ability of two PI3-K inhibitors, LY294002 and wortmannin, to inhibit Akt/PKB phosphorylation. Fig. 2A  ?  shows that both LY294002 and wortmannin completely inhibited phosphorylation of S473 in the three NSCLC cell lines that maintain S473 phosphorylation under serum deprivation. Native Akt/PKB levels did not change. Similar results were obtained for T308 phosphorylation (Fig. 2B) ?  . "
"1829","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:increases","false",,,"These data demonstrate that Akt/PKB phosphorylation in the three positive cell lines is PI3-K-dependent, making it unlikely that other kinases are directly involved in activating Akt/PKB. "
"1830","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:increases","false",,,"Fig. 5A  ?  shows that in the three cell lines with high Akt/PKB activity, basal levels of apoptosis were potentiated 6–16-fold by LY294002 (Lanes 1). "
"1831","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:directlyDecreases","false",,,"we transiently cotransfected NSCLC cell lines with HA-tagged dominant negative Akt/PKB (K179M Akt/PKB) and GFP and assessed apoptosis in the GFP-positive cells. Fig. 6 ?  shows that in the cell lines with high Akt/PKB activity, transfection of K179M Akt/PKB resulted in a 2–5-fold increase in basal apoptosis. "
"1832","Brognard JClark ASNi YDennis PA","11358816","Cancer research","PubMed",,,"bel:increases","false",,,"we transiently cotransfected NSCLC cell lines with HA-tagged dominant negative Akt/PKB (K179M Akt/PKB) and GFP and assessed apoptosis in the GFP-positive cells. Fig. 6 ?  shows that in the cell lines with high Akt/PKB activity, transfection of K179M Akt/PKB resulted in a 2–5-fold increase in basal apoptosis. "
"1833","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:decreases","false",,,"platelet adhesion is an essential function in response to vascular injury and is generally viewed as the first step during which single platelets bind through specific membrane receptors to cellular and extracellular matrix constituents of the vessel wall and tissues. This response initiates thrombus formation that arrests hemorrhage and permits wound healing"
"1834","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"platelet adhesion is an essential function in response to vascular injury and is generally viewed as the first step during which single platelets bind through specific membrane receptors to cellular and extracellular matrix constituents of the vessel wall and tissues. This response initiates thrombus formation that arrests hemorrhage and permits wound healing"
"1835","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"In pathological conditions, platelets are a major contributor to arterial thrombosis, which typically occurs at sites of atherosclerosis with stenosis of the vessel lumen, where shear-stress values are considerably higher than in the normal circulation.11–1"
"1836","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:decreases","false",,,"Shear stress, in contrast, influences the lifetime of an adhesive bond once formed, thus the off-rate of the interaction, and the consequence is decreased efficiency caused by detachment of adherent cells with increasing shear stress. The point has been well documented for leukocyte adhesion.14"
"1837","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"The results demonstrate that the adhesive function of GPIba is as necessary as that of aIIbB3 to sustain platelet aggregation at the edge of a growing thrombus"
"1838","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"The results demonstrate that the adhesive function of GPIba is as necessary as that of aIIbB3 to sustain platelet aggregation at the edge of a growing thrombus"
"1839","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"Among the substrates required for normal thrombus formation, VWF is unique for its role in initiating platelet adhesion and sustaining platelet aggregation under conditions of elevated shear stress.16,18"
"1840","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"Among the substrates required for normal thrombus formation, VWF is unique for its role in initiating platelet adhesion and sustaining platelet aggregation under conditions of elevated shear stress.16,18"
"1841","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"The
integrin aIIb3, on the other hand, binds several ligands, in
addition to VWF, that are key to the process of platelet
adhesion and aggregation, primarily fibrinogen,64 fibronectin,
65 and CD40 ligand.66"
"1842","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"The
integrin aIIb3, on the other hand, binds several ligands, in
addition to VWF, that are key to the process of platelet
adhesion and aggregation, primarily fibrinogen,64 fibronectin,
65 and CD40 ligand.66"
"1843","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"The
integrin aIIb3, on the other hand, binds several ligands, in
addition to VWF, that are key to the process of platelet
adhesion and aggregation, primarily fibrinogen,64 fibronectin,
65 and CD40 ligand.66"
"1844","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"The
integrin aIIb3, on the other hand, binds several ligands, in
addition to VWF, that are key to the process of platelet
adhesion and aggregation, primarily fibrinogen,64 fibronectin,
65 and CD40 ligand.66"
"1845","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"The
integrin aIIb3, on the other hand, binds several ligands, in
addition to VWF, that are key to the process of platelet
adhesion and aggregation, primarily fibrinogen,64 fibronectin,
65 and CD40 ligand.66"
"1846","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"The
integrin aIIb3, on the other hand, binds several ligands, in
addition to VWF, that are key to the process of platelet
adhesion and aggregation, primarily fibrinogen,64 fibronectin,
65 and CD40 ligand.66"
"1847","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"The
integrin aIIb3, on the other hand, binds several ligands, in
addition to VWF, that are key to the process of platelet
adhesion and aggregation, primarily fibrinogen,64 fibronectin,
65 and CD40 ligand.66"
"1848","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"The
integrin aIIb3, on the other hand, binds several ligands, in
addition to VWF, that are key to the process of platelet
adhesion and aggregation, primarily fibrinogen,64 fibronectin,
65 and CD40 ligand.66"
"1849","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"ADAMTS-13 can cleave circulating
VWF multimers while they mediate activationindependent
interplatelet cohesion under high shear stress,
thus dispersing the aggregates.73"
"1850","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"In
contrast, blocking the other receptor, GPVI, impairs thrombus
formation on all types of collagen fibers.77,78"
"1851","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:positiveCorrelation","false",,,"The expression of alpha2beta1 on normal
platelets varies by as much as 1 order of magnitude,92 and
may positively correlate to the rapidity of the initial phase of
platelet adhesion to collagen"
"1852","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"In the latter study, with blood
perfused over fibrillar collagen type I at shear rates between
400 and 1300 sec1, the isolated deficiency of a2b1 or
GPVI-Fc receptor -chain (FcR-g) complex caused an equivalent
partial defect of platelet thrombus formation, whereas
the combined deficiency caused complete inhibition.97"
"1853","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"In the latter study, with blood
perfused over fibrillar collagen type I at shear rates between
400 and 1300 sec1, the isolated deficiency of a2b1 or
GPVI-Fc receptor -chain (FcR-g) complex caused an equivalent
partial defect of platelet thrombus formation, whereas
the combined deficiency caused complete inhibition.97"
"1854","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:directlyIncreases","false",,,"Fibronectin is an essential adhesive substrate in many fundamental
biological processes.24 Platelets possess 2 main receptors
for this protein, alpha5beta1 and alphaIIbBeta3,114 the latter of which
requires activation to function.65"
"1855","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:directlyIncreases","false",,,"Fibronectin is an essential adhesive substrate in many fundamental
biological processes.24 Platelets possess 2 main receptors
for this protein, alpha5beta1 and alphaIIbBeta3,114 the latter of which
requires activation to function.65"
"1856","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"alpha5beta1 supports platelet adhesion to endothelial
extracellular matrix"
"1857","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"thrombospondin-1 binds
to the platelet membrane and mediates adhesion"
"1858","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:positiveCorrelation","false",,,"The
significance of thrombospondin-1 in platelet thrombus formation
is still unclear, although it is intriguing to note that
this glycoprotein is abundant in atherosclerotic plaques"
"1859","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"These findings delineate a synergistic role for alpha5beta1
and GPVI as laminin receptors, coupled to distinct activation
pathways convergent on the function of the Syk tyrosine kinase"
"1860","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:increases","false",,,"These findings delineate a synergistic role for alpha5beta1
and GPVI as laminin receptors, coupled to distinct activation
pathways convergent on the function of the Syk tyrosine kinase"
"1861","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:directlyIncreases","false",,,"The platelet membrane is endowed with several collagen
receptors, including the integrin alpha2beta1,79–81 GPVI,82,83 GPIV
(CD-36),84–86 and the 65-kDa protein (p65) reportedly specific specific
for type I collagen.87"
"1862","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:directlyIncreases","false",,,"The platelet membrane is endowed with several collagen
receptors, including the integrin alpha2beta1,79–81 GPVI,82,83 GPIV
(CD-36),84–86 and the 65-kDa protein (p65) reportedly specific specific
for type I collagen.87"
"1863","Ruggeri ZMMendolicchio GL","17585075","Circulation research","PubMed",,,"bel:directlyIncreases","false",,,"The platelet membrane is endowed with several collagen
receptors, including the integrin alpha2beta1,79–81 GPVI,82,83 GPIV
(CD-36),84–86 and the 65-kDa protein (p65) reportedly specific specific
for type I collagen.87"
"1864","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"As expected,
VEGF treatment significantly induced both migration
and proliferation in HUVECs (Figs. 2A–B and Table 1).
Interestingly, CSE exposure was associated with a selective
inhibition of VEGF-induced HUVEC migration, whereas
cellular proliferation was not significantly affected (Figs. 2A–
B and Table 1)."
"1865","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"As expected,
VEGF treatment significantly induced both migration
and proliferation in HUVECs (Figs. 2A–B and Table 1).
Interestingly, CSE exposure was associated with a selective
inhibition of VEGF-induced HUVEC migration, whereas
cellular proliferation was not significantly affected (Figs. 2A–
B and Table 1)."
"1866","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:decreases","false",,,"Surface integrins have been shown to be critical
regulators of endothelial cell migration in response to VEGF and
NO. Here we found that VEGF-stimulated HUVECs exposed to
CSE had a significant reduction in the expression of several
surface integrins including ?v?3, ?v?5, ?5?1 and ?2?1 (Fig.
2C). Moreover, the adhesion of VEGF-stimulated HUVECs was
significantly reduced following exposure to 10% CSE, suggesting
an impairment of integrin activity/function (Fig. 2D)."
"1867","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:decreases","false",,,"Surface integrins have been shown to be critical
regulators of endothelial cell migration in response to VEGF and
NO. Here we found that VEGF-stimulated HUVECs exposed to
CSE had a significant reduction in the expression of several
surface integrins including ?v?3, ?v?5, ?5?1 and ?2?1 (Fig.
2C). Moreover, the adhesion of VEGF-stimulated HUVECs was
significantly reduced following exposure to 10% CSE, suggesting
an impairment of integrin activity/function (Fig. 2D)."
"1868","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:decreases","false",,,"Surface integrins have been shown to be critical
regulators of endothelial cell migration in response to VEGF and
NO. Here we found that VEGF-stimulated HUVECs exposed to
CSE had a significant reduction in the expression of several
surface integrins including ?v?3, ?v?5, ?5?1 and ?2?1 (Fig.
2C). Moreover, the adhesion of VEGF-stimulated HUVECs was
significantly reduced following exposure to 10% CSE, suggesting
an impairment of integrin activity/function (Fig. 2D)."
"1869","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:decreases","false",,,"Surface integrins have been shown to be critical
regulators of endothelial cell migration in response to VEGF and
NO. Here we found that VEGF-stimulated HUVECs exposed to
CSE had a significant reduction in the expression of several
surface integrins including ?v?3, ?v?5, ?5?1 and ?2?1 (Fig.
2C). Moreover, the adhesion of VEGF-stimulated HUVECs was
significantly reduced following exposure to 10% CSE, suggesting
an impairment of integrin activity/function (Fig. 2D)."
"1870","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:decreases","false",,,"Surface integrins have been shown to be critical
regulators of endothelial cell migration in response to VEGF and
NO. Here we found that VEGF-stimulated HUVECs exposed to
CSE had a significant reduction in the expression of several
surface integrins including ?v?3, ?v?5, ?5?1 and ?2?1 (Fig.
2C). Moreover, the adhesion of VEGF-stimulated HUVECs was
significantly reduced following exposure to 10% CSE, suggesting
an impairment of integrin activity/function (Fig. 2D)."
"1871","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"CSE show an important increase of intracellular ROS, as
assessed by 2?,7?-dichlorofluorescin diacetate (DCFH-DA)
(Fig. 3). Importantly, antioxidants such as NAC and vitamin
C can significantly reduce the generation of ROS in HUVECs
exposed to CSE (Fig. 3)."
"1872","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:decreases","false",,," Similarly, we found that the
induction of NO by VEGF in endothelial cell cultures was
severely compromised in the presence of CSE, but that NO
levels could be normalized with antioxidants (Fig. 4C).
Globally, these data suggest that ROS are involved in the
impairment of VEGF-induced Akt/eNOS/NO pathway by CSE."
"1873","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:decreases","false",,," Similarly, we found that the
induction of NO by VEGF in endothelial cell cultures was
severely compromised in the presence of CSE, but that NO
levels could be normalized with antioxidants (Fig. 4C).
Globally, these data suggest that ROS are involved in the
impairment of VEGF-induced Akt/eNOS/NO pathway by CSE."
"1874","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"Because NO is an essential mediator of endothelial cell
migration and VEGF-induced angiogenesis, we investigated the
effect of CSE exposure on VEGF-dependent Akt/eNOS/NO
pathway. VEGF-stimulated HUVECs exposed to CSE show a
dose-dependent inhibition of phosphorylated Akt and eNOS
(Fig. 4A). Importantly, the activation of Akt and eNOS by
VEGF can be rescued following treatment with the antioxidants
NAC and vitamin C (Fig. 4B)."
"1875","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"Because NO is an essential mediator of endothelial cell
migration and VEGF-induced angiogenesis, we investigated the
effect of CSE exposure on VEGF-dependent Akt/eNOS/NO
pathway. VEGF-stimulated HUVECs exposed to CSE show a
dose-dependent inhibition of phosphorylated Akt and eNOS
(Fig. 4A). Importantly, the activation of Akt and eNOS by
VEGF can be rescued following treatment with the antioxidants
NAC and vitamin C (Fig. 4B)."
"1876","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"Because NO is an essential mediator of endothelial cell
migration and VEGF-induced angiogenesis, we investigated the
effect of CSE exposure on VEGF-dependent Akt/eNOS/NO
pathway. VEGF-stimulated HUVECs exposed to CSE show a
dose-dependent inhibition of phosphorylated Akt and eNOS
(Fig. 4A). Importantly, the activation of Akt and eNOS by
VEGF can be rescued following treatment with the antioxidants
NAC and vitamin C (Fig. 4B)."
"1877","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"These data suggest that CSE
prevents VEGF-induced endothelial cell migration and
tube formation by increasing oxidative stress. The
importance of NO in that physiopathology was demonstrated
by showing that NO donors (SNAP 75 ?M, SNP
0.1 mM) or a cGMP analog (8-Br-cGMP 2 mM) rescued
integrin expression (Fig. 5A), cellular migration (Fig. 5B)
and tube formation (Fig. 5C) in endothelial cells exposed
to CSE."
"1878","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"These data suggest that CSE
prevents VEGF-induced endothelial cell migration and
tube formation by increasing oxidative stress. The
importance of NO in that physiopathology was demonstrated
by showing that NO donors (SNAP 75 ?M, SNP
0.1 mM) or a cGMP analog (8-Br-cGMP 2 mM) rescued
integrin expression (Fig. 5A), cellular migration (Fig. 5B)
and tube formation (Fig. 5C) in endothelial cells exposed
to CSE."
"1879","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"These data suggest that CSE
prevents VEGF-induced endothelial cell migration and
tube formation by increasing oxidative stress. The
importance of NO in that physiopathology was demonstrated
by showing that NO donors (SNAP 75 ?M, SNP
0.1 mM) or a cGMP analog (8-Br-cGMP 2 mM) rescued
integrin expression (Fig. 5A), cellular migration (Fig. 5B)
and tube formation (Fig. 5C) in endothelial cells exposed
to CSE."
"1880","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"These data suggest that CSE
prevents VEGF-induced endothelial cell migration and
tube formation by increasing oxidative stress. The
importance of NO in that physiopathology was demonstrated
by showing that NO donors (SNAP 75 ?M, SNP
0.1 mM) or a cGMP analog (8-Br-cGMP 2 mM) rescued
integrin expression (Fig. 5A), cellular migration (Fig. 5B)
and tube formation (Fig. 5C) in endothelial cells exposed
to CSE."
"1881","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"These data suggest that CSE
prevents VEGF-induced endothelial cell migration and
tube formation by increasing oxidative stress. The
importance of NO in that physiopathology was demonstrated
by showing that NO donors (SNAP 75 ?M, SNP
0.1 mM) or a cGMP analog (8-Br-cGMP 2 mM) rescued
integrin expression (Fig. 5A), cellular migration (Fig. 5B)
and tube formation (Fig. 5C) in endothelial cells exposed
to CSE."
"1882","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"These data suggest that CSE
prevents VEGF-induced endothelial cell migration and
tube formation by increasing oxidative stress. The
importance of NO in that physiopathology was demonstrated
by showing that NO donors (SNAP 75 ?M, SNP
0.1 mM) or a cGMP analog (8-Br-cGMP 2 mM) rescued
integrin expression (Fig. 5A), cellular migration (Fig. 5B)
and tube formation (Fig. 5C) in endothelial cells exposed
to CSE."
"1883","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"These data suggest that CSE
prevents VEGF-induced endothelial cell migration and
tube formation by increasing oxidative stress. The
importance of NO in that physiopathology was demonstrated
by showing that NO donors (SNAP 75 ?M, SNP
0.1 mM) or a cGMP analog (8-Br-cGMP 2 mM) rescued
integrin expression (Fig. 5A), cellular migration (Fig. 5B)
and tube formation (Fig. 5C) in endothelial cells exposed
to CSE."
"1884","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"These data suggest that CSE
prevents VEGF-induced endothelial cell migration and
tube formation by increasing oxidative stress. The
importance of NO in that physiopathology was demonstrated
by showing that NO donors (SNAP 75 ?M, SNP
0.1 mM) or a cGMP analog (8-Br-cGMP 2 mM) rescued
integrin expression (Fig. 5A), cellular migration (Fig. 5B)
and tube formation (Fig. 5C) in endothelial cells exposed
to CSE."
"1885","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"These data suggest that CSE
prevents VEGF-induced endothelial cell migration and
tube formation by increasing oxidative stress. The
importance of NO in that physiopathology was demonstrated
by showing that NO donors (SNAP 75 ?M, SNP
0.1 mM) or a cGMP analog (8-Br-cGMP 2 mM) rescued
integrin expression (Fig. 5A), cellular migration (Fig. 5B)
and tube formation (Fig. 5C) in endothelial cells exposed
to CSE."
"1886","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"These data suggest that CSE
prevents VEGF-induced endothelial cell migration and
tube formation by increasing oxidative stress. The
importance of NO in that physiopathology was demonstrated
by showing that NO donors (SNAP 75 ?M, SNP
0.1 mM) or a cGMP analog (8-Br-cGMP 2 mM) rescued
integrin expression (Fig. 5A), cellular migration (Fig. 5B)
and tube formation (Fig. 5C) in endothelial cells exposed
to CSE."
"1887","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"These data suggest that CSE
prevents VEGF-induced endothelial cell migration and
tube formation by increasing oxidative stress. The
importance of NO in that physiopathology was demonstrated
by showing that NO donors (SNAP 75 ?M, SNP
0.1 mM) or a cGMP analog (8-Br-cGMP 2 mM) rescued
integrin expression (Fig. 5A), cellular migration (Fig. 5B)
and tube formation (Fig. 5C) in endothelial cells exposed
to CSE."
"1888","Michaud SEDussault SGroleau JHaddad PRivard A","16806264","Journal of molecular and cellular cardiology","PubMed",,,"bel:increases","false",,,"These data suggest that CSE
prevents VEGF-induced endothelial cell migration and
tube formation by increasing oxidative stress. The
importance of NO in that physiopathology was demonstrated
by showing that NO donors (SNAP 75 ?M, SNP
0.1 mM) or a cGMP analog (8-Br-cGMP 2 mM) rescued
integrin expression (Fig. 5A), cellular migration (Fig. 5B)
and tube formation (Fig. 5C) in endothelial cells exposed
to CSE."
"1889","Borges EJan YRuoslahti E","10964931","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Here we examine the nature of the physical interaction between the alpha(v)beta(3) integrin and two receptor tyrosine kinases (RTKs), the platelet-derived growth factor receptor beta (PDGF-Rbeta) and the vascular endothelial growth factor receptor 2 (VEGF-R2, also known as KDR and flk-1). Both of these RTKs associate with the alpha(v)beta(3) integrin but do not associate with beta(1) integrins. Furthermore, growth factor stimulation of these RTKs promotes increased cell proliferation and migration when cells are attached to the alpha(v)beta(3) ligand, vitronectin."
"1890","Borges EJan YRuoslahti E","10964931","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Previous studies have shown that PDGF-Rb (9, 10)
and VEGF-R2 (12) associate with the avb3 integrin but not with
b1 integrins. The association was detected after cells were
stimulated with the respective growth factor."
"1891","Borges EJan YRuoslahti E","10964931","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Previous studies have shown that PDGF-Rb (9, 10)
and VEGF-R2 (12) associate with the avb3 integrin but not with
b1 integrins. The association was detected after cells were
stimulated with the respective growth factor."
"1892","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:increases","false",,,"Ligation of alpha6beta4  in primary human keratinocytes caused tyrosine phosphorylation of Shc, recruitment of Grb2, activation of Ras and stimulation of the MAP kinases Erk and Jnk."
"1893","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:increases","false",,,"Ligation of alpha6beta4  in primary human keratinocytes caused tyrosine phosphorylation of Shc, recruitment of Grb2, activation of Ras and stimulation of the MAP kinases Erk and Jnk."
"1894","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:increases","false",,,"Ligation of alpha6beta4  in primary human keratinocytes caused tyrosine phosphorylation of Shc, recruitment of Grb2, activation of Ras and stimulation of the MAP kinases Erk and Jnk."
"1895","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:increases","false",,,"Ligation of alpha6beta4  in primary human keratinocytes caused tyrosine phosphorylation of Shc, recruitment of Grb2, activation of Ras and stimulation of the MAP kinases Erk and Jnk."
"1896","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:increases","false",,,"Ligation of alpha6beta4  in primary human keratinocytes caused tyrosine phosphorylation of Shc, recruitment of Grb2, activation of Ras and stimulation of the MAP kinases Erk and Jnk."
"1897","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:increases","false",,,"Ligation of alpha6beta4  in primary human keratinocytes caused tyrosine phosphorylation of Shc, recruitment of Grb2, activation of Ras and stimulation of the MAP kinases Erk and Jnk."
"1898","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:causesNoChange","false",,,"Ligation of alpha6beta4  in primary human keratinocytes caused tyrosine phosphorylation of Shc, recruitment of Grb2, activation of Ras and stimulation of the MAP kinases Erk and Jnk. In contrast, ligation of the laminin- and collagen-binding integrins alpha3beta1  and alpha2beta1  did not cause these events."
"1899","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:causesNoChange","false",,,"Ligation of alpha6beta4  in primary human keratinocytes caused tyrosine phosphorylation of Shc, recruitment of Grb2, activation of Ras and stimulation of the MAP kinases Erk and Jnk. In contrast, ligation of the laminin- and collagen-binding integrins alpha3beta1  and alpha2beta1  did not cause these events."
"1900","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:causesNoChange","false",,,"Ligation of alpha6beta4  in primary human keratinocytes caused tyrosine phosphorylation of Shc, recruitment of Grb2, activation of Ras and stimulation of the MAP kinases Erk and Jnk. In contrast, ligation of the laminin- and collagen-binding integrins alpha3beta1  and alpha2beta1  did not cause these events."
"1901","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:increases","false",,,"Ligation of alpha6beta4  in primary human keratinocytes caused tyrosine phosphorylation of Shc, recruitment of Grb2, activation of Ras and stimulation of the MAP kinases Erk and Jnk. In contrast, ligation of the laminin- and collagen-binding integrins alpha3beta1  and alpha2beta1  did not cause these events."
"1902","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:directlyDecreases","false",,,"While the stimulation of Erk by alpha6beta4  was suppressed by dominant-negative Shc, Ras and RhoA, the activation of Jnk was inhibited by dominant-negative Ras and Rac1 and by the phosphoinositide 3-kinase inhibitor Wortmannin. "
"1903","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:increases","false",,,"Adhesion mediated by alpha6beta4induced transcription from the Fos serum response element and promoted cell cycle progression in response to mitogens."
"1904","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:increases","false",,,"Adhesion mediated by alpha6beta4induced transcription from the Fos serum response element and promoted cell cycle progression in response to mitogens."
"1905","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"These results are consistent with the hypothesis that the recruitment of Shc to activated alpha6beta4  is mediated by tyrosine phosphorylation of the cytoplasmic domain of beta4."
"1906","Mainiero FMurgia CWary KKCuratola AMPepe ABlumemberg MWestwick JKDer CJGiancotti FG","9171350","The EMBO journal","PubMed",,,"bel:causesNoChange","false",,,"This suggests that ligation of alpha6beta4, but not alpha2beta1, is sufficient to promote transcription from the Fos SRE in the absence of mitogens."
"1907","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"secreted proteins such as Norrin
and R?Spondin were shown to be activators
of the canonical Wnt pathway owing
to their interaction with Frizzled–LRP
receptors79,80"
"1908","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"secreted proteins such as Norrin
and R?Spondin were shown to be activators
of the canonical Wnt pathway owing
to their interaction with Frizzled–LRP
receptors79,80"
"1909","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"secreted proteins such as Norrin
and R?Spondin were shown to be activators
of the canonical Wnt pathway owing
to their interaction with Frizzled–LRP
receptors79,80"
"1910","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"secreted proteins such as Norrin
and R?Spondin were shown to be activators
of the canonical Wnt pathway owing
to their interaction with Frizzled–LRP
receptors79,80"
"1911","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:directlyIncreases","false",,,"secreted proteins such as Norrin
and R?Spondin were shown to be activators
of the canonical Wnt pathway owing
to their interaction with Frizzled–LRP
receptors79,80"
"1912","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:directlyIncreases","false",,,"secreted proteins such as Norrin
and R?Spondin were shown to be activators
of the canonical Wnt pathway owing
to their interaction with Frizzled–LRP
receptors79,80"
"1913","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:directlyIncreases","false",,,"Following
phosphorylation, b?catenin is targeted for
proteasome-dependent degradation involving
interaction with b?TrCP (b-transducin
repeat-containing protein), a component
of the E3 ubiquitin ligase complex89–92"
"1914","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:directlyIncreases","false",,,"Following
phosphorylation, b?catenin is targeted for
proteasome-dependent degradation involving
interaction with b?TrCP (b-transducin
repeat-containing protein), a component
of the E3 ubiquitin ligase complex89–92"
"1915","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:directlyIncreases","false",,,"Following
phosphorylation, b?catenin is targeted for
proteasome-dependent degradation involving
interaction with b?TrCP (b-transducin
repeat-containing protein), a component
of the E3 ubiquitin ligase complex89–92"
"1916","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:positiveCorrelation","false",,,"Moreover, uncontrolled Wnt??-catenin
signalling that is associated with elevated
??catenin levels is also linked to aggressive
fibromatosis and pulmonary fibrosis140,141"
"1917","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"It was shown
that the frequency of CD29+CD24+ stem
cells in the mammary gland increases by a
factor of 6.4 following activation of WNT1
(Ref . 201)."
"1918","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"It was shown
that the frequency of CD29+CD24+ stem
cells in the mammary gland increases by a
factor of 6.4 following activation of WNT1
(Ref . 201)."
"1919","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"It was shown
that the frequency of CD29+CD24+ stem
cells in the mammary gland increases by a
factor of 6.4 following activation of WNT1
(Ref . 201)."
"1920","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"In
recent years, other mechanisms of activation
of the canonical Wnt pathway in tumours
have been discovered; for example, silencing
of the genes that encode the inhibitory Wnt
ligands SFRPs and DKKs by hypermethylation,
or by overexpression of Wnt proteins
(WNT2B for example), Frizzleds (FZD10
for example) or Dishevelled142?149"
"1921","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"In
recent years, other mechanisms of activation
of the canonical Wnt pathway in tumours
have been discovered; for example, silencing
of the genes that encode the inhibitory Wnt
ligands SFRPs and DKKs by hypermethylation,
or by overexpression of Wnt proteins
(WNT2B for example), Frizzleds (FZD10
for example) or Dishevelled142?149"
"1922","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"In
recent years, other mechanisms of activation
of the canonical Wnt pathway in tumours
have been discovered; for example, silencing
of the genes that encode the inhibitory Wnt
ligands SFRPs and DKKs by hypermethylation,
or by overexpression of Wnt proteins
(WNT2B for example), Frizzleds (FZD10
for example) or Dishevelled142?149"
"1923","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"Wnt??-catenin signalling has been
proposed to increase haematopoietic stem
cell renewal58,185?187"
"1924","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"Wnt??-catenin signalling has been
proposed to increase haematopoietic stem
cell renewal58,185?187"
"1925","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:decreases","false",,,"DKK1 antagonizes
Wnt signalling during head formation
in mice77. An additional DKK-receptor,
Kremen, was shown to inhibit the Wnt signalling
pathway by internalization of LRP"
"1926","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:decreases","false",,,"DKK1 antagonizes
Wnt signalling during head formation
in mice77. An additional DKK-receptor,
Kremen, was shown to inhibit the Wnt signalling
pathway by internalization of LRP"
"1927","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"DKK1 antagonizes
Wnt signalling during head formation
in mice77. An additional DKK-receptor,
Kremen, was shown to inhibit the Wnt signalling
pathway by internalization of LRP"
"1928","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:negativeCorrelation","false",,,"AXIN1
and AXIN2 loss-of-function mutations have
also been detected in rare cases of colorectal
cancer124,125."
"1929","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:negativeCorrelation","false",,,"AXIN1
and AXIN2 loss-of-function mutations have
also been detected in rare cases of colorectal
cancer124,125."
"1930","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:negativeCorrelation","false",,,"loss of Indian hedgehog,
also contribute to the progression of colorectal
cancer157"
"1931","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"In the presence of canonical Wnt ligands
(FIG. 1b), LRP5-LRP6 is phosphorylated by
CK1gamma and GSK3beta96,97 (and possibly other
protein kinases yet to be identified), and
Dishevelled is recruited to the plasma
membrane, where it interacts with Frizzled
receptors and polymerizes with other
Dishevelled molecules98,99."
"1932","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"In the presence of canonical Wnt ligands
(FIG. 1b), LRP5-LRP6 is phosphorylated by
CK1gamma and GSK3beta96,97 (and possibly other
protein kinases yet to be identified), and
Dishevelled is recruited to the plasma
membrane, where it interacts with Frizzled
receptors and polymerizes with other
Dishevelled molecules98,99."
"1933","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"In the presence of canonical Wnt ligands
(FIG. 1b), LRP5-LRP6 is phosphorylated by
CK1gamma and GSK3beta96,97 (and possibly other
protein kinases yet to be identified), and
Dishevelled is recruited to the plasma
membrane, where it interacts with Frizzled
receptors and polymerizes with other
Dishevelled molecules98,99."
"1934","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"Surplus ??catenin then translocates to the
nucleus, interacts with the LEF and TCF
transcription factors, and persistently
transactivates genes associated with the
regulation of cell proliferation, such as MYC
and cyclin D1 (Refs 30,32,106,135?137)."
"1935","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:directlyIncreases","false",,,"Surplus ??catenin then translocates to the
nucleus, interacts with the LEF and TCF
transcription factors, and persistently
transactivates genes associated with the
regulation of cell proliferation, such as MYC
and cyclin D1 (Refs 30,32,106,135?137)."
"1936","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:directlyIncreases","false",,,"Surplus ??catenin then translocates to the
nucleus, interacts with the LEF and TCF
transcription factors, and persistently
transactivates genes associated with the
regulation of cell proliferation, such as MYC
and cyclin D1 (Refs 30,32,106,135?137)."
"1937","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:directlyIncreases","false",,,"Surplus ??catenin then translocates to the
nucleus, interacts with the LEF and TCF
transcription factors, and persistently
transactivates genes associated with the
regulation of cell proliferation, such as MYC
and cyclin D1 (Refs 30,32,106,135?137)."
"1938","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:directlyIncreases","false",,,"N?terminal phosphorylation of b?catenin by the kinases CK1a (casein kinase 1a) and GSK3b (glycogen
synthase kinase 3b), and subsequent ubiquitylation by b?TrCP (b-transducin repeat-containing protein,
an E3 ubiquitin ligase), b?catenin is proteasomally degraded"
"1939","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"In the nucleus,
??catenin forms a transcriptionally active
complex with LEF and TCF transcription
factors30–32 by displacing Grouchos and
interacting with other co-activators such
as BCL9, Pygopus, CBP (CREB-binding
protein) or Hyrax47–51,101–105 (TIMELINE)."
"1940","Klaus ABirchmeier W","18432252","Nature reviews. Cancer","PubMed",,,"bel:increases","false",,,"In the nucleus,
??catenin forms a transcriptionally active
complex with LEF and TCF transcription
factors30–32 by displacing Grouchos and
interacting with other co-activators such
as BCL9, Pygopus, CBP (CREB-binding
protein) or Hyrax47–51,101–105 (TIMELINE)."
"1941","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"Here, we show that Wnt/beta-catenin signaling regulates proximal-distal differentiation of airway epithelium. Inhibition of Wnt/beta-catenin signaling, either by expression of Dkk1 or by tissue-specific deletion of beta-catenin, results in disruption of distal airway development and expansion of proximal airways."
"1942","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"Here, we show that Wnt/beta-catenin signaling regulates proximal-distal differentiation of airway epithelium. Inhibition of Wnt/beta-catenin signaling, either by expression of Dkk1 or by tissue-specific deletion of beta-catenin, results in disruption of distal airway development and expansion of proximal airways."
"1943","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:directlyIncreases","false",,,"Moreover, we show that beta-catenin and LEF/TCF activate the promoters of BMP4 and N-myc."
"1944","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:directlyIncreases","false",,,"Moreover, we show that beta-catenin and LEF/TCF activate the promoters of BMP4 and N-myc."
"1945","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:directlyIncreases","false",,,"Moreover, we show that beta-catenin and LEF/TCF activate the promoters of BMP4 and N-myc."
"1946","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:directlyIncreases","false",,,"Moreover, we show that beta-catenin and LEF/TCF activate the promoters of BMP4 and N-myc."
"1947","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"This pattern of activity and expression
overlaps extensively with that of Wnt7b, which is known to
play a key role in lung epithelial differentiation (Shu et al.,
2002)."
"1948","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:decreases","false",,,"These data
suggest that, along with airway epithelium, the proximal–
distal expression of smooth muscle in lung mesoderm is
disrupted in SP-C/rtTA X tetO-Dkk1 double transgenic
embryos and that Wnt signaling lies upstream of signals
regulating proximal–distal patterning of both endodermal
(airway epithelium) and mesodermal (airway smooth
muscle) cell lineages."
"1949","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:decreases","false",,,"These data
suggest that, along with airway epithelium, the proximal–
distal expression of smooth muscle in lung mesoderm is
disrupted in SP-C/rtTA X tetO-Dkk1 double transgenic
embryos and that Wnt signaling lies upstream of signals
regulating proximal–distal patterning of both endodermal
(airway epithelium) and mesodermal (airway smooth
muscle) cell lineages."
"1950","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"These data
suggest that, along with airway epithelium, the proximal–
distal expression of smooth muscle in lung mesoderm is
disrupted in SP-C/rtTA X tetO-Dkk1 double transgenic
embryos and that Wnt signaling lies upstream of signals
regulating proximal–distal patterning of both endodermal
(airway epithelium) and mesodermal (airway smooth
muscle) cell lineages."
"1951","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"These data
suggest that, along with airway epithelium, the proximal–
distal expression of smooth muscle in lung mesoderm is
disrupted in SP-C/rtTA X tetO-Dkk1 double transgenic
embryos and that Wnt signaling lies upstream of signals
regulating proximal–distal patterning of both endodermal
(airway epithelium) and mesodermal (airway smooth
muscle) cell lineages."
"1952","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"Wnt signaling has been directly associated with cell
proliferation in a multitude of tissues and cell types including
colon epithelium and in stem cell self renewal (Pinto et al.,
2003; Reya et al., 2003; van de Wetering et al., 2002)."
"1953","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"Loss of Nmyc
function has been shown to result in defective
branching morphogenesis in the lung (Moens et al., 1993;
Okubo et al., 2005; Sawai et al., 1993; Stanton et al.,
1992). Furthermore, N-myc has been recently implicated
in the regulation of distal airway progenitor development
(Okubo et al., 2005). c-myc, a highly related myc gene, is
a well-established down-stream target of Wnt/h-catenin
signaling in several tissues including intestinal epithelium
(Anna et al., 2003; Cong et al., 2003; Pinto et al., 2003)."
"1954","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"Loss of Nmyc
function has been shown to result in defective
branching morphogenesis in the lung (Moens et al., 1993;
Okubo et al., 2005; Sawai et al., 1993; Stanton et al.,
1992). Furthermore, N-myc has been recently implicated
in the regulation of distal airway progenitor development
(Okubo et al., 2005). c-myc, a highly related myc gene, is
a well-established down-stream target of Wnt/h-catenin
signaling in several tissues including intestinal epithelium
(Anna et al., 2003; Cong et al., 2003; Pinto et al., 2003)."
"1955","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"Loss of Nmyc
function has been shown to result in defective
branching morphogenesis in the lung (Moens et al., 1993;
Okubo et al., 2005; Sawai et al., 1993; Stanton et al.,
1992). Furthermore, N-myc has been recently implicated
in the regulation of distal airway progenitor development
(Okubo et al., 2005). c-myc, a highly related myc gene, is
a well-established down-stream target of Wnt/h-catenin
signaling in several tissues including intestinal epithelium
(Anna et al., 2003; Cong et al., 2003; Pinto et al., 2003)."
"1956","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:decreases","false",,,"As
expected, N-myc is expressed at high levels in distal
airway epithelium in wild-type lung tissue at E12.5 and
E16.5 (Figs. 5A and C). However, N-myc expression in
E12.5 SP-C/rtTA:tetO-cre X h-cateninflox and E16.5 SP-C/
Dkk1 lung tissue was severely attenuated (Figs. 5B and D). 
These data indicate that N-myc is down-stream of
Wnt/h-catenin signaling in airway epithelium."
"1957","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"As
expected, N-myc is expressed at high levels in distal
airway epithelium in wild-type lung tissue at E12.5 and
E16.5 (Figs. 5A and C). However, N-myc expression in
E12.5 SP-C/rtTA:tetO-cre X h-cateninflox and E16.5 SP-C/
Dkk1 lung tissue was severely attenuated (Figs. 5B and D). 
These data indicate that N-myc is down-stream of
Wnt/h-catenin signaling in airway epithelium."
"1958","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"Previous studies have implicated BMP signaling in the
regulation of lung airway morphogenesis, specifically
proximal–distal patterning of the airways (Lu et al.,
2001; Weaver et al., 1999)."
"1959","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:decreases","false",,,"In SP-C/Dkk1 embryos, however,
BMP4 expression is significantly reduced (Fig. 5J). As
discussed above, at E12.5, the efficiency of h-catenin
excision in many SP-C/rtTA:tetO-cre X h-cateninflox
embryos is less than 100% in some embryos resulting in a
mosaic pattern of h-catenin expression in the lung airway
epithelium. However, this result proves advantageous since
we can determine in a precise cell specific manner whether
loss of h-catenin leads to a loss of BMP4. As expected,
BMP4 and h-catenin are expressed at high levels in distal
airway epithelium in wild-type lungs at E12.5 (Figs. 5K–
M). Lungs exhibiting mosaic expression of h-catenin also
express BMP4 in a mosaic pattern that closely correlates
with presence of h-catenin (Figs. 5N–P). Complete loss of
h-catenin leads to a complete loss of BMP4 expression
(Figs. 5Q–S)."
"1960","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"In SP-C/Dkk1 embryos, however,
BMP4 expression is significantly reduced (Fig. 5J). As
discussed above, at E12.5, the efficiency of h-catenin
excision in many SP-C/rtTA:tetO-cre X h-cateninflox
embryos is less than 100% in some embryos resulting in a
mosaic pattern of h-catenin expression in the lung airway
epithelium. However, this result proves advantageous since
we can determine in a precise cell specific manner whether
loss of h-catenin leads to a loss of BMP4. As expected,
BMP4 and h-catenin are expressed at high levels in distal
airway epithelium in wild-type lungs at E12.5 (Figs. 5K–
M). Lungs exhibiting mosaic expression of h-catenin also
express BMP4 in a mosaic pattern that closely correlates
with presence of h-catenin (Figs. 5N–P). Complete loss of
h-catenin leads to a complete loss of BMP4 expression
(Figs. 5Q–S)."
"1961","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"FGF signaling is known to be a critical regulator of lung
airway development. Loss of FGF signaling in the lung,
either through loss of FGF10 expression or expression of a
dominant-negative FGF receptor, results in a severe abrogation
of lung airway branching (Bellusci et al., 1997; Min et
al., 1998; Peters et al., 1994; Sekine et al., 1999)."
"1962","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"In situ
hybridization demonstrates that FGFR2 expression is dramatically
reduced in lung airway epithelium but not tracheal
epithelium of SP-C/rtTA:tetO-cre X h-cateninflox (Figs. 6A
and B)."
"1963","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"Loss of h-catenin
expression leads to a dramatic reduction in ERK1/2 activity
(Figs. 6C and D)."
"1964","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:increases","false",,,"Loss of h-catenin
expression leads to a dramatic reduction in ERK1/2 activity
(Figs. 6C and D)."
"1965","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:directlyIncreases","false",,,"Co-transfection of
luciferase reporter plasmids containing these sequences
along with expression plasmids encoding either an activated
h-catenin containing mutations in the GSK-3h phosphorylation
sites (h-catenin/4145) or with a TCF3-VP16 fusion
protein demonstrated that both promoter sequences could be
activated by transcriptional mediators of Wnt signaling
(Figs. 7A and B). Addition of both h-catenin/4154 and
TCF3-VP16 resulted in cooperative activation of both
promoters (Figs. 7A and B). Furthermore, a dominantnegative
TCF3 construct repressed both BMP4 and N-myc
promoters (Figs. 7C and D). Chromatin immunoprecipitation
assays show that h-catenin associates with the
conserved LEF/TCF DNA binding sites located in the
BMP4 and N-myc promoters, indicating direct regulation of
these promoters by canonical Wnt signaling (Figs. 7E and
F). Together, these results demonstrate that BMP4 and Nmyc
are targets of Wnt/h-catenin signaling in lung airway
epithelium."
"1966","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:directlyIncreases","false",,,"Co-transfection of
luciferase reporter plasmids containing these sequences
along with expression plasmids encoding either an activated
h-catenin containing mutations in the GSK-3h phosphorylation
sites (h-catenin/4145) or with a TCF3-VP16 fusion
protein demonstrated that both promoter sequences could be
activated by transcriptional mediators of Wnt signaling
(Figs. 7A and B). Addition of both h-catenin/4154 and
TCF3-VP16 resulted in cooperative activation of both
promoters (Figs. 7A and B). Furthermore, a dominantnegative
TCF3 construct repressed both BMP4 and N-myc
promoters (Figs. 7C and D). Chromatin immunoprecipitation
assays show that h-catenin associates with the
conserved LEF/TCF DNA binding sites located in the
BMP4 and N-myc promoters, indicating direct regulation of
these promoters by canonical Wnt signaling (Figs. 7E and
F). Together, these results demonstrate that BMP4 and Nmyc
are targets of Wnt/h-catenin signaling in lung airway
epithelium."
"1967","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:directlyIncreases","false",,,"Co-transfection of
luciferase reporter plasmids containing these sequences
along with expression plasmids encoding either an activated
h-catenin containing mutations in the GSK-3h phosphorylation
sites (h-catenin/4145) or with a TCF3-VP16 fusion
protein demonstrated that both promoter sequences could be
activated by transcriptional mediators of Wnt signaling
(Figs. 7A and B). Addition of both h-catenin/4154 and
TCF3-VP16 resulted in cooperative activation of both
promoters (Figs. 7A and B). Furthermore, a dominantnegative
TCF3 construct repressed both BMP4 and N-myc
promoters (Figs. 7C and D). Chromatin immunoprecipitation
assays show that h-catenin associates with the
conserved LEF/TCF DNA binding sites located in the
BMP4 and N-myc promoters, indicating direct regulation of
these promoters by canonical Wnt signaling (Figs. 7E and
F). Together, these results demonstrate that BMP4 and Nmyc
are targets of Wnt/h-catenin signaling in lung airway
epithelium."
"1968","Shu WGuttentag SWang ZAndl TBallard PLu MMPiccolo SBirchmeier WWhitsett JAMillar SEMorrisey EE","15907834","Developmental biology","PubMed",,,"bel:directlyIncreases","false",,,"Co-transfection of
luciferase reporter plasmids containing these sequences
along with expression plasmids encoding either an activated
h-catenin containing mutations in the GSK-3h phosphorylation
sites (h-catenin/4145) or with a TCF3-VP16 fusion
protein demonstrated that both promoter sequences could be
activated by transcriptional mediators of Wnt signaling
(Figs. 7A and B). Addition of both h-catenin/4154 and
TCF3-VP16 resulted in cooperative activation of both
promoters (Figs. 7A and B). Furthermore, a dominantnegative
TCF3 construct repressed both BMP4 and N-myc
promoters (Figs. 7C and D). Chromatin immunoprecipitation
assays show that h-catenin associates with the
conserved LEF/TCF DNA binding sites located in the
BMP4 and N-myc promoters, indicating direct regulation of
these promoters by canonical Wnt signaling (Figs. 7E and
F). Together, these results demonstrate that BMP4 and Nmyc
are targets of Wnt/h-catenin signaling in lung airway
epithelium."
"1969","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:increases","false",,,"Exposure of rats to 80 mg/m(3) tobacco smoke significantly induced apoptosis in the lungs. Tobacco smoke resulted in inhibition of NF-kappaB activity, noted by suppression of inhibitor of kappaB (IkappaB) kinase (IKK), accumulation of IkappaBalpha, decrease of NF-kappaB DNA binding activity, and downregulation of NF-kappaB-dependent anti-apoptotic proteins, including Bcl-2, Bcl-xl, and inhibitors of apoptosis."
"1970","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"Exposure of rats to 80 mg/m(3) tobacco smoke significantly induced apoptosis in the lungs. Tobacco smoke resulted in inhibition of NF-kappaB activity, noted by suppression of inhibitor of kappaB (IkappaB) kinase (IKK), accumulation of IkappaBalpha, decrease of NF-kappaB DNA binding activity, and downregulation of NF-kappaB-dependent anti-apoptotic proteins, including Bcl-2, Bcl-xl, and inhibitors of apoptosis."
"1971","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"Exposure of rats to 80 mg/m(3) tobacco smoke significantly induced apoptosis in the lungs. Tobacco smoke resulted in inhibition of NF-kappaB activity, noted by suppression of inhibitor of kappaB (IkappaB) kinase (IKK), accumulation of IkappaBalpha, decrease of NF-kappaB DNA binding activity, and downregulation of NF-kappaB-dependent anti-apoptotic proteins, including Bcl-2, Bcl-xl, and inhibitors of apoptosis."
"1972","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:increases","false",,,"Exposure of rats to 80 mg/m(3) tobacco smoke significantly induced apoptosis in the lungs. Tobacco smoke resulted in inhibition of NF-kappaB activity, noted by suppression of inhibitor of kappaB (IkappaB) kinase (IKK), accumulation of IkappaBalpha, decrease of NF-kappaB DNA binding activity, and downregulation of NF-kappaB-dependent anti-apoptotic proteins, including Bcl-2, Bcl-xl, and inhibitors of apoptosis."
"1973","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"Exposure of rats to 80 mg/m(3) tobacco smoke significantly induced apoptosis in the lungs. Tobacco smoke resulted in inhibition of NF-kappaB activity, noted by suppression of inhibitor of kappaB (IkappaB) kinase (IKK), accumulation of IkappaBalpha, decrease of NF-kappaB DNA binding activity, and downregulation of NF-kappaB-dependent anti-apoptotic proteins, including Bcl-2, Bcl-xl, and inhibitors of apoptosis."
"1974","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"Exposure of rats to 80 mg/m(3) tobacco smoke significantly induced apoptosis in the lungs. Tobacco smoke resulted in inhibition of NF-kappaB activity, noted by suppression of inhibitor of kappaB (IkappaB) kinase (IKK), accumulation of IkappaBalpha, decrease of NF-kappaB DNA binding activity, and downregulation of NF-kappaB-dependent anti-apoptotic proteins, including Bcl-2, Bcl-xl, and inhibitors of apoptosis."
"1975","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:increases","false",,,"Initiator caspases for the death receptor pathway (caspase 8) and the mitochondrial pathway (caspase 9) as well as effector caspase 3 were activated following tobacco smoke exposure."
"1976","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:increases","false",,,"Initiator caspases for the death receptor pathway (caspase 8) and the mitochondrial pathway (caspase 9) as well as effector caspase 3 were activated following tobacco smoke exposure."
"1977","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:increases","false",,,"Initiator caspases for the death receptor pathway (caspase 8) and the mitochondrial pathway (caspase 9) as well as effector caspase 3 were activated following tobacco smoke exposure."
"1978","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"In contrast, exposure of animals to 80 mg/m3 tobacco smoke resulted in a significant decrease of NF-?B -DNA binding activity. In addition to NF-?B –DNA binding activity, the level of NF-?B subunits, including p65 and p50 in the nucleus, were measure by Western blot analyses. Consistent with the EMSA results, the nuclear protein levels of both NF-?B p65 and p50 were significantly reduced in the lungs of rats exposed to 80 mg/m3 with respect to FA control animals (Fig. 3)."
"1979","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:increases","false",,,"In order to better understand the underlying mechanisms of tobacco smoke on NF-?B activity, the NF-?B activation pathway was examined. Fig. 4B demonstrates that the levels of the inhibitor of NF-?B (I?B)-? in cytoplasm were significantly elevated in rats exposed to 80 mg/m3 tobacco smoke, whereas the cytoplasmic levels of I?B-? was not changed by tobacco smoke exposure, regardless of concentration."
"1980","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"Examination of I?B kinases (IKK) revealed that 80 mg/m3 of tobacco smoke suppressed the levels of IKK? and IKK? phosphorylation (activation). No significant changes were observed for the levels of IKK? and IKK? activation from rats exposed to 30 mg/m3 tobacco smoke."
"1981","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"Examination of I?B kinases (IKK) revealed that 80 mg/m3 of tobacco smoke suppressed the levels of IKK? and IKK? phosphorylation (activation). No significant changes were observed for the levels of IKK? and IKK? activation from rats exposed to 30 mg/m3 tobacco smoke."
"1982","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"Examination of I?B kinases (IKK) revealed that 80 mg/m3 of tobacco smoke suppressed the levels of IKK? and IKK? phosphorylation (activation). No significant changes were observed for the levels of IKK? and IKK? activation from rats exposed to 30 mg/m3 tobacco smoke."
"1983","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:directlyIncreases","false",,,"Examination of I?B kinases (IKK) revealed that 80 mg/m3 of tobacco smoke suppressed the levels of IKK? and IKK? phosphorylation (activation). No significant changes were observed for the levels of IKK? and IKK? activation from rats exposed to 30 mg/m3 tobacco smoke."
"1984","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:directlyIncreases","false",,,"Examination of I?B kinases (IKK) revealed that 80 mg/m3 of tobacco smoke suppressed the levels of IKK? and IKK? phosphorylation (activation). No significant changes were observed for the levels of IKK? and IKK? activation from rats exposed to 30 mg/m3 tobacco smoke."
"1985","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:directlyIncreases","false",,,"Examination of I?B kinases (IKK) revealed that 80 mg/m3 of tobacco smoke suppressed the levels of IKK? and IKK? phosphorylation (activation). No significant changes were observed for the levels of IKK? and IKK? activation from rats exposed to 30 mg/m3 tobacco smoke."
"1986","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"Examination of I?B kinases (IKK) revealed that 80 mg/m3 of tobacco smoke suppressed the levels of IKK? and IKK? phosphorylation (activation). No significant changes were observed for the levels of IKK? and IKK? activation from rats exposed to 30 mg/m3 tobacco smoke."
"1987","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"Examination of I?B kinases (IKK) revealed that 80 mg/m3 of tobacco smoke suppressed the levels of IKK? and IKK? phosphorylation (activation). No significant changes were observed for the levels of IKK? and IKK? activation from rats exposed to 30 mg/m3 tobacco smoke."
"1988","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"Examination of I?B kinases (IKK) revealed that 80 mg/m3 of tobacco smoke suppressed the levels of IKK? and IKK? phosphorylation (activation). No significant changes were observed for the levels of IKK? and IKK? activation from rats exposed to 30 mg/m3 tobacco smoke."
"1989","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:directlyIncreases","false",,,"Examination of I?B kinases (IKK) revealed that 80 mg/m3 of tobacco smoke suppressed the levels of IKK? and IKK? phosphorylation (activation). No significant changes were observed for the levels of IKK? and IKK? activation from rats exposed to 30 mg/m3 tobacco smoke."
"1990","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:directlyDecreases","false",,,"Because of their molecular chaperone property, heat shock proteins (HSP), HSP70 in particular, can exert an inhibitory effect on NF-?B as a partial substitute for I?B. Therefore, the effect of tobacco smoke on HSP70 induction was examined. The level of HSP70 was significantly greater (152%) in animals exposed to 80 mg/m3 tobacco smoke compared to animals exposed to FA (Fig. 4D)."
"1991","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:increases","false",,,"Because of their molecular chaperone property, heat shock proteins (HSP), HSP70 in particular, can exert an inhibitory effect on NF-?B as a partial substitute for I?B. Therefore, the effect of tobacco smoke on HSP70 induction was examined. The level of HSP70 was significantly greater (152%) in animals exposed to 80 mg/m3 tobacco smoke compared to animals exposed to FA (Fig. 4D)."
"1992","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"In line with the NF-?B activity described above, exposure to 80 mg/m3 tobacco smoke significantly down regulated the expression levels of Bcl-2, Bcl-xl, c-IAP1, c-IA2 and XIAP by 49.7%, 67%, 75.9%, 57.1%, and 63.2%, respectively (Fig. 5B)."
"1993","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"In line with the NF-?B activity described above, exposure to 80 mg/m3 tobacco smoke significantly down regulated the expression levels of Bcl-2, Bcl-xl, c-IAP1, c-IA2 and XIAP by 49.7%, 67%, 75.9%, 57.1%, and 63.2%, respectively (Fig. 5B)."
"1994","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"In line with the NF-?B activity described above, exposure to 80 mg/m3 tobacco smoke significantly down regulated the expression levels of Bcl-2, Bcl-xl, c-IAP1, c-IA2 and XIAP by 49.7%, 67%, 75.9%, 57.1%, and 63.2%, respectively (Fig. 5B)."
"1995","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"In line with the NF-?B activity described above, exposure to 80 mg/m3 tobacco smoke significantly down regulated the expression levels of Bcl-2, Bcl-xl, c-IAP1, c-IA2 and XIAP by 49.7%, 67%, 75.9%, 57.1%, and 63.2%, respectively (Fig. 5B)."
"1996","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:decreases","false",,,"In line with the NF-?B activity described above, exposure to 80 mg/m3 tobacco smoke significantly down regulated the expression levels of Bcl-2, Bcl-xl, c-IAP1, c-IA2 and XIAP by 49.7%, 67%, 75.9%, 57.1%, and 63.2%, respectively (Fig. 5B)."
"1997","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:increases","false",,,"Apoptosis is executed through the activation of caspases. To further verify the effect of tobacco smoke in the induction of apoptosis, the levels of cleaved caspases 8, 9, and 3 in rat lungs were determined. In agreement with the apoptotic results described above, exposure of rats to 80 mg/m3 tobacco smoke resulted in significantly increased levels of cleaved caspases 8, 9, and 3, indicating the activation of these caspases (Fig. 7B). Compared to FA control animals, the cleaved caspases 8, 9, and 3 were elevated by 98.1%, 113.9%, and 84.7 %, respectively."
"1998","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:increases","false",,,"Apoptosis is executed through the activation of caspases. To further verify the effect of tobacco smoke in the induction of apoptosis, the levels of cleaved caspases 8, 9, and 3 in rat lungs were determined. In agreement with the apoptotic results described above, exposure of rats to 80 mg/m3 tobacco smoke resulted in significantly increased levels of cleaved caspases 8, 9, and 3, indicating the activation of these caspases (Fig. 7B). Compared to FA control animals, the cleaved caspases 8, 9, and 3 were elevated by 98.1%, 113.9%, and 84.7 %, respectively."
"1999","Zhong CYZhou YMPinkerton KE","18355884","Toxicology and applied pharmacology","PubMed",,,"bel:increases","false",,,"Apoptosis is executed through the activation of caspases. To further verify the effect of tobacco smoke in the induction of apoptosis, the levels of cleaved caspases 8, 9, and 3 in rat lungs were determined. In agreement with the apoptotic results described above, exposure of rats to 80 mg/m3 tobacco smoke resulted in significantly increased levels of cleaved caspases 8, 9, and 3, indicating the activation of these caspases (Fig. 7B). Compared to FA control animals, the cleaved caspases 8, 9, and 3 were elevated by 98.1%, 113.9%, and 84.7 %, respectively."
"2000","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:increases","false",,,"Following the molecular characterization of several angiogenic growth factors, landmark studies in the early 1990s showed that hypoxia could induce expression of platelet-derived growth factor mRNA9 and vascular endothelial growth factor (VEGF) mRNA in tissue culture10."
"2001","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:increases","false",,,"Following the molecular characterization of several angiogenic growth factors, landmark studies in the early 1990s showed that hypoxia could induce expression of platelet-derived growth factor mRNA9 and vascular endothelial growth factor (VEGF) mRNA in tissue culture10."
"2002","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:increases","false",,,"Circulating erythropoietin increases several hundred fold within hours of hypoxic stimulation (reviewed in ref. 13). "
"2003","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two prolyl residues (Pro402 and Pro564 in human HIF-1alpha) mediates interactions with the von Hippel?Lindau (VHL) E3 ubiquitin ligase complex that targets HIF-alpha for proteasomal destruction28, 29, 30, 34. Each site can interact independently with VHL E3, potentially contributing to the extremely rapid proteolysis of HIF-alpha that is observed in oxygenated cells34. These sites contain a conserved LxxLAP motif and are targeted by a newly defined prolyl hydroxylase activity, that in mammalian cells is provided by three isoforms termed PHD (prolyl hydroxylase domain) 1?3 (refs. 31,32)."
"2004","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two prolyl residues (Pro402 and Pro564 in human HIF-1alpha) mediates interactions with the von Hippel?Lindau (VHL) E3 ubiquitin ligase complex that targets HIF-alpha for proteasomal destruction28, 29, 30, 34. Each site can interact independently with VHL E3, potentially contributing to the extremely rapid proteolysis of HIF-alpha that is observed in oxygenated cells34. These sites contain a conserved LxxLAP motif and are targeted by a newly defined prolyl hydroxylase activity, that in mammalian cells is provided by three isoforms termed PHD (prolyl hydroxylase domain) 1?3 (refs. 31,32)."
"2005","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two prolyl residues (Pro402 and Pro564 in human HIF-1alpha) mediates interactions with the von Hippel?Lindau (VHL) E3 ubiquitin ligase complex that targets HIF-alpha for proteasomal destruction28, 29, 30, 34. Each site can interact independently with VHL E3, potentially contributing to the extremely rapid proteolysis of HIF-alpha that is observed in oxygenated cells34. These sites contain a conserved LxxLAP motif and are targeted by a newly defined prolyl hydroxylase activity, that in mammalian cells is provided by three isoforms termed PHD (prolyl hydroxylase domain) 1?3 (refs. 31,32)."
"2006","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two prolyl residues (Pro402 and Pro564 in human HIF-1alpha) mediates interactions with the von Hippel?Lindau (VHL) E3 ubiquitin ligase complex that targets HIF-alpha for proteasomal destruction28, 29, 30, 34. Each site can interact independently with VHL E3, potentially contributing to the extremely rapid proteolysis of HIF-alpha that is observed in oxygenated cells34. These sites contain a conserved LxxLAP motif and are targeted by a newly defined prolyl hydroxylase activity, that in mammalian cells is provided by three isoforms termed PHD (prolyl hydroxylase domain) 1?3 (refs. 31,32)."
"2007","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two prolyl residues (Pro402 and Pro564 in human HIF-1alpha) mediates interactions with the von Hippel?Lindau (VHL) E3 ubiquitin ligase complex that targets HIF-alpha for proteasomal destruction28, 29, 30, 34. Each site can interact independently with VHL E3, potentially contributing to the extremely rapid proteolysis of HIF-alpha that is observed in oxygenated cells34. These sites contain a conserved LxxLAP motif and are targeted by a newly defined prolyl hydroxylase activity, that in mammalian cells is provided by three isoforms termed PHD (prolyl hydroxylase domain) 1?3 (refs. 31,32)."
"2008","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two prolyl residues (Pro402 and Pro564 in human HIF-1alpha) mediates interactions with the von Hippel?Lindau (VHL) E3 ubiquitin ligase complex that targets HIF-alpha for proteasomal destruction28, 29, 30, 34. Each site can interact independently with VHL E3, potentially contributing to the extremely rapid proteolysis of HIF-alpha that is observed in oxygenated cells34. These sites contain a conserved LxxLAP motif and are targeted by a newly defined prolyl hydroxylase activity, that in mammalian cells is provided by three isoforms termed PHD (prolyl hydroxylase domain) 1?3 (refs. 31,32)."
"2009","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two prolyl residues (Pro402 and Pro564 in human HIF-1alpha) mediates interactions with the von Hippel?Lindau (VHL) E3 ubiquitin ligase complex that targets HIF-alpha for proteasomal destruction28, 29, 30, 34. Each site can interact independently with VHL E3, potentially contributing to the extremely rapid proteolysis of HIF-alpha that is observed in oxygenated cells34. These sites contain a conserved LxxLAP motif and are targeted by a newly defined prolyl hydroxylase activity, that in mammalian cells is provided by three isoforms termed PHD (prolyl hydroxylase domain) 1?3 (refs. 31,32)."
"2010","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two prolyl residues (Pro402 and Pro564 in human HIF-1alpha) mediates interactions with the von Hippel?Lindau (VHL) E3 ubiquitin ligase complex that targets HIF-alpha for proteasomal destruction28, 29, 30, 34. Each site can interact independently with VHL E3, potentially contributing to the extremely rapid proteolysis of HIF-alpha that is observed in oxygenated cells34. These sites contain a conserved LxxLAP motif and are targeted by a newly defined prolyl hydroxylase activity, that in mammalian cells is provided by three isoforms termed PHD (prolyl hydroxylase domain) 1?3 (refs. 31,32)."
"2011","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two prolyl residues (Pro402 and Pro564 in human HIF-1alpha) mediates interactions with the von Hippel?Lindau (VHL) E3 ubiquitin ligase complex that targets HIF-alpha for proteasomal destruction28, 29, 30, 34. Each site can interact independently with VHL E3, potentially contributing to the extremely rapid proteolysis of HIF-alpha that is observed in oxygenated cells34. These sites contain a conserved LxxLAP motif and are targeted by a newly defined prolyl hydroxylase activity, that in mammalian cells is provided by three isoforms termed PHD (prolyl hydroxylase domain) 1?3 (refs. 31,32)."
"2012","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two prolyl residues (Pro402 and Pro564 in human HIF-1alpha) mediates interactions with the von Hippel?Lindau (VHL) E3 ubiquitin ligase complex that targets HIF-alpha for proteasomal destruction28, 29, 30, 34. Each site can interact independently with VHL E3, potentially contributing to the extremely rapid proteolysis of HIF-alpha that is observed in oxygenated cells34. These sites contain a conserved LxxLAP motif and are targeted by a newly defined prolyl hydroxylase activity, that in mammalian cells is provided by three isoforms termed PHD (prolyl hydroxylase domain) 1?3 (refs. 31,32)."
"2013","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"Hydroxylation at two prolyl residues (Pro402 and Pro564 in human HIF-1alpha) mediates interactions with the von Hippel?Lindau (VHL) E3 ubiquitin ligase complex that targets HIF-alpha for proteasomal destruction28, 29, 30, 34. Each site can interact independently with VHL E3, potentially contributing to the extremely rapid proteolysis of HIF-alpha that is observed in oxygenated cells34. These sites contain a conserved LxxLAP motif and are targeted by a newly defined prolyl hydroxylase activity, that in mammalian cells is provided by three isoforms termed PHD (prolyl hydroxylase domain) 1?3 (refs. 31,32)."
"2014","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"In a second hydroxylation-dependent control, beta-hydroxylation of an asparaginyl residue in the C-terminal activation domain of HIF-alpha (Asn803 in human HIF-1alpha)35 is regulated by a HIF asparaginyl hydroxylase33, 36 termed FIH (factor inhibiting HIF)37. Hydroxylation at this site blocks interaction of the HIF-alpha C-terminal activation domain with the transcriptional coactivator p300. "
"2015","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyDecreases","false",,,"In a second hydroxylation-dependent control, beta-hydroxylation of an asparaginyl residue in the C-terminal activation domain of HIF-alpha (Asn803 in human HIF-1alpha)35 is regulated by a HIF asparaginyl hydroxylase33, 36 termed FIH (factor inhibiting HIF)37. Hydroxylation at this site blocks interaction of the HIF-alpha C-terminal activation domain with the transcriptional coactivator p300. "
"2016","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"In oxygenated cells, these hydroxylation reactions provide a dual mechanism of HIF inactivation that involves proteolytic destruction and inhibition of transcriptional activity (Fig. 1). The HIF hydroxylases are all Fe(II)- and 2-oxoglutarate-dependent dioxygenases that have an absolute requirement for molecular oxygen, allowing HIF to escape inactivation in hypoxia. "
"2017","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"In oxygenated cells, these hydroxylation reactions provide a dual mechanism of HIF inactivation that involves proteolytic destruction and inhibition of transcriptional activity (Fig. 1). The HIF hydroxylases are all Fe(II)- and 2-oxoglutarate-dependent dioxygenases that have an absolute requirement for molecular oxygen, allowing HIF to escape inactivation in hypoxia. "
"2018","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"In oxygenated cells, these hydroxylation reactions provide a dual mechanism of HIF inactivation that involves proteolytic destruction and inhibition of transcriptional activity (Fig. 1). The HIF hydroxylases are all Fe(II)- and 2-oxoglutarate-dependent dioxygenases that have an absolute requirement for molecular oxygen, allowing HIF to escape inactivation in hypoxia. "
"2019","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"In oxygenated cells, these hydroxylation reactions provide a dual mechanism of HIF inactivation that involves proteolytic destruction and inhibition of transcriptional activity (Fig. 1). The HIF hydroxylases are all Fe(II)- and 2-oxoglutarate-dependent dioxygenases that have an absolute requirement for molecular oxygen, allowing HIF to escape inactivation in hypoxia. "
"2020","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"In oxygenated cells, these hydroxylation reactions provide a dual mechanism of HIF inactivation that involves proteolytic destruction and inhibition of transcriptional activity (Fig. 1). The HIF hydroxylases are all Fe(II)- and 2-oxoglutarate-dependent dioxygenases that have an absolute requirement for molecular oxygen, allowing HIF to escape inactivation in hypoxia. "
"2021","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"In oxygenated cells, these hydroxylation reactions provide a dual mechanism of HIF inactivation that involves proteolytic destruction and inhibition of transcriptional activity (Fig. 1). The HIF hydroxylases are all Fe(II)- and 2-oxoglutarate-dependent dioxygenases that have an absolute requirement for molecular oxygen, allowing HIF to escape inactivation in hypoxia. "
"2022","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"In oxygenated cells, these hydroxylation reactions provide a dual mechanism of HIF inactivation that involves proteolytic destruction and inhibition of transcriptional activity (Fig. 1). The HIF hydroxylases are all Fe(II)- and 2-oxoglutarate-dependent dioxygenases that have an absolute requirement for molecular oxygen, allowing HIF to escape inactivation in hypoxia. "
"2023","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"In oxygenated cells, these hydroxylation reactions provide a dual mechanism of HIF inactivation that involves proteolytic destruction and inhibition of transcriptional activity (Fig. 1). The HIF hydroxylases are all Fe(II)- and 2-oxoglutarate-dependent dioxygenases that have an absolute requirement for molecular oxygen, allowing HIF to escape inactivation in hypoxia. "
"2024","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"In oxygenated cells, these hydroxylation reactions provide a dual mechanism of HIF inactivation that involves proteolytic destruction and inhibition of transcriptional activity (Fig. 1). The HIF hydroxylases are all Fe(II)- and 2-oxoglutarate-dependent dioxygenases that have an absolute requirement for molecular oxygen, allowing HIF to escape inactivation in hypoxia. "
"2025","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"In oxygenated cells, these hydroxylation reactions provide a dual mechanism of HIF inactivation that involves proteolytic destruction and inhibition of transcriptional activity (Fig. 1). The HIF hydroxylases are all Fe(II)- and 2-oxoglutarate-dependent dioxygenases that have an absolute requirement for molecular oxygen, allowing HIF to escape inactivation in hypoxia. "
"2026","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"In oxygenated cells, these hydroxylation reactions provide a dual mechanism of HIF inactivation that involves proteolytic destruction and inhibition of transcriptional activity (Fig. 1). The HIF hydroxylases are all Fe(II)- and 2-oxoglutarate-dependent dioxygenases that have an absolute requirement for molecular oxygen, allowing HIF to escape inactivation in hypoxia. "
"2027","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"In oxygenated cells, these hydroxylation reactions provide a dual mechanism of HIF inactivation that involves proteolytic destruction and inhibition of transcriptional activity (Fig. 1). The HIF hydroxylases are all Fe(II)- and 2-oxoglutarate-dependent dioxygenases that have an absolute requirement for molecular oxygen, allowing HIF to escape inactivation in hypoxia. "
"2028","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"In hypoxia, VEGF transcription is upregulated by HIF18, 19, mRNA stability is increased by binding of proteins to specific sequences in the 3' UTR71, and an internal ribosomal entry site allows preserved translation in the face of normal cellular hypoxic shutdown72. The biological activity of secreted VEGF is further influenced by hypoxia-inducible expression of the Flt-1 receptor49, "
"2029","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:increases","false",,,"In hypoxia, VEGF transcription is upregulated by HIF18, 19, mRNA stability is increased by binding of proteins to specific sequences in the 3' UTR71, and an internal ribosomal entry site allows preserved translation in the face of normal cellular hypoxic shutdown72. The biological activity of secreted VEGF is further influenced by hypoxia-inducible expression of the Flt-1 receptor49, "
"2030","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:increases","false",,,"In hypoxia, VEGF transcription is upregulated by HIF18, 19, mRNA stability is increased by binding of proteins to specific sequences in the 3' UTR71, and an internal ribosomal entry site allows preserved translation in the face of normal cellular hypoxic shutdown72. The biological activity of secreted VEGF is further influenced by hypoxia-inducible expression of the Flt-1 receptor49, "
"2031","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:increases","false",,,"In keeping with the central role of HIF in responses to hypoxia observed in tissue culture, targeted inactivation of either Hif1a (refs. 68,70,74) or Arnt (encoding HIF-1beta)75 in the mouse results in abnormal vascular development and embryonic lethality. "
"2032","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:increases","false",,,"In keeping with the central role of HIF in responses to hypoxia observed in tissue culture, targeted inactivation of either Hif1a (refs. 68,70,74) or Arnt (encoding HIF-1beta)75 in the mouse results in abnormal vascular development and embryonic lethality. "
"2033","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:increases","false",,,"In addition to activation by hypoxia, the HIF system is also induced or amplified by a wide range of growth-promoting stimuli and oncogenic pathways such as the insulin, insulin-like growth factor-1, epidermal growth factor and mutant Ras and Src kinase pathways. "
"2034","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:increases","false",,,"In addition to activation by hypoxia, the HIF system is also induced or amplified by a wide range of growth-promoting stimuli and oncogenic pathways such as the insulin, insulin-like growth factor-1, epidermal growth factor and mutant Ras and Src kinase pathways. "
"2035","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:increases","false",,,"In addition to activation by hypoxia, the HIF system is also induced or amplified by a wide range of growth-promoting stimuli and oncogenic pathways such as the insulin, insulin-like growth factor-1, epidermal growth factor and mutant Ras and Src kinase pathways. "
"2036","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:increases","false",,,"In addition to activation by hypoxia, the HIF system is also induced or amplified by a wide range of growth-promoting stimuli and oncogenic pathways such as the insulin, insulin-like growth factor-1, epidermal growth factor and mutant Ras and Src kinase pathways. "
"2037","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:increases","false",,,"In addition to activation by hypoxia, the HIF system is also induced or amplified by a wide range of growth-promoting stimuli and oncogenic pathways such as the insulin, insulin-like growth factor-1, epidermal growth factor and mutant Ras and Src kinase pathways. "
"2038","Pugh CWRatcliffe PJ","12778166","Nature medicine","PubMed",,,"bel:increases","false",,,"In addition to activation by hypoxia, the HIF system is also induced or amplified by a wide range of growth-promoting stimuli and oncogenic pathways such as the insulin, insulin-like growth factor-1, epidermal growth factor and mutant Ras and Src kinase pathways. "
"2039","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"Numerous studies have shown that the RB protein is an
inhibitor of cell proliferation"
"2040","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"RB and the
related family members p107 and p130 can each bind E2F
to repress genes that are otherwise important for progression
from G1 to S phase."
"2041","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"RB and the
related family members p107 and p130 can each bind E2F
to repress genes that are otherwise important for progression
from G1 to S phase."
"2042","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"RB and the
related family members p107 and p130 can each bind E2F
to repress genes that are otherwise important for progression
from G1 to S phase."
"2043","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyDecreases","false",,,"RB and the
related family members p107 and p130 can each bind E2F
to repress genes that are otherwise important for progression
from G1 to S phase."
"2044","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyDecreases","false",,,"The binding of RB, p107, or p130
has two simultaneous consequences: (1) binding prevents
E2F from interacting with transcriptional co-activators (e.g.,
p300);"
"2045","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyDecreases","false",,,"The binding of RB, p107, or p130
has two simultaneous consequences: (1) binding prevents
E2F from interacting with transcriptional co-activators (e.g.,
p300);"
"2046","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyDecreases","false",,,"The binding of RB, p107, or p130
has two simultaneous consequences: (1) binding prevents
E2F from interacting with transcriptional co-activators (e.g.,
p300);"
"2047","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyIncreases","false",,,"In normal G1 progression, the Cyclin D1/CDK4
kinase phosphorylates RB, triggers disruption of the RB/
E2F complex, and frees E2F to activate genes that are
necessary for S-phase progression."
"2048","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyDecreases","false",,,"In normal G1 progression, the Cyclin D1/CDK4
kinase phosphorylates RB, triggers disruption of the RB/
E2F complex, and frees E2F to activate genes that are
necessary for S-phase progression."
"2049","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyDecreases","false",,,"The p16 protein is a
CDK4 inhibitor that restrains the activity of Cyclin D1/
CDK4 and thus inhibits G1 progression."
"2050","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"The p16 protein is a
CDK4 inhibitor that restrains the activity of Cyclin D1/
CDK4 and thus inhibits G1 progression."
"2051","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"Cyclin D1 overexpression/amplification
is associated with numerous cancers."
"2052","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"HBP1 is consistently up regulated in differentiation
and under conditions of cell cycle arrest in muscle, adipocyte,
erythroid, and other cell types"
"2053","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"HBP1 is consistently up regulated in differentiation
and under conditions of cell cycle arrest in muscle, adipocyte,
erythroid, and other cell types"
"2054","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"HBP1 is consistently up regulated in differentiation
and under conditions of cell cycle arrest in muscle, adipocyte,
erythroid, and other cell types"
"2055","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"HBP1 is consistently up regulated in differentiation
and under conditions of cell cycle arrest in muscle, adipocyte,
erythroid, and other cell types"
"2056","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"HBP1 is consistently up regulated in differentiation
and under conditions of cell cycle arrest in muscle, adipocyte,
erythroid, and other cell types"
"2057","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"HBP1 is consistently up regulated in differentiation
and under conditions of cell cycle arrest in muscle, adipocyte,
erythroid, and other cell types"
"2058","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"Consistent with these results,
we showed that overexpression of HBP1 in cells inhibited
G1 and S-phase progression (Tevosian et al., 1997)."
"2059","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"Our detailed investigation showed that
both Cyclin D1 and c-MYC expression was extinguished
upon HBP1 expression."
"2060","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"Our detailed investigation showed that
both Cyclin D1 and c-MYC expression was extinguished
upon HBP1 expression."
"2061","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"Specifically, HBP1 inhibited the
activity of LEF/TCFs."
"2062","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"A constitutive Wnt
signaling pathway has been linked to breast, colon, and
other cancers (for reviews, see Bienz and Clevers, 2000;
Polakis, 2000)."
"2063","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"A constitutive Wnt
signaling pathway has been linked to breast, colon, and
other cancers (for reviews, see Bienz and Clevers, 2000;
Polakis, 2000)."
"2064","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyIncreases","false",,,"The accumulation
of b-catenin results from the inhibition of the GSK3b
kinase, which normally would phosphorylate b-catenin as
a degradation signal."
"2065","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:increases","false",,,"The accumulation
of b-catenin results from the inhibition of the GSK3b
kinase, which normally would phosphorylate b-catenin as
a degradation signal."
"2066","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:prognosticBiomarkerFor","false",,,"high b-catenin levels
correlate with poor prognosis in human breast cancer and
result from biochemical, not genetic, dysregulation (Ryo et
al., 2001; Wulf et al., 2001, 2003)."
"2067","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"Cyclin D1,
MYC, and Cox-2 are three clinically relevant Wnt target genes that are overexpressed in breast and many other
cancers (e.g., Weinstat-Saslow et al., 1995; Naidu et al.,
2002a,b; Singh and Luci, 2002; Spizzo et al., 2003)."
"2068","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"Cyclin D1,
MYC, and Cox-2 are three clinically relevant Wnt target genes that are overexpressed in breast and many other
cancers (e.g., Weinstat-Saslow et al., 1995; Naidu et al.,
2002a,b; Singh and Luci, 2002; Spizzo et al., 2003)."
"2069","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"Cyclin D1,
MYC, and Cox-2 are three clinically relevant Wnt target genes that are overexpressed in breast and many other
cancers (e.g., Weinstat-Saslow et al., 1995; Naidu et al.,
2002a,b; Singh and Luci, 2002; Spizzo et al., 2003)."
"2070","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyIncreases","false",,,"Cyclin
D1 and MYC are examples of direct Wnt target genes in
proliferation and whose activation requires the LEF/TCF
sites in the respective promoters (He et al., 1998; Tetsu and
McCormick, 1999)."
"2071","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyIncreases","false",,,"Cyclin
D1 and MYC are examples of direct Wnt target genes in
proliferation and whose activation requires the LEF/TCF
sites in the respective promoters (He et al., 1998; Tetsu and
McCormick, 1999)."
"2072","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"Cyclin D1 expression best correlates
with breast proliferation."
"2073","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"Increased Cyclin D1 levels in breast cancer cell lines and
tumors have been correlated with increased b-catenin accumulation
and constitutive Wnt signaling (Lin et al., 2000)."
"2074","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"Increased Cyclin D1 levels in breast cancer cell lines and
tumors have been correlated with increased b-catenin accumulation
and constitutive Wnt signaling (Lin et al., 2000)."
"2075","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyIncreases","false",,,"The NADPH oxidase is the principle source
of intracellular reactive oxygen species (ROS) that is generated
by mitogenic signaling."
"2076","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:hasComponents","false",,,"The importance
of a functional NADPH oxidase is underscored by the
observation that mutations of the p47phox and gp91phox
genes are associated with chronic granulomatosis, in which
patients have increased susceptibility to bacterial and fungal
infections (reviewed in Cheng et al., 2001)."
"2077","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:increases","false",,,"Stable transfection of NIH/3T3 fibroblasts with
active Ras (H-RasV12) results in transformation and in
significant intracellular ROS generation. The importance
of intracellular ROS in RAS-mediated transformation is
highlighted by the observation that pharmacological inhibition
of the NADPH oxidase reverses transformation (Irani et
al., 1997)."
"2078","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyIncreases","false",,,"Stable transfection of NIH/3T3 fibroblasts with
active Ras (H-RasV12) results in transformation and in
significant intracellular ROS generation. The importance
of intracellular ROS in RAS-mediated transformation is
highlighted by the observation that pharmacological inhibition
of the NADPH oxidase reverses transformation (Irani et
al., 1997)."
"2079","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:increases","false",,,"the expression of the Nox1/Mox1
catalytic subunit of the NADPH oxidase in NIH/3T3 fibroblasts
not only triggered increased superoxide production,
but also oncogenic transformation (Suh et al., 1999; Arnold
et al., 2001)."
"2080","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:hasComponent","false",,,"RAC itself is also an obligate subunit of
the cellular NADPH oxidase"
"2081","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:increases","false",,,"The expression of active Rac1
in many cell types causes increased superoxide production,
while expression of a dominant-negative Rac1 block superoxide
production....superoxide production is necessary for Rac dependent
G1 progression and cellular shape changes"
"2082","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:increases","false",,,"The expression of active Rac1
in many cell types causes increased superoxide production,
while expression of a dominant-negative Rac1 block superoxide
production....superoxide production is necessary for Rac dependent
G1 progression and cellular shape changes"
"2083","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:increases","false",,,"The expression of active Rac1
in many cell types causes increased superoxide production,
while expression of a dominant-negative Rac1 block superoxide
production....superoxide production is necessary for Rac dependent
G1 progression and cellular shape changes"
"2084","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyDecreases","false",,,"The promoter of the p47phox gene
contains six tandem high-affinity HBP1 DNA binding
elements at -1243 to -1318 bp from the transcriptional
start site and which were required for repression."
"2085","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"We identified the N-MYC gene as a new
HBP1 target (Tevosian et al., 1997).The expression of NMYC
is increased in neuroblastomas."
"2086","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyIncreases","false",,,"HBP1 was identified
as a regulator of the Histone H1 0 gene. HBP1 appears to be
an activator for this gene."
"2087","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:prognosticBiomarkerFor","false",,,"Myeloperoxidase is a clinical prognostic marker
for the progression of myeloid leukemia"
"2088","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"p38 MAPK activity is also linked
with differentiation and recently, with senescence and tumor
suppression (reviewed in Kyriakis and Avruch, 2001 and
see below)."
"2089","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"p38 MAPK activity is also linked
with differentiation and recently, with senescence and tumor
suppression (reviewed in Kyriakis and Avruch, 2001 and
see below)."
"2090","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:negativeCorrelation","false",,,"p38 MAPK activity is also linked
with differentiation and recently, with senescence and tumor
suppression (reviewed in Kyriakis and Avruch, 2001 and
see below)."
"2091","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyIncreases","false",,,"p21
protein levels increased by a post-transcriptional mechanism
and concluded that the SAPKs p38 MAPK and JNK were
involved in stabilizing the p21 protein. A specific site on
p21 (serine 190) was defined for p38 MAPK-mediated
stabilization (Kim et al., 2002)."
"2092","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"p21
protein levels increased by a post-transcriptional mechanism
and concluded that the SAPKs p38 MAPK and JNK were
involved in stabilizing the p21 protein. A specific site on
p21 (serine 190) was defined for p38 MAPK-mediated
stabilization (Kim et al., 2002)."
"2093","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyIncreases","false",,,"the apparent mechanism was that p38 MAPK-mediated
phosphorylation of the HBP1 led to increased protein
stability and a G1 arrest"
"2094","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"the apparent mechanism was that p38 MAPK-mediated
phosphorylation of the HBP1 led to increased protein
stability and a G1 arrest"
"2095","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:increases","false",,,"the activation of the
upstream kinases MKK 6 and MKK 3 lead to a senescent
phenotype that was dependent on p38 MAPK activity"
"2096","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:increases","false",,,"the activation of the
upstream kinases MKK 6 and MKK 3 lead to a senescent
phenotype that was dependent on p38 MAPK activity"
"2097","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:increases","false",,,"the activation of the
upstream kinases MKK 6 and MKK 3 lead to a senescent
phenotype that was dependent on p38 MAPK activity"
"2098","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"A loss of both MKK6 and MKK3 resulted in cells
with increased proliferation and susceptibility to tumorigenic
conversion (Brancho et al., 2003)."
"2099","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"A loss of both MKK6 and MKK3 resulted in cells
with increased proliferation and susceptibility to tumorigenic
conversion (Brancho et al., 2003)."
"2100","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"A loss of both MKK6 and MKK3 resulted in cells
with increased proliferation and susceptibility to tumorigenic
conversion (Brancho et al., 2003)."
"2101","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"A loss of both MKK6 and MKK3 resulted in cells
with increased proliferation and susceptibility to tumorigenic
conversion (Brancho et al., 2003)."
"2102","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:decreases","false",,,"deletion of the p38a (mapk14) isoform also resulted in cells
with increased susceptibility to tumorigenic conversion
(Bulavin et al., 2002)."
"2103","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:positiveCorrelation","false",,,"In breast cancer,
amplification of the human epidermal growth factor receptor-
2 (Her-2) is associated with aggressively proliferating
breast cancers."
"2104","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:negativeCorrelation","false",,,
"2105","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:negativeCorrelation","false",,,"In addition, excessive
EGFR signaling is a common scenario in breast
cancer, specifically in estrogen receptor-negative subtypes"
"2106","Yee ASPaulson EKMcDevitt MARieger-Christ KSummerhayes IBerasi SPKim JHuang CYZhang X","15225871","Gene","PubMed",,,"bel:directlyDecreases","false",,,"Herceptin therapy is blocking the Her-2
receptor and its resulting signaling."
"2107","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"UCP-1 allows the
re-entry of protons and, as a consequence, energy liberated
from substrate oxidation is dissipated as heat (Fig. 1)."
"2108","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"Acute activation of BAT
thermogenesis appears to be mediated by noradrenaline (NA)
liberated from the sympathetic nervous system"
"2109","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"By acting
through b-receptors, NA increases intracellular cAMP levels,
which in turn activate lipolysis (Fig. 1)."
"2110","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"By acting
through b-receptors, NA increases intracellular cAMP levels,
which in turn activate lipolysis (Fig. 1)."
"2111","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"By acting
through b-receptors, NA increases intracellular cAMP levels,
which in turn activate lipolysis (Fig. 1)."
"2112","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"The resulting free
fatty acids are used as substrates for mitochondrial
respiration and as activators of UCP-1 [5]."
"2113","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"The resulting free
fatty acids are used as substrates for mitochondrial
respiration and as activators of UCP-1 [5]."
"2114","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"The resulting free
fatty acids are used as substrates for mitochondrial
respiration and as activators of UCP-1 [5]."
"2115","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:positiveCorrelation","false",,,"They found an A/C transition in the 5' untranslated
region of exon 1 (112 bp upstream of the translation
initiation codon) and also a Met229/Leu variant.
Interestingly, the allele frequencies for the C variant and for
the Leu229 variant were higher in the Type 2 diabetic group
than in the control group."
"2116","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:positiveCorrelation","false",,,"They found an A/C transition in the 5' untranslated
region of exon 1 (112 bp upstream of the translation
initiation codon) and also a Met229/Leu variant.
Interestingly, the allele frequencies for the C variant and for
the Leu229 variant were higher in the Type 2 diabetic group
than in the control group."
"2117","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Insulin and IGF-I initiate the biological effects in target
cells by binding to and activating its endogenous tyrosine
kinase receptors [23,24]. These receptors are believed to
transduce signals by phosphorylation on tyrosine residues of several cellular substrates including IRS proteins (IRS-1,-2,-
3 and –4) [25-28]."
"2118","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Insulin and IGF-I initiate the biological effects in target
cells by binding to and activating its endogenous tyrosine
kinase receptors [23,24]. These receptors are believed to
transduce signals by phosphorylation on tyrosine residues of several cellular substrates including IRS proteins (IRS-1,-2,-
3 and –4) [25-28]."
"2119","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Insulin and IGF-I initiate the biological effects in target
cells by binding to and activating its endogenous tyrosine
kinase receptors [23,24]. These receptors are believed to
transduce signals by phosphorylation on tyrosine residues of several cellular substrates including IRS proteins (IRS-1,-2,-
3 and –4) [25-28]."
"2120","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Insulin and IGF-I initiate the biological effects in target
cells by binding to and activating its endogenous tyrosine
kinase receptors [23,24]. These receptors are believed to
transduce signals by phosphorylation on tyrosine residues of several cellular substrates including IRS proteins (IRS-1,-2,-
3 and –4) [25-28]."
"2121","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Insulin and IGF-I initiate the biological effects in target
cells by binding to and activating its endogenous tyrosine
kinase receptors [23,24]. These receptors are believed to
transduce signals by phosphorylation on tyrosine residues of several cellular substrates including IRS proteins (IRS-1,-2,-
3 and –4) [25-28]."
"2122","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Insulin and IGF-I initiate the biological effects in target
cells by binding to and activating its endogenous tyrosine
kinase receptors [23,24]. These receptors are believed to
transduce signals by phosphorylation on tyrosine residues of several cellular substrates including IRS proteins (IRS-1,-2,-
3 and –4) [25-28]."
"2123","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Insulin and IGF-I initiate the biological effects in target
cells by binding to and activating its endogenous tyrosine
kinase receptors [23,24]. These receptors are believed to
transduce signals by phosphorylation on tyrosine residues of several cellular substrates including IRS proteins (IRS-1,-2,-
3 and –4) [25-28]."
"2124","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Insulin and IGF-I initiate the biological effects in target
cells by binding to and activating its endogenous tyrosine
kinase receptors [23,24]. These receptors are believed to
transduce signals by phosphorylation on tyrosine residues of several cellular substrates including IRS proteins (IRS-1,-2,-
3 and –4) [25-28]."
"2125","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"The p85 regulatory subunit of phosphatidylinositol 3-kinase
(PI 3-kinase) contains two SH2 domains that allow its
binding to the IRS proteins [29]."
"2126","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"PI 3-kinase is a heterodimer
composed of an 85-kDa regulatory subunit and a 110-kDa
catalytic subunit, capable of phosphorylating
phosphoinositides at the 3´-position of the inositol ring,
thus initiating phospholipid turnover [29]."
"2127","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"The
phosphoinositides produced by PI 3-kinase activate the
phosphoinositide-dependent kinases 1 and 2. These kinases
phosphorylate and activate the serine/threonine kinase
PKB/Akt [32]."
"2128","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"The
phosphoinositides produced by PI 3-kinase activate the
phosphoinositide-dependent kinases 1 and 2. These kinases
phosphorylate and activate the serine/threonine kinase
PKB/Akt [32]."
"2129","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"The mammalian target of rapamycin
(mTOR), a 290 kDa serine/threonine kinase and aminoacid
sensor, is a direct target for Akt [33]."
"2130","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"P70s6k is involved
in the phosphorylation of ribosomal protein S6"
"2131","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"One of the well-known
downstream targets of MAPK is p90 RSK (ribosomal S6
kinase)."
"2132","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"Fetal brown adipocytes primary cultures offer an
excellent cell model to study the molecular mechanisms of
insulin/IGF-I-mediated differentiation processes. In these
cells insulin and IGF-I, acting independently, up-regulate the
expression of adipogenic-related genes (fatty acid synthase,
glycerol-3-phosphate dehydrogenase, malic enzyme, glucose-
6-phosphate dehydrogenase) in a dose and time-dependent
manner at the transcriptional level, resulting in an increase of
cytosolic lipid content [20,40]."
"2133","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"Fetal brown adipocytes primary cultures offer an
excellent cell model to study the molecular mechanisms of
insulin/IGF-I-mediated differentiation processes. In these
cells insulin and IGF-I, acting independently, up-regulate the
expression of adipogenic-related genes (fatty acid synthase,
glycerol-3-phosphate dehydrogenase, malic enzyme, glucose-
6-phosphate dehydrogenase) in a dose and time-dependent
manner at the transcriptional level, resulting in an increase of
cytosolic lipid content [20,40]."
"2134","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"Fetal brown adipocytes primary cultures offer an
excellent cell model to study the molecular mechanisms of
insulin/IGF-I-mediated differentiation processes. In these
cells insulin and IGF-I, acting independently, up-regulate the
expression of adipogenic-related genes (fatty acid synthase,
glycerol-3-phosphate dehydrogenase, malic enzyme, glucose-
6-phosphate dehydrogenase) in a dose and time-dependent
manner at the transcriptional level, resulting in an increase of
cytosolic lipid content [20,40]."
"2135","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"Fetal brown adipocytes primary cultures offer an
excellent cell model to study the molecular mechanisms of
insulin/IGF-I-mediated differentiation processes. In these
cells insulin and IGF-I, acting independently, up-regulate the
expression of adipogenic-related genes (fatty acid synthase,
glycerol-3-phosphate dehydrogenase, malic enzyme, glucose-
6-phosphate dehydrogenase) in a dose and time-dependent
manner at the transcriptional level, resulting in an increase of
cytosolic lipid content [20,40]."
"2136","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"Fetal brown adipocytes primary cultures offer an
excellent cell model to study the molecular mechanisms of
insulin/IGF-I-mediated differentiation processes. In these
cells insulin and IGF-I, acting independently, up-regulate the
expression of adipogenic-related genes (fatty acid synthase,
glycerol-3-phosphate dehydrogenase, malic enzyme, glucose-
6-phosphate dehydrogenase) in a dose and time-dependent
manner at the transcriptional level, resulting in an increase of
cytosolic lipid content [20,40]."
"2137","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"Fetal brown adipocytes primary cultures offer an
excellent cell model to study the molecular mechanisms of
insulin/IGF-I-mediated differentiation processes. In these
cells insulin and IGF-I, acting independently, up-regulate the
expression of adipogenic-related genes (fatty acid synthase,
glycerol-3-phosphate dehydrogenase, malic enzyme, glucose-
6-phosphate dehydrogenase) in a dose and time-dependent
manner at the transcriptional level, resulting in an increase of
cytosolic lipid content [20,40]."
"2138","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"Activation of PI 3-
kinase mediates GLUT4 redistribution from an intracellular
compartment to the plasma membrane upon insulin
stimulation [47]"
"2139","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"Activation of PI 3-
kinase mediates GLUT4 redistribution from an intracellular
compartment to the plasma membrane upon insulin
stimulation [47]"
"2140","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"In primary cultures of brown adipocytes, insulin
and IGF-I transactivated the GLUT4 promoter and upregulated
the expression of the GLUT4 gene, producing a
time-dependent mRNA accumulation and significantly
increasing the amount of protein located in total membrane
fraction."
"2141","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"In primary cultures of brown adipocytes, insulin
and IGF-I transactivated the GLUT4 promoter and upregulated
the expression of the GLUT4 gene, producing a
time-dependent mRNA accumulation and significantly
increasing the amount of protein located in total membrane
fraction."
"2142","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"In primary cultures of brown adipocytes, insulin
and IGF-I transactivated the GLUT4 promoter and upregulated
the expression of the GLUT4 gene, producing a
time-dependent mRNA accumulation and significantly
increasing the amount of protein located in total membrane
fraction."
"2143","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"In primary cultures of brown adipocytes, insulin
and IGF-I transactivated the GLUT4 promoter and upregulated
the expression of the GLUT4 gene, producing a
time-dependent mRNA accumulation and significantly
increasing the amount of protein located in total membrane
fraction."
"2144","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"insulin
and IGF-I transactivated the GLUT4 promoter and upregulated
the expression of the GLUT4 gene, producing a
time-dependent mRNA accumulation and significantly
increasing the amount of protein located in total membrane
fraction. Consequently, glucose uptake was augmented [49]."
"2145","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"LY294002 down-regulated insulin-induced GLUT4 mRNA
accumulation or GLUT4 protein content as well as precluded
the transactivation of the GLUT4 promoter. Similar results
have been obtained by transient transfection of primary
brown adipocytes with constructs encoding dominant
negative p85 (Dp85)."
"2146","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"LY294002 down-regulated insulin-induced GLUT4 mRNA
accumulation or GLUT4 protein content as well as precluded
the transactivation of the GLUT4 promoter. Similar results
have been obtained by transient transfection of primary
brown adipocytes with constructs encoding dominant
negative p85 (Dp85)."
"2147","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyDecreases","false",,,"Conversely, the use of
1-(5-Chloronaphthalene-1-sulfonyl) homopiperazine (ML-9)
compound (Fig. 5) as an inhibitor of PKB/Akt enzymatic
activity (IC50=10-50 mM) [50] has revealed that activation of
PKB/Akt is necessary for the acute (GLUT4 translocation) and chronic (GLUT4 gene expression) insulin effects that
lead to glucose uptake [51]"
"2148","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyDecreases","false",,,"Okadaic acid is
an ionophore-like polyether derivate of a C38 fatty acid
compound that has tumor promoting properties (Fig. 6)
[52]. It is a potent inhibitor of protein serine/threonine
phosphatase 1 (IC50=10-15 nM) and protein serine/threonine
phosphatase 2A (IC50=0.1 nM) without any inhibitory effect
on the activity of tyrosine phosphatases."
"2149","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"Primary brown
adipocytes pretreated with this compound before insulin
stimulation showed a marked increase in IRS-1/2 serine
phosphorylation with a concomitant decrease in tyrosine
phosphorylation of these molecules and a partial inhibition
of IRS-1- and IRS-2-associated PI 3-kinase activity [53]."
"2150","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"Primary brown
adipocytes pretreated with this compound before insulin
stimulation showed a marked increase in IRS-1/2 serine
phosphorylation with a concomitant decrease in tyrosine
phosphorylation of these molecules and a partial inhibition
of IRS-1- and IRS-2-associated PI 3-kinase activity [53]."
"2151","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:negativeCorrelation","false",,,"Primary brown
adipocytes pretreated with this compound before insulin
stimulation showed a marked increase in IRS-1/2 serine
phosphorylation with a concomitant decrease in tyrosine
phosphorylation of these molecules and a partial inhibition
of IRS-1- and IRS-2-associated PI 3-kinase activity [53]."
"2152","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:negativeCorrelation","false",,,"Primary brown
adipocytes pretreated with this compound before insulin
stimulation showed a marked increase in IRS-1/2 serine
phosphorylation with a concomitant decrease in tyrosine
phosphorylation of these molecules and a partial inhibition
of IRS-1- and IRS-2-associated PI 3-kinase activity [53]."
"2153","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyDecreases","false",,,"PD098059
blocks the activity of MEK and not that of MAPK. In
addition, PD098059 did not inhibit a number of other
kinase activities both in vitro and in cultured cells. These
include Raf kinase, PKC, cyclic AMP-dependent kinase, vsrc
kinase, PDGF receptor tyrosine kinase and PI 3-kinase"
"2154","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:causesNoChange","false",,,"PD098059
blocks the activity of MEK and not that of MAPK. In
addition, PD098059 did not inhibit a number of other
kinase activities both in vitro and in cultured cells. These
include Raf kinase, PKC, cyclic AMP-dependent kinase, vsrc
kinase, PDGF receptor tyrosine kinase and PI 3-kinase"
"2155","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:causesNoChange","false",,,"PD098059
blocks the activity of MEK and not that of MAPK. In
addition, PD098059 did not inhibit a number of other
kinase activities both in vitro and in cultured cells. These
include Raf kinase, PKC, cyclic AMP-dependent kinase, vsrc
kinase, PDGF receptor tyrosine kinase and PI 3-kinase"
"2156","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:causesNoChange","false",,,"PD098059
blocks the activity of MEK and not that of MAPK. In
addition, PD098059 did not inhibit a number of other
kinase activities both in vitro and in cultured cells. These
include Raf kinase, PKC, cyclic AMP-dependent kinase, vsrc
kinase, PDGF receptor tyrosine kinase and PI 3-kinase"
"2157","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:causesNoChange","false",,,"PD098059
blocks the activity of MEK and not that of MAPK. In
addition, PD098059 did not inhibit a number of other
kinase activities both in vitro and in cultured cells. These
include Raf kinase, PKC, cyclic AMP-dependent kinase, vsrc
kinase, PDGF receptor tyrosine kinase and PI 3-kinase"
"2158","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:causesNoChange","false",,,"PD098059
blocks the activity of MEK and not that of MAPK. In
addition, PD098059 did not inhibit a number of other
kinase activities both in vitro and in cultured cells. These
include Raf kinase, PKC, cyclic AMP-dependent kinase, vsrc
kinase, PDGF receptor tyrosine kinase and PI 3-kinase"
"2159","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:causesNoChange","false",,,"PD098059
blocks the activity of MEK and not that of MAPK. In
addition, PD098059 did not inhibit a number of other
kinase activities both in vitro and in cultured cells. These
include Raf kinase, PKC, cyclic AMP-dependent kinase, vsrc
kinase, PDGF receptor tyrosine kinase and PI 3-kinase"
"2160","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"insulin and IGF-I are novel
thermogenic factors through the ability to increase UCP-1
gene transcription rate and also UCP-1 mRNA accumulation
[19,21]."
"2161","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"insulin and IGF-I are novel
thermogenic factors through the ability to increase UCP-1
gene transcription rate and also UCP-1 mRNA accumulation
[19,21]."
"2162","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"The
first reported action of TNFa in brown adipocytes was the
induction of insulin resistance [62]."
"2163","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:decreases","false",,,"The antiadipogenic effect of TNFa was accompanied by a
down-regulation of the mRNAs for the transcription factors
C/EBPa and b."
"2164","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:decreases","false",,,"The antiadipogenic effect of TNFa was accompanied by a
down-regulation of the mRNAs for the transcription factors
C/EBPa and b."
"2165","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"TNFa caused an insulin
resistance on the insulin-induced glucose uptake in brown
adipocytes."
"2166","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"TNFa mediates the production
of ceramide which triggers PKB/Akt dephosphorylation
through the activation of a protein phosphatase [63]."
"2167","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:decreases","false",,,"TNFa mediates the production
of ceramide which triggers PKB/Akt dephosphorylation
through the activation of a protein phosphatase [63]."
"2168","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:decreases","false",,,"TNFa is also a direct
inhibitor of adipogenic genes and UCP-1 expression acting
through mechanisms mediated by TNFa receptors, but
unrelated with the induction of insulin resistance [64,65]."
"2169","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"IRS-1 has recently been described as an essential
signaling molecule, acting through PI 3-kinase, in the  differentiation of brown adipocytes in vitro based on
protocols developed in mouse fibroblasts [67] and in brown
fat preadipocytes [56]."
"2170","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"Moreover, the loss of insulin-induced PI 3-
kinase activity in IRS-1-/- brown adipocytes was
accompanied by a decrease in the phosphorylation of
PKB/Akt, without changes in the phospho-70s6k content"
"2171","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:causesNoChange","false",,,"Moreover, the loss of insulin-induced PI 3-
kinase activity in IRS-1-/- brown adipocytes was
accompanied by a decrease in the phosphorylation of
PKB/Akt, without changes in the phospho-70s6k content"
"2172","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"IRS-1 diminished the
cytosolic lipid content in serum-starved homozygous and
heterozygous IRS-1-deficient brown adipocytes, as compared
to wild-type cells."
"2173","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"PI 3-
kinase/PKCz, but not PI 3-kinase/Akt signaling pathway, is
inhibited in IRS-2-deficient brown adipocytes upon insulin
stimulation"
"2174","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:causesNoChange","false",,,"PI 3-
kinase/PKCz, but not PI 3-kinase/Akt signaling pathway, is
inhibited in IRS-2-deficient brown adipocytes upon insulin
stimulation"
"2175","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"wild-type cells expressing a
kinase inactive (KI) mutant of PKCz lack insulin
responsiveness in induce GLUT4 translocation and glucose
uptake [78]."
"2176","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"wild-type cells expressing a
kinase inactive (KI) mutant of PKCz lack insulin
responsiveness in induce GLUT4 translocation and glucose
uptake [78]."
"2177","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:directlyIncreases","false",,,"TZD
induce their diverse effects by binding to and activating the
peroxisome proliferator- activated receptor (PPAR)g [79]."
"2178","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"increased GLUT4
expression has been reported in adipocytes treated with TZD
[82]."
"2179","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"In brown adipocytes, TZD increase UCP-1 expression
[83,84]."
"2180","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"IRS-2 protein expression
increased after TZD treatment in murine 3T3-L1 and human
adipocytes [85]."
"2181","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:increases","false",,,"IRS-2 protein expression
increased after TZD treatment in murine 3T3-L1 and human
adipocytes [85]."
"2182","Valverde AMBenito M","15777261","Mini reviews in medicinal chemistry","PubMed",,,"bel:negativeCorrelation","false",,,"Previous work reported
by Angel et al. [94] demonstrated that GLUT4 mRNA and
protein levels are decreased in WAT and BAT of Type 2
diabetic rats."
"2183","Szentirmay MNYang HXPawar SAVinson CSawadogo M","12857727","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"USF1 and USF2 bound the IGF2R promoter in vitro, and both USF1 and USF2, but not c-Myc, were present within the IGF2R promoter-associated chromatin in vivo. Overexpressed USF2, but not USF1, transactivated the IGF2R promoter, and IGF2R mRNA was markedly decreased by expression of a USF-specific dominant negative mutant, identifying IGF2R as a USF2 target."
"2184","Szentirmay MNYang HXPawar SAVinson CSawadogo M","12857727","The Journal of biological chemistry","PubMed",,,"bel:causesNoChange","false",,,"USF1 and USF2 bound the IGF2R promoter in vitro, and both USF1 and USF2, but not c-Myc, were present within the IGF2R promoter-associated chromatin in vivo. Overexpressed USF2, but not USF1, transactivated the IGF2R promoter, and IGF2R mRNA was markedly decreased by expression of a USF-specific dominant negative mutant, identifying IGF2R as a USF2 target."
"2185","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:increases","false",,,"The epidermis develops depending on the transcription factor p63, a member of the p53 family of transcription factors."
"2186","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:positiveCorrelation","false",,,"Here we report that microRNA (miR)-203 is induced in vitro in primary keratinocytes in parallel with differentiation. We found that miR-203 specifically targets human and mouse p63 3'-UTRs and not SOCS-3, despite bioinformatics alignment between miR-203 and SOCS-3 3'-UTR."
"2187","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:positiveCorrelation","false",,,"Here we report that microRNA (miR)-203 is induced in vitro in primary keratinocytes in parallel with differentiation. We found that miR-203 specifically targets human and mouse p63 3'-UTRs and not SOCS-3, despite bioinformatics alignment between miR-203 and SOCS-3 3'-UTR."
"2188","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:directlyDecreases","false",,,"Here we report that microRNA (miR)-203 is induced in vitro in primary keratinocytes in parallel with differentiation. We found that miR-203 specifically targets human and mouse p63 3'-UTRs and not SOCS-3, despite bioinformatics alignment between miR-203 and SOCS-3 3'-UTR."
"2189","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:decreases","false",,,"In addition, we demonstrate that miR-203 is downregulated during the epithelial commitment of embryonic stem cells, and that overexpression of miR-203 in rapidly proliferating human primary keratinocytes significantly reduces their clonogenic capacity. The results suggest that miR-203, by regulating the DeltaNp63 expression level, is a key molecule controlling the p63-dependent proliferative potential of epithelial precursor cells both during keratinocyte differentiation and in epithelial development."
"2190","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:positiveCorrelation","false",,,"As shown in Figure 1a and b, miR-203 was rapidly
upregulated (about 12-fold in mouse keratinocytes upon 24 h
calcium treatment) when cells where induced by calcium to
differentiate in vitro. Concurrently, with miR-203 upregulation,
we observed DNp63 downregulation in differentiating cells
(Figure 1a and b)."
"2191","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:negativeCorrelation","false",,,"As shown in Figure 1a and b, miR-203 was rapidly
upregulated (about 12-fold in mouse keratinocytes upon 24 h
calcium treatment) when cells where induced by calcium to
differentiate in vitro. Concurrently, with miR-203 upregulation,
we observed DNp63 downregulation in differentiating cells
(Figure 1a and b)."
"2192","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:causesNoChange","false",,,"To further evaluate directly if SOCS-3 is indeed a genuine
target of miR-203, we exogenously expressed miR-203 in
mouse keratinocytes by infection with adenovirus containing
miR-203. Figure 1c (lanes 4–6) shows a slight upregulation
of SOCS-3 as compared with keratinocytes infected with
adenovirus containing scrambled sequence (lanes 1–3).
These data indicate that SOSC-3 is not repressed by miR-
203; conversely its upregulation is presumably independent of
miR-203."
"2193","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:directlyDecreases","false",,,"As
control, Figure 2d also shows p63 mRNA levels in keratinocytes
induced to differentiate by calcium treatment. p63
protein expression was also markedly diminished in mouse
keratinocytes infected with adenovirus containing miR-203
(Figure 2e, lanes 3–4) compared with mouse keratinocytes
infected with adenovirus containing a scrambled sequence
(lanes 1–2). Together, these results indicate that effect of
miR-203 on p63 is direct and is mediated by a specific 30-UTR
target site."
"2194","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:directlyIncreases","false",,,"Indeed, we have previously
shown that the ubiquitin E3 ligase, Itch, contributes to the
reduction in DNp63 protein levels.21"
"2195","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:decreases","false",,,"As
expected, pre-miR-transfected cells showed reduced cell
growth when compared to cells transfected with scrambled
oligonucleotides. In contrast, overexpression of antagomiR-
203 resulted in an increase in cell growth (Figure 4)."
"2196","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:increases","false",,,"This suggests that overexpression of miR-203 triggers
cells toward differentiation by interfering with the proliferative
potential of proliferating keratinocytes through DNp63
downregulation. This result is consistent with a requirement
for DNp63 in maintaining proliferative potential of epidermal
stem cells."
"2197","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:increases","false",,,"Embryonic
stem cells can recapitulate in vitro the main steps of
embryonic epidermal differentiation upon exogenous
addition of bone morphogenic protein (BMP)-4."
"2198","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:increases","false",,,"Soon after BMP-4 treatment, the DNp63
gene is activated and remains strongly expressed until the
cells undergo terminal epidermal differentiation.28 Using
these experimental conditions, and concomitant with
DNp63 mRNA upregulation, we observed that miR-203
expression is downregulated (Figure 5c)."
"2199","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:decreases","false",,,"Soon after BMP-4 treatment, the DNp63
gene is activated and remains strongly expressed until the
cells undergo terminal epidermal differentiation.28 Using
these experimental conditions, and concomitant with
DNp63 mRNA upregulation, we observed that miR-203
expression is downregulated (Figure 5c)."
"2200","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:positiveCorrelation","false",,,"Besides the epidermis
and other stratified squamous epithelia, DNp63 is commonly
overexpressed in up to 80% of primary head and neck
squamous cell carcinomas (HNSCCs).29"
"2201","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:positiveCorrelation","false",,,"Besides the epidermis
and other stratified squamous epithelia, DNp63 is commonly
overexpressed in up to 80% of primary head and neck
squamous cell carcinomas (HNSCCs).29"
"2202","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:decreases","false",,,"Recently, it has been shown that DNp63a is also
overexpressed in HNSCC cell lines (including JHU-012) and
in these cells, it acts as a crucial survival factor by
suppressing p73-dependent apoptosis.29,32–34 Knockdown
of DNp63 induces the proapoptotic bcl-2-family members
Puma and Noxa, and both their induction and cell death are
p53-independent, but require transactivating isoforms of p73.
The inhibition of p73-dependent transcription by DNp63a
involves both direct promoter binding and physical
sequestration of p73 by protein–protein interaction.29,34–35"
"2203","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:decreases","false",,,"Recently, it has been shown that DNp63a is also
overexpressed in HNSCC cell lines (including JHU-012) and
in these cells, it acts as a crucial survival factor by
suppressing p73-dependent apoptosis.29,32–34 Knockdown
of DNp63 induces the proapoptotic bcl-2-family members
Puma and Noxa, and both their induction and cell death are
p53-independent, but require transactivating isoforms of p73.
The inhibition of p73-dependent transcription by DNp63a
involves both direct promoter binding and physical
sequestration of p73 by protein–protein interaction.29,34–35"
"2204","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:decreases","false",,,"Recently, it has been shown that DNp63a is also
overexpressed in HNSCC cell lines (including JHU-012) and
in these cells, it acts as a crucial survival factor by
suppressing p73-dependent apoptosis.29,32–34 Knockdown
of DNp63 induces the proapoptotic bcl-2-family members
Puma and Noxa, and both their induction and cell death are
p53-independent, but require transactivating isoforms of p73.
The inhibition of p73-dependent transcription by DNp63a
involves both direct promoter binding and physical
sequestration of p73 by protein–protein interaction.29,34–35"
"2205","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:increases","false",,,"Recently, it has been shown that DNp63a is also
overexpressed in HNSCC cell lines (including JHU-012) and
in these cells, it acts as a crucial survival factor by
suppressing p73-dependent apoptosis.29,32–34 Knockdown
of DNp63 induces the proapoptotic bcl-2-family members
Puma and Noxa, and both their induction and cell death are
p53-independent, but require transactivating isoforms of p73.
The inhibition of p73-dependent transcription by DNp63a
involves both direct promoter binding and physical
sequestration of p73 by protein–protein interaction.29,34–35"
"2206","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:increases","false",,,"Recently, it has been shown that DNp63a is also
overexpressed in HNSCC cell lines (including JHU-012) and
in these cells, it acts as a crucial survival factor by
suppressing p73-dependent apoptosis.29,32–34 Knockdown
of DNp63 induces the proapoptotic bcl-2-family members
Puma and Noxa, and both their induction and cell death are
p53-independent, but require transactivating isoforms of p73.
The inhibition of p73-dependent transcription by DNp63a
involves both direct promoter binding and physical
sequestration of p73 by protein–protein interaction.29,34–35"
"2207","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:directlyDecreases","false",,,"Recently, it has been shown that DNp63a is also
overexpressed in HNSCC cell lines (including JHU-012) and
in these cells, it acts as a crucial survival factor by
suppressing p73-dependent apoptosis.29,32–34 Knockdown
of DNp63 induces the proapoptotic bcl-2-family members
Puma and Noxa, and both their induction and cell death are
p53-independent, but require transactivating isoforms of p73.
The inhibition of p73-dependent transcription by DNp63a
involves both direct promoter binding and physical
sequestration of p73 by protein–protein interaction.29,34–35"
"2208","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:decreases","false",,,"As shown in Figure 6a, DNp63 expression was already decreased in
JHU-012 cells 12 h after UVC treatment. Simultaneously, with
DNp63 downregulation, miR-203 was significantly upregulated
as evaluated by real-time PCR (Figure 6b)."
"2209","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:increases","false",,,"As shown in Figure 6a, DNp63 expression was already decreased in
JHU-012 cells 12 h after UVC treatment. Simultaneously, with
DNp63 downregulation, miR-203 was significantly upregulated
as evaluated by real-time PCR (Figure 6b)."
"2210","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:decreases","false",,,"To verify that the observed effect on apoptosis and cell cycle
is, at least in part, mediated by miR-203, we infected JHU-012
cells with adenoviruses containing miR-203 or scrambled
sequence. DNp63 protein expression was markedly
diminished (about 50%) in JHU-012 cells infected with
adenovirus containing miR-203 as compared with cells
infected with adenovirus containing scrambled sequence
(Figure 7a). In addition, we observed a significant increase
of cell death (from 5 to 17%, Figure 7b), an increased number
of cells in G1 and a reduction in the proportion of cells in G2
(Figure 7c)."
"2211","Lena AMShalom-Feuerstein RRivetti di Val Cervo PAberdam DKnight RAMelino GCandi E","18483491","Cell death and differentiation","PubMed",,,"bel:increases","false",,,"To verify that the observed effect on apoptosis and cell cycle
is, at least in part, mediated by miR-203, we infected JHU-012
cells with adenoviruses containing miR-203 or scrambled
sequence. DNp63 protein expression was markedly
diminished (about 50%) in JHU-012 cells infected with
adenovirus containing miR-203 as compared with cells
infected with adenovirus containing scrambled sequence
(Figure 7a). In addition, we observed a significant increase
of cell death (from 5 to 17%, Figure 7b), an increased number
of cells in G1 and a reduction in the proportion of cells in G2
(Figure 7c)."
"2212","Erber RThurnher AKatsen ADGroth GKerger HHammes HPMenger MDUllrich AVajkoczy P","14657001","The FASEB journal : official publication of the Federation of American Societies for Experimental Biology","PubMed",,,"bel:directlyDecreases","false",,,"intravital microscopy failed to demonstrate that
targeting of VEGFR-2 (by the tyrosine kinase inhibitor SU5416) induces significant regression
of experimental tumor blood vessels."
"2213","Erber RThurnher AKatsen ADGroth GKerger HHammes HPMenger MDUllrich AVajkoczy P","14657001","The FASEB journal : official publication of the Federation of American Societies for Experimental Biology","PubMed",,,"bel:directlyIncreases","false",,,"this resistance of tumor blood vessels to
VEGFR-2 targeting is conferred by pericytes that stabilize blood vessels and provide endothelial
cell survival signals via the Ang-1/Tie2 pathway."
"2214","Erber RThurnher AKatsen ADGroth GKerger HHammes HPMenger MDUllrich AVajkoczy P","14657001","The FASEB journal : official publication of the Federation of American Societies for Experimental Biology","PubMed",,,"bel:increases","false",,,"this resistance of tumor blood vessels to
VEGFR-2 targeting is conferred by pericytes that stabilize blood vessels and provide endothelial
cell survival signals via the Ang-1/Tie2 pathway."
"2215","Erber RThurnher AKatsen ADGroth GKerger HHammes HPMenger MDUllrich AVajkoczy P","14657001","The FASEB journal : official publication of the Federation of American Societies for Experimental Biology","PubMed",,,"bel:directlyDecreases","false",,,"targeting VEGFR-2 plus the platelet-
derived growth factor receptor (PDGFR)-b system (PDGFR-b) signaling (by SU6668) rapidly
forced 40% of tumor blood vessels into regression, rendering these tumors hypoxic as
shown by phosphorescence quenching."
"2216","Erber RThurnher AKatsen ADGroth GKerger HHammes HPMenger MDUllrich AVajkoczy P","14657001","The FASEB journal : official publication of the Federation of American Societies for Experimental Biology","PubMed",,,"bel:increases","false",,,"targeting VEGFR-2 plus the platelet-
derived growth factor receptor (PDGFR)-b system (PDGFR-b) signaling (by SU6668) rapidly
forced 40% of tumor blood vessels into regression, rendering these tumors hypoxic as
shown by phosphorescence quenching."
"2217","Erber RThurnher AKatsen ADGroth GKerger HHammes HPMenger MDUllrich AVajkoczy P","14657001","The FASEB journal : official publication of the Federation of American Societies for Experimental Biology","PubMed",,,"bel:increases","false",,,"targeting VEGFR-2 plus the platelet-
derived growth factor receptor (PDGFR)-b system (PDGFR-b) signaling (by SU6668) rapidly
forced 40% of tumor blood vessels into regression, rendering these tumors hypoxic as
shown by phosphorescence quenching."
"2218","Erber RThurnher AKatsen ADGroth GKerger HHammes HPMenger MDUllrich AVajkoczy P","14657001","The FASEB journal : official publication of the Federation of American Societies for Experimental Biology","PubMed",,,"bel:increases","false",,,"VEGFR-2 plus PDGFR-b targeting enforced tumor blood
vessel regression by inducing endothelial cell apoptosis."
"2219","Erber RThurnher AKatsen ADGroth GKerger HHammes HPMenger MDUllrich AVajkoczy P","14657001","The FASEB journal : official publication of the Federation of American Societies for Experimental Biology","PubMed",,,"bel:increases","false",,,"Whereas
expression of the VEGF and FGF systems remained largely unchanged, expression of PDGFR-b
and Tie2 were nearly doubled and expression of Ang-1 was increased by ninefold in SU5416-
treated tumors (Fig. 3A-C)."
"2220","Erber RThurnher AKatsen ADGroth GKerger HHammes HPMenger MDUllrich AVajkoczy P","14657001","The FASEB journal : official publication of the Federation of American Societies for Experimental Biology","PubMed",,,"bel:increases","false",,,"Whereas
expression of the VEGF and FGF systems remained largely unchanged, expression of PDGFR-b
and Tie2 were nearly doubled and expression of Ang-1 was increased by ninefold in SU5416-
treated tumors (Fig. 3A-C)."
"2221","Erber RThurnher AKatsen ADGroth GKerger HHammes HPMenger MDUllrich AVajkoczy P","14657001","The FASEB journal : official publication of the Federation of American Societies for Experimental Biology","PubMed",,,"bel:increases","false",,,"Whereas
expression of the VEGF and FGF systems remained largely unchanged, expression of PDGFR-b
and Tie2 were nearly doubled and expression of Ang-1 was increased by ninefold in SU5416-
treated tumors (Fig. 3A-C)."
"2222","Erber RThurnher AKatsen ADGroth GKerger HHammes HPMenger MDUllrich AVajkoczy P","14657001","The FASEB journal : official publication of the Federation of American Societies for Experimental Biology","PubMed",,,"bel:increases","false",,,"the increased expression of
PDGFR-b and Tie2 was clearly attributable to pericytes and endothelial cells (i.e., cells of mouse
origin), respectively."
"2223","Erber RThurnher AKatsen ADGroth GKerger HHammes HPMenger MDUllrich AVajkoczy P","14657001","The FASEB journal : official publication of the Federation of American Societies for Experimental Biology","PubMed",,,"bel:increases","false",,,"the increased expression of
PDGFR-b and Tie2 was clearly attributable to pericytes and endothelial cells (i.e., cells of mouse
origin), respectively."
"2224","Erber RThurnher AKatsen ADGroth GKerger HHammes HPMenger MDUllrich AVajkoczy P","14657001","The FASEB journal : official publication of the Federation of American Societies for Experimental Biology","PubMed",,,"bel:causesNoChange","false",,,"However, by
none of these means we could detect significant Ang-1 mRNA levels in normal skin, neither in
control nor in treated tissue."
"2225","Erber RThurnher AKatsen ADGroth GKerger HHammes HPMenger MDUllrich AVajkoczy P","14657001","The FASEB journal : official publication of the Federation of American Societies for Experimental Biology","PubMed",,,"bel:increases","false",,,"tumor blood vessels
in SU6668-treated tumors presented with endothelial hyperplasia and an increased number of
luminal folds (Fig. 5C and D; compare with Fig. 2D)."
"2226","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:decreases","false",,,"In situ hybridization of injured and control carotid arteries also revealed marked downregulation of miR-143 and miR-145 expression in the thickened vascular wall, coincident with decreased expression of the differentiation marker, smooth muscle a-actin (Sm-a actin) (Supplementary Fig. 4a)."
"2227","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:decreases","false",,,"In situ hybridization of injured and control carotid arteries also revealed marked downregulation of miR-143 and miR-145 expression in the thickened vascular wall, coincident with decreased expression of the differentiation marker, smooth muscle a-actin (Sm-a actin) (Supplementary Fig. 4a)."
"2228","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:positiveCorrelation","false",,,"In situ hybridization of injured and control carotid arteries also revealed marked downregulation of miR-143 and miR-145 expression in the thickened vascular wall, coincident with decreased expression of the differentiation marker, smooth muscle a-actin (Sm-a actin) (Supplementary Fig. 4a)."
"2229","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:positiveCorrelation","false",,,"In situ hybridization of injured and control carotid arteries also revealed marked downregulation of miR-143 and miR-145 expression in the thickened vascular wall, coincident with decreased expression of the differentiation marker, smooth muscle a-actin (Sm-a actin) (Supplementary Fig. 4a)."
"2230","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:increases","false",,,"miR-143 and miR-145 expression
was also decreased in hearts of Nkx2.5 mutant mouse embryos in a dose-dependent fashion
(Fig. 2h)."
"2231","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:increases","false",,,"miR-143 and miR-145 expression
was also decreased in hearts of Nkx2.5 mutant mouse embryos in a dose-dependent fashion
(Fig. 2h)."
"2232","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:increases","false",,,"lentiviral-mediated
introduction of miR-145 into ligated mouse carotid arteries in vivo increased expression of
markers of VSMC differentiation (e.g., Calponin and Sm-a-actin), as well as Myocd, compared
to control-infected injured carotid arteries (Supplementary Fig. 7)."
"2233","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:increases","false",,,"lentiviral-mediated
introduction of miR-145 into ligated mouse carotid arteries in vivo increased expression of
markers of VSMC differentiation (e.g., Calponin and Sm-a-actin), as well as Myocd, compared
to control-infected injured carotid arteries (Supplementary Fig. 7)."
"2234","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:increases","false",,,"lentiviral-mediated
introduction of miR-145 into ligated mouse carotid arteries in vivo increased expression of
markers of VSMC differentiation (e.g., Calponin and Sm-a-actin), as well as Myocd, compared
to control-infected injured carotid arteries (Supplementary Fig. 7)."
"2235","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:increases","false",,,"miR-143 and miR-145 were each expressed at lower levels in SRF-null embryoid bodies (EBs) compared to wildtype EBs derived from the respective ES cells (Fig. 2g)"
"2236","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:increases","false",,,"miR-143 and miR-145 were each expressed at lower levels in SRF-null embryoid bodies (EBs) compared to wildtype EBs derived from the respective ES cells (Fig. 2g)"
"2237","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:directlyIncreases","false",,,"Nkx2.5 could also independently activate this enhancer (miR-143/145
enhancer), and the combination of SRF, Myocd,
and Nkx2.5, which also interacts with SRF26, had additive effects on luciferase activity.
Mutation of each binding site progressively decreased luciferase activity (Fig. 2f)."
"2238","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:directlyIncreases","false",,,"Nkx2.5 could also independently activate this enhancer (miR-143/145
enhancer), and the combination of SRF, Myocd,
and Nkx2.5, which also interacts with SRF26, had additive effects on luciferase activity.
Mutation of each binding site progressively decreased luciferase activity (Fig. 2f)."
"2239","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:directlyIncreases","false",,,"Nkx2.5 could also independently activate this enhancer (miR-143/145
enhancer), and the combination of SRF, Myocd,
and Nkx2.5, which also interacts with SRF26, had additive effects on luciferase activity.
Mutation of each binding site progressively decreased luciferase activity (Fig. 2f)."
"2240","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:directlyIncreases","false",,,"Nkx2.5 could also independently activate this enhancer (miR-143/145
enhancer), and the combination of SRF, Myocd,
and Nkx2.5, which also interacts with SRF26, had additive effects on luciferase activity.
Mutation of each binding site progressively decreased luciferase activity (Fig. 2f)."
"2241","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:directlyIncreases","false",,,"Nkx2.5 could also independently activate this enhancer (miR-143/145
enhancer), and the combination of SRF, Myocd,
and Nkx2.5, which also interacts with SRF26, had additive effects on luciferase activity.
Mutation of each binding site progressively decreased luciferase activity (Fig. 2f)."
"2242","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:directlyIncreases","false",,,"Nkx2.5 could also independently activate this enhancer (miR-143/145
enhancer), and the combination of SRF, Myocd,
and Nkx2.5, which also interacts with SRF26, had additive effects on luciferase activity.
Mutation of each binding site progressively decreased luciferase activity (Fig. 2f)."
"2243","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:directlyIncreases","false",,,"Nkx2.5 could also independently activate this enhancer (miR-143/145
enhancer), and the combination of SRF, Myocd,
and Nkx2.5, which also interacts with SRF26, had additive effects on luciferase activity.
Mutation of each binding site progressively decreased luciferase activity (Fig. 2f)."
"2244","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:directlyIncreases","false",,,"Nkx2.5 could also independently activate this enhancer (miR-143/145
enhancer), and the combination of SRF, Myocd,
and Nkx2.5, which also interacts with SRF26, had additive effects on luciferase activity.
Mutation of each binding site progressively decreased luciferase activity (Fig. 2f)."
"2245","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:increases","false",,,"These findings suggest that
miR-145 may promote VSMC differentiation by directly repressing numerous transcription
factors that promote the proliferative state while stabilizing factors that promote the
differentiated state of VSMCs (Fig. 5)."
"2246","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:increases","false",,,"introduction of
miR-145, but not miR-143, with the luciferase vector in Cos cells resulted in relief of the
repression and an ~150-fold increase in luciferase activity compared to the CMV-luciferase-
Myocd 3? UTR-luciferase vector alone (Fig. 4d)."
"2247","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:causesNoChange","false",,,"introduction of
miR-145, but not miR-143, with the luciferase vector in Cos cells resulted in relief of the
repression and an ~150-fold increase in luciferase activity compared to the CMV-luciferase-
Myocd 3? UTR-luciferase vector alone (Fig. 4d)."
"2248","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:directlyDecreases","false",,,"In the presence of the Elk-1 3? UTR, miR-143 repressed luciferase activity; this repression was diminished upon mutation of one of the two miR-143 binding sites (Fig. 4a). "
"2249","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:increases","false",,,"SRF weakly activated the miR-143/145 enhancer upstream of a luciferase reporter, but co-transfection of Myocd synergistically and robustly activated luciferase activity in Cos cells (Fig. 2f)."
"2250","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:increases","false",,,"SRF weakly activated the miR-143/145 enhancer upstream of a luciferase reporter, but co-transfection of Myocd synergistically and robustly activated luciferase activity in Cos cells (Fig. 2f)."
"2251","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:directlyDecreases","false",,,"The miR-145 binding site in the 3? UTR of Klf4 specifically mediated miR-145- dependent repression in luciferase assays (Fig. 4e and Supplementary Fig. 6c). "
"2252","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:negativeCorrelation","false",,,"miR-145 and miR-143 were direct transcriptional targets of serum response factor, myocardin and Nkx2-5 (NK2 transcription factor related, locus 5) and were downregulated in injured or atherosclerotic vessels containing proliferating, less differentiated smooth muscle cells"
"2253","Cordes KRSheehy NTWhite MPBerry ECMorton SUMuth ANLee THMiano JMIvey KNSrivastava D","19578358","Nature","PubMed",,,"bel:negativeCorrelation","false",,,"miR-145 and miR-143 were direct transcriptional targets of serum response factor, myocardin and Nkx2-5 (NK2 transcription factor related, locus 5) and were downregulated in injured or atherosclerotic vessels containing proliferating, less differentiated smooth muscle cells"
"2254","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"In human embryonic kidney 293 cells, IL-1beta induces IkappaB kinase beta (IKKbeta) activation, IkappaBalpha degradation, NF-kappaB transactivation, and weak Akt activation. "
"2255","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"In human embryonic kidney 293 cells, IL-1beta induces IkappaB kinase beta (IKKbeta) activation, IkappaBalpha degradation, NF-kappaB transactivation, and weak Akt activation. "
"2256","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"In human embryonic kidney 293 cells, IL-1beta induces IkappaB kinase beta (IKKbeta) activation, IkappaBalpha degradation, NF-kappaB transactivation, and weak Akt activation. "
"2257","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"In human embryonic kidney 293 cells, IL-1beta induces IkappaB kinase beta (IKKbeta) activation, IkappaBalpha degradation, NF-kappaB transactivation, and weak Akt activation. "
"2258","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"However, IL-1beta-induced NF-kappaB activity is attenuated by increased intracellular calcium in response to ionomycin, UTP, or thapsigargin or by overexpression of CaMKKc and/or Akt. Ionomycin and CaMKKc overexpression increases Akt phosphorylation on Thr(308) and enzyme activity. Under these conditions or upon overexpression of wild type Akt, IL-1beta-induced IKKbeta activity is diminished. Furthermore, a dominant negative mutant of Akt abolishes IKKbeta inhibition by CaMKKc and ionomycin, suggesting that Akt acts as a mediator of CaMKK signaling to inhibit IL-1beta-induced IKK activity at an upstream target site."
"2259","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"However, IL-1beta-induced NF-kappaB activity is attenuated by increased intracellular calcium in response to ionomycin, UTP, or thapsigargin or by overexpression of CaMKKc and/or Akt. Ionomycin and CaMKKc overexpression increases Akt phosphorylation on Thr(308) and enzyme activity. Under these conditions or upon overexpression of wild type Akt, IL-1beta-induced IKKbeta activity is diminished. Furthermore, a dominant negative mutant of Akt abolishes IKKbeta inhibition by CaMKKc and ionomycin, suggesting that Akt acts as a mediator of CaMKK signaling to inhibit IL-1beta-induced IKK activity at an upstream target site."
"2260","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"However, IL-1beta-induced NF-kappaB activity is attenuated by increased intracellular calcium in response to ionomycin, UTP, or thapsigargin or by overexpression of CaMKKc and/or Akt. Ionomycin and CaMKKc overexpression increases Akt phosphorylation on Thr(308) and enzyme activity. Under these conditions or upon overexpression of wild type Akt, IL-1beta-induced IKKbeta activity is diminished. Furthermore, a dominant negative mutant of Akt abolishes IKKbeta inhibition by CaMKKc and ionomycin, suggesting that Akt acts as a mediator of CaMKK signaling to inhibit IL-1beta-induced IKK activity at an upstream target site."
"2261","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"However, IL-1beta-induced NF-kappaB activity is attenuated by increased intracellular calcium in response to ionomycin, UTP, or thapsigargin or by overexpression of CaMKKc and/or Akt. Ionomycin and CaMKKc overexpression increases Akt phosphorylation on Thr(308) and enzyme activity. Under these conditions or upon overexpression of wild type Akt, IL-1beta-induced IKKbeta activity is diminished. Furthermore, a dominant negative mutant of Akt abolishes IKKbeta inhibition by CaMKKc and ionomycin, suggesting that Akt acts as a mediator of CaMKK signaling to inhibit IL-1beta-induced IKK activity at an upstream target site."
"2262","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"However, IL-1beta-induced NF-kappaB activity is attenuated by increased intracellular calcium in response to ionomycin, UTP, or thapsigargin or by overexpression of CaMKKc and/or Akt. Ionomycin and CaMKKc overexpression increases Akt phosphorylation on Thr(308) and enzyme activity. Under these conditions or upon overexpression of wild type Akt, IL-1beta-induced IKKbeta activity is diminished. Furthermore, a dominant negative mutant of Akt abolishes IKKbeta inhibition by CaMKKc and ionomycin, suggesting that Akt acts as a mediator of CaMKK signaling to inhibit IL-1beta-induced IKK activity at an upstream target site."
"2263","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"However, IL-1beta-induced NF-kappaB activity is attenuated by increased intracellular calcium in response to ionomycin, UTP, or thapsigargin or by overexpression of CaMKKc and/or Akt. Ionomycin and CaMKKc overexpression increases Akt phosphorylation on Thr(308) and enzyme activity. Under these conditions or upon overexpression of wild type Akt, IL-1beta-induced IKKbeta activity is diminished. Furthermore, a dominant negative mutant of Akt abolishes IKKbeta inhibition by CaMKKc and ionomycin, suggesting that Akt acts as a mediator of CaMKK signaling to inhibit IL-1beta-induced IKK activity at an upstream target site."
"2264","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"However, IL-1beta-induced NF-kappaB activity is attenuated by increased intracellular calcium in response to ionomycin, UTP, or thapsigargin or by overexpression of CaMKKc and/or Akt. Ionomycin and CaMKKc overexpression increases Akt phosphorylation on Thr(308) and enzyme activity. Under these conditions or upon overexpression of wild type Akt, IL-1beta-induced IKKbeta activity is diminished. Furthermore, a dominant negative mutant of Akt abolishes IKKbeta inhibition by CaMKKc and ionomycin, suggesting that Akt acts as a mediator of CaMKK signaling to inhibit IL-1beta-induced IKK activity at an upstream target site."
"2265","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"CaMKKc and Akt overexpression decreases IRAK1-mediated NF-kappaB activity and its association with MyD88 in response to IL-1beta stimulation. Furthermore, CaMKKc and Akt overexpression increases IRAK1 phosphorylation at Thr(100), and point mutation of this site abrogates the inhibitory effect of Akt on IRAK1-mediated NF-kappaB activation."
"2266","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"CaMKKc and Akt overexpression decreases IRAK1-mediated NF-kappaB activity and its association with MyD88 in response to IL-1beta stimulation. Furthermore, CaMKKc and Akt overexpression increases IRAK1 phosphorylation at Thr(100), and point mutation of this site abrogates the inhibitory effect of Akt on IRAK1-mediated NF-kappaB activation."
"2267","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"CaMKKc and Akt overexpression decreases IRAK1-mediated NF-kappaB activity and its association with MyD88 in response to IL-1beta stimulation. Furthermore, CaMKKc and Akt overexpression increases IRAK1 phosphorylation at Thr(100), and point mutation of this site abrogates the inhibitory effect of Akt on IRAK1-mediated NF-kappaB activation."
"2268","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"In cells transfected with negative mutants of IKK?, IKK?, and NIK, IL-1?-induced ?B luciferase activity were inhibited by 32 ± 7%, 70 ± 11%, and 33 ± 8%, respectively (Fig. 1  D). Compared with the distinct selectivity for IL-1? action, IKK? and IKK? mutants reduced the NIK-induced ?B response to a similar extent (Fig. 1  D). "
"2269","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"In cells transfected with negative mutants of IKK?, IKK?, and NIK, IL-1?-induced ?B luciferase activity were inhibited by 32 ± 7%, 70 ± 11%, and 33 ± 8%, respectively (Fig. 1  D). Compared with the distinct selectivity for IL-1? action, IKK? and IKK? mutants reduced the NIK-induced ?B response to a similar extent (Fig. 1  D). "
"2270","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"In cells transfected with negative mutants of IKK?, IKK?, and NIK, IL-1?-induced ?B luciferase activity were inhibited by 32 ± 7%, 70 ± 11%, and 33 ± 8%, respectively (Fig. 1  D). Compared with the distinct selectivity for IL-1? action, IKK? and IKK? mutants reduced the NIK-induced ?B response to a similar extent (Fig. 1  D). "
"2271","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Probing of immunoblots with antibodies specific for phosphorylated Akt showed that 10 ng/ml of IL-1? slightly increased Akt Thr308 and Ser473 phosphorylation within 60 min (Fig.2). Using histone H2B as an Akt substrate, a slight increase in Akt kinase activity was noted within the same time interval as Akt phosphorylation (Fig. 2)."
"2272","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Probing of immunoblots with antibodies specific for phosphorylated Akt showed that 10 ng/ml of IL-1? slightly increased Akt Thr308 and Ser473 phosphorylation within 60 min (Fig.2). Using histone H2B as an Akt substrate, a slight increase in Akt kinase activity was noted within the same time interval as Akt phosphorylation (Fig. 2)."
"2273","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Probing of immunoblots with antibodies specific for phosphorylated Akt showed that 10 ng/ml of IL-1? slightly increased Akt Thr308 and Ser473 phosphorylation within 60 min (Fig.2). Using histone H2B as an Akt substrate, a slight increase in Akt kinase activity was noted within the same time interval as Akt phosphorylation (Fig. 2)."
"2274","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"A shows that IL-1? at 10 ng/ml increased IRAK1 activity, which reached a maximum after 10 min and was sustained for at least 90 min. "
"2275","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:causesNoChange","false",,,"In support of previous findings, kinase-dead IRAK1 (K239A) transfection efficiently triggered ?B luciferase activity at a level equivalent to that of wild type IRAK1, and this activity was similarly reduced by CaMKKc and Akt (Fig. 9  C). These results suggest that the inhibition of IRAK1-dependent signaling by Akt is unrelated to the kinase activity of IRAK1. "
"2276","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Upon stimulation with 10 ng/ml IL-1? for 15 or 30 min, IRAK1 co-immunoprecipitation with MyD88 was enhanced, whereas it was reduced by the overexpression of Akt and CaMKKc (Fig. 10, C andD). "
"2277","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Upon stimulation with 10 ng/ml IL-1? for 15 or 30 min, IRAK1 co-immunoprecipitation with MyD88 was enhanced, whereas it was reduced by the overexpression of Akt and CaMKKc (Fig. 10, C andD). "
"2278","Chen BCWu WTHo FMLin WW","11976320","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Upon stimulation with 10 ng/ml IL-1? for 15 or 30 min, IRAK1 co-immunoprecipitation with MyD88 was enhanced, whereas it was reduced by the overexpression of Akt and CaMKKc (Fig. 10, C andD). "
"2279","Faulkner GPallavicini AComelli ASalamon MBortoletto GIevolella CTrevisan SKojic' SDalla Vecchia FLaveder PValle GLanfranchi G","10984498","The Journal of biological chemistry","PubMed",,,"bel:positiveCorrelation","false",,,"The level of FATZ protein in muscle cells increases during differentiation, being clearly detectable before the onset of myosin"
"2280","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"The tumor necrosis factor alpha receptor (TNFR1) activates downstream effectors that include the mitogen-activated protein kinase kinase 7 (MKK7)/c-Jun-NH(2)-kinase (JNK)/activator protein 1 (AP1) cascade. Here, we report that JNK is activated in a majority of spontaneous human squamous cell carcinomas (SCC)."
"2281","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"The tumor necrosis factor alpha receptor (TNFR1) activates downstream effectors that include the mitogen-activated protein kinase kinase 7 (MKK7)/c-Jun-NH(2)-kinase (JNK)/activator protein 1 (AP1) cascade. Here, we report that JNK is activated in a majority of spontaneous human squamous cell carcinomas (SCC)."
"2282","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"The tumor necrosis factor alpha receptor (TNFR1) activates downstream effectors that include the mitogen-activated protein kinase kinase 7 (MKK7)/c-Jun-NH(2)-kinase (JNK)/activator protein 1 (AP1) cascade. Here, we report that JNK is activated in a majority of spontaneous human squamous cell carcinomas (SCC)."
"2283","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:positiveCorrelation","false",,,"The tumor necrosis factor alpha receptor (TNFR1) activates downstream effectors that include the mitogen-activated protein kinase kinase 7 (MKK7)/c-Jun-NH(2)-kinase (JNK)/activator protein 1 (AP1) cascade. Here, we report that JNK is activated in a majority of spontaneous human squamous cell carcinomas (SCC)."
"2284","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:positiveCorrelation","false",,,"To study the frequency of JNK induction in human SCC, we probed tissue microarrays of
spontaneous human SCC samples (n = 52) with antibodies directed against the phosphorylated
active forms of JNK. Eighty-one percent of SCCs examined exhibited either strong or
moderately strong induction of phosphorylated JNK (pJNK) over normal tissues (Fig. 1A)."
"2285","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:directlyDecreases","false",,,"To address this, we first studied
the effect of a JNK-specific inhibitor, SP600125 (30), which has been shown to inhibit JNK
function and epidermal hyperplasia in epidermis expressing I?B? or deficient in relA (16)."
"2286","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"Ras-driven epidermal neoplasias generated on the surface of immunodeficient SCID mice were
treated topically with DMSO vehicle or SP600125 daily for 5 weeks. DMSO and untreated
control tissues displayed typical findings of neoplasia, including invasion and disruption of the
BMZ, as visualized by type VII collagen staining (Fig. 2A). In contrast, tissues treated with
SP600125 lacked invasive neoplasia and retained sharp delineation of the BMZ, with a humanspecific
desmoglein-3 antibody confirming the human origin of these tissues (Fig. 2A)."
"2287","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"To investigate whether JNK/AP1 dependency is a general process common to other SCC cell
types, we expressed DNc-Jun in spontaneous human SCC cell lines, A431 and SCC25, and
found that DNc-Jun significantly inhibited their s.c. tumor growth as well (Fig. 2B–C).
Furthermore, retroviral-mediated RNA interference knockdown of MKK7, the upstream
activator of JNK, also prevented s.c. tumor growth of A431, SCC25, and primary keratinocytes
transformed by Ras and I?B? (Fig. 2B–D)."
"2288","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"To investigate whether JNK/AP1 dependency is a general process common to other SCC cell
types, we expressed DNc-Jun in spontaneous human SCC cell lines, A431 and SCC25, and
found that DNc-Jun significantly inhibited their s.c. tumor growth as well (Fig. 2B–C).
Furthermore, retroviral-mediated RNA interference knockdown of MKK7, the upstream
activator of JNK, also prevented s.c. tumor growth of A431, SCC25, and primary keratinocytes
transformed by Ras and I?B? (Fig. 2B–D)."
"2289","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"To investigate whether JNK/AP1 dependency is a general process common to other SCC cell
types, we expressed DNc-Jun in spontaneous human SCC cell lines, A431 and SCC25, and
found that DNc-Jun significantly inhibited their s.c. tumor growth as well (Fig. 2B–C).
Furthermore, retroviral-mediated RNA interference knockdown of MKK7, the upstream
activator of JNK, also prevented s.c. tumor growth of A431, SCC25, and primary keratinocytes
transformed by Ras and I?B? (Fig. 2B–D)."
"2290","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"To investigate whether JNK/AP1 dependency is a general process common to other SCC cell
types, we expressed DNc-Jun in spontaneous human SCC cell lines, A431 and SCC25, and
found that DNc-Jun significantly inhibited their s.c. tumor growth as well (Fig. 2B–C).
Furthermore, retroviral-mediated RNA interference knockdown of MKK7, the upstream
activator of JNK, also prevented s.c. tumor growth of A431, SCC25, and primary keratinocytes
transformed by Ras and I?B? (Fig. 2B–D)."
"2291","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"We next asked whether components of the JNK cascade could directly promote human
epidermal neoplasia. We expressed either active MKK7 or c-Jun in primary keratinocytes and
examined their capacity to promote tumorigenesis in combination with Ras in the absence of
I?B?. First, we confirmed induction of AP1-dependent gene reporter activity by MKK7 in
vitro (Supplementary Fig. S4). Surface skin grafts were then regenerated with primary
keratinocytes expressing MKK7 and Ras; these developed into clinical tumors resembling SCC
(Fig. 3A). Dermal invasion, one of the hallmarks of spontaneous human SCC, is apparent in
tumors induced by MKK7 and Ras as revealed by both histologic appearance and BMZ
disruption (Fig. 3B–C). MKK7 and Ras-induced neoplasia depends on intact AP1 function as 
concurrent expression of DNc-Jun prevents tumorigenesis (Fig. 3A–C)."
"2292","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"We next asked whether components of the JNK cascade could directly promote human
epidermal neoplasia. We expressed either active MKK7 or c-Jun in primary keratinocytes and
examined their capacity to promote tumorigenesis in combination with Ras in the absence of
I?B?. First, we confirmed induction of AP1-dependent gene reporter activity by MKK7 in
vitro (Supplementary Fig. S4). Surface skin grafts were then regenerated with primary
keratinocytes expressing MKK7 and Ras; these developed into clinical tumors resembling SCC
(Fig. 3A). Dermal invasion, one of the hallmarks of spontaneous human SCC, is apparent in
tumors induced by MKK7 and Ras as revealed by both histologic appearance and BMZ
disruption (Fig. 3B–C). MKK7 and Ras-induced neoplasia depends on intact AP1 function as 
concurrent expression of DNc-Jun prevents tumorigenesis (Fig. 3A–C)."
"2293","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"We next asked whether components of the JNK cascade could directly promote human
epidermal neoplasia. We expressed either active MKK7 or c-Jun in primary keratinocytes and
examined their capacity to promote tumorigenesis in combination with Ras in the absence of
I?B?. First, we confirmed induction of AP1-dependent gene reporter activity by MKK7 in
vitro (Supplementary Fig. S4). Surface skin grafts were then regenerated with primary
keratinocytes expressing MKK7 and Ras; these developed into clinical tumors resembling SCC
(Fig. 3A). Dermal invasion, one of the hallmarks of spontaneous human SCC, is apparent in
tumors induced by MKK7 and Ras as revealed by both histologic appearance and BMZ
disruption (Fig. 3B–C). MKK7 and Ras-induced neoplasia depends on intact AP1 function as 
concurrent expression of DNc-Jun prevents tumorigenesis (Fig. 3A–C)."
"2294","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"Of interest, although Ras by itself activates AP1, coexpression
of Ras with MKK7 induces significantly higher levels of AP1 activity in primary human
keratinocytes than either one alone (Supplementary Fig. S5), indicating that Ras and MKK7
act in synergy to induce downstream signaling."
"2295","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"Of interest, although Ras by itself activates AP1, coexpression
of Ras with MKK7 induces significantly higher levels of AP1 activity in primary human
keratinocytes than either one alone (Supplementary Fig. S5), indicating that Ras and MKK7
act in synergy to induce downstream signaling."
"2296","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"Of interest, although Ras by itself activates AP1, coexpression
of Ras with MKK7 induces significantly higher levels of AP1 activity in primary human
keratinocytes than either one alone (Supplementary Fig. S5), indicating that Ras and MKK7
act in synergy to induce downstream signaling."
"2297","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:decreases","false",,,"Oncogenic Ras alone induces growth arrest in primary human keratinocytes in the G1 phase
of the cell cycle (19,31)."
"2298","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"CDK4 is a
cyclin-dependent kinase promoting G1 progression previously shown to be
posttranscriptionally down-regulated by Ras, a finding whose functional importance has been
confirmed because CDK4 can bypass Ras-induced growth arrest (31). CDK4 protein was also
restored to near-normal levels by MKK7."
"2299","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:decreases","false",,,"CDK4 is a
cyclin-dependent kinase promoting G1 progression previously shown to be
posttranscriptionally down-regulated by Ras, a finding whose functional importance has been
confirmed because CDK4 can bypass Ras-induced growth arrest (31). CDK4 protein was also
restored to near-normal levels by MKK7."
"2300","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"In
support of this, TNFR1 has recently been implicated in murine epidermal tumorigenesis.
Genetic deletion of Tnfr1 diminished occurrence of neoplasia in mice induced by both NF-?B
blockade and chemical carcinogenesis (33,34)."
"2301","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:decreases","false",,,"Moreover, recent findings showed that
epidermal NF-?B blockade relieves constitutive repression of JNK activity by the NF-?B RelA
subunit and that TNFR1 is required both for the JNK induction as well as the epidermal
hyperplasia that occurs in this setting (16,17)."
"2302","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"In contrast, tissues treated with TNFR1 antibody, although hyperplastic,
retained BMZ structure and proper desmoglein-3 expression, indicating intact tissue polarity
(Fig. 5A and B). Blockade of TNFR1 signaling was accompanied by the absence of detectable
pJNK in the tissues treated by the TNFR1 antibody (Supplementary Fig. S7). In addition,
TNFR1 blockade reduced the mitotic index and limited mitotic cells to the basal layer, whereas
proliferating cells were widespread and abundant in the control tumor tissue (Fig. 5C and D).
These findings indicate that antagonizing TNFR1 function prevents Ras-driven tumorigenesis."
"2303","Zhang JYAdams AERidky TWTao SKhavari PA","17440097","Cancer research","PubMed",,,"bel:increases","false",,,"In agreement with this, antibody-mediated
TNFR1 blockade significantly inhibited s.c. tumor growth of three independent SCC tumor
lines, A431, SCC25, and CAL27 (Supplementary Fig. S8A). To determine if TNFR1 action in
this context is tumor cell intrinsic, we used retroviral-mediated RNA interference to decrease
TNFR1 expression. Reduced levels of TNFR1, as confirmed by immunoblotting, significantly
inhibited s.c. growth of Ras-driven tumors and SCC lines (Supplementary Fig. S8B)."
"2304","Ho VMSchaffer BEKarnezis ANPark KSSage J","19151761","Oncogene","PubMed",,,"bel:increases","false",,,"Based on these observations, a mouse model of lung adenocarcinoma has been generated in which nasal instillation of Ad-Cre to the lungs of K-Ras+/LSL?G12D  conditional mutant mice (Figure 1a) results in the expression of oncogenic K-RasG12D and the development of lesions that resemble human tumors (Jackson et al., 2001)."
"2305","Ho VMSchaffer BEKarnezis ANPark KSSage J","19151761","Oncogene","PubMed",,,"bel:negativeCorrelation","false",,,"The RB tumor suppressor is inactivated in a broad range of human tumors (Classon and Harlow, 2002; Sherr and McCormick, 2002), including pediatric retinoblastomas and ~90% of human small cell lung carcinomas (SCLCs). "
"2306","Ho VMSchaffer BEKarnezis ANPark KSSage J","19151761","Oncogene","PubMed",,,"bel:negativeCorrelation","false",,,"The RB tumor suppressor is inactivated in a broad range of human tumors (Classon and Harlow, 2002; Sherr and McCormick, 2002), including pediatric retinoblastomas and ~90% of human small cell lung carcinomas (SCLCs). "
"2307","Ho VMSchaffer BEKarnezis ANPark KSSage J","19151761","Oncogene","PubMed",,,"bel:negativeCorrelation","false",,,"For instance, RB is rarely found mutated in lung adeno-carcinomas whereas p16INK4a, an upstream activator of the pRb protein and the two related proteins p107 and p130, is frequently inactivated in this tumor type (Wistuba et al., 2001)."
"2308","Ho VMSchaffer BEKarnezis ANPark KSSage J","19151761","Oncogene","PubMed",,,"bel:negativeCorrelation","false",,,"In addition, loss of function of the pRb family member p130 may be part of tumor progression in several types of human cancers, including lung adenocarcinomas (Claudio et al., 2000; Cinti et al., 2005), but a causal role for loss of p130 in lung cancer progression also remains to be determined. "
"2309","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:increases","false",,,"inhibition of fibroblast proliferation was mediated exclusively by activation of Epac-1. PGE(2) and Epac-1 inhibited cell proliferation through activation of the small GTPase Rap1, since decreasing Rap1 activity by transfection with Rap1GAP or the dominant-negative Rap1N17 prevented, and transfection with the constitutively active Rap1V12 mimicked, the anti-proliferative effects of PGE(2) "
"2310","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:increases","false",,,"inhibition of fibroblast proliferation was mediated exclusively by activation of Epac-1. PGE(2) and Epac-1 inhibited cell proliferation through activation of the small GTPase Rap1, since decreasing Rap1 activity by transfection with Rap1GAP or the dominant-negative Rap1N17 prevented, and transfection with the constitutively active Rap1V12 mimicked, the anti-proliferative effects of PGE(2) "
"2311","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:decreases","false",,,"inhibition of fibroblast proliferation was mediated exclusively by activation of Epac-1. PGE(2) and Epac-1 inhibited cell proliferation through activation of the small GTPase Rap1, since decreasing Rap1 activity by transfection with Rap1GAP or the dominant-negative Rap1N17 prevented, and transfection with the constitutively active Rap1V12 mimicked, the anti-proliferative effects of PGE(2) "
"2312","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:directlyIncreases","false",,,"Work in our laboratory (13) and others (14) has shown that the inhibitory actions of PGE2 in lung fibroblasts are a result of increases in cAMP, mediated through the Gas-coupled EP2 receptor;"
"2313","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:increases","false",,,"Work in our laboratory (13) and others (14) has shown that the inhibitory actions of PGE2 in lung fibroblasts are a result of increases in cAMP, mediated through the Gas-coupled EP2 receptor;"
"2314","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:decreases","false",,,"Work in our laboratory (13) and others (14) has shown that the inhibitory actions of PGE2 in lung fibroblasts are a result of increases in cAMP, mediated through the Gas-coupled EP2 receptor;"
"2315","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:directlyIncreases","false",,,"To determine which cAMP effector-PKA or Epac-is capable of inhibiting collagen expression and proliferation, fibroblasts were treated with varying concentrations of the selective PKA agonist 6-bnz-cAMP or the selective Epac agonist 8-pCPT-29-O-Me-cAMP."
"2316","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:directlyIncreases","false",,,"To determine which cAMP effector-PKA or Epac-is capable of inhibiting collagen expression and proliferation, fibroblasts were treated with varying concentrations of the selective PKA agonist 6-bnz-cAMP or the selective Epac agonist 8-pCPT-29-O-Me-cAMP."
"2317","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:decreases","false",,,"the Epac agonist elicited a dose-dependent decrease in proliferation but had no effect on collagen expression (Figure 1D)"
"2318","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:causesNoChange","false",,,"the Epac agonist elicited a dose-dependent decrease in proliferation but had no effect on collagen expression (Figure 1D)"
"2319","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:causesNoChange","false",,,"cells expressing PKACa exhibited a reduction in collagen expression, but not in proliferation (Figure 2A)"
"2320","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:decreases","false",,,"cells expressing PKACa exhibited a reduction in collagen expression, but not in proliferation (Figure 2A)"
"2321","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:increases","false",,,"We found that both PGE2 and the Epac agonist stimulated Rap1 activity, as measured by the RalGDS pulldown of active GTP-loaded Rap1, whereas the PKA agonist actually had an inhibitory effect on Rap1 activity (Figure 4A). "
"2322","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:increases","false",,,"We found that both PGE2 and the Epac agonist stimulated Rap1 activity, as measured by the RalGDS pulldown of active GTP-loaded Rap1, whereas the PKA agonist actually had an inhibitory effect on Rap1 activity (Figure 4A). "
"2323","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:decreases","false",,,"We found that both PGE2 and the Epac agonist stimulated Rap1 activity, as measured by the RalGDS pulldown of active GTP-loaded Rap1, whereas the PKA agonist actually had an inhibitory effect on Rap1 activity (Figure 4A). "
"2324","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:decreases","false",,,"PGE2 and the PKA agonist, but not the Epac agonist, inhibited PKC-d phosphorylation (Figure 5A)"
"2325","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:decreases","false",,,"PGE2 and the PKA agonist, but not the Epac agonist, inhibited PKC-d phosphorylation (Figure 5A)"
"2326","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:decreases","false",,,"Cells transfected with the catalytic subunit of PKA also showed diminished PKC-d phosphorylation (Figure 5B)."
"2327","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:directlyDecreases","false",,,"Inhibition with the specific PKC-d inhibitor rottlerin resulted in decreased collagen expression (Figure 5C)"
"2328","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:decreases","false",,,"Inhibition with the specific PKC-d inhibitor rottlerin resulted in decreased collagen expression (Figure 5C)"
"2329","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:decreases","false",,,"The PKA agonist dose-dependently inhibited collagen expression but had no effect on proliferation (Figure 1C)"
"2330","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:causesNoChange","false",,,"The PKA agonist dose-dependently inhibited collagen expression but had no effect on proliferation (Figure 1C)"
"2331","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:decreases","false",,,"In keeping with the agonist data, cells expressing PKACa exhibited a reduction in collagen expression, but not in proliferation (Figure 2A)"
"2332","Huang SKWettlaufer SHChung JPeters-Golden M","18421013","American journal of respiratory cell and molecular biology","PubMed",,,"bel:causesNoChange","false",,,"In keeping with the agonist data, cells expressing PKACa exhibited a reduction in collagen expression, but not in proliferation (Figure 2A)"
"2333","Tomshine JCSeverson SRWigle DASun ZBeleford DAShridhar VHorazdovsky BF","19570984","The Journal of biological chemistry","PubMed",,,"bel:directlyDecreases","false",,,"Rin1 is a Rab5 guanine nucleotide exchange factor that plays
an important role in Ras-activated endocytosis and growth factor
receptor trafficking in fibroblasts. In"
"2334","Tomshine JCSeverson SRWigle DASun ZBeleford DAShridhar VHorazdovsky BF","19570984","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Rin1 depletion
from A549 cells resulted in a decrease in cell proliferation
that was correlated to a decrease in epidermal growth factor
receptor (EGFR) signaling. Expression of wild type Rin1 but not
the Rab5 guanine nucleotide exchange factor-deficient Rin1
(Rin1?) complemented the Rin1 depletion effects, and overexpression
of Rin1? had a dominant negative effect on cell proliferation."
"2335","Tomshine JCSeverson SRWigle DASun ZBeleford DAShridhar VHorazdovsky BF","19570984","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Rin1 depletion stabilized the cell surface levels of EGFR,
suggesting that internalization was necessary for robust signaling
in A549 cells. In support of this conclusion, introduction of
either dominant negative Rab5 or dominant negative dynamin
decreased A549 proliferation and EGFR signaling."
"2336","Tomshine JCSeverson SRWigle DASun ZBeleford DAShridhar VHorazdovsky BF","19570984","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"To test whether the cell proliferation defect observed with
Rin1 depletion was because of altered EGFR signaling, A549
cells were transfected with control or Rin1-specific morpholinos,
serum-starved, and then stimulated with EGF. The levels
of phosphorylated ERK1/2 (pERK) were used to assess EGF
signaling (Fig. 2C). Depletion of Rin1 from A549 cells resulted
in at least a 2-fold decrease in pERK levels (Fig. 2, C and D), but
not total ERK levels (supplemental Fig. 2), indicating that the
decrease in cell proliferation correlated with a decrease in EGF
signaling."
"2337","Tomshine JCSeverson SRWigle DASun ZBeleford DAShridhar VHorazdovsky BF","19570984","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"After 10 min of EGF treatment, EGFR levels
dropped ~2-fold in cells transfected with the control morpholino
(Fig. 6, A and B), whereas cells depleted of Rin1 showed
very little receptor loss following EGF stimulation."
"2338","Tomshine JCSeverson SRWigle DASun ZBeleford DAShridhar VHorazdovsky BF","19570984","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"To confirm that EGFR internalization was critical for potentiating
EGFR signaling, a GFP-tagged dominant negative
dynamin (dn-dynamin) K44A expression construct was transiently
transfected into A549 cells, and the impact of its expression
on EGF-stimulated signaling was determined (Fig. 7A).
The expression of dn-dynamin (Fig. 7B) resulted in an ~2-fold
decrease in ERK1/2 activation in response to EGF stimulation
(Fig. 7, A and C); this observation supports the conclusion that
internalization of EGFR is critical for proper signaling in A549
cells."
"2339","Tomshine JCSeverson SRWigle DASun ZBeleford DAShridhar VHorazdovsky BF","19570984","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"To confirm that EGFR internalization was critical for potentiating
EGFR signaling, a GFP-tagged dominant negative
dynamin (dn-dynamin) K44A expression construct was transiently
transfected into A549 cells, and the impact of its expression
on EGF-stimulated signaling was determined (Fig. 7A).
The expression of dn-dynamin (Fig. 7B) resulted in an ~2-fold
decrease in ERK1/2 activation in response to EGF stimulation
(Fig. 7, A and C); this observation supports the conclusion that
internalization of EGFR is critical for proper signaling in A549
cells."
"2340","Tomshine JCSeverson SRWigle DASun ZBeleford DAShridhar VHorazdovsky BF","19570984","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"To confirm that EGFR internalization was critical for potentiating
EGFR signaling, a GFP-tagged dominant negative
dynamin (dn-dynamin) K44A expression construct was transiently
transfected into A549 cells, and the impact of its expression
on EGF-stimulated signaling was determined (Fig. 7A).
The expression of dn-dynamin (Fig. 7B) resulted in an ~2-fold
decrease in ERK1/2 activation in response to EGF stimulation
(Fig. 7, A and C); this observation supports the conclusion that
internalization of EGFR is critical for proper signaling in A549
cells."
"2341","Tomshine JCSeverson SRWigle DASun ZBeleford DAShridhar VHorazdovsky BF","19570984","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"To test the role of Rab5 in these processes, A549 cells were
transfected with a GFP-tagged dominant negative Rab5 S34N
(GFP-dnRab5) expression construct (Fig. 7A). Similar to the
results with Rin1 depletion, expression of GFP-dnRab5 resulted
in an ~2-fold decrease in pERK levels when compared with
control cells expressing GFP alone."
"2342","Tomshine JCSeverson SRWigle DASun ZBeleford DAShridhar VHorazdovsky BF","19570984","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Finally, to confirm that
dnRab5 and dn-dynamin expression impacted cell proliferation
in a manner similar to Rin1 depletion, A549 cells transiently
transfected with expression constructs encoding GFP-dnRab5,
GFP-dn-dynamin, or GFP alone were tested for their ability to
form colonies (Fig. 8). Cells transfected with GFP-dnRab5 or
GFP-dn-dynamin expression constructs showed decreased cell
proliferation, supporting the conclusion that proper EGFR
internalization and Rab5-mediated endosomal trafficking of
EGFR are critical for potentiating proliferative signaling in
A549 cells."
"2343","Tomshine JCSeverson SRWigle DASun ZBeleford DAShridhar VHorazdovsky BF","19570984","The Journal of biological chemistry","PubMed",,,"bel:positiveCorrelation","false",,,"Gene expression from 186 human lung tumors
with associated clinical information were surveyed for statistically
significant variations in RIN1 mRNA levels (34). Of three
Rin1 probe sets on the Affymetrix U95 array, one probe set
(1777_at) was significantly up-regulated in adenocarcinoma,
bronchioalveolar carcinoma, metastatic adenocarcinoma, and
carcinoid and squamous cell carcinoma compared with normal
lung (Fig. 9). The other two probe sets demonstrated statistically
significant up-regulation in both squamous cell carcinoma
and metastatic adenocarcinoma of the lung."
"2344","Tomshine JCSeverson SRWigle DASun ZBeleford DAShridhar VHorazdovsky BF","19570984","The Journal of biological chemistry","PubMed",,,"bel:positiveCorrelation","false",,,"Gene expression from 186 human lung tumors
with associated clinical information were surveyed for statistically
significant variations in RIN1 mRNA levels (34). Of three
Rin1 probe sets on the Affymetrix U95 array, one probe set
(1777_at) was significantly up-regulated in adenocarcinoma,
bronchioalveolar carcinoma, metastatic adenocarcinoma, and
carcinoid and squamous cell carcinoma compared with normal
lung (Fig. 9). The other two probe sets demonstrated statistically
significant up-regulation in both squamous cell carcinoma
and metastatic adenocarcinoma of the lung."
"2345","Tomshine JCSeverson SRWigle DASun ZBeleford DAShridhar VHorazdovsky BF","19570984","The Journal of biological chemistry","PubMed",,,"bel:positiveCorrelation","false",,,"Gene expression from 186 human lung tumors
with associated clinical information were surveyed for statistically
significant variations in RIN1 mRNA levels (34). Of three
Rin1 probe sets on the Affymetrix U95 array, one probe set
(1777_at) was significantly up-regulated in adenocarcinoma,
bronchioalveolar carcinoma, metastatic adenocarcinoma, and
carcinoid and squamous cell carcinoma compared with normal
lung (Fig. 9). The other two probe sets demonstrated statistically
significant up-regulation in both squamous cell carcinoma
and metastatic adenocarcinoma of the lung."
"2346","Tomshine JCSeverson SRWigle DASun ZBeleford DAShridhar VHorazdovsky BF","19570984","The Journal of biological chemistry","PubMed",,,"bel:positiveCorrelation","false",,,"Gene expression from 186 human lung tumors
with associated clinical information were surveyed for statistically
significant variations in RIN1 mRNA levels (34). Of three
Rin1 probe sets on the Affymetrix U95 array, one probe set
(1777_at) was significantly up-regulated in adenocarcinoma,
bronchioalveolar carcinoma, metastatic adenocarcinoma, and
carcinoid and squamous cell carcinoma compared with normal
lung (Fig. 9). The other two probe sets demonstrated statistically
significant up-regulation in both squamous cell carcinoma
and metastatic adenocarcinoma of the lung."
"2347","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:increases","false",,,"In human pancreatic islets, specific insulin biosynthesis, i.e. after normalization to total protein biosynthesis, increased by 2-fold (P < 0.01) upon stimulation with glucose and by 2.3-fold (P < 0.01) upon stimulation with insulin (Fig. 1?)"
"2348","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:directlyDecreases","false",,,"we combined the stimulation with glucose or insulin with the cotreatment with inhibitors of the insulin receptor tyrosine kinase [hydroxy-2-naphthalenylmethylphosphonic acid trisacetoxymethyl ester (HNMPA)], PI 3-kinase (wortmannin and LY294002), and mTOR (rapamycin). As shown in Figs. 1? and 2?, HNMPA, wortmannin, LY294002, and rapamycin inhibited both glucose- and insulin-stimulated insulin biosynthesis in both human pancreatic islets and RIN ?-cells."
"2349","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:directlyDecreases","false",,,"we combined the stimulation with glucose or insulin with the cotreatment with inhibitors of the insulin receptor tyrosine kinase [hydroxy-2-naphthalenylmethylphosphonic acid trisacetoxymethyl ester (HNMPA)], PI 3-kinase (wortmannin and LY294002), and mTOR (rapamycin). As shown in Figs. 1? and 2?, HNMPA, wortmannin, LY294002, and rapamycin inhibited both glucose- and insulin-stimulated insulin biosynthesis in both human pancreatic islets and RIN ?-cells."
"2350","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:increases","false",,,"As shown in Fig. 9?, A–C, exposure of RIN ?-cells to high glucose resulted in an increased phosphorylation of both JNK and the transcription factor c-Jun, a physiological substrate of JNK as well as the ERK-1 and -2 members of MAPK family."
"2351","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:directlyIncreases","false",,,"As shown in Fig. 9?, A–C, exposure of RIN ?-cells to high glucose resulted in an increased phosphorylation of both JNK and the transcription factor c-Jun, a physiological substrate of JNK as well as the ERK-1 and -2 members of MAPK family."
"2352","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:directlyIncreases","false",,,"As shown in Fig. 9?, A–C, exposure of RIN ?-cells to high glucose resulted in an increased phosphorylation of both JNK and the transcription factor c-Jun, a physiological substrate of JNK as well as the ERK-1 and -2 members of MAPK family."
"2353","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:increases","false",,,"exposure of RIN ?-cells to high glucose increased phosphorylation of both IRS-1 Ser307 and IRS-1 Ser612 (Fig. 10?, A and B"
"2354","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:increases","false",,,"exposure of RIN ?-cells to high glucose increased phosphorylation of both IRS-1 Ser307 and IRS-1 Ser612 (Fig. 10?, A and B"
"2355","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:directlyDecreases","false",,,"Inhibition of hexosamine biosynthesis by the GFAT inhibitor azaserine reversed the stimulatory effects of glucose on JNK, c-Jun, and ERK1/2 activation (Fig. 9?, A–C) as well as IRS-1 phosphorylation at Ser307 and Ser612 (Fig. 10?, A and B)."
"2356","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:increases","false",,,"exposure of RIN ?-cells to glucosamine resulted in an increased phosphorylation of JNK, c-Jun, and ERK1/2 as compared with control RIN ?-cells (Fig. 9?, A–C)."
"2357","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:increases","false",,,"exposure of RIN ?-cells to glucosamine resulted in an increased phosphorylation of JNK, c-Jun, and ERK1/2 as compared with control RIN ?-cells (Fig. 9?, A–C)."
"2358","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:increases","false",,,"exposure of RIN ?-cells to glucosamine resulted in an increased phosphorylation of JNK, c-Jun, and ERK1/2 as compared with control RIN ?-cells (Fig. 9?, A–C)."
"2359","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:increases","false",,,"exposure of RIN ?-cells to glucosamine resulted in an increased phosphorylation of JNK, c-Jun, and ERK1/2 as compared with control RIN ?-cells (Fig. 9?, A–C)."
"2360","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:increases","false",,,"Exposure of RIN ?-cells to glucosamine increased phosphorylation of both IRS-1 Ser307 and IRS-1 Ser612, which was reversed by treatment with either a cell-permeable JNK inhibitor or PD98059, a reversible MAPK kinase (MEK)1 inhibitor, the enzyme that directly activates ERK1/2, respectively (Fig. 10?, A and B)"
"2361","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:increases","false",,,"Exposure of RIN ?-cells to glucosamine increased phosphorylation of both IRS-1 Ser307 and IRS-1 Ser612, which was reversed by treatment with either a cell-permeable JNK inhibitor or PD98059, a reversible MAPK kinase (MEK)1 inhibitor, the enzyme that directly activates ERK1/2, respectively (Fig. 10?, A and B)"
"2362","Andreozzi FD'Alessandris CFederici MLaratta EDel Guerra SDel Prato SMarchetti PLauro RPerticone FSesti G","15001544","Endocrinology","PubMed",,,"bel:directlyDecreases","false",,,"Exposure of RIN ?-cells to glucosamine increased phosphorylation of both IRS-1 Ser307 and IRS-1 Ser612, which was reversed by treatment with either a cell-permeable JNK inhibitor or PD98059, a reversible MAPK kinase (MEK)1 inhibitor, the enzyme that directly activates ERK1/2, respectively (Fig. 10?, A and B)"
"2363","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Triggering of the IL-1R or TLR causes the adaptor protein MyD88 to be recruited to the receptor complex, which in turn promotes association with the IL-1R-associated kinases IRAK4 and IRAK1. During the formation of this complex, IRAK4 is activated, leading to the hyperphosphorylation of IRAK-1, which then induces the interaction of TRAF6 with the complex. "
"2364","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Triggering of the IL-1R or TLR causes the adaptor protein MyD88 to be recruited to the receptor complex, which in turn promotes association with the IL-1R-associated kinases IRAK4 and IRAK1. During the formation of this complex, IRAK4 is activated, leading to the hyperphosphorylation of IRAK-1, which then induces the interaction of TRAF6 with the complex. "
"2365","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Triggering of the IL-1R or TLR causes the adaptor protein MyD88 to be recruited to the receptor complex, which in turn promotes association with the IL-1R-associated kinases IRAK4 and IRAK1. During the formation of this complex, IRAK4 is activated, leading to the hyperphosphorylation of IRAK-1, which then induces the interaction of TRAF6 with the complex. "
"2366","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Triggering of the IL-1R or TLR causes the adaptor protein MyD88 to be recruited to the receptor complex, which in turn promotes association with the IL-1R-associated kinases IRAK4 and IRAK1. During the formation of this complex, IRAK4 is activated, leading to the hyperphosphorylation of IRAK-1, which then induces the interaction of TRAF6 with the complex. "
"2367","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"The IRAK-4·IRAK-1·TRAF6 complex then interacts at the membrane with another preformed complex consisting of TAK1, TAB1, and TAB2. This interaction induces phosphorylation of TAB2 and TAK1, which then translocate together with TRAF6 and TAB1 to the cytosol."
"2368","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"The IRAK-4·IRAK-1·TRAF6 complex then interacts at the membrane with another preformed complex consisting of TAK1, TAB1, and TAB2. This interaction induces phosphorylation of TAB2 and TAK1, which then translocate together with TRAF6 and TAB1 to the cytosol."
"2369","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"TAK1 is subsequently activated in the cytoplasm, leading to the activation of IKK. Inactive IKK sequesters NF-?B in the cytoplasm, but activation leads to phosphorylation and degradation of I?B and consequent release of NF-?B. Activation of TAK1 also results in the activation of MAP kinases and c-Jun NH2-terminal kinase (JNK). "
"2370","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"TAK1 is subsequently activated in the cytoplasm, leading to the activation of IKK. Inactive IKK sequesters NF-?B in the cytoplasm, but activation leads to phosphorylation and degradation of I?B and consequent release of NF-?B. Activation of TAK1 also results in the activation of MAP kinases and c-Jun NH2-terminal kinase (JNK). "
"2371","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"TAK1 is subsequently activated in the cytoplasm, leading to the activation of IKK. Inactive IKK sequesters NF-?B in the cytoplasm, but activation leads to phosphorylation and degradation of I?B and consequent release of NF-?B. Activation of TAK1 also results in the activation of MAP kinases and c-Jun NH2-terminal kinase (JNK). "
"2372","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"TAK1 is subsequently activated in the cytoplasm, leading to the activation of IKK. Inactive IKK sequesters NF-?B in the cytoplasm, but activation leads to phosphorylation and degradation of I?B and consequent release of NF-?B. Activation of TAK1 also results in the activation of MAP kinases and c-Jun NH2-terminal kinase (JNK). "
"2373","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"MyD88 was originally isolated as a myeloid differentiation primary response gene that is rapidly induced upon IL-6-stimulated differentiation of M1 myeloleukemic cells into macrophages"
"2374","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Although the kinase activity of IRAK-1 increases strongly following IL-1 stimulation, IRAK-1 kinase activity is not required for its signaling function, because overexpression of a kinase-defective mutant of IRAK-1 is observed to strongly induce NF-?B activation in cells otherwise deficient for IRAK-1. Upon stimulation, IRAK-1 is recruited to the receptor through a homophilic interaction with the DD of MyD88. "
"2375","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Although the kinase activity of IRAK-1 increases strongly following IL-1 stimulation, IRAK-1 kinase activity is not required for its signaling function, because overexpression of a kinase-defective mutant of IRAK-1 is observed to strongly induce NF-?B activation in cells otherwise deficient for IRAK-1. Upon stimulation, IRAK-1 is recruited to the receptor through a homophilic interaction with the DD of MyD88. "
"2376","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Although the kinase activity of IRAK-1 increases strongly following IL-1 stimulation, IRAK-1 kinase activity is not required for its signaling function, because overexpression of a kinase-defective mutant of IRAK-1 is observed to strongly induce NF-?B activation in cells otherwise deficient for IRAK-1. Upon stimulation, IRAK-1 is recruited to the receptor through a homophilic interaction with the DD of MyD88. "
"2377","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"IRAK-1-deficient mice and cell lines showed diminished cytokine production in response to IL-1 and LPS;"
"2378","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"IRAK-1-deficient mice and cell lines showed diminished cytokine production in response to IL-1 and LPS;"
"2379","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Data with IRAK-M knock-out mice have revealed that IRAK-M serves as a negative regulator of IL-1R/TLR signaling (19). IRAK-M-deficient macrophages produced significantly higher cytokine levels in response to a variety of IL-1R/TLR ligands. "
"2380","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Data with IRAK-M knock-out mice have revealed that IRAK-M serves as a negative regulator of IL-1R/TLR signaling (19). IRAK-M-deficient macrophages produced significantly higher cytokine levels in response to a variety of IL-1R/TLR ligands. "
"2381","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Studies using small interfering RNA (siRNA) to inhibit TAK1 expression show that TAK1 is essential for both IL-1- and TNF-?-induced NF-?B activation. Two TAK1-binding proteins, TAB1 and TAB2, have been identified (24, 25). When ectopically co-expressed, TAB1 augments the kinase activity of TAK1, indicating that TAB1 functions as an activator of TAK1. "
"2382","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Studies using small interfering RNA (siRNA) to inhibit TAK1 expression show that TAK1 is essential for both IL-1- and TNF-?-induced NF-?B activation. Two TAK1-binding proteins, TAB1 and TAB2, have been identified (24, 25). When ectopically co-expressed, TAB1 augments the kinase activity of TAK1, indicating that TAB1 functions as an activator of TAK1. "
"2383","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Studies using small interfering RNA (siRNA) to inhibit TAK1 expression show that TAK1 is essential for both IL-1- and TNF-?-induced NF-?B activation. Two TAK1-binding proteins, TAB1 and TAB2, have been identified (24, 25). When ectopically co-expressed, TAB1 augments the kinase activity of TAK1, indicating that TAB1 functions as an activator of TAK1. "
"2384","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"TAB2 is associated with the cell membrane in unstimulated conditions, but upon stimulation it translocates to the cytosol, where it functions as an adaptor linking TAK1 to TRAF6, thereby facilitating TAK1 activation. "
"2385","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"It has been shown recently that ubiquitination plays an important role in TAK1 activation (26, 27). IKK activation by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex composed of Ubc13 and Uev1A as well as the TAK1·kinase complex. TRAF6 can interact through its RING finger domain with Ubc13 in the Ubc13·Uev1A complex. This Ubc·TRAF6 complex catalyzes the formation of a Lys-63-linked polyubiquitin chain, which triggers TAK1 activation through a unique proteasome-independent mechanism. "
"2386","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"It has been shown recently that ubiquitination plays an important role in TAK1 activation (26, 27). IKK activation by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex composed of Ubc13 and Uev1A as well as the TAK1·kinase complex. TRAF6 can interact through its RING finger domain with Ubc13 in the Ubc13·Uev1A complex. This Ubc·TRAF6 complex catalyzes the formation of a Lys-63-linked polyubiquitin chain, which triggers TAK1 activation through a unique proteasome-independent mechanism. "
"2387","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Tollip—Tollip (Toll-interacting protein) was originally cloned as a protein interacting with the IL-1 receptor accessory protein (28). Tollip also associates with TLR2 and TLR4. In resting cells, Tollip forms a complex with members of the IRAK family, thereby preventing NF-?B activation. Upon activation Tollip·IRAK-1 complexes are recruited to the cognate receptor, resulting in the rapid autophosphorylation of IRAK-1 and its dissociation from the receptor. "
"2388","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Pellino 1 is required for IL-1-induced NF-?B activation and IL-8 gene expression (30). Pellino 2 has also been shown to be involved in IL-1R/TLR signaling pathways (31). Following IL-1 stimulation, IRAK-1 and Pellino 2 associate to form complexes. Ectopic expression of a Pellino 2 antisense construct was shown to inhibit IL-1- and LPS-dependent but not TNF-?-dependent activation of the IL-8 promoter."
"2389","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"LPS stimulation has been shown to result in tyrosine phosphorylation of MyD88 and formation of a PI 3-kinase·MyD88 complex (33)."
"2390","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"LPS stimulation has been shown to result in tyrosine phosphorylation of MyD88 and formation of a PI 3-kinase·MyD88 complex (33)."
"2391","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"it is noteworthy that, compared with other TLR ligands, poly(I-C) stimulation induces the production of relatively large amounts of type I interferons and interferon-inducible genes but smaller amounts of inflammatory cytokines such as TNF-? and IL-6, further suggesting that TLR3 does not utilize the MyD88-dependent pathway for signaling."
"2392","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"it is noteworthy that, compared with other TLR ligands, poly(I-C) stimulation induces the production of relatively large amounts of type I interferons and interferon-inducible genes but smaller amounts of inflammatory cytokines such as TNF-? and IL-6, further suggesting that TLR3 does not utilize the MyD88-dependent pathway for signaling."
"2393","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Following virus infection, double-stranded RNA, or LPS treatment, IRF-3 undergoes phosphorylation and translocates from the cytoplasm to the nucleus, resulting in the transcriptional activation of type I interferons. "
"2394","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Following virus infection, double-stranded RNA, or LPS treatment, IRF-3 undergoes phosphorylation and translocates from the cytoplasm to the nucleus, resulting in the transcriptional activation of type I interferons. "
"2395","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Following virus infection, double-stranded RNA, or LPS treatment, IRF-3 undergoes phosphorylation and translocates from the cytoplasm to the nucleus, resulting in the transcriptional activation of type I interferons. "
"2396","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Overexpression of TRIF, but not MyD88 or TIRAP, preferentially activates the IFN-? promoter. A dominant-negative form (DN) of TRIF, but not MyD88DN or TIRAPDN, blocked the TLR3-mediated response to poly(I-C), "
"2397","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Overexpression of TRIF, but not MyD88 or TIRAP, preferentially activates the IFN-? promoter. A dominant-negative form (DN) of TRIF, but not MyD88DN or TIRAPDN, blocked the TLR3-mediated response to poly(I-C), "
"2398","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:causesNoChange","false",,,"Overexpression of TRIF, but not MyD88 or TIRAP, preferentially activates the IFN-? promoter. A dominant-negative form (DN) of TRIF, but not MyD88DN or TIRAPDN, blocked the TLR3-mediated response to poly(I-C), "
"2399","Akira S","12893815","The Journal of biological chemistry","PubMed",,,"bel:causesNoChange","false",,,"Overexpression of TRIF, but not MyD88 or TIRAP, preferentially activates the IFN-? promoter. A dominant-negative form (DN) of TRIF, but not MyD88DN or TIRAPDN, blocked the TLR3-mediated response to poly(I-C), "
"2400","Dejmek JDib KJ??nsson MAndersson T","12471617","International journal of cancer. Journal international du cancer","PubMed",,,"bel:increases","false",,,"We have observed previously that adhesion of normal HB2 cells to collagen I is accompanied by a collagen-induced phosphorylation of DDR1.9 The present experiments show that adhesion to collagen IV also causes a phosphorylation of DDR1 in mammary epithelial cells (Fig. 1b)."
"2401","Dejmek JDib KJ??nsson MAndersson T","12471617","International journal of cancer. Journal international du cancer","PubMed",,,"bel:increases","false",,,"We have observed previously that adhesion of normal HB2 cells to collagen I is accompanied by a collagen-induced phosphorylation of DDR1.9 The present experiments show that adhesion to collagen IV also causes a phosphorylation of DDR1 in mammary epithelial cells (Fig. 1b)."
"2402","Dejmek JDib KJ??nsson MAndersson T","12471617","International journal of cancer. Journal international du cancer","PubMed",,,"bel:decreases","false",,,"In accordance with the observed effects on phosphorylation of DDR1in HB2 cells (Fig. 2), we subsequently found that pertussis toxin, but not cholera toxin, impaired the adhesion of normal HB2 cells to collagen (Fig. 3a,b respectively)."
"2403","Dejmek JDib KJ??nsson MAndersson T","12471617","International journal of cancer. Journal international du cancer","PubMed",,,"bel:causesNoChange","false",,,"In accordance with the observed effects on phosphorylation of DDR1in HB2 cells (Fig. 2), we subsequently found that pertussis toxin, but not cholera toxin, impaired the adhesion of normal HB2 cells to collagen (Fig. 3a,b respectively)."
"2404","Dejmek JDib KJ??nsson MAndersson T","12471617","International journal of cancer. Journal international du cancer","PubMed",,,"bel:increases","false",,,"?2?1 integrins have been reported to be the major receptor responsible for attachment of HB2 cells to collagen.9, 24 We found, however, that adhesion of HB2 cells to collagen was decreased by less than 50% in the presence of an anti-?1 integrin Ab (Fig. 3a), which indicates that, in addition to engagement of ?1 integrins, at least 1 other mechanism must be involved in adherence of these cells to collagen. "
"2405","Dejmek JDib KJ??nsson MAndersson T","12471617","International journal of cancer. Journal international du cancer","PubMed",,,"bel:increases","false",,,"Furthermore, we tested the effects of pertussis toxin on Wnt-5a-deficient HB2 (Fig. 4a) and MCF-7 mammary tumor (Fig. 4b) cells. As expected, both of these Wnt-5a-deficient cell lines exhibited significantly less adhesion that reached a maximum (50–60% of the plated cells) after 90–120 min (Fig. 4), which is nearly half of the adhesive capacity of Wnt-5a-expressing HB2 cells (Fig. 3). "
"2406","Dejmek JDib KJ??nsson MAndersson T","12471617","International journal of cancer. Journal international du cancer","PubMed",,,"bel:increases","false",,,"We found that treatment with 7.5 ?M mastoparan enabled a marked collagen-induced phosphorylation of DDR1 after only 30 min (Fig. 5a) and a concomitant increase in adhesion after 60 and 90 min (Fig. 5b). Other investigators have previously reported that the indicated concentration of mastoparan primarily activates Gi/o-proteins, whereas a significantly higher concentration is needed to stimulate transducin and Gs-proteins."
"2407","Dejmek JDib KJ??nsson MAndersson T","12471617","International journal of cancer. Journal international du cancer","PubMed",,,"bel:increases","false",,,"We found that treatment with 7.5 ?M mastoparan enabled a marked collagen-induced phosphorylation of DDR1 after only 30 min (Fig. 5a) and a concomitant increase in adhesion after 60 and 90 min (Fig. 5b). Other investigators have previously reported that the indicated concentration of mastoparan primarily activates Gi/o-proteins, whereas a significantly higher concentration is needed to stimulate transducin and Gs-proteins."
"2408","Dejmek JDib KJ??nsson MAndersson T","12471617","International journal of cancer. Journal international du cancer","PubMed",,,"bel:directlyDecreases","false",,,"To further ascertain whether such a link exists between Wnt-5a signaling, collagen-induced DDR1 activation, and the adhesiveness of HB2 cells, we tested the effects of PP1, a specific inhibitor of Src family tyrosine kinases. We found that PP1 abolished the collagen-induced phosphorylation of DDR1 (Fig. 6a), and that it also decreased adhesion of normal HB2 cells by about 50% (Fig. 6b). "
"2409","Dejmek JDib KJ??nsson MAndersson T","12471617","International journal of cancer. Journal international du cancer","PubMed",,,"bel:decreases","false",,,"To further ascertain whether such a link exists between Wnt-5a signaling, collagen-induced DDR1 activation, and the adhesiveness of HB2 cells, we tested the effects of PP1, a specific inhibitor of Src family tyrosine kinases. We found that PP1 abolished the collagen-induced phosphorylation of DDR1 (Fig. 6a), and that it also decreased adhesion of normal HB2 cells by about 50% (Fig. 6b). "
"2410","Dejmek JDib KJ??nsson MAndersson T","12471617","International journal of cancer. Journal international du cancer","PubMed",,,"bel:increases","false",,,"Furthermore, we noted that collagen-stimulated DDR1 interacted with the p85 subunit of PI3K (Fig. 7b), and we also observed that adherence of HB2 cells to collagen caused tyrosine phosphorylation of the p85 of PI3K (Fig. 7c), a phenomenon associated with activation of this enzyme. Neither of these events was observed in cells pretreated with pertussis toxin (Fig. 7a,b,c)."
"2411","Dejmek JDib KJ??nsson MAndersson T","12471617","International journal of cancer. Journal international du cancer","PubMed",,,"bel:increases","false",,,"Furthermore, we noted that collagen-stimulated DDR1 interacted with the p85 subunit of PI3K (Fig. 7b), and we also observed that adherence of HB2 cells to collagen caused tyrosine phosphorylation of the p85 of PI3K (Fig. 7c), a phenomenon associated with activation of this enzyme. Neither of these events was observed in cells pretreated with pertussis toxin (Fig. 7a,b,c)."
"2412","Dejmek JDib KJ??nsson MAndersson T","12471617","International journal of cancer. Journal international du cancer","PubMed",,,"bel:directlyIncreases","false",,,"Furthermore, we noted that collagen-stimulated DDR1 interacted with the p85 subunit of PI3K (Fig. 7b), and we also observed that adherence of HB2 cells to collagen caused tyrosine phosphorylation of the p85 of PI3K (Fig. 7c), a phenomenon associated with activation of this enzyme. Neither of these events was observed in cells pretreated with pertussis toxin (Fig. 7a,b,c)."
"2413","Dejmek JDib KJ??nsson MAndersson T","12471617","International journal of cancer. Journal international du cancer","PubMed",,,"bel:increases","false",,,"Thus, a G(i/o)-protein signaling pathway mediates the effect of Wnt-5a expression by enabling collagen-induced activation of DDR1, which, in parallel with beta(1) integrins, regulates adhesion of mammary cells."
"2414","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Tumor necrosis factor alpha (TNF alpha) strongly increased the expression of E-selectin in human umbilical vein endothelial cells (HUVEC). This effect was independent of the activation of SAPK2/p38 induced by TNF alpha. "
"2415","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Tumor necrosis factor alpha (TNF alpha) strongly increased the expression of E-selectin in human umbilical vein endothelial cells (HUVEC). This effect was independent of the activation of SAPK2/p38 induced by TNF alpha. "
"2416","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Adhesion of HT-29 cells on a monolayer of HUVEC pretreated with TNF alpha was dependent on E-selectin expression but was independent of SAPK2/p38 activity of both HUVEC and tumor cells. The adhesion of HT-29 cells to E-selectin-expressing HUVEC led to the activation of SAPK2/p38 in the tumor cells as reflected by the increased phosphorylation of the actin-polymerizing factor HSP27 by mitogen-activated protein kinase 2/3, a direct target of SAPK2/p38. Moreover, a recombinant E-selectin/Fc chimera quickly increased the activation of SAPK2/p38 in HT-29 cells. Blocking the increased activity of SAPK2/p38 of HT-29 cells by SB203580 or by expressing a dominant negative form of SAPK2/p38 inhibited their transendothelial migration. "
"2417","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Adhesion of HT-29 cells on a monolayer of HUVEC pretreated with TNF alpha was dependent on E-selectin expression but was independent of SAPK2/p38 activity of both HUVEC and tumor cells. The adhesion of HT-29 cells to E-selectin-expressing HUVEC led to the activation of SAPK2/p38 in the tumor cells as reflected by the increased phosphorylation of the actin-polymerizing factor HSP27 by mitogen-activated protein kinase 2/3, a direct target of SAPK2/p38. Moreover, a recombinant E-selectin/Fc chimera quickly increased the activation of SAPK2/p38 in HT-29 cells. Blocking the increased activity of SAPK2/p38 of HT-29 cells by SB203580 or by expressing a dominant negative form of SAPK2/p38 inhibited their transendothelial migration. "
"2418","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Adhesion of HT-29 cells on a monolayer of HUVEC pretreated with TNF alpha was dependent on E-selectin expression but was independent of SAPK2/p38 activity of both HUVEC and tumor cells. The adhesion of HT-29 cells to E-selectin-expressing HUVEC led to the activation of SAPK2/p38 in the tumor cells as reflected by the increased phosphorylation of the actin-polymerizing factor HSP27 by mitogen-activated protein kinase 2/3, a direct target of SAPK2/p38. Moreover, a recombinant E-selectin/Fc chimera quickly increased the activation of SAPK2/p38 in HT-29 cells. Blocking the increased activity of SAPK2/p38 of HT-29 cells by SB203580 or by expressing a dominant negative form of SAPK2/p38 inhibited their transendothelial migration. "
"2419","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Adhesion of HT-29 cells on a monolayer of HUVEC pretreated with TNF alpha was dependent on E-selectin expression but was independent of SAPK2/p38 activity of both HUVEC and tumor cells. The adhesion of HT-29 cells to E-selectin-expressing HUVEC led to the activation of SAPK2/p38 in the tumor cells as reflected by the increased phosphorylation of the actin-polymerizing factor HSP27 by mitogen-activated protein kinase 2/3, a direct target of SAPK2/p38. Moreover, a recombinant E-selectin/Fc chimera quickly increased the activation of SAPK2/p38 in HT-29 cells. Blocking the increased activity of SAPK2/p38 of HT-29 cells by SB203580 or by expressing a dominant negative form of SAPK2/p38 inhibited their transendothelial migration. "
"2420","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Adhesion of HT-29 cells on a monolayer of HUVEC pretreated with TNF alpha was dependent on E-selectin expression but was independent of SAPK2/p38 activity of both HUVEC and tumor cells. The adhesion of HT-29 cells to E-selectin-expressing HUVEC led to the activation of SAPK2/p38 in the tumor cells as reflected by the increased phosphorylation of the actin-polymerizing factor HSP27 by mitogen-activated protein kinase 2/3, a direct target of SAPK2/p38. Moreover, a recombinant E-selectin/Fc chimera quickly increased the activation of SAPK2/p38 in HT-29 cells. Blocking the increased activity of SAPK2/p38 of HT-29 cells by SB203580 or by expressing a dominant negative form of SAPK2/p38 inhibited their transendothelial migration. "
"2421","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Adhesion of HT-29 cells on a monolayer of HUVEC pretreated with TNF alpha was dependent on E-selectin expression but was independent of SAPK2/p38 activity of both HUVEC and tumor cells. The adhesion of HT-29 cells to E-selectin-expressing HUVEC led to the activation of SAPK2/p38 in the tumor cells as reflected by the increased phosphorylation of the actin-polymerizing factor HSP27 by mitogen-activated protein kinase 2/3, a direct target of SAPK2/p38. Moreover, a recombinant E-selectin/Fc chimera quickly increased the activation of SAPK2/p38 in HT-29 cells. Blocking the increased activity of SAPK2/p38 of HT-29 cells by SB203580 or by expressing a dominant negative form of SAPK2/p38 inhibited their transendothelial migration. "
"2422","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Adhesion of HT-29 cells on a monolayer of HUVEC pretreated with TNF alpha was dependent on E-selectin expression but was independent of SAPK2/p38 activity of both HUVEC and tumor cells. The adhesion of HT-29 cells to E-selectin-expressing HUVEC led to the activation of SAPK2/p38 in the tumor cells as reflected by the increased phosphorylation of the actin-polymerizing factor HSP27 by mitogen-activated protein kinase 2/3, a direct target of SAPK2/p38. Moreover, a recombinant E-selectin/Fc chimera quickly increased the activation of SAPK2/p38 in HT-29 cells. Blocking the increased activity of SAPK2/p38 of HT-29 cells by SB203580 or by expressing a dominant negative form of SAPK2/p38 inhibited their transendothelial migration. "
"2423","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Adhesion of HT-29 cells on a monolayer of HUVEC pretreated with TNF alpha was dependent on E-selectin expression but was independent of SAPK2/p38 activity of both HUVEC and tumor cells. The adhesion of HT-29 cells to E-selectin-expressing HUVEC led to the activation of SAPK2/p38 in the tumor cells as reflected by the increased phosphorylation of the actin-polymerizing factor HSP27 by mitogen-activated protein kinase 2/3, a direct target of SAPK2/p38. Moreover, a recombinant E-selectin/Fc chimera quickly increased the activation of SAPK2/p38 in HT-29 cells. Blocking the increased activity of SAPK2/p38 of HT-29 cells by SB203580 or by expressing a dominant negative form of SAPK2/p38 inhibited their transendothelial migration. "
"2424","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"In primary cultures of HUVEC, TNF? induced a strong activation of the expression of endothelial adhesion proteins that include E-selectin and ICAM (Fig.1, A—D, and data not shown). This induction was maximal after 4 h and required de novo protein synthesis being inhibited by cycloheximide (Fig. 1,E and F). "
"2425","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"In primary cultures of HUVEC, TNF? induced a strong activation of the expression of endothelial adhesion proteins that include E-selectin and ICAM (Fig.1, A—D, and data not shown). This induction was maximal after 4 h and required de novo protein synthesis being inhibited by cycloheximide (Fig. 1,E and F). "
"2426","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"As illustrated in Fig.2, A–C, the expression of E-selectin correlated with an increased adhesion of both colon carcinoma HT-29 cells and HL-60 leukemia cells to a monolayer of HUVEC. After 30 min, the number of HT-29 cells that adhered to HUVEC-expressing E-selectin, following activation with TNF?, was 5-fold higher than when adhering to inactivated HUVEC. Similarly, HT-29 cells quickly adhered to immobilized recombinant human E-selectin/Fc chimera (data not shown). An anti-E-selectin neutralizing antibody, but not a matched isotype antibody, decreased the adhesion of both cancer cell types to the activated endothelium (Fig. 2, A–C). "
"2427","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"As illustrated in Fig.2, A–C, the expression of E-selectin correlated with an increased adhesion of both colon carcinoma HT-29 cells and HL-60 leukemia cells to a monolayer of HUVEC. After 30 min, the number of HT-29 cells that adhered to HUVEC-expressing E-selectin, following activation with TNF?, was 5-fold higher than when adhering to inactivated HUVEC. Similarly, HT-29 cells quickly adhered to immobilized recombinant human E-selectin/Fc chimera (data not shown). An anti-E-selectin neutralizing antibody, but not a matched isotype antibody, decreased the adhesion of both cancer cell types to the activated endothelium (Fig. 2, A–C). "
"2428","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"TNF? also induced in HUVEC, a marked time- and dose-dependent stimulation of SAPK2/p38 that is characterized by an increased activity of MAPKAP K2/3, a direct physiological target of SAPK2/p38 (21). "
"2429","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"TNF? also induced in HUVEC, a marked time- and dose-dependent stimulation of SAPK2/p38 that is characterized by an increased activity of MAPKAP K2/3, a direct physiological target of SAPK2/p38 (21). "
"2430","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"TNF? also induced in HUVEC, a marked time- and dose-dependent stimulation of SAPK2/p38 that is characterized by an increased activity of MAPKAP K2/3, a direct physiological target of SAPK2/p38 (21). "
"2431","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:directlyDecreases","false",,,"inhibiting the TNF?-induced increase in SAPK2/p38 activity by SB203580 did not impair the expression of E-selectin, which suggested that activation of SAPK2/p38 was not required for the expression of this adhesion molecule (Fig. 1,G and H). Accordingly, blocking the SAPK2/p38 activity of HUVEC with SB203580 did not inhibit the adhesion of HT-29 cells to HUVEC (Fig. 2  A)."
"2432","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:causesNoChange","false",,,"inhibiting the TNF?-induced increase in SAPK2/p38 activity by SB203580 did not impair the expression of E-selectin, which suggested that activation of SAPK2/p38 was not required for the expression of this adhesion molecule (Fig. 1,G and H). Accordingly, blocking the SAPK2/p38 activity of HUVEC with SB203580 did not inhibit the adhesion of HT-29 cells to HUVEC (Fig. 2  A)."
"2433","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:causesNoChange","false",,,"inhibiting the TNF?-induced increase in SAPK2/p38 activity by SB203580 did not impair the expression of E-selectin, which suggested that activation of SAPK2/p38 was not required for the expression of this adhesion molecule (Fig. 1,G and H). Accordingly, blocking the SAPK2/p38 activity of HUVEC with SB203580 did not inhibit the adhesion of HT-29 cells to HUVEC (Fig. 2  A)."
"2434","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"However, HT-29 cells migrated across an endothelial layer of HUVEC, and this migration was enhanced by pretreating HUVEC with TNF? (Fig.4  A). This increase in cell migration was reduced down to control levels by pretreating HUVEC with the anti-E-selectin antibody indicating the requirement of E-selectin expression and E-selectin-dependent adhesion for HT-29 cell migration across an endothelial cell layer (Fig. 4  A). "
"2435","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"However, HT-29 cells migrated across an endothelial layer of HUVEC, and this migration was enhanced by pretreating HUVEC with TNF? (Fig.4  A). This increase in cell migration was reduced down to control levels by pretreating HUVEC with the anti-E-selectin antibody indicating the requirement of E-selectin expression and E-selectin-dependent adhesion for HT-29 cell migration across an endothelial cell layer (Fig. 4  A). "
"2436","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Impairing E-selectin-mediated activation of SAPK2p38 and HSP27 phosphorylation of HT-29 cells with SB203580 (Fig. 4  A and data not shown) or by expressing a dominant negative form of SAPK2/p38 inhibited their migration across activated HUVEC (Fig.4  B). "
"2437","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Impairing E-selectin-mediated activation of SAPK2p38 and HSP27 phosphorylation of HT-29 cells with SB203580 (Fig. 4  A and data not shown) or by expressing a dominant negative form of SAPK2/p38 inhibited their migration across activated HUVEC (Fig.4  B). "
"2438","Laferriere JHoule FTaher MMValerie KHuot J","11448946","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Impairing E-selectin-mediated activation of SAPK2p38 and HSP27 phosphorylation of HT-29 cells with SB203580 (Fig. 4  A and data not shown) or by expressing a dominant negative form of SAPK2/p38 inhibited their migration across activated HUVEC (Fig.4  B). "
"2439","Rajavashisth TBLiao JKGalis ZSTripathi SLaufs UTripathi JChai NNXu XPJovinge SShah PKLibby P","10207013","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,
"2440","Rajavashisth TBLiao JKGalis ZSTripathi SLaufs UTripathi JChai NNXu XPJovinge SShah PKLibby P","10207013","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,
"2441","Rajavashisth TBLiao JKGalis ZSTripathi SLaufs UTripathi JChai NNXu XPJovinge SShah PKLibby P","10207013","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Incubation of medium conditioned by human smooth muscle cells that contained pro-MMP-2, with plasma membrane extracts prepared from EC treated with TNF-a, interleukin-1b, or OxLDL, increased the proteolytic conversion of 72-kDa proMMP-2 to new gelatinolytic bands of 70- and 68-kDa corresponding to the processed active MMP-2 (Fig. 7A). Proteolytic processing of pro-MMP-2 was reduced in membrane extracts incubated with anti-MT1-MMP antibody (Fig. 7A and B)."
"2442","Rajavashisth TBLiao JKGalis ZSTripathi SLaufs UTripathi JChai NNXu XPJovinge SShah PKLibby P","10207013","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Incubation of medium conditioned by human smooth muscle cells that contained pro-MMP-2, with plasma membrane extracts prepared from EC treated with TNF-a, interleukin-1b, or OxLDL, increased the proteolytic conversion of 72-kDa proMMP-2 to new gelatinolytic bands of 70- and 68-kDa corresponding to the processed active MMP-2 (Fig. 7A). Proteolytic processing of pro-MMP-2 was reduced in membrane extracts incubated with anti-MT1-MMP antibody (Fig. 7A and B)."
"2443","Rajavashisth TBLiao JKGalis ZSTripathi SLaufs UTripathi JChai NNXu XPJovinge SShah PKLibby P","10207013","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Incubation of medium conditioned by human smooth muscle cells that contained pro-MMP-2, with plasma membrane extracts prepared from EC treated with TNF-a, interleukin-1b, or OxLDL, increased the proteolytic conversion of 72-kDa proMMP-2 to new gelatinolytic bands of 70- and 68-kDa corresponding to the processed active MMP-2 (Fig. 7A). Proteolytic processing of pro-MMP-2 was reduced in membrane extracts incubated with anti-MT1-MMP antibody (Fig. 7A and B)."
"2444","Rajavashisth TBLiao JKGalis ZSTripathi SLaufs UTripathi JChai NNXu XPJovinge SShah PKLibby P","10207013","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Incubation of medium conditioned by human smooth muscle cells that contained pro-MMP-2, with plasma membrane extracts prepared from EC treated with TNF-a, interleukin-1b, or OxLDL, increased the proteolytic conversion of 72-kDa proMMP-2 to new gelatinolytic bands of 70- and 68-kDa corresponding to the processed active MMP-2 (Fig. 7A). Proteolytic processing of pro-MMP-2 was reduced in membrane extracts incubated with anti-MT1-MMP antibody (Fig. 7A and B)."
"2445","Rajavashisth TBLiao JKGalis ZSTripathi SLaufs UTripathi JChai NNXu XPJovinge SShah PKLibby P","10207013","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Northern analyses and RNase protection assays revealed that exposure of cultured EC to TNF-a, interleukin-1, or Ox-LDL results in the accumulation of MT1- MMP mRNA"
"2446","Rajavashisth TBLiao JKGalis ZSTripathi SLaufs UTripathi JChai NNXu XPJovinge SShah PKLibby P","10207013","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Northern analyses and RNase protection assays revealed that exposure of cultured EC to TNF-a, interleukin-1, or Ox-LDL results in the accumulation of MT1- MMP mRNA"
"2447","Rajavashisth TBLiao JKGalis ZSTripathi SLaufs UTripathi JChai NNXu XPJovinge SShah PKLibby P","10207013","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Northern analyses and RNase protection assays revealed that exposure of cultured EC to TNF-a, interleukin-1, or Ox-LDL results in the accumulation of MT1- MMP mRNA"
"2448","Rajavashisth TBLiao JKGalis ZSTripathi SLaufs UTripathi JChai NNXu XPJovinge SShah PKLibby P","10207013","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Northern analyses and RNase protection assays revealed that exposure of cultured EC to TNF-a, interleukin-1, or Ox-LDL results in the accumulation of MT1- MMP mRNA"
"2449","Rajavashisth TBLiao JKGalis ZSTripathi SLaufs UTripathi JChai NNXu XPJovinge SShah PKLibby P","10207013","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Stimulation of EC with TNF-a and/or Ox-LDL for 24 h increased the number of MT1-MMP-bearing cells to about 1.8-fold (Ox-LDL), 1.7-fold (TNF-a), or 2.5-fold (TNF-a and Ox-LDL together) as compared with unstimulated cells "
"2450","Rajavashisth TBLiao JKGalis ZSTripathi SLaufs UTripathi JChai NNXu XPJovinge SShah PKLibby P","10207013","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Stimulation of EC with TNF-a and/or Ox-LDL for 24 h increased the number of MT1-MMP-bearing cells to about 1.8-fold (Ox-LDL), 1.7-fold (TNF-a), or 2.5-fold (TNF-a and Ox-LDL together) as compared with unstimulated cells "
"2451","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:increases","false",,,"TSC exposure dramatically increased the tumorigenicity
of Calu-6cells (Fig. 1B)."
"2452","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:increases","false",,,"Tumors
arising from TSC-treated A549 cells tended to be somewhat larger
than those developing from untreated cells (364 F 333 versus
200 F 329 mg; P = 0.25, two-tailed t test; data not shown)."
"2453","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:decreases","false",,,"Interestingly, Dkk-1, encoding a Wnt
signaling antagonist frequently silenced by DNA methylation in
cancer cells (20, 26), was down-regulated in a dose-dependent
manner in both cell lines. Quantitative RT-PCR experiments
(Fig. 1C) confirmed that TSC mediated dose-dependent decreases
in Dkk-1 mRNA copy numbers in A549 and Calu-6cells, which
exhibited relatively high Dkk-1 expression."
"2454","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:decreases","false",,,"Interestingly, Dkk-1, encoding a Wnt
signaling antagonist frequently silenced by DNA methylation in
cancer cells (20, 26), was down-regulated in a dose-dependent
manner in both cell lines. Quantitative RT-PCR experiments
(Fig. 1C) confirmed that TSC mediated dose-dependent decreases
in Dkk-1 mRNA copy numbers in A549 and Calu-6cells, which
exhibited relatively high Dkk-1 expression."
"2455","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:decreases","false",,,"Diminished Dkk-1 expression
coincided with reduced Dkk-1 protein levels in A549 and Calu-6
cells following TSC exposure (Fig. 1D)."
"2456","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:decreases","false",,,"Diminished Dkk-1 expression
coincided with reduced Dkk-1 protein levels in A549 and Calu-6
cells following TSC exposure (Fig. 1D)."
"2457","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:decreases","false",,,"Interestingly, TSC exposure decreased H4K16Ac and
increased H3K27me3 levels within the Dkk-1 promoter region in
both lung cancer lines."
"2458","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:increases","false",,,"Interestingly, TSC exposure decreased H4K16Ac and
increased H3K27me3 levels within the Dkk-1 promoter region in
both lung cancer lines."
"2459","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:decreases","false",,,"Interestingly, TSC exposure decreased H4K16Ac and
increased H3K27me3 levels within the Dkk-1 promoter region in
both lung cancer lines."
"2460","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:increases","false",,,"Interestingly, TSC exposure decreased H4K16Ac and
increased H3K27me3 levels within the Dkk-1 promoter region in
both lung cancer lines."
"2461","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:positiveCorrelation","false",,,"Chromatin immunoprecipitation analysis (Fig. 3B)
revealed a dose-dependent increase in H3K27me3, which coincided
with recruitment of EZH2 and SUZ12 (components of the
‘‘initiation’’ polycomb repressor complex 2 that catalyze
H3K27me3), as well as Bmi1, a member of ‘‘maintenance’’
polycomb repressor complex 1 (27). Additional analysis confirmed
the dose-dependent deacetylation of H4K16, which coincided with
recruitment of SirT1, a class III histone deacetylase that mediates
H4K16deacet ylation (28)."
"2462","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:positiveCorrelation","false",,,"Chromatin immunoprecipitation analysis (Fig. 3B)
revealed a dose-dependent increase in H3K27me3, which coincided
with recruitment of EZH2 and SUZ12 (components of the
‘‘initiation’’ polycomb repressor complex 2 that catalyze
H3K27me3), as well as Bmi1, a member of ‘‘maintenance’’
polycomb repressor complex 1 (27). Additional analysis confirmed
the dose-dependent deacetylation of H4K16, which coincided with
recruitment of SirT1, a class III histone deacetylase that mediates
H4K16deacet ylation (28)."
"2463","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:directlyDecreases","false",,,"Quantitative RT-PCR analysis showed
that knockdown of EZH2 increased Dkk-1 expression in untreated
Calu-6cells and partially abrogated TSC-mediated repression of
Dkk-1 (Fig. 4C)"
"2464","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:decreases","false",,,"Knockdown of SirT1 also seemed to somewhat
increase Dkk-1 expression in untreated Calu-6cells and partially
abrogate TSC-mediated repression of Dkk-1 (Fig. 4C)."
"2465","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:increases","false",,,"Western blot analysis (Fig. 5B) revealed that TSC-mediated
repression of Dkk-1 coincided with dose-dependent phosphorylation
of LDL receptor related protein 6(LRP-6 ) and dishevelled-2
(Dvl-2) indicative of activation of Wnt receptor complex, as well as
JNK, a downstream effector of noncanonical Wnt signaling."
"2466","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:increases","false",,,"Western blot analysis (Fig. 5B) revealed that TSC-mediated
repression of Dkk-1 coincided with dose-dependent phosphorylation
of LDL receptor related protein 6(LRP-6 ) and dishevelled-2
(Dvl-2) indicative of activation of Wnt receptor complex, as well as
JNK, a downstream effector of noncanonical Wnt signaling."
"2467","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:increases","false",,,"Western blot analysis (Fig. 5B) revealed that TSC-mediated
repression of Dkk-1 coincided with dose-dependent phosphorylation
of LDL receptor related protein 6(LRP-6 ) and dishevelled-2
(Dvl-2) indicative of activation of Wnt receptor complex, as well as
JNK, a downstream effector of noncanonical Wnt signaling."
"2468","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:increases","false",,,"Western blot analysis (Fig. 5B) revealed that TSC-mediated
repression of Dkk-1 coincided with dose-dependent phosphorylation
of LDL receptor related protein 6(LRP-6 ) and dishevelled-2
(Dvl-2) indicative of activation of Wnt receptor complex, as well as
JNK, a downstream effector of noncanonical Wnt signaling."
"2469","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:decreases","false",,,"shRNA-mediated knockdown of Dkk-1 enhanced phosphorylation of JNK in Calu-6cells (Fig. 5C), suggesting that activation of JNK in
these cells following TSC exposure was due, at least in part, to
activation of Wnt signaling, rather than nonspecific responses to
genotoxic stress."
"2470","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:increases","false",,,"Wnt5a (which encodes a
ligand implicated in noncanonical Wnt signaling; ref. 32) was
markedly induced in TSC-treated Calu-6cells as well as Calu-6cells
transfected with shRNA targeting Dkk-1."
"2471","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:decreases","false",,,"Wnt5a (which encodes a
ligand implicated in noncanonical Wnt signaling; ref. 32) was
markedly induced in TSC-treated Calu-6cells as well as Calu-6cells
transfected with shRNA targeting Dkk-1."
"2472","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:negativeCorrelation","false",,,"Additional analysis confirmed
the dose-dependent deacetylation of H4K16, which coincided with
recruitment of SirT1, a class III histone deacetylase that mediates
H4K16deacet ylation (28)."
"2473","Hussain MRao MHumphries AEHong JALiu FYang MCaragacianu DSchrump DS","19351856","Cancer research","PubMed",,,"bel:decreases","false",,," Knockdown of Dkk-1 recapitulated the dramatic protumorigenic effects of TSC exposure in Calu-6 cells. "
"2474","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"IL-6 is produced by various types of lymphoid and nonlymphoid cells, such as T cells, B cells, monocytes, fibroblasts, keratinocytes, endothelial cells, mesangial cells, and several tumor cells [14] . It induces growth of T cells and differentiation of cytotoxic T cells [15-19] by augmenting the expression of IL-2 receptor [15] and the production of IL-2 [20] ."
"2475","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"IL-6 is produced by various types of lymphoid and nonlymphoid cells, such as T cells, B cells, monocytes, fibroblasts, keratinocytes, endothelial cells, mesangial cells, and several tumor cells [14] . It induces growth of T cells and differentiation of cytotoxic T cells [15-19] by augmenting the expression of IL-2 receptor [15] and the production of IL-2 [20] ."
"2476","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"IL-6 is produced by various types of lymphoid and nonlymphoid cells, such as T cells, B cells, monocytes, fibroblasts, keratinocytes, endothelial cells, mesangial cells, and several tumor cells [14] . It induces growth of T cells and differentiation of cytotoxic T cells [15-19] by augmenting the expression of IL-2 receptor [15] and the production of IL-2 [20] ."
"2477","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"IL-6 is produced by various types of lymphoid and nonlymphoid cells, such as T cells, B cells, monocytes, fibroblasts, keratinocytes, endothelial cells, mesangial cells, and several tumor cells [14] . It induces growth of T cells and differentiation of cytotoxic T cells [15-19] by augmenting the expression of IL-2 receptor [15] and the production of IL-2 [20] ."
"2478","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"IL-6 also induces differentiation of macrophages [26] , megakaryocytes [27-29] , and osteoclasts [30] . "
"2479","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"IL-6 also induces differentiation of macrophages [26] , megakaryocytes [27-29] , and osteoclasts [30] . "
"2480","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"IL-6 also induces differentiation of macrophages [26] , megakaryocytes [27-29] , and osteoclasts [30] . "
"2481","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"In the acute-phase reaction, this cytokine stimulates hepatocytes to produce acute-phase proteins such as C-reactive protein (CRP), fibrinogen, ?1-antitrypsin, and serum amyloid A [12,13] , and it simultaneously suppresses albumin production [11] . "
"2482","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"In the acute-phase reaction, this cytokine stimulates hepatocytes to produce acute-phase proteins such as C-reactive protein (CRP), fibrinogen, ?1-antitrypsin, and serum amyloid A [12,13] , and it simultaneously suppresses albumin production [11] . "
"2483","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"In the acute-phase reaction, this cytokine stimulates hepatocytes to produce acute-phase proteins such as C-reactive protein (CRP), fibrinogen, ?1-antitrypsin, and serum amyloid A [12,13] , and it simultaneously suppresses albumin production [11] . "
"2484","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"In the acute-phase reaction, this cytokine stimulates hepatocytes to produce acute-phase proteins such as C-reactive protein (CRP), fibrinogen, ?1-antitrypsin, and serum amyloid A [12,13] , and it simultaneously suppresses albumin production [11] . "
"2485","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:decreases","false",,,"In the acute-phase reaction, this cytokine stimulates hepatocytes to produce acute-phase proteins such as C-reactive protein (CRP), fibrinogen, ?1-antitrypsin, and serum amyloid A [12,13] , and it simultaneously suppresses albumin production [11] . "
"2486","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"It causes leukocytosis and fever when administered in vivo[31] and also acts as a growth factor for renal mesangial cells [32] , epidermal keratinocytes [33,34] , and various types of tumor cells, for example, in plasmacytoma [8] , multiple myeloma [35] , and renal cell carcinoma [36] ."
"2487","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"It causes leukocytosis and fever when administered in vivo[31] and also acts as a growth factor for renal mesangial cells [32] , epidermal keratinocytes [33,34] , and various types of tumor cells, for example, in plasmacytoma [8] , multiple myeloma [35] , and renal cell carcinoma [36] ."
"2488","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"It causes leukocytosis and fever when administered in vivo[31] and also acts as a growth factor for renal mesangial cells [32] , epidermal keratinocytes [33,34] , and various types of tumor cells, for example, in plasmacytoma [8] , multiple myeloma [35] , and renal cell carcinoma [36] ."
"2489","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"It causes leukocytosis and fever when administered in vivo[31] and also acts as a growth factor for renal mesangial cells [32] , epidermal keratinocytes [33,34] , and various types of tumor cells, for example, in plasmacytoma [8] , multiple myeloma [35] , and renal cell carcinoma [36] ."
"2490","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"It causes leukocytosis and fever when administered in vivo[31] and also acts as a growth factor for renal mesangial cells [32] , epidermal keratinocytes [33,34] , and various types of tumor cells, for example, in plasmacytoma [8] , multiple myeloma [35] , and renal cell carcinoma [36] ."
"2491","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Our group and others found that JAK1, JAK2, and Tky-2 are activated and are tyrosine-phosphorylated in response to IL-6, CNTF, LIF, and OSM [14]"
"2492","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Our group and others found that JAK1, JAK2, and Tky-2 are activated and are tyrosine-phosphorylated in response to IL-6, CNTF, LIF, and OSM [14]"
"2493","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Our group and others found that JAK1, JAK2, and Tky-2 are activated and are tyrosine-phosphorylated in response to IL-6, CNTF, LIF, and OSM [14]"
"2494","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Our group and others found that JAK1, JAK2, and Tky-2 are activated and are tyrosine-phosphorylated in response to IL-6, CNTF, LIF, and OSM [14]"
"2495","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Our group and others found that JAK1, JAK2, and Tky-2 are activated and are tyrosine-phosphorylated in response to IL-6, CNTF, LIF, and OSM [14]"
"2496","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Our group and others found that JAK1, JAK2, and Tky-2 are activated and are tyrosine-phosphorylated in response to IL-6, CNTF, LIF, and OSM [14]"
"2497","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Our group and others found that JAK1, JAK2, and Tky-2 are activated and are tyrosine-phosphorylated in response to IL-6, CNTF, LIF, and OSM [14]"
"2498","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Our group and others found that JAK1, JAK2, and Tky-2 are activated and are tyrosine-phosphorylated in response to IL-6, CNTF, LIF, and OSM [14]"
"2499","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Our group and others found that JAK1, JAK2, and Tky-2 are activated and are tyrosine-phosphorylated in response to IL-6, CNTF, LIF, and OSM [14]"
"2500","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Our group and others found that JAK1, JAK2, and Tky-2 are activated and are tyrosine-phosphorylated in response to IL-6, CNTF, LIF, and OSM [14]"
"2501","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Our group and others found that JAK1, JAK2, and Tky-2 are activated and are tyrosine-phosphorylated in response to IL-6, CNTF, LIF, and OSM [14]"
"2502","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Our group and others found that JAK1, JAK2, and Tky-2 are activated and are tyrosine-phosphorylated in response to IL-6, CNTF, LIF, and OSM [14]"
"2503","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"IL-6 activates STAT1 and STAT5 in addition to STAT3. "
"2504","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"IL-6 activates STAT1 and STAT5 in addition to STAT3. "
"2505","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"IL-6 activates STAT1 and STAT5 in addition to STAT3. "
"2506","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"The binding activity of NF-IL-6 is probably induced by IL-6 through the increased expression of the NF-IL-6 gene rather than through its post-translational modification. "
"2507","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:decreases","false",,,"It is known that IL-6 induces growth arrest and macrophage differentiation in the murine myeloid leukemic cell line M1. The essential role of STAT3 in the IL-6-induced macrophage differentiation of M1 cells was demonstrated by using dominant negative forms of STAT3 [67] , which inhibit both IL-6-induced growth arrest and macrophage differentiation in M1 transformants. Blocking STAT3 activation inhibits IL-6-induced repression of c-Myb and c-Myc, but not EGR-1 induction [68] , while IL-6 enhances the growth of M1 cells when STAT3 is suppressed. "
"2508","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"It is known that IL-6 induces growth arrest and macrophage differentiation in the murine myeloid leukemic cell line M1. The essential role of STAT3 in the IL-6-induced macrophage differentiation of M1 cells was demonstrated by using dominant negative forms of STAT3 [67] , which inhibit both IL-6-induced growth arrest and macrophage differentiation in M1 transformants. Blocking STAT3 activation inhibits IL-6-induced repression of c-Myb and c-Myc, but not EGR-1 induction [68] , while IL-6 enhances the growth of M1 cells when STAT3 is suppressed. "
"2509","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"It is known that IL-6 induces growth arrest and macrophage differentiation in the murine myeloid leukemic cell line M1. The essential role of STAT3 in the IL-6-induced macrophage differentiation of M1 cells was demonstrated by using dominant negative forms of STAT3 [67] , which inhibit both IL-6-induced growth arrest and macrophage differentiation in M1 transformants. Blocking STAT3 activation inhibits IL-6-induced repression of c-Myb and c-Myc, but not EGR-1 induction [68] , while IL-6 enhances the growth of M1 cells when STAT3 is suppressed. "
"2510","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:decreases","false",,,"It is known that IL-6 induces growth arrest and macrophage differentiation in the murine myeloid leukemic cell line M1. The essential role of STAT3 in the IL-6-induced macrophage differentiation of M1 cells was demonstrated by using dominant negative forms of STAT3 [67] , which inhibit both IL-6-induced growth arrest and macrophage differentiation in M1 transformants. Blocking STAT3 activation inhibits IL-6-induced repression of c-Myb and c-Myc, but not EGR-1 induction [68] , while IL-6 enhances the growth of M1 cells when STAT3 is suppressed. "
"2511","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:decreases","false",,,"It is known that IL-6 induces growth arrest and macrophage differentiation in the murine myeloid leukemic cell line M1. The essential role of STAT3 in the IL-6-induced macrophage differentiation of M1 cells was demonstrated by using dominant negative forms of STAT3 [67] , which inhibit both IL-6-induced growth arrest and macrophage differentiation in M1 transformants. Blocking STAT3 activation inhibits IL-6-induced repression of c-Myb and c-Myc, but not EGR-1 induction [68] , while IL-6 enhances the growth of M1 cells when STAT3 is suppressed. "
"2512","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:decreases","false",,,"It is known that IL-6 induces growth arrest and macrophage differentiation in the murine myeloid leukemic cell line M1. The essential role of STAT3 in the IL-6-induced macrophage differentiation of M1 cells was demonstrated by using dominant negative forms of STAT3 [67] , which inhibit both IL-6-induced growth arrest and macrophage differentiation in M1 transformants. Blocking STAT3 activation inhibits IL-6-induced repression of c-Myb and c-Myc, but not EGR-1 induction [68] , while IL-6 enhances the growth of M1 cells when STAT3 is suppressed. "
"2513","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"It is known that IL-6 induces growth arrest and macrophage differentiation in the murine myeloid leukemic cell line M1. The essential role of STAT3 in the IL-6-induced macrophage differentiation of M1 cells was demonstrated by using dominant negative forms of STAT3 [67] , which inhibit both IL-6-induced growth arrest and macrophage differentiation in M1 transformants. Blocking STAT3 activation inhibits IL-6-induced repression of c-Myb and c-Myc, but not EGR-1 induction [68] , while IL-6 enhances the growth of M1 cells when STAT3 is suppressed. "
"2514","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:decreases","false",,,"It is known that IL-6 induces growth arrest and macrophage differentiation in the murine myeloid leukemic cell line M1. The essential role of STAT3 in the IL-6-induced macrophage differentiation of M1 cells was demonstrated by using dominant negative forms of STAT3 [67] , which inhibit both IL-6-induced growth arrest and macrophage differentiation in M1 transformants. Blocking STAT3 activation inhibits IL-6-induced repression of c-Myb and c-Myc, but not EGR-1 induction [68] , while IL-6 enhances the growth of M1 cells when STAT3 is suppressed. "
"2515","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:decreases","false",,,"It is known that IL-6 induces growth arrest and macrophage differentiation in the murine myeloid leukemic cell line M1. The essential role of STAT3 in the IL-6-induced macrophage differentiation of M1 cells was demonstrated by using dominant negative forms of STAT3 [67] , which inhibit both IL-6-induced growth arrest and macrophage differentiation in M1 transformants. Blocking STAT3 activation inhibits IL-6-induced repression of c-Myb and c-Myc, but not EGR-1 induction [68] , while IL-6 enhances the growth of M1 cells when STAT3 is suppressed. "
"2516","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Furthermore, nonreceptor tyrosine kinases, such as Btk, Tec, Fes, and Hck [72,73] are activated through the IL-6 receptor, as well as through a variety of other cytokine receptors [74] , although the biological significance of these signal transduction pathways remains to be clarified. "
"2517","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Furthermore, nonreceptor tyrosine kinases, such as Btk, Tec, Fes, and Hck [72,73] are activated through the IL-6 receptor, as well as through a variety of other cytokine receptors [74] , although the biological significance of these signal transduction pathways remains to be clarified. "
"2518","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Furthermore, nonreceptor tyrosine kinases, such as Btk, Tec, Fes, and Hck [72,73] are activated through the IL-6 receptor, as well as through a variety of other cytokine receptors [74] , although the biological significance of these signal transduction pathways remains to be clarified. "
"2519","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:increases","false",,,"Furthermore, nonreceptor tyrosine kinases, such as Btk, Tec, Fes, and Hck [72,73] are activated through the IL-6 receptor, as well as through a variety of other cytokine receptors [74] , although the biological significance of these signal transduction pathways remains to be clarified. "
"2520","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:directlyDecreases","false",,,"SOCS-1 directly interacts with JAKs, and thus inhibits their catalytic activity. SOCS-3 also inhibits JAK activity (but only partially in comparison with SOCS-1) although the augmentation of its effect in the presence of receptors suggests that SOCS-3 inhibits cytokine signaling by binding to the receptor complex. "
"2521","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:decreases","false",,,"SOCS-1 directly interacts with JAKs, and thus inhibits their catalytic activity. SOCS-3 also inhibits JAK activity (but only partially in comparison with SOCS-1) although the augmentation of its effect in the presence of receptors suggests that SOCS-3 inhibits cytokine signaling by binding to the receptor complex. "
"2522","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:directlyDecreases","false",,,"Overexpression studies have shown that PIAS-1 associates only with activated STAT1 dimers and inhibits their DNA-binding activity, but that no monomeric forms of STAT1 are present [99] . Similarly, PIAS-3 associates specifically with activated STAT3 but not with STAT1, resulting in the blocking of all STAT3-mediated gene transcriptions, and is especially well known as an inhibitor of IL-6 signaling in M1 cell lines [98] . "
"2523","Naka TNishimoto NKishimoto T","12110143","Arthritis research","PubMed",,,"bel:directlyDecreases","false",,,"Overexpression studies have shown that PIAS-1 associates only with activated STAT1 dimers and inhibits their DNA-binding activity, but that no monomeric forms of STAT1 are present [99] . Similarly, PIAS-3 associates specifically with activated STAT3 but not with STAT1, resulting in the blocking of all STAT3-mediated gene transcriptions, and is especially well known as an inhibitor of IL-6 signaling in M1 cell lines [98] . "
"2524","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Vascular endothelial growth factor (VEGF)
is one of the key angiogenic growth factors and stimulates
migration, proliferation, and tube formation of ECs primarily
through the VEGF receptor type2 (VEGR2, KDR/Flk1) (76)."
"2525","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Vascular endothelial growth factor (VEGF)
is one of the key angiogenic growth factors and stimulates
migration, proliferation, and tube formation of ECs primarily
through the VEGF receptor type2 (VEGR2, KDR/Flk1) (76)."
"2526","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Vascular endothelial growth factor (VEGF)
is one of the key angiogenic growth factors and stimulates
migration, proliferation, and tube formation of ECs primarily
through the VEGF receptor type2 (VEGR2, KDR/Flk1) (76)."
"2527","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Vascular endothelial growth factor (VEGF)
is one of the key angiogenic growth factors and stimulates
migration, proliferation, and tube formation of ECs primarily
through the VEGF receptor type2 (VEGR2, KDR/Flk1) (76)."
"2528","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Excess amounts of reactive oxygen species (ROS) such as
O2.- and H2O2 have deleterious effects on cells and contribute
to various cardiovascular diseases including hypertension,
heart failure, atherosclerosis, and diabetes (41), while physiological
concentrations of ROS are involved in signaling to
mediate cell migration, growth, and differentiation (32)."
"2529","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Excess amounts of reactive oxygen species (ROS) such as
O2.- and H2O2 have deleterious effects on cells and contribute
to various cardiovascular diseases including hypertension,
heart failure, atherosclerosis, and diabetes (41), while physiological
concentrations of ROS are involved in signaling to
mediate cell migration, growth, and differentiation (32)."
"2530","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Excess amounts of reactive oxygen species (ROS) such as
O2.- and H2O2 have deleterious effects on cells and contribute
to various cardiovascular diseases including hypertension,
heart failure, atherosclerosis, and diabetes (41), while physiological
concentrations of ROS are involved in signaling to
mediate cell migration, growth, and differentiation (32)."
"2531","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"ROS stimulate induction of VEGF, which in turn increases
ROS through activation of NADPH oxidases that are
involved in VEGFR2 autophosphorylation, EC migration,
and proliferation (49, 100, 111)."
"2532","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Nox2 is a critical component of endothelial NADPH oxidase
(38), and its expression and Nox2-dependent ROS production are
increased by oxidized LDL, endothelin-1, angiotensin II, VEGF,
and angiopoietin-2 in ECs (99). Nox1 is involved in shear stressinduced
ROS production which is required for monocyte adhesion
(93) and stimulates branching morphogenesis in sinusoidal
ECs (55). Nox4 is most abundantly expressed in ECs, and involved
in basal- (2) and Ang II-induced (109) O2- production.
Moreover, p47phox is involved in cytokine, growth factor, or
shear stress-stimulated ROS production in ECs (48, 67, 107)."
"2533","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Nox2 is a critical component of endothelial NADPH oxidase
(38), and its expression and Nox2-dependent ROS production are
increased by oxidized LDL, endothelin-1, angiotensin II, VEGF,
and angiopoietin-2 in ECs (99). Nox1 is involved in shear stressinduced
ROS production which is required for monocyte adhesion
(93) and stimulates branching morphogenesis in sinusoidal
ECs (55). Nox4 is most abundantly expressed in ECs, and involved
in basal- (2) and Ang II-induced (109) O2- production.
Moreover, p47phox is involved in cytokine, growth factor, or
shear stress-stimulated ROS production in ECs (48, 67, 107)."
"2534","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"Nox2 is a critical component of endothelial NADPH oxidase
(38), and its expression and Nox2-dependent ROS production are
increased by oxidized LDL, endothelin-1, angiotensin II, VEGF,
and angiopoietin-2 in ECs (99). Nox1 is involved in shear stressinduced
ROS production which is required for monocyte adhesion
(93) and stimulates branching morphogenesis in sinusoidal
ECs (55). Nox4 is most abundantly expressed in ECs, and involved
in basal- (2) and Ang II-induced (109) O2- production.
Moreover, p47phox is involved in cytokine, growth factor, or
shear stress-stimulated ROS production in ECs (48, 67, 107)."
"2535","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Nox2 is a critical component of endothelial NADPH oxidase
(38), and its expression and Nox2-dependent ROS production are
increased by oxidized LDL, endothelin-1, angiotensin II, VEGF,
and angiopoietin-2 in ECs (99). Nox1 is involved in shear stressinduced
ROS production which is required for monocyte adhesion
(93) and stimulates branching morphogenesis in sinusoidal
ECs (55). Nox4 is most abundantly expressed in ECs, and involved
in basal- (2) and Ang II-induced (109) O2- production.
Moreover, p47phox is involved in cytokine, growth factor, or
shear stress-stimulated ROS production in ECs (48, 67, 107)."
"2536","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Nox2 is a critical component of endothelial NADPH oxidase
(38), and its expression and Nox2-dependent ROS production are
increased by oxidized LDL, endothelin-1, angiotensin II, VEGF,
and angiopoietin-2 in ECs (99). Nox1 is involved in shear stressinduced
ROS production which is required for monocyte adhesion
(93) and stimulates branching morphogenesis in sinusoidal
ECs (55). Nox4 is most abundantly expressed in ECs, and involved
in basal- (2) and Ang II-induced (109) O2- production.
Moreover, p47phox is involved in cytokine, growth factor, or
shear stress-stimulated ROS production in ECs (48, 67, 107)."
"2537","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Nox2 is a critical component of endothelial NADPH oxidase
(38), and its expression and Nox2-dependent ROS production are
increased by oxidized LDL, endothelin-1, angiotensin II, VEGF,
and angiopoietin-2 in ECs (99). Nox1 is involved in shear stressinduced
ROS production which is required for monocyte adhesion
(93) and stimulates branching morphogenesis in sinusoidal
ECs (55). Nox4 is most abundantly expressed in ECs, and involved
in basal- (2) and Ang II-induced (109) O2- production.
Moreover, p47phox is involved in cytokine, growth factor, or
shear stress-stimulated ROS production in ECs (48, 67, 107)."
"2538","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Nox2 is a critical component of endothelial NADPH oxidase
(38), and its expression and Nox2-dependent ROS production are
increased by oxidized LDL, endothelin-1, angiotensin II, VEGF,
and angiopoietin-2 in ECs (99). Nox1 is involved in shear stressinduced
ROS production which is required for monocyte adhesion
(93) and stimulates branching morphogenesis in sinusoidal
ECs (55). Nox4 is most abundantly expressed in ECs, and involved
in basal- (2) and Ang II-induced (109) O2- production.
Moreover, p47phox is involved in cytokine, growth factor, or
shear stress-stimulated ROS production in ECs (48, 67, 107)."
"2539","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Nox2 is a critical component of endothelial NADPH oxidase
(38), and its expression and Nox2-dependent ROS production are
increased by oxidized LDL, endothelin-1, angiotensin II, VEGF,
and angiopoietin-2 in ECs (99). Nox1 is involved in shear stressinduced
ROS production which is required for monocyte adhesion
(93) and stimulates branching morphogenesis in sinusoidal
ECs (55). Nox4 is most abundantly expressed in ECs, and involved
in basal- (2) and Ang II-induced (109) O2- production.
Moreover, p47phox is involved in cytokine, growth factor, or
shear stress-stimulated ROS production in ECs (48, 67, 107)."
"2540","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Nox2 is a critical component of endothelial NADPH oxidase
(38), and its expression and Nox2-dependent ROS production are
increased by oxidized LDL, endothelin-1, angiotensin II, VEGF,
and angiopoietin-2 in ECs (99). Nox1 is involved in shear stressinduced
ROS production which is required for monocyte adhesion
(93) and stimulates branching morphogenesis in sinusoidal
ECs (55). Nox4 is most abundantly expressed in ECs, and involved
in basal- (2) and Ang II-induced (109) O2- production.
Moreover, p47phox is involved in cytokine, growth factor, or
shear stress-stimulated ROS production in ECs (48, 67, 107)."
"2541","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Nox2 is a critical component of endothelial NADPH oxidase
(38), and its expression and Nox2-dependent ROS production are
increased by oxidized LDL, endothelin-1, angiotensin II, VEGF,
and angiopoietin-2 in ECs (99). Nox1 is involved in shear stressinduced
ROS production which is required for monocyte adhesion
(93) and stimulates branching morphogenesis in sinusoidal
ECs (55). Nox4 is most abundantly expressed in ECs, and involved
in basal- (2) and Ang II-induced (109) O2- production.
Moreover, p47phox is involved in cytokine, growth factor, or
shear stress-stimulated ROS production in ECs (48, 67, 107)."
"2542","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Exogenous H2O2 stimulates induction of HIF1? and VEGF
by various cell types including ECs, and promote cell proliferation
and migration, cytoskeletal reorganization, and tube formation
in ECs (99)."
"2543","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Exogenous H2O2 stimulates induction of HIF1? and VEGF
by various cell types including ECs, and promote cell proliferation
and migration, cytoskeletal reorganization, and tube formation
in ECs (99)."
"2544","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Exogenous H2O2 stimulates induction of HIF1? and VEGF
by various cell types including ECs, and promote cell proliferation
and migration, cytoskeletal reorganization, and tube formation
in ECs (99)."
"2545","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Exogenous H2O2 stimulates induction of HIF1? and VEGF
by various cell types including ECs, and promote cell proliferation
and migration, cytoskeletal reorganization, and tube formation
in ECs (99)."
"2546","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Exogenous H2O2 stimulates induction of HIF1? and VEGF
by various cell types including ECs, and promote cell proliferation
and migration, cytoskeletal reorganization, and tube formation
in ECs (99)."
"2547","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"The mitogenic and chemotactic effects of VEGF in ECs are mediated mainly
through VEGFR2 (76). VEGFR2 is activated through ligandstimulated
receptor dimerization and transphosphorylation
(autophosphorylation) of tyrosine residues in the cytoplasmic
kinase domain. At present, tyrosine residues 951 and
996 in the kinase insert domain, and 1054 and 1059 in the kinase
catalytic domain, have been identified as autophosphorylation
sites for VEGFR2 in a bacterial expression system
(30). This event is followed by activation of downstream
signaling pathways such as Src, PI3 kinase, MAP kinases,
and Akt, which is essential for VEGF-induced actin reorganization,
cell migration, and proliferation of ECs."
"2548","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"The mitogenic and chemotactic effects of VEGF in ECs are mediated mainly
through VEGFR2 (76). VEGFR2 is activated through ligandstimulated
receptor dimerization and transphosphorylation
(autophosphorylation) of tyrosine residues in the cytoplasmic
kinase domain. At present, tyrosine residues 951 and
996 in the kinase insert domain, and 1054 and 1059 in the kinase
catalytic domain, have been identified as autophosphorylation
sites for VEGFR2 in a bacterial expression system
(30). This event is followed by activation of downstream
signaling pathways such as Src, PI3 kinase, MAP kinases,
and Akt, which is essential for VEGF-induced actin reorganization,
cell migration, and proliferation of ECs."
"2549","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"The mitogenic and chemotactic effects of VEGF in ECs are mediated mainly
through VEGFR2 (76). VEGFR2 is activated through ligandstimulated
receptor dimerization and transphosphorylation
(autophosphorylation) of tyrosine residues in the cytoplasmic
kinase domain. At present, tyrosine residues 951 and
996 in the kinase insert domain, and 1054 and 1059 in the kinase
catalytic domain, have been identified as autophosphorylation
sites for VEGFR2 in a bacterial expression system
(30). This event is followed by activation of downstream
signaling pathways such as Src, PI3 kinase, MAP kinases,
and Akt, which is essential for VEGF-induced actin reorganization,
cell migration, and proliferation of ECs."
"2550","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"The mitogenic and chemotactic effects of VEGF in ECs are mediated mainly
through VEGFR2 (76). VEGFR2 is activated through ligandstimulated
receptor dimerization and transphosphorylation
(autophosphorylation) of tyrosine residues in the cytoplasmic
kinase domain. At present, tyrosine residues 951 and
996 in the kinase insert domain, and 1054 and 1059 in the kinase
catalytic domain, have been identified as autophosphorylation
sites for VEGFR2 in a bacterial expression system
(30). This event is followed by activation of downstream
signaling pathways such as Src, PI3 kinase, MAP kinases,
and Akt, which is essential for VEGF-induced actin reorganization,
cell migration, and proliferation of ECs."
"2551","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"The mitogenic and chemotactic effects of VEGF in ECs are mediated mainly
through VEGFR2 (76). VEGFR2 is activated through ligandstimulated
receptor dimerization and transphosphorylation
(autophosphorylation) of tyrosine residues in the cytoplasmic
kinase domain. At present, tyrosine residues 951 and
996 in the kinase insert domain, and 1054 and 1059 in the kinase
catalytic domain, have been identified as autophosphorylation
sites for VEGFR2 in a bacterial expression system
(30). This event is followed by activation of downstream
signaling pathways such as Src, PI3 kinase, MAP kinases,
and Akt, which is essential for VEGF-induced actin reorganization,
cell migration, and proliferation of ECs."
"2552","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"The mitogenic and chemotactic effects of VEGF in ECs are mediated mainly
through VEGFR2 (76). VEGFR2 is activated through ligandstimulated
receptor dimerization and transphosphorylation
(autophosphorylation) of tyrosine residues in the cytoplasmic
kinase domain. At present, tyrosine residues 951 and
996 in the kinase insert domain, and 1054 and 1059 in the kinase
catalytic domain, have been identified as autophosphorylation
sites for VEGFR2 in a bacterial expression system
(30). This event is followed by activation of downstream
signaling pathways such as Src, PI3 kinase, MAP kinases,
and Akt, which is essential for VEGF-induced actin reorganization,
cell migration, and proliferation of ECs."
"2553","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"The mitogenic and chemotactic effects of VEGF in ECs are mediated mainly
through VEGFR2 (76). VEGFR2 is activated through ligandstimulated
receptor dimerization and transphosphorylation
(autophosphorylation) of tyrosine residues in the cytoplasmic
kinase domain. At present, tyrosine residues 951 and
996 in the kinase insert domain, and 1054 and 1059 in the kinase
catalytic domain, have been identified as autophosphorylation
sites for VEGFR2 in a bacterial expression system
(30). This event is followed by activation of downstream
signaling pathways such as Src, PI3 kinase, MAP kinases,
and Akt, which is essential for VEGF-induced actin reorganization,
cell migration, and proliferation of ECs."
"2554","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"The mitogenic and chemotactic effects of VEGF in ECs are mediated mainly
through VEGFR2 (76). VEGFR2 is activated through ligandstimulated
receptor dimerization and transphosphorylation
(autophosphorylation) of tyrosine residues in the cytoplasmic
kinase domain. At present, tyrosine residues 951 and
996 in the kinase insert domain, and 1054 and 1059 in the kinase
catalytic domain, have been identified as autophosphorylation
sites for VEGFR2 in a bacterial expression system
(30). This event is followed by activation of downstream
signaling pathways such as Src, PI3 kinase, MAP kinases,
and Akt, which is essential for VEGF-induced actin reorganization,
cell migration, and proliferation of ECs."
"2555","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"Several PTPs,
including SHP-1, SHP-2, and LMW-PTP (HCPTPA), inducibly
associate with VEGFR2 after VEGF stimulation (42, 46, 57)."
"2556","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"Several PTPs,
including SHP-1, SHP-2, and LMW-PTP (HCPTPA), inducibly
associate with VEGFR2 after VEGF stimulation (42, 46, 57)."
"2557","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"Several PTPs,
including SHP-1, SHP-2, and LMW-PTP (HCPTPA), inducibly
associate with VEGFR2 after VEGF stimulation (42, 46, 57)."
"2558","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:decreases","false",,,"HCPTPA overexpression inhibits VEGFinduced
VEGFR2 autophosphorylation, EC migration, and proliferation
(46). High cell density-enhanced PTP1 (DEP-
1)/CD148 attenuates phosphorylation of VEGFR2 in
contact-inhibited confluent ECs (40). A small molecule inhibitor
of PTP1B enhances VEGF-induced VEGFR2 autophosphoryla-
tion, migration, and proliferation of EC, as well as neovascularization
in a mouse matrigel model (92). Angiopoietin-1 stimulates
association of SHP-2 to the phosphorylated Tie-2 receptor
(47), which in turn inhibits PI3 kinase-dependent signaling pathways
leading to EC migration."
"2559","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyDecreases","false",,,"HCPTPA overexpression inhibits VEGFinduced
VEGFR2 autophosphorylation, EC migration, and proliferation
(46). High cell density-enhanced PTP1 (DEP-
1)/CD148 attenuates phosphorylation of VEGFR2 in
contact-inhibited confluent ECs (40). A small molecule inhibitor
of PTP1B enhances VEGF-induced VEGFR2 autophosphoryla-
tion, migration, and proliferation of EC, as well as neovascularization
in a mouse matrigel model (92). Angiopoietin-1 stimulates
association of SHP-2 to the phosphorylated Tie-2 receptor
(47), which in turn inhibits PI3 kinase-dependent signaling pathways
leading to EC migration."
"2560","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyDecreases","false",,,"HCPTPA overexpression inhibits VEGFinduced
VEGFR2 autophosphorylation, EC migration, and proliferation
(46). High cell density-enhanced PTP1 (DEP-
1)/CD148 attenuates phosphorylation of VEGFR2 in
contact-inhibited confluent ECs (40). A small molecule inhibitor
of PTP1B enhances VEGF-induced VEGFR2 autophosphoryla-
tion, migration, and proliferation of EC, as well as neovascularization
in a mouse matrigel model (92). Angiopoietin-1 stimulates
association of SHP-2 to the phosphorylated Tie-2 receptor
(47), which in turn inhibits PI3 kinase-dependent signaling pathways
leading to EC migration."
"2561","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyDecreases","false",,,"The SHP-2 is oxidatively inactivated
by PDGF-induced ROS when it binds to PDGFR (78).
Thus, it is essential to identify the PTPs which are reversibly oxidized
and inactivated after VEGF stimulation in ECs (Fig. 1)."
"2562","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"VEGF rapidly activates Rac1 and
promotes translocation of Rac1 from the cytosol to the
membrane, thereby activating NADPH oxidase in ECs (100).
Overexpression of dominant negative N17Rac1 significantly
inhibits VEGF-induced ROS production that is involved in
VEGFR2 activation, EC migration, and proliferation (100)."
"2563","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"VEGF rapidly activates Rac1 and
promotes translocation of Rac1 from the cytosol to the
membrane, thereby activating NADPH oxidase in ECs (100).
Overexpression of dominant negative N17Rac1 significantly
inhibits VEGF-induced ROS production that is involved in
VEGFR2 activation, EC migration, and proliferation (100)."
"2564","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyDecreases","false",,,"VEGFR2 is present in endothelial
caveolae through association with Cav1 which negatively
regulates receptor activity in basal state (Fig. 1) (61). Dissociation
of VEGFR2 from caveolae/Cav1 seems to be essential
for VEGFR2 autophosphorylation and activation of
downstream signaling events (61)."
"2565","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"Cav1 is tyrosine phosphorylated
by ROS (14, 17) and by various growth factors
(54, 70), including VEGF (61). We have demonstrated that
VEGF promotes the release of VEGFR2 from caveolae/lipid
rafts, which is contemporaneous with the tyrosine phosphorylation
of Cav1 (Tyr14) and VEGFR2 and their colocalization
at focal complexes, appearing as small-dot like structures
at the edge of lamellipodia (Figs. 1 and 2)(52)."
"2566","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyDecreases","false",,,"Cav1 is tyrosine phosphorylated
by ROS (14, 17) and by various growth factors
(54, 70), including VEGF (61). We have demonstrated that
VEGF promotes the release of VEGFR2 from caveolae/lipid
rafts, which is contemporaneous with the tyrosine phosphorylation
of Cav1 (Tyr14) and VEGFR2 and their colocalization
at focal complexes, appearing as small-dot like structures
at the edge of lamellipodia (Figs. 1 and 2)(52)."
"2567","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"Phospho-caveolin interacts with Grb7 (63), low molecular
weight protein tyrosine phosphatase (16), and Csk, a negative
regulator for Src (13)."
"2568","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"Phospho-caveolin interacts with Grb7 (63), low molecular
weight protein tyrosine phosphatase (16), and Csk, a negative
regulator for Src (13)."
"2569","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"Phospho-caveolin interacts with Grb7 (63), low molecular
weight protein tyrosine phosphatase (16), and Csk, a negative
regulator for Src (13)."
"2570","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:decreases","false",,,"Of note, overexpression of mutant Cav1 (Y14F) blocks
VEGF-stimulated localization of phospho-VEGFR2 at focal
complexes as well as EC migration and proliferation."
"2571","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:decreases","false",,,"Of note, overexpression of mutant Cav1 (Y14F) blocks
VEGF-stimulated localization of phospho-VEGFR2 at focal
complexes as well as EC migration and proliferation."
"2572","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"In ECs, VEGF stimulates ARF6 association with
Rac1, which is cotemporaneous with Rac1 activation. The
dominant negative ARF6 (T27N), inhibits VEGF-stimulated
GTP-loading of Rac1, ROS production, and VEGFR2 autophosphorylation.
These results suggest that ARF6 is an
upstream mediator for Rac1, which may contribute to ROS
production that mediates VEGFR2 autophosphorylation in
ECs (Fig. 1)."
"2573","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"In ECs, VEGF stimulates ARF6 association with
Rac1, which is cotemporaneous with Rac1 activation. The
dominant negative ARF6 (T27N), inhibits VEGF-stimulated
GTP-loading of Rac1, ROS production, and VEGFR2 autophosphorylation.
These results suggest that ARF6 is an
upstream mediator for Rac1, which may contribute to ROS
production that mediates VEGFR2 autophosphorylation in
ECs (Fig. 1)."
"2574","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"In ECs, VEGF stimulates ARF6 association with
Rac1, which is cotemporaneous with Rac1 activation. The
dominant negative ARF6 (T27N), inhibits VEGF-stimulated
GTP-loading of Rac1, ROS production, and VEGFR2 autophosphorylation.
These results suggest that ARF6 is an
upstream mediator for Rac1, which may contribute to ROS
production that mediates VEGFR2 autophosphorylation in
ECs (Fig. 1)."
"2575","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyDecreases","false",,,"Tyrosine phosphorylation of VE-cadherin
is required for reducing cell–cell adhesions and is mediated
through cSrc which is dependent on ROS (69, 103)."
"2576","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:directlyIncreases","false",,,"Tyrosine phosphorylation of VE-cadherin
is required for reducing cell–cell adhesions and is mediated
through cSrc which is dependent on ROS (69, 103)."
"2577","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"IQGAP1 captures and stabilizes microtubules by
interacting with CLIP-170, a microtubule plus end binding
protein, near the cell cortical regions (83). Activated Rac1
promotes capture of CLIP-170-capped microtubules in lamellipodia
(75)."
"2578","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"At the leading edge of cells, Rac1 also links the
adenomatous polyposis coli (APC) protein to actin filaments
through binding to IQGAP1, thereby regulating polarization
and directional migration by forming a complex with APC
and CLIP-170. Of note, Nox2 also binds to and colocalizes
with IQGAP1 at the leading edge in actively migrating ECs
(Fig. 2) (50)."
"2579","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"At the leading edge of cells, Rac1 also links the
adenomatous polyposis coli (APC) protein to actin filaments
through binding to IQGAP1, thereby regulating polarization
and directional migration by forming a complex with APC
and CLIP-170. Of note, Nox2 also binds to and colocalizes
with IQGAP1 at the leading edge in actively migrating ECs
(Fig. 2) (50)."
"2580","Ushio-Fukai M","17511588","Antioxidants & redox signaling","PubMed",,,"bel:increases","false",,,"We also
demonstrated that VEGF-induced capillary tube formation in
three-dimensional culture in type I collagen gels is impaired
in IQGAP1 knocked down ECs."
"2581","Obukowicz MWelsch DSalsgiver WMartin-Berger CChinn KDuffin KRaz ANeedleman P","10419129","Lipids","PubMed",,,"bel:decreases","false",,,"The model was appropriate for testing the effects of desaturase inhibition because, after subplantar injection of carrageenan, an acute and localized inflammatory response occurs in the footpad, characterized by increased edema and neutrophil infiltration. Inhibition of edema was obtained with aspirin and indomethacin and was comparable to that obtained in the rat model. "
"2582","Obukowicz MWelsch DSalsgiver WMartin-Berger CChinn KDuffin KRaz ANeedleman P","10419129","Lipids","PubMed",,,"bel:decreases","false",,,"The model was appropriate for testing the effects of desaturase inhibition because, after subplantar injection of carrageenan, an acute and localized inflammatory response occurs in the footpad, characterized by increased edema and neutrophil infiltration. Inhibition of edema was obtained with aspirin and indomethacin and was comparable to that obtained in the rat model. "
"2583","Obukowicz MWelsch DSalsgiver WMartin-Berger CChinn KDuffin KRaz ANeedleman P","10419129","Lipids","PubMed",,,"bel:subProcessOf","false",,,"The model was appropriate for testing the effects of desaturase inhibition because, after subplantar injection of carrageenan, an acute and localized inflammatory response occurs in the footpad, characterized by increased edema and neutrophil infiltration. Inhibition of edema was obtained with aspirin and indomethacin and was comparable to that obtained in the rat model. "
"2584","Obukowicz MWelsch DSalsgiver WMartin-Berger CChinn KDuffin KRaz ANeedleman P","10419129","Lipids","PubMed",,,"bel:subProcessOf","false",,,"The model was appropriate for testing the effects of desaturase inhibition because, after subplantar injection of carrageenan, an acute and localized inflammatory response occurs in the footpad, characterized by increased edema and neutrophil infiltration. Inhibition of edema was obtained with aspirin and indomethacin and was comparable to that obtained in the rat model. "
"2585","Obukowicz MWelsch DSalsgiver WMartin-Berger CChinn KDuffin KRaz ANeedleman P","10419129","Lipids","PubMed",,,"bel:directlyIncreases","false",,,"Desaturase activity was determined directly in mouse liver by quantifying the conversion of 14C-DGLA ? 14C-AA (?5 desaturase activity) or 14C-LA ? 14C-AA (combined ?6 desaturase + elongase + ?5 desaturase activities). "
"2586","Obukowicz MWelsch DSalsgiver WMartin-Berger CChinn KDuffin KRaz ANeedleman P","10419129","Lipids","PubMed",,,"bel:increases","false",,,"A. SC-26196 inhibited ?6 desaturase activity and decreased edema.

SC-26196 inhibited desaturase activity in vivo(ED50 = 20 mpk) and decreased edema dose-dependently (fig.3). Nearly complete inhibition of the conversion of 14C-LA to 14C-GLA +14C-DGLA + 14C-AA in mouse liver was obtained with a single 100 mpk i.p. or i.g. dose (90–100% inhibition). "
"2587","Obukowicz MWelsch DSalsgiver WMartin-Berger CChinn KDuffin KRaz ANeedleman P","10419129","Lipids","PubMed",,,"bel:increases","false",,,"A. SC-26196 inhibited ?6 desaturase activity and decreased edema.

SC-26196 inhibited desaturase activity in vivo(ED50 = 20 mpk) and decreased edema dose-dependently (fig.3). Nearly complete inhibition of the conversion of 14C-LA to 14C-GLA +14C-DGLA + 14C-AA in mouse liver was obtained with a single 100 mpk i.p. or i.g. dose (90–100% inhibition). "
"2588","Obukowicz MWelsch DSalsgiver WMartin-Berger CChinn KDuffin KRaz ANeedleman P","10419129","Lipids","PubMed",,,"bel:increases","false",,,"D. Dietary AA restored edema and MPO activity."
"2589","Obukowicz MWelsch DSalsgiver WMartin-Berger CChinn KDuffin KRaz ANeedleman P","10419129","Lipids","PubMed",,,"bel:increases","false",,,"D. Dietary AA restored edema and MPO activity."
"2590","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyIncreases","false",,,"Phosphorylation of cytoplasmic FOXO at specific sites by JNK initiates translocation into the nucleus"
"2591","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:increases","false",,,"Phosphorylation of cytoplasmic FOXO at specific sites by JNK initiates translocation into the nucleus"
"2592","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyIncreases","false",,,"Akt-dependent phosphorylation reduces the DNA-binding activity of FOXO, interferes with binding to the co-activators p300/CBP, and inactivates the FOXO nuclear translocation signal"
"2593","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyDecreases","false",,,"Akt-dependent phosphorylation reduces the DNA-binding activity of FOXO, interferes with binding to the co-activators p300/CBP, and inactivates the FOXO nuclear translocation signal"
"2594","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:decreases","false",,,"Akt-dependent phosphorylation reduces the DNA-binding activity of FOXO, interferes with binding to the co-activators p300/CBP, and inactivates the FOXO nuclear translocation signal"
"2595","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:decreases","false",,,"Akt-dependent phosphorylation reduces the DNA-binding activity of FOXO, interferes with binding to the co-activators p300/CBP, and inactivates the FOXO nuclear translocation signal"
"2596","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:decreases","false",,,"Akt-dependent phosphorylation reduces the DNA-binding activity of FOXO, interferes with binding to the co-activators p300/CBP, and inactivates the FOXO nuclear translocation signal"
"2597","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyDecreases","false",,,"Akt-dependent phosphorylation reduces the DNA-binding activity of FOXO, interferes with binding to the co-activators p300/CBP, and inactivates the FOXO nuclear translocation signal"
"2598","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyIncreases","false",,,"The Akt-phosphorylated FOXO is exported from the nucleus in a CRM1- and 14-3-3-dependent process"
"2599","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyIncreases","false",,,"The Akt-phosphorylated FOXO is exported from the nucleus in a CRM1- and 14-3-3-dependent process"
"2600","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:increases","false",,,"Akt-phosphorylated FOXO interacts with the ubiquitin ligase Skp2 and is targeted for proteasomal degradation"
"2601","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyIncreases","false",,,"Akt-phosphorylated FOXO interacts with the ubiquitin ligase Skp2 and is targeted for proteasomal degradation"
"2602","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:increases","false",,,"FOXO proteins intervene in the cell cycle by activating the cyclin-dependent kinase (CDK) inhibitors p27kip1 and p21 cip1."
"2603","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:increases","false",,,"FOXO proteins intervene in the cell cycle by activating the cyclin-dependent kinase (CDK) inhibitors p27kip1 and p21 cip1."
"2604","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyDecreases","false",,,"They also repress transcription of cyclin D1 and D2, which results in an attenuation of CDK4 activity and reduced phosphorylation of Rb protein, and hence increased binding activity of E2F family members to Rb."
"2605","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyDecreases","false",,,"They also repress transcription of cyclin D1 and D2, which results in an attenuation of CDK4 activity and reduced phosphorylation of Rb protein, and hence increased binding activity of E2F family members to Rb."
"2606","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyIncreases","false",,,"They also repress transcription of cyclin D1 and D2, which results in an attenuation of CDK4 activity and reduced phosphorylation of Rb protein, and hence increased binding activity of E2F family members to Rb."
"2607","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyIncreases","false",,,"They also repress transcription of cyclin D1 and D2, which results in an attenuation of CDK4 activity and reduced phosphorylation of Rb protein, and hence increased binding activity of E2F family members to Rb."
"2608","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyIncreases","false",,,"They also repress transcription of cyclin D1 and D2, which results in an attenuation of CDK4 activity and reduced phosphorylation of Rb protein, and hence increased binding activity of E2F family members to Rb."
"2609","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyDecreases","false",,,"They also repress transcription of cyclin D1 and D2, which results in an attenuation of CDK4 activity and reduced phosphorylation of Rb protein, and hence increased binding activity of E2F family members to Rb."
"2610","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:decreases","false",,,"The overall effect of FOXO on cell cycle control is G1 arrest"
"2611","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyIncreases","false",,,"Phosphorylation of the N-terminal Akt motif disrupts the interaction of this domain with the transcriptional co-activators p300/CBP and facilitates binding of FOXO to a 14-3-3 protein instead"
"2612","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:increases","false",,,"Oxidative stress... leads to an activation of the small GTPase Ral, which in turn is instrumental in the phosphorylation and activation of the Jun N-terminal kinase JNK."
"2613","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:increases","false",,,"Oxidative stress... leads to an activation of the small GTPase Ral, which in turn is instrumental in the phosphorylation and activation of the Jun N-terminal kinase JNK."
"2614","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:increases","false",,,"JNK-induced phosphorylation initiates nuclear import of FOXO proteins and activation of their transcriptional regulatory potential. "
"2615","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:increases","false",,,"JNK-induced phosphorylation initiates nuclear import of FOXO proteins and activation of their transcriptional regulatory potential. "
"2616","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:increases","false",,,"Nuclear import triggered by oxidative stress results in association of FOXO proteins with proteins that have histone acetylase activity, such as p300/CBP and p300/CBP-associated factor (PCAF)."
"2617","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:increases","false",,,"Nuclear import triggered by oxidative stress results in association of FOXO proteins with proteins that have histone acetylase activity, such as p300/CBP and p300/CBP-associated factor (PCAF)."
"2618","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:increases","false",,,"Nuclear import triggered by oxidative stress results in association of FOXO proteins with proteins that have histone acetylase activity, such as p300/CBP and p300/CBP-associated factor (PCAF)."
"2619","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:increases","false",,,"Nuclear import triggered by oxidative stress results in association of FOXO proteins with proteins that have histone acetylase activity, such as p300/CBP and p300/CBP-associated factor (PCAF)."
"2620","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:increases","false",,,"Nuclear import triggered by oxidative stress results in association of FOXO proteins with proteins that have histone acetylase activity, such as p300/CBP and p300/CBP-associated factor (PCAF)."
"2621","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyDecreases","false",,,"acetylation of FOXO appears to reduce transcriptional activity"
"2622","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:increases","false",,,"Acetylated and JNK-phosphorylated nuclear FOXO then recruits SIRT1, a constitutively nuclear, nicotinamide adenine dinucleotide-dependent protein deacetylase. This recruitment, like the nuclear import, is dependent on oxidative stress signals."
"2623","Vogt PKJiang HAoki M","15917664","Cell cycle (Georgetown, Tex.)","PubMed",,,"bel:directlyIncreases","false",,,"For FOXO3A, the critical kinase is IKKbeta rather than Akt, and the relevant target residue is serine 644, attracting an as yet unidentified ubiquitin ligase"
"2624","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyDecreases","false",,,"Therapies that target the EGF receptor (EGFR), such as gefitinib (IRESSA), are effective in a subset of patients with advanced non-small cell lung cancer (NSCLC)."
"2625","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:decreases","false",,,"In this study, we observe that gefitinib reduces phospho-Akt levels only in NSCLC cell lines in which it inhibits growth. "
"2626","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In this study, we observe that gefitinib reduces phospho-Akt levels only in NSCLC cell lines in which it inhibits growth. "
"2627","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"In this study, we observe that gefitinib reduces phospho-Akt levels only in NSCLC cell lines in which it inhibits growth. "
"2628","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:decreases","false",,,"We observe that PI3K associates with ErbB-3 exclusively in gefitinib-sensitive NSCLC cell lines. Gefitinib dissociates this complex, thereby linking EGFR inhibition to decreased Akt activity. "
"2629","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"We observe that PI3K associates with ErbB-3 exclusively in gefitinib-sensitive NSCLC cell lines. Gefitinib dissociates this complex, thereby linking EGFR inhibition to decreased Akt activity. "
"2630","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Down-regulation of ErbB-3 by means of short hairpin RNA leads to decreased phospho-Akt levels in the gefitinib-sensitive NSCLC cell lines, Calu-3 (WT EGFR) and H3255 (L858R EGFR), but has no effect on Akt activation in the gefitinib-resistant cell lines, A549 and H522."
"2631","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:causesNoChange","false",,,"Down-regulation of ErbB-3 by means of short hairpin RNA leads to decreased phospho-Akt levels in the gefitinib-sensitive NSCLC cell lines, Calu-3 (WT EGFR) and H3255 (L858R EGFR), but has no effect on Akt activation in the gefitinib-resistant cell lines, A549 and H522."
"2632","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:causesNoChange","false",,,"Down-regulation of ErbB-3 by means of short hairpin RNA leads to decreased phospho-Akt levels in the gefitinib-sensitive NSCLC cell lines, Calu-3 (WT EGFR) and H3255 (L858R EGFR), but has no effect on Akt activation in the gefitinib-resistant cell lines, A549 and H522."
"2633","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:decreases","false",,,"Therefore, the p85 IPs were probed with anti-ErbB-3
antibodies. In the gefitinib-sensitive NSCLC cell lines, there is
indeed a gefitinib-labile interaction between p85 and ErbB-3
(Fig. 2A Bottom Right)."
"2634","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:decreases","false",,,"Therefore, the p85 IPs were probed with anti-ErbB-3
antibodies. In the gefitinib-sensitive NSCLC cell lines, there is
indeed a gefitinib-labile interaction between p85 and ErbB-3
(Fig. 2A Bottom Right)."
"2635","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"As shown in
Fig. 3A, EGF stimulated an association between p85 and ErbB-3
(also observed as the 210-kDa PTyr protein). This association
was blocked by exposing the cells to 1 ?M gefitinib. Assessment
of ErbB-3 immunoprecipitations reveals that gefitinib leads to a
decrease in ErbB-3 tyrosine phosphorylation (Fig. 3B Top) and
the amount of coprecipitated p85 (Fig. 3B Middle)."
"2636","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"As shown in
Fig. 5, the ErbB-3 shRNA efficiently down-regulated ErbB-3 in
both the Calu-3 and H3255 cells, leading to a marked reduction
in phospho-Akt levels and demonstrating that ErbB-3 couples to
the PI3K/Akt pathway in these cells. In contrast, the amount of
phospho-Akt was unchanged in the A549 and H522 cell lines
infected with ErbB-3 shRNA."
"2637","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:causesNoChange","false",,,"As shown in
Fig. 5, the ErbB-3 shRNA efficiently down-regulated ErbB-3 in
both the Calu-3 and H3255 cells, leading to a marked reduction
in phospho-Akt levels and demonstrating that ErbB-3 couples to
the PI3K/Akt pathway in these cells. In contrast, the amount of
phospho-Akt was unchanged in the A549 and H522 cell lines
infected with ErbB-3 shRNA."
"2638","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:causesNoChange","false",,,"As shown in
Fig. 5, the ErbB-3 shRNA efficiently down-regulated ErbB-3 in
both the Calu-3 and H3255 cells, leading to a marked reduction
in phospho-Akt levels and demonstrating that ErbB-3 couples to
the PI3K/Akt pathway in these cells. In contrast, the amount of
phospho-Akt was unchanged in the A549 and H522 cell lines
infected with ErbB-3 shRNA."
"2639","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"As shown in
Fig. 3A, EGF stimulated an association between p85 and ErbB-3
(also observed as the 210-kDa PTyr protein). This association
was blocked by exposing the cells to 1 ?M gefitinib. Assessment
of ErbB-3 immunoprecipitations reveals that gefitinib leads to a
decrease in ErbB-3 tyrosine phosphorylation (Fig. 3B Top) and
the amount of coprecipitated p85 (Fig. 3B Middle)."
"2640","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:decreases","false",,,"As shown in
Fig. 3A, EGF stimulated an association between p85 and ErbB-3
(also observed as the 210-kDa PTyr protein). This association
was blocked by exposing the cells to 1 ?M gefitinib. Assessment
of ErbB-3 immunoprecipitations reveals that gefitinib leads to a
decrease in ErbB-3 tyrosine phosphorylation (Fig. 3B Top) and
the amount of coprecipitated p85 (Fig. 3B Middle)."
"2641","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:decreases","false",,,"As shown in
Fig. 3A, EGF stimulated an association between p85 and ErbB-3
(also observed as the 210-kDa PTyr protein). This association
was blocked by exposing the cells to 1 ?M gefitinib. Assessment
of ErbB-3 immunoprecipitations reveals that gefitinib leads to a
decrease in ErbB-3 tyrosine phosphorylation (Fig. 3B Top) and
the amount of coprecipitated p85 (Fig. 3B Middle)."
"2642","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:decreases","false",,,"As shown in Fig. 3C, phosphorylated Akt levels are
dramatically reduced by 0.25 ?M gefitinib. At this concentration,
we also observe a reduction in the amount of ErbB-3 associated
with p85 and decreased levels of phosphorylated ErbB-3 and
phosphorylated EGFR. In contrast, phosphorylated ErbB-2
levels are not significantly reduced until concentrations of 4 ?M
are used."
"2643","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:decreases","false",,,"As shown in Fig. 3C, phosphorylated Akt levels are
dramatically reduced by 0.25 ?M gefitinib. At this concentration,
we also observe a reduction in the amount of ErbB-3 associated
with p85 and decreased levels of phosphorylated ErbB-3 and
phosphorylated EGFR. In contrast, phosphorylated ErbB-2
levels are not significantly reduced until concentrations of 4 ?M
are used."
"2644","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:decreases","false",,,"As shown in Fig. 3C, phosphorylated Akt levels are
dramatically reduced by 0.25 ?M gefitinib. At this concentration,
we also observe a reduction in the amount of ErbB-3 associated
with p85 and decreased levels of phosphorylated ErbB-3 and
phosphorylated EGFR. In contrast, phosphorylated ErbB-2
levels are not significantly reduced until concentrations of 4 ?M
are used."
"2645","Engelman JAJ??nne PAMermel CPearlberg JMukohara TFleet CCichowski KJohnson BECantley LC","15731348","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:causesNoChange","false",,,"As shown in Fig. 3C, phosphorylated Akt levels are
dramatically reduced by 0.25 ?M gefitinib. At this concentration,
we also observe a reduction in the amount of ErbB-3 associated
with p85 and decreased levels of phosphorylated ErbB-3 and
phosphorylated EGFR. In contrast, phosphorylated ErbB-2
levels are not significantly reduced until concentrations of 4 ?M
are used."
"2646","Carmeliet PMoons LLuttun AVincenti VCompernolle VDe Mol MWu YBono FDevy LBeck HScholz DAcker TDiPalma TDewerchin MNoel AStalmans IBarra ABlacher SVandendriessche TPonten AEriksson UPlate KHFoidart JMSchaper WCharnock-Jones DSHicklin DJHerbert JMCollen DPersico MG","11329059","Nature medicine","PubMed",,,"bel:increases","false",,,"Vascular endothelial growth factor (VEGF) stimulates angiogenesis by activating VEGF receptor-2 (VEGFR-2). "
"2647","Carmeliet PMoons LLuttun AVincenti VCompernolle VDe Mol MWu YBono FDevy LBeck HScholz DAcker TDiPalma TDewerchin MNoel AStalmans IBarra ABlacher SVandendriessche TPonten AEriksson UPlate KHFoidart JMSchaper WCharnock-Jones DSHicklin DJHerbert JMCollen DPersico MG","11329059","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"Vascular endothelial growth factor (VEGF) stimulates angiogenesis by activating VEGF receptor-2 (VEGFR-2). "
"2648","Carmeliet PMoons LLuttun AVincenti VCompernolle VDe Mol MWu YBono FDevy LBeck HScholz DAcker TDiPalma TDewerchin MNoel AStalmans IBarra ABlacher SVandendriessche TPonten AEriksson UPlate KHFoidart JMSchaper WCharnock-Jones DSHicklin DJHerbert JMCollen DPersico MG","11329059","Nature medicine","PubMed",,,"bel:increases","false",,,"Vascular endothelial growth factor (VEGF) stimulates angiogenesis by activating VEGF receptor-2 (VEGFR-2). "
"2649","Carmeliet PMoons LLuttun AVincenti VCompernolle VDe Mol MWu YBono FDevy LBeck HScholz DAcker TDiPalma TDewerchin MNoel AStalmans IBarra ABlacher SVandendriessche TPonten AEriksson UPlate KHFoidart JMSchaper WCharnock-Jones DSHicklin DJHerbert JMCollen DPersico MG","11329059","Nature medicine","PubMed",,,"bel:increases","false",,,"However, loss of PlGF impaired angiogenesis, plasma extravasation and collateral growth during ischemia, inflammation, wound healing and cancer. Transplantation of wild-type bone marrow rescued the impaired angiogenesis and collateral growth in Pgf-/- mice, indicating that PlGF might have contributed to vessel growth in the adult by mobilizing bone-marrow-derived cells."
"2650","Carmeliet PMoons LLuttun AVincenti VCompernolle VDe Mol MWu YBono FDevy LBeck HScholz DAcker TDiPalma TDewerchin MNoel AStalmans IBarra ABlacher SVandendriessche TPonten AEriksson UPlate KHFoidart JMSchaper WCharnock-Jones DSHicklin DJHerbert JMCollen DPersico MG","11329059","Nature medicine","PubMed",,,"bel:directlyIncreases","false",,,"The synergism between PlGF and VEGF was specific, as PlGF deficiency impaired the response to VEGF, but not to bFGF or histamine. VEGFR-1 was activated by PlGF, given that anti-VEGFR-1 antibodies and a Src-kinase inhibitor blocked the endothelial response to PlGF or VEGF/PlGF."
"2651","Carmeliet PMoons LLuttun AVincenti VCompernolle VDe Mol MWu YBono FDevy LBeck HScholz DAcker TDiPalma TDewerchin MNoel AStalmans IBarra ABlacher SVandendriessche TPonten AEriksson UPlate KHFoidart JMSchaper WCharnock-Jones DSHicklin DJHerbert JMCollen DPersico MG","11329059","Nature medicine","PubMed",,,"bel:causesNoChange","false",,,"To examine the role of PlGF in angiogenesis, we inactivated
the gene expressing PlGF (Pgf) in mice. Unexpectedly, the absence
of PlGF—even in combination with a loss of VEGF-B—had
a negligible effect on vascular development."
"2652","Carmeliet PMoons LLuttun AVincenti VCompernolle VDe Mol MWu YBono FDevy LBeck HScholz DAcker TDiPalma TDewerchin MNoel AStalmans IBarra ABlacher SVandendriessche TPonten AEriksson UPlate KHFoidart JMSchaper WCharnock-Jones DSHicklin DJHerbert JMCollen DPersico MG","11329059","Nature medicine","PubMed",,,"bel:causesNoChange","false",,,"VEGF-B is another ligand of VEGFR-1 (ref. 18), but loss of
VEGF-B (Vegfb–/–) does not affect vascular development19."
"2653","Carmeliet PMoons LLuttun AVincenti VCompernolle VDe Mol MWu YBono FDevy LBeck HScholz DAcker TDiPalma TDewerchin MNoel AStalmans IBarra ABlacher SVandendriessche TPonten AEriksson UPlate KHFoidart JMSchaper WCharnock-Jones DSHicklin DJHerbert JMCollen DPersico MG","11329059","Nature medicine","PubMed",,,"bel:increases","false",,,"Fewer vessels developed in corpora lutea at 4.5
days of pregnancy in Pgf–/– mice (vessels/mm2: 910 ± 62 in 6 wildtype
mice versus 430 ± 80 in 6 Pgf–/– mice; P < 0.005;
Fig. 1e and f), but did not impair reproduction.
Thus, loss of PlGF impaired VEGF-dependent retinal
and luteal angiogenesis."
"2654","Carmeliet PMoons LLuttun AVincenti VCompernolle VDe Mol MWu YBono FDevy LBeck HScholz DAcker TDiPalma TDewerchin MNoel AStalmans IBarra ABlacher SVandendriessche TPonten AEriksson UPlate KHFoidart JMSchaper WCharnock-Jones DSHicklin DJHerbert JMCollen DPersico MG","11329059","Nature medicine","PubMed",,,"bel:increases","false",,,"Fewer vessels developed in corpora lutea at 4.5
days of pregnancy in Pgf–/– mice (vessels/mm2: 910 ± 62 in 6 wildtype
mice versus 430 ± 80 in 6 Pgf–/– mice; P < 0.005;
Fig. 1e and f), but did not impair reproduction.
Thus, loss of PlGF impaired VEGF-dependent retinal
and luteal angiogenesis."
"2655","Carmeliet PMoons LLuttun AVincenti VCompernolle VDe Mol MWu YBono FDevy LBeck HScholz DAcker TDiPalma TDewerchin MNoel AStalmans IBarra ABlacher SVandendriessche TPonten AEriksson UPlate KHFoidart JMSchaper WCharnock-Jones DSHicklin DJHerbert JMCollen DPersico MG","11329059","Nature medicine","PubMed",,,"bel:increases","false",,,"When both tumor and host expressed PlGF, tumors were
large and highly vascularized (4 ± 1 g; n = 8; Fig. 1g and j). In contrast,
when they both lacked PlGF, tumors remained small and
poorly vascularized (1.0 ± 0.3 g; n = 8; Fig. 1h and j),"
"2656","Carmeliet PMoons LLuttun AVincenti VCompernolle VDe Mol MWu YBono FDevy LBeck HScholz DAcker TDiPalma TDewerchin MNoel AStalmans IBarra ABlacher SVandendriessche TPonten AEriksson UPlate KHFoidart JMSchaper WCharnock-Jones DSHicklin DJHerbert JMCollen DPersico MG","11329059","Nature medicine","PubMed",,,"bel:increases","false",,,"When both tumor and host expressed PlGF, tumors were
large and highly vascularized (4 ± 1 g; n = 8; Fig. 1g and j). In contrast,
when they both lacked PlGF, tumors remained small and
poorly vascularized (1.0 ± 0.3 g; n = 8; Fig. 1h and j),"
"2657","Carmeliet PMoons LLuttun AVincenti VCompernolle VDe Mol MWu YBono FDevy LBeck HScholz DAcker TDiPalma TDewerchin MNoel AStalmans IBarra ABlacher SVandendriessche TPonten AEriksson UPlate KHFoidart JMSchaper WCharnock-Jones DSHicklin DJHerbert JMCollen DPersico MG","11329059","Nature medicine","PubMed",,,"bel:increases","false",,,"We analyzed revascularization of myocardial
infarcts after ligating the left anterior descending
coronary artery25. Compared with wildtype
mice, Pgf–/– infarcts contained
approximately 20% fewer vessels (vessels/mm2:
134 ± 9 in wild-type mice versus 111 ± 5 in
Pgf–/– mice; n = 12 to 24; P < 0.05; Fig. 2f and g)."
"2658","Carmeliet PMoons LLuttun AVincenti VCompernolle VDe Mol MWu YBono FDevy LBeck HScholz DAcker TDiPalma TDewerchin MNoel AStalmans IBarra ABlacher SVandendriessche TPonten AEriksson UPlate KHFoidart JMSchaper WCharnock-Jones DSHicklin DJHerbert JMCollen DPersico MG","11329059","Nature medicine","PubMed",,,"bel:increases","false",,,"Healing of skin incisions progressed more slowly in Pgf–/– mice
versus wild-type (Fig. 3a–c)"
"2659","Carmeliet PMoons LLuttun AVincenti VCompernolle VDe Mol MWu YBono FDevy LBeck HScholz DAcker TDiPalma TDewerchin MNoel AStalmans IBarra ABlacher SVandendriessche TPonten AEriksson UPlate KHFoidart JMSchaper WCharnock-Jones DSHicklin DJHerbert JMCollen DPersico MG","11329059","Nature medicine","PubMed",,,"bel:decreases","false",,,"In pathological conditions, PlGF is upregulated and
stimulates angiogenesis via displacement of VEGF from VEGF-R1 to VEGFR2
and via activation of VEGFR-1, of which a larger fraction is membraneassociated."
"2660","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,
"2661","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Here we tested whether the related human
LRIG1 (also called Lig-1) protein can act as a negative
regulator of EGF receptor and its relatives, ErbB2,
ErbB3, and ErbB4. We observed that in co-transfected
293T cells, LRIG1 forms a complex with each of the ErbB
receptors independent of growth factor binding. We further
observed that co-expression of LRIG1 with EGF
receptor suppresses cellular receptor levels, shortens
receptor half-life, and enhances ligand-stimulated receptor
ubiquitination."
"2662","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Here we tested whether the related human
LRIG1 (also called Lig-1) protein can act as a negative
regulator of EGF receptor and its relatives, ErbB2,
ErbB3, and ErbB4. We observed that in co-transfected
293T cells, LRIG1 forms a complex with each of the ErbB
receptors independent of growth factor binding. We further
observed that co-expression of LRIG1 with EGF
receptor suppresses cellular receptor levels, shortens
receptor half-life, and enhances ligand-stimulated receptor
ubiquitination."
"2663","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Here we tested whether the related human
LRIG1 (also called Lig-1) protein can act as a negative
regulator of EGF receptor and its relatives, ErbB2,
ErbB3, and ErbB4. We observed that in co-transfected
293T cells, LRIG1 forms a complex with each of the ErbB
receptors independent of growth factor binding. We further
observed that co-expression of LRIG1 with EGF
receptor suppresses cellular receptor levels, shortens
receptor half-life, and enhances ligand-stimulated receptor
ubiquitination."
"2664","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Interestingly, when lysates from co-transfection experiments
were blotted with anti-receptor antibodies, a loss of EGFR,
ErbB2, ErbB3, and ErbB4 was observed in the presence of
LRIG1, but no loss of insulin receptor was observed despite
very efficient transfection of these cells (Fig. 1C, compare lanes
1 and 3 in all panels). These observations suggest that a functional
consequence of LRIG1 interaction with receptor tyrosine
kinases may be suppression of receptor levels to lower the
efficiency of signaling."
"2665","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Interestingly, when lysates from co-transfection experiments
were blotted with anti-receptor antibodies, a loss of EGFR,
ErbB2, ErbB3, and ErbB4 was observed in the presence of
LRIG1, but no loss of insulin receptor was observed despite
very efficient transfection of these cells (Fig. 1C, compare lanes
1 and 3 in all panels). These observations suggest that a functional
consequence of LRIG1 interaction with receptor tyrosine
kinases may be suppression of receptor levels to lower the
efficiency of signaling."
"2666","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Interestingly, when lysates from co-transfection experiments
were blotted with anti-receptor antibodies, a loss of EGFR,
ErbB2, ErbB3, and ErbB4 was observed in the presence of
LRIG1, but no loss of insulin receptor was observed despite
very efficient transfection of these cells (Fig. 1C, compare lanes
1 and 3 in all panels). These observations suggest that a functional
consequence of LRIG1 interaction with receptor tyrosine
kinases may be suppression of receptor levels to lower the
efficiency of signaling."
"2667","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Interestingly, when lysates from co-transfection experiments
were blotted with anti-receptor antibodies, a loss of EGFR,
ErbB2, ErbB3, and ErbB4 was observed in the presence of
LRIG1, but no loss of insulin receptor was observed despite
very efficient transfection of these cells (Fig. 1C, compare lanes
1 and 3 in all panels). These observations suggest that a functional
consequence of LRIG1 interaction with receptor tyrosine
kinases may be suppression of receptor levels to lower the
efficiency of signaling."
"2668","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"To determine whether LRIG1 expression influences the ubiquitination
and degradation rate of ErbB receptors in the inducible
expression system, we focused on the effect of LRIG1 expression
on the properties of EGFR in the PC3-LRIG1 cells. Similar
to the results with transfected 293T cells (Fig. 3), we observed
that the induction of LRIG1 expression markedly augmented the
ubiquitination of EGFR in response to EGF treatment (Fig. 5A).
This potentiation of ligand-stimulated EGFR ubiquitination correlated
with a suppression of EGFR tyrosine phosphorylation
and receptor levels after growth factor treatment."
"2669","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"To determine whether LRIG1 expression influences the ubiquitination
and degradation rate of ErbB receptors in the inducible
expression system, we focused on the effect of LRIG1 expression
on the properties of EGFR in the PC3-LRIG1 cells. Similar
to the results with transfected 293T cells (Fig. 3), we observed
that the induction of LRIG1 expression markedly augmented the
ubiquitination of EGFR in response to EGF treatment (Fig. 5A).
This potentiation of ligand-stimulated EGFR ubiquitination correlated
with a suppression of EGFR tyrosine phosphorylation
and receptor levels after growth factor treatment."
"2670","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"In the experiment
illustrated in Fig. 5B, PC3-LRIG1 cells were treated with
and without tetracycline to induce LRIG1 expression, and a time
course of EGF stimulation of the cells was carried out. Lysates
were immunoblotted with anti-phosphotyrosine and anti-EGFR
antibodies. In the presence of LRIG1, EGFR responded less efficiently
to EGF as determined by blotting autophosphorylated
receptors with anti-phosphotyrosine. Interestingly, LRIG1 expression
also resulted in an accelerated loss of EGFR."
"2671","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"In the experiment
illustrated in Fig. 5B, PC3-LRIG1 cells were treated with
and without tetracycline to induce LRIG1 expression, and a time
course of EGF stimulation of the cells was carried out. Lysates
were immunoblotted with anti-phosphotyrosine and anti-EGFR
antibodies. In the presence of LRIG1, EGFR responded less efficiently
to EGF as determined by blotting autophosphorylated
receptors with anti-phosphotyrosine. Interestingly, LRIG1 expression
also resulted in an accelerated loss of EGFR."
"2672","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"As shown in Fig. 5C, the presence of
LRIG1 accelerated the rate at which EGF receptor was degraded
by cells. Taken together, the results depicted in Fig. 5 suggest
that LRIG1 negatively regulates ErbB receptors by promoting
receptor ubiquitination and increasing the basal and ligand-stimulated
rates of receptor degradation."
"2673","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Interestingly, other LRR domain-containing proteins have
also been demonstrated to interact with receptor tyrosine
kinases. Decorin, a secreted proteoglycan containing nine
LRRs, has been shown to interact with the EGF receptor and
ErbB2 to initially enhance their activities (27, 28). Decorin
interaction with receptors has been suggested to mediate
prolonged receptor down-regulation and the inhibition of cellular
growth through enhanced expression of p21waf1 (29)."
"2674","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Interestingly, other LRR domain-containing proteins have
also been demonstrated to interact with receptor tyrosine
kinases. Decorin, a secreted proteoglycan containing nine
LRRs, has been shown to interact with the EGF receptor and
ErbB2 to initially enhance their activities (27, 28). Decorin
interaction with receptors has been suggested to mediate
prolonged receptor down-regulation and the inhibition of cellular
growth through enhanced expression of p21waf1 (29)."
"2675","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Interestingly, other LRR domain-containing proteins have
also been demonstrated to interact with receptor tyrosine
kinases. Decorin, a secreted proteoglycan containing nine
LRRs, has been shown to interact with the EGF receptor and
ErbB2 to initially enhance their activities (27, 28). Decorin
interaction with receptors has been suggested to mediate
prolonged receptor down-regulation and the inhibition of cellular
growth through enhanced expression of p21waf1 (29)."
"2676","Laederich MBFunes-Duran MYen LIngalla EWu XCarraway KLSweeney C","15345710","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"Interestingly, other LRR domain-containing proteins have
also been demonstrated to interact with receptor tyrosine
kinases. Decorin, a secreted proteoglycan containing nine
LRRs, has been shown to interact with the EGF receptor and
ErbB2 to initially enhance their activities (27, 28). Decorin
interaction with receptors has been suggested to mediate
prolonged receptor down-regulation and the inhibition of cellular
growth through enhanced expression of p21waf1 (29)."
"2677","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"Insulin-like growth factor-I (IGF-I) has been shown to stimulate a hypertrophy response in skeletal muscles in vivo. In vitro studies have delineated two primary intracellular pathways that appear to mediate the effects of IGF-I in skeletal muscle: the Ras-ERK pathway and the phosphoinositide-3 kinase pathway."
"2678","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"Insulin-like growth factor-I (IGF-I) has been shown to stimulate a hypertrophy response in skeletal muscles in vivo. In vitro studies have delineated two primary intracellular pathways that appear to mediate the effects of IGF-I in skeletal muscle: the Ras-ERK pathway and the phosphoinositide-3 kinase pathway."
"2679","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"Insulin-like growth factor-I (IGF-I) has been shown to stimulate a hypertrophy response in skeletal muscles in vivo. In vitro studies have delineated two primary intracellular pathways that appear to mediate the effects of IGF-I in skeletal muscle: the Ras-ERK pathway and the phosphoinositide-3 kinase pathway."
"2680","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"Insulin-like growth factor-I (IGF-I) has been shown to stimulate a hypertrophy response in skeletal muscles in vivo. In vitro studies have delineated two primary intracellular pathways that appear to mediate the effects of IGF-I in skeletal muscle: the Ras-ERK pathway and the phosphoinositide-3 kinase pathway."
"2681","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"In vitro, the Ras pathway appears to regulate the mitogenic effects of IGF-I signaling, whereas the phosphoinositide-3 kinase pathway is associated with cellular differentiation."
"2682","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"In vitro, the Ras pathway appears to regulate the mitogenic effects of IGF-I signaling, whereas the phosphoinositide-3 kinase pathway is associated with cellular differentiation."
"2683","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"In vitro, the Ras pathway appears to regulate the mitogenic effects of IGF-I signaling, whereas the phosphoinositide-3 kinase pathway is associated with cellular differentiation."
"2684","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"In vitro, the Ras pathway appears to regulate the mitogenic effects of IGF-I signaling, whereas the phosphoinositide-3 kinase pathway is associated with cellular differentiation."
"2685","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:decreases","false",,,"Our results show that 14 days of coinfusion of MAPK/ERK kinase inhibitor PD-098059 (PD) limited the phosphorylation of ERK and prevented IGF-I induced increases in protein (18%, P < 0.05 vs. 7%, not significant) or myofibrillar protein (23%, P < 0.01 vs. 5%, not significant)."
"2686","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"The most notable impact on IGF-I signaling was a significant blunting of IGF-I induced increase in S6K1 phosphorylation by PD-98059 coinfusion ( approximately 5-fold, P < 0.001 vs. 3-fold, P < 0.01). "
"2687","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"The most notable impact on IGF-I signaling was a significant blunting of IGF-I induced increase in S6K1 phosphorylation by PD-98059 coinfusion ( approximately 5-fold, P < 0.001 vs. 3-fold, P < 0.01). "
"2688","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:positiveCorrelation","false",,,
"2689","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"Muscle hypertrophy. Local infusion of IGF-I for 14 days
resulted in a 19% increase in muscle wet weight and an 18%
increase in the total protein content of the IGF but not the
IGF+PD plantaris muscles (Fig. 1A, Table 1). Total protein
concentration was unchanged in both treatment groups (Table
1). IGF-I infusion resulted in a 23% increase in myofibrillar
protein content (IGF group) that was completely blunted by
coinfusion of MEK inhibitor PD-098059 (Fig. 1B)."
"2690","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"Mitogenic indicators. The DNA content of the IGF and
IGF+PD infused muscles increased ~50% compared with the
contralateral muscles (Fig. 2A). The concentration of DNA was
also increased by both treatments (Table 1). Similarly, there
was a significant increase in the expression and/or accumulation
of cyclin D1 mRNA in the IGF and IGF+PD muscles
(Fig. 2B)."
"2691","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"Mitogenic indicators. The DNA content of the IGF and
IGF+PD infused muscles increased ~50% compared with the
contralateral muscles (Fig. 2A). The concentration of DNA was
also increased by both treatments (Table 1). Similarly, there
was a significant increase in the expression and/or accumulation
of cyclin D1 mRNA in the IGF and IGF+PD muscles
(Fig. 2B)."
"2692","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"Myogenic processes. The mRNA for myogenin, a putative
marker of myogenic differentiation, increased significantly in
the IGF+PD muscles, whereas this change was not significant
after IGF-I infusion alone (Fig. 3)."
"2693","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:causesNoChange","false",,,"Myogenic processes. The mRNA for myogenin, a putative
marker of myogenic differentiation, increased significantly in
the IGF+PD muscles, whereas this change was not significant
after IGF-I infusion alone (Fig. 3)."
"2694","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:positiveCorrelation","false",,,"Myogenic processes. The mRNA for myogenin, a putative
marker of myogenic differentiation, increased significantly in
the IGF+PD muscles, whereas this change was not significant
after IGF-I infusion alone (Fig. 3)."
"2695","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"Intracellular signaling. Infusion of IGF-I resulted in an
approximate fivefold increase in the phosphorylation of ERKs
1 and 2 (Fig. 4), whereas the total ERK levels were unchanged
vs. contralateral muscles (data not shown). Coinfusion
(IGF+PD) completely blunted the increase in ERK1 phosphorylation
and significantly reduced the increase in ERK2 phosphorylation
(Fig. 4B). Similar to ERK2, the phosphorylation of
S6K1 was increased fivefold in the IGF and 2.8-fold in the
IGF+PD muscles (Fig. 5). The infusion protocols did not
impact the total amount of S6K1 (data not shown)."
"2696","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"Intracellular signaling. Infusion of IGF-I resulted in an
approximate fivefold increase in the phosphorylation of ERKs
1 and 2 (Fig. 4), whereas the total ERK levels were unchanged
vs. contralateral muscles (data not shown). Coinfusion
(IGF+PD) completely blunted the increase in ERK1 phosphorylation
and significantly reduced the increase in ERK2 phosphorylation
(Fig. 4B). Similar to ERK2, the phosphorylation of
S6K1 was increased fivefold in the IGF and 2.8-fold in the
IGF+PD muscles (Fig. 5). The infusion protocols did not
impact the total amount of S6K1 (data not shown)."
"2697","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"IGF-I-related mRNA. IGF-I infusion resulted in a 48 and
63% increase in IGFBP-5 mRNA in the IGF and IGFPD
muscles, respectively (Fig. 7A). The mRNA for IGFBP-4
increased significantly (4-fold) in the IGFPD but not IGF
muscles (Fig. 7B)."
"2698","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"IGF-I-related mRNA. IGF-I infusion resulted in a 48 and
63% increase in IGFBP-5 mRNA in the IGF and IGFPD
muscles, respectively (Fig. 7A). The mRNA for IGFBP-4
increased significantly (4-fold) in the IGFPD but not IGF
muscles (Fig. 7B)."
"2699","Haddad FAdams GR","12959952","Journal of applied physiology (Bethesda, Md. : 1985)","PubMed",,,"bel:increases","false",,,"IGF-I-related mRNA. IGF-I infusion resulted in a 48 and
63% increase in IGFBP-5 mRNA in the IGF and IGFPD
muscles, respectively (Fig. 7A). The mRNA for IGFBP-4
increased significantly (4-fold) in the IGFPD but not IGF
muscles (Fig. 7B)."
"2700","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"Under conditions where
activation of neither RAF nor AKT alone was sufficient to
induce DNA synthesis, coactivation of both kinases elicited a
strong cooperative response."
"2701","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"Activation of AKT or
RAF alone led to a two- or threefold induction of cyclin D1
expression, respectively (Fig. 2A). However, coactivation of
both signaling pathways led to a sixfold induction of cyclin D1."
"2702","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:decreases","false",,,"Strikingly, coactivation of
RAF and AKT led to a rapid and profound repression of
p27Kip1 expression that was clearly evident at 6 h and continued
up to 24 h (Fig. 2A)."
"2703","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:decreases","false",,,"Consistent with previous observations,
activation of AKT alone led to a 
50% reduction of KIP1
mRNA that was evident after 24 h (38). Activation of RAF
alone led to a 
65% reduction of KIP1 mRNA that was best
evident after 24 h."
"2704","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:decreases","false",,,"Consistent with previous observations,
activation of AKT alone led to a 
50% reduction of KIP1
mRNA that was evident after 24 h (38). Activation of RAF
alone led to a 
65% reduction of KIP1 mRNA that was best
evident after 24 h."
"2705","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"PDGF stimulation of quiescent
NIH 3T3 cells leads to activation of both the PI3'-kinase3
PDK13AKT and the RAF3MEK3ERK signaling pathways
and repression of p27Kip1 expression (Fig. 3A)."
"2706","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"PDGF stimulation of quiescent
NIH 3T3 cells leads to activation of both the PI3'-kinase3
PDK13AKT and the RAF3MEK3ERK signaling pathways
and repression of p27Kip1 expression (Fig. 3A)."
"2707","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:decreases","false",,,"PDGF stimulation of quiescent
NIH 3T3 cells leads to activation of both the PI3'-kinase3
PDK13AKT and the RAF3MEK3ERK signaling pathways
and repression of p27Kip1 expression (Fig. 3A)."
"2708","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:decreases","false",,,"Consistent with observations
described above, PDGF repressed KIP1 mRNA by 
60%."
"2709","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"RAF and AKT cooperate to promote cell cycle progression"
"2710","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"Serum deprivation of parental NIH 3T3 cells leads to elevated p27Kip1 expression and cell cycle arrest (Fig. 4A)."
"2711","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"Serum deprivation of parental NIH 3T3 cells leads to elevated p27Kip1 expression and cell cycle arrest (Fig. 4A)."
"2712","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"Hs766T cells express activated KRAS and display elevated levels of pERK1/2 and pAKT (Fig. 4C)."
"2713","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"Hs766T cells express activated KRAS and display elevated levels of pERK1/2 and pAKT (Fig. 4C)."
"2714","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"Hs766T cells express activated KRAS and display elevated levels of pERK1/2 and pAKT (Fig. 4C)."
"2715","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:decreases","false",,,"Treatment of Hs766T cells with the PI3'-kinase inhibitor LY294002 led to a selective decrease in pAKT with little or no effect on pERK1/2."
"2716","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:causesNoChange","false",,,"Treatment of Hs766T cells with the PI3'-kinase inhibitor LY294002 led to a selective decrease in pAKT with little or no effect on pERK1/2."
"2717","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:causesNoChange","false",,,"Treatment of Hs766T cells with the PI3'-kinase inhibitor LY294002 led to a selective decrease in pAKT with little or no effect on pERK1/2."
"2718","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:decreases","false",,,"By contrast, treatment of the cells with the MEK inhibitor U0126 or CI-1040 led to a selective decrease in pERK1/2 with little or no effect on pAKT"
"2719","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:decreases","false",,,"By contrast, treatment of the cells with the MEK inhibitor U0126 or CI-1040 led to a selective decrease in pERK1/2 with little or no effect on pAKT"
"2720","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:causesNoChange","false",,,"By contrast, treatment of the cells with the MEK inhibitor U0126 or CI-1040 led to a selective decrease in pERK1/2 with little or no effect on pAKT"
"2721","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:directlyDecreases","false",,,"both the PI3'-kinase and the MEK inhibitors led to accumulation of p27Kip1 expression."
"2722","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:decreases","false",,,"both the PI3'-kinase and the MEK inhibitors led to accumulation of p27Kip1 expression."
"2723","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:decreases","false",,,"both the PI3'-kinase and the MEK inhibitors led to accumulation of p27Kip1 expression."
"2724","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"both the PI3'-kinase and the MEK inhibitors led to accumulation of p27Kip1 expression."
"2725","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"both the PI3'-kinase and the MEK inhibitors led to accumulation of p27Kip1 expression."
"2726","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:directlyIncreases","false",,,"Phosphorylation of p27Kip1 on threonine 187 (T187) by active cdk2 leads to its recognition by the F-box protein SCFSkp2, thereby promoting p27Kip1 ubiquitination and destruction by the 26S proteasome (45)."
"2727","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:directlyIncreases","false",,,"Phosphorylation of p27Kip1 on threonine 187 (T187) by active cdk2 leads to its recognition by the F-box protein SCFSkp2, thereby promoting p27Kip1 ubiquitination and destruction by the 26S proteasome (45)."
"2728","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:directlyIncreases","false",,,"Phosphorylation of p27Kip1 on threonine 187 (T187) by active cdk2 leads to its recognition by the F-box protein SCFSkp2, thereby promoting p27Kip1 ubiquitination and destruction by the 26S proteasome (45)."
"2729","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:directlyIncreases","false",,,"Phosphorylation of p27Kip1 on threonine 187 (T187) by active cdk2 leads to its recognition by the F-box protein SCFSkp2, thereby promoting p27Kip1 ubiquitination and destruction by the 26S proteasome (45)."
"2730","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:causesNoChange","false",,,"Activation of AKT alone had little or no effect on total p21Cip1 expression measured in whole-cell lysates (Fig. 7A, lanes 1 to 4), whereas activation of RAF alone led to robust induction of p21Cip1 as reported previously (Fig. 7A, lanes 5 to7, and 7B)."
"2731","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"Activation of AKT alone had little or no effect on total p21Cip1 expression measured in whole-cell lysates (Fig. 7A, lanes 1 to 4), whereas activation of RAF alone led to robust induction of p21Cip1 as reported previously (Fig. 7A, lanes 5 to7, and 7B)."
"2732","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"coactivation of RAF and AKT led to sustained cdk2 activity (lanes 8 to 10), whereas activation of RAF or AKT alone elicited, at best, only transient activation of cdk2 (lanes 2 to 7). "
"2733","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"RAF-induced p21Cip1 was readily detected in complex with cdk2 (lanes 5 to 7)."
"2734","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:decreases","false",,,"AKT activation elicits sustained cdk2 activation, not by inhibiting p21Cip1 expression but by promoting the removal of p21Cip1 from cdk2 complexes."
"2735","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:directlyDecreases","false",,,"AKT activation elicits sustained cdk2 activation, not by inhibiting p21Cip1 expression but by promoting the removal of p21Cip1 from cdk2 complexes."
"2736","Mirza AMGysin SMalek NNakayama KRoberts JMMcMahon M","15572689","Molecular and cellular biology","PubMed",,,"bel:increases","false",,,"AKT promoted nuclear export of RAF-induced p21Cip1 into a cytoplasmic compartment as reported previously (Fig. 7C) (65)."
"2737","Kirsh OSeeler JSPichler AGast AM??ller SMiska EMathieu MHarel-Bellan AKouzarides TMelchior FDejean A","12032081","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"COS-7 cells were transiently transfected with expression vectors for SUMO-1 together with HDAC4 or HDAC4-K559R followed by immunoprecipitation using the anti-HDAC4 antibodies and an assay for histone deacetylase activity (Figure 4B). Although the two proteins were expressed at a similar level (inset), the HDAC activity associated with HDAC4-K559R was significantly reduced, to a level barely above that of endogenous HDAC4 (compare lane 3 with lanes 1 and 2)."
"2738","Kirsh OSeeler JSPichler AGast AM??ller SMiska EMathieu MHarel-Bellan AKouzarides TMelchior FDejean A","12032081","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"The ability of the sumoylation-deficient HDAC4-K559R mutant to repress transcription was slightly impaired when compared with that of the wild-type HDAC4 protein (Figure 4A)."
"2739","Kirsh OSeeler JSPichler AGast AM??ller SMiska EMathieu MHarel-Bellan AKouzarides TMelchior FDejean A","12032081","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"As expected, expression of a construct (HDAC4-DeltaNLS) lacking these residues rendered the protein entirely cytoplasmic, albeit without impairing the protein's ability to aggregate (Figure 6B). Western blot analysis of cells expressing HDAC4-DeltaNLS demonstrated this protein to be unable to undergo SUMO-1 modification (Figure 6C, lane 3), even upon co-expression of exogenous His-SUMO-1 (Figure 6C, lane 4). This inability, however, is not an intrinsic property of this protein since modification by SUMO-1 occurs as efficiently as for the full-length HDAC4 protein using the in vitro assay (Figure 6C, compare lane 8 with lane 6)."
"2740","Kirsh OSeeler JSPichler AGast AM??ller SMiska EMathieu MHarel-Bellan AKouzarides TMelchior FDejean A","12032081","The EMBO journal","PubMed",,,"bel:increases","false",,,"Consistent with previous observations, transfection of a constitutively active CaMKI vector in HeLa cells induced nuclear exclusion of HDAC4 in the vast majority of the cells (Figure 6D). "
"2741","Kirsh OSeeler JSPichler AGast AM??ller SMiska EMathieu MHarel-Bellan AKouzarides TMelchior FDejean A","12032081","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"Moreover RanBP2 functions catalytically as 5 ng of BP2DeltaFG were sufficient to promote modification of a 100-fold molar excess of HDAC4. Thus, RanBP2 plays an E3-like role in SUMO modification of HDAC4. "
"2742","Figueroa CTarras STaylor JVojtek AB","14504284","The Journal of biological chemistry","PubMed",,,"bel:decreases","false",,,"In addition, we show that the association of MLK3 with POSH is increased upon inhibition of the endogenous phosphatidylinositol 3-kinase/Akt signaling pathway."
"2743","Figueroa CTarras STaylor JVojtek AB","14504284","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"Akt2 binds to a POSH-MLK-MKK-JNK complex and phosphorylates MLK3"
"2744","Figueroa CTarras STaylor JVojtek AB","14504284","The Journal of biological chemistry","PubMed",,,"bel:directlyDecreases","false",,,"phosphorylation of MLK3 by Akt2 results in the disassembly of the JNK complex bound to POSH and down-regulation of the JNK signaling pathway"
"2745","Figueroa CTarras STaylor JVojtek AB","14504284","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"This increase in the MLK-POSH complex is accompanied by an increase in phospho-c-Jun, a measure of JNK pathway activation (Fig. 5B)."
"2746","Figueroa CTarras STaylor JVojtek AB","14504284","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"This increase in the MLK-POSH complex is accompanied by an increase in phospho-c-Jun, a measure of JNK pathway activation (Fig. 5B)."
"2747","Figueroa CTarras STaylor JVojtek AB","14504284","The Journal of biological chemistry","PubMed",,,"bel:directlyIncreases","false",,,"This increase in the MLK-POSH complex is accompanied by an increase in phospho-c-Jun, a measure of JNK pathway activation (Fig. 5B)."
"2748","Figueroa CTarras STaylor JVojtek AB","14504284","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"The association of MLK3 with POSH is substantially increased by LY294002 treatment (Fig. 5C). Thus, inhibition of endogenous Akt kinases enhances the ability of POSH to scaffold MLK3. "
"2749","Figueroa CTarras STaylor JVojtek AB","14504284","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Introduction of MLK3 into cells alone activates the JNK signaling pathway, as assessed by Western blot analysis of phospho-c-Jun levels (Fig. 6A)."
"2750","Figueroa CTarras STaylor JVojtek AB","14504284","The Journal of biological chemistry","PubMed",,,"bel:increases","false",,,"Introduction of MLK3 into cells alone activates the JNK signaling pathway, as assessed by Western blot analysis of phospho-c-Jun levels (Fig. 6A)."
"2751","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Transgenic expression of PGC-1alpha recently has been shown to dramatically increase the content of type I muscle fibers in skeletal muscle, but the relationship between PGC-1alpha expression and the key components in calcium signaling is not clear."
"2752","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In this report, we show that the PGC-1alpha promoter is regulated by both CaMKIV and CnA activity. CaMKIV activates PGC-1alpha largely through the binding of cAMP response element-binding protein to the PGC-1alpha promoter. "
"2753","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In this report, we show that the PGC-1alpha promoter is regulated by both CaMKIV and CnA activity. CaMKIV activates PGC-1alpha largely through the binding of cAMP response element-binding protein to the PGC-1alpha promoter. "
"2754","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Transgenic expression of PGC-1alpha recently has been shown to dramatically increase the content of type I muscle fibers in skeletal muscle, but the relationship between PGC-1alpha expression and the key components in calcium signaling is not clear. "
"2755","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"Moreover, we show that a positive feedback loop exists between PGC-1alpha and members of the myocyte enhancer factor 2 (MEF2) family of transcription factors. MEF2s bind to the PGC-1alpha promoter and activate it, predominantly when coactivated by PGC-1alpha. MEF2 activity is stimulated further by CnA signaling."
"2756","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"Moreover, we show that a positive feedback loop exists between PGC-1alpha and members of the myocyte enhancer factor 2 (MEF2) family of transcription factors. MEF2s bind to the PGC-1alpha promoter and activate it, predominantly when coactivated by PGC-1alpha. MEF2 activity is stimulated further by CnA signaling."
"2757","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Moreover, we show that a positive feedback loop exists between PGC-1alpha and members of the myocyte enhancer factor 2 (MEF2) family of transcription factors. MEF2s bind to the PGC-1alpha promoter and activate it, predominantly when coactivated by PGC-1alpha. MEF2 activity is stimulated further by CnA signaling."
"2758","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,
"2759","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"Promoter fragments that contain either
2 or 6 kb of 5' flanking region of mouse PGC-1? both are
activated at least 3-fold by the expression of constitutively active
CaMKIV (Fig. 1A). In contrast, expression of a constitutively
active CnA has very little effect on reporter gene activity,
consistent with the results obtained previously for PGC-1?
mRNA expression in CaMKIV and CnA transgenic mice (11).
However, the combination of CaMKIV and CnA has a powerful
effect on the PGC-1? promoter, increasing transcription by
~7-fold (Fig. 1A)."
"2760","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:causesNoChange","false",,,"Promoter fragments that contain either
2 or 6 kb of 5' flanking region of mouse PGC-1? both are
activated at least 3-fold by the expression of constitutively active
CaMKIV (Fig. 1A). In contrast, expression of a constitutively
active CnA has very little effect on reporter gene activity,
consistent with the results obtained previously for PGC-1?
mRNA expression in CaMKIV and CnA transgenic mice (11).
However, the combination of CaMKIV and CnA has a powerful
effect on the PGC-1? promoter, increasing transcription by
~7-fold (Fig. 1A)."
"2761","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"CaMKIV has been shown to phosphorylate and activate many
proteins, including CREB. Because CREB has been shown to be
an important activator of PGC-1? gene expression in the fasted
liver (24), we used the dominant-negative ACREB protein to
examine a potential role for CREB in the CaMKIV-mediated
control of the PGC-1? promoter. Although ACREB alone had
no effect on the PGC-1? promoter, this protein severely reduced
the activation of the PGC-1? promoter by CaMKIV alone or
CaMKIV in combination with CnA (Fig. 1A)."
"2762","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"CaMKIV has been shown to phosphorylate and activate many
proteins, including CREB. Because CREB has been shown to be
an important activator of PGC-1? gene expression in the fasted
liver (24), we used the dominant-negative ACREB protein to
examine a potential role for CREB in the CaMKIV-mediated
control of the PGC-1? promoter. Although ACREB alone had
no effect on the PGC-1? promoter, this protein severely reduced
the activation of the PGC-1? promoter by CaMKIV alone or
CaMKIV in combination with CnA (Fig. 1A)."
"2763","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"CaMKIV has been shown to phosphorylate and activate many
proteins, including CREB. Because CREB has been shown to be
an important activator of PGC-1? gene expression in the fasted
liver (24), we used the dominant-negative ACREB protein to
examine a potential role for CREB in the CaMKIV-mediated
control of the PGC-1? promoter. Although ACREB alone had
no effect on the PGC-1? promoter, this protein severely reduced
the activation of the PGC-1? promoter by CaMKIV alone or
CaMKIV in combination with CnA (Fig. 1A)."
"2764","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"As shown in Fig. 1C, mutagenesis of the CRE site abolished
induction of the mouse PGC-1? promoter by forskolin, as
expected."
"2765","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Because MEF2 and NFAT transcription factors are
known targets of CaMKIV and CnA in muscle fiber-type
determination, we tested the role of these factors in the control
of the PGC-1? promoter."
"2766","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Because MEF2 and NFAT transcription factors are
known targets of CaMKIV and CnA in muscle fiber-type
determination, we tested the role of these factors in the control
of the PGC-1? promoter."
"2767","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"As shown in Fig. 2A, a
coactivation by PGC-1? of both MEF2C and MEF2D, but not
NFAT, was observed on the PGC-1? promoter. These data
suggest that PGC-1? might participate in the activation of its own
promoter and that the MEF2 proteins may function both in the
regulation of PGC-1? expression and as downstream targets of
PGC-1? coactivation of other muscle-selective genes."
"2768","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"As shown in Fig. 2A, a
coactivation by PGC-1? of both MEF2C and MEF2D, but not
NFAT, was observed on the PGC-1? promoter. These data
suggest that PGC-1? might participate in the activation of its own
promoter and that the MEF2 proteins may function both in the
regulation of PGC-1? expression and as downstream targets of
PGC-1? coactivation of other muscle-selective genes."
"2769","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"We next examined whether mutations of this MEF2 site affects
MEF2 activity on the PGC-1? promoter. The mutated 2-kb
promoter (called ?MEF2; see Fig. 3A) is no longer able to
mediate MEF2C or MEF2D induction alone, when activated by
CnA or coactivated by PGC-1?, suggesting that this site is
responsible for the MEF2 action (Fig. 3B). Moreover, electrophoretic
mobility-shift assays revealed binding of MEF2C to this
MEF-binding site but not the mutated ?MEF site in the PGC-1?
promoter (Fig. 3C). The identity of the MEF2C–DNA complex
was confirmed by using an anti-MEF2 antibody that leads to a
supershift of the DNA–protein complex."
"2770","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"We next examined whether mutations of this MEF2 site affects
MEF2 activity on the PGC-1? promoter. The mutated 2-kb
promoter (called ?MEF2; see Fig. 3A) is no longer able to
mediate MEF2C or MEF2D induction alone, when activated by
CnA or coactivated by PGC-1?, suggesting that this site is
responsible for the MEF2 action (Fig. 3B). Moreover, electrophoretic
mobility-shift assays revealed binding of MEF2C to this
MEF-binding site but not the mutated ?MEF site in the PGC-1?
promoter (Fig. 3C). The identity of the MEF2C–DNA complex
was confirmed by using an anti-MEF2 antibody that leads to a
supershift of the DNA–protein complex."
"2771","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"To confirm that the coactivation of MEF2C by PGC-1?
observed in reporter gene assays (Fig. 3B) was linked to direct
binding of these two proteins, we tested whether PGC-1? directly
interacts with MEF2C on this MEF-binding site. Increasing
amounts of PGC-1? protein (amino acids 31–797) decreased the
mobility of the complex containing MEF2C bound to the
MEF-binding site, as visualized by a supershift in electrophoretic
mobility-shift assays (Fig. 3D). As a control, PGC-1? protein that
lacks the MEF2C-interaction domain (amino acids 1–180; see
ref. 7) was not able to bind to MEF2C. Inclusion of an MEF2-
specific antibody was able to supershift further the protein–DNA
complex containing MEF2C, PGC-1?, and the MEF2-binding
site (Fig. 3E). Neither a shift nor a supershift could be obtained
when using the mutated ?MEF site. These results indicate that
MEF2s bind to the PGC-1? promoter and that PGC-1? coactivates
MEF2 proteins on the PGC-1? promoter by a direct
protein–protein interaction."
"2772","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"To confirm that the coactivation of MEF2C by PGC-1?
observed in reporter gene assays (Fig. 3B) was linked to direct
binding of these two proteins, we tested whether PGC-1? directly
interacts with MEF2C on this MEF-binding site. Increasing
amounts of PGC-1? protein (amino acids 31–797) decreased the
mobility of the complex containing MEF2C bound to the
MEF-binding site, as visualized by a supershift in electrophoretic
mobility-shift assays (Fig. 3D). As a control, PGC-1? protein that
lacks the MEF2C-interaction domain (amino acids 1–180; see
ref. 7) was not able to bind to MEF2C. Inclusion of an MEF2-
specific antibody was able to supershift further the protein–DNA
complex containing MEF2C, PGC-1?, and the MEF2-binding
site (Fig. 3E). Neither a shift nor a supershift could be obtained
when using the mutated ?MEF site. These results indicate that
MEF2s bind to the PGC-1? promoter and that PGC-1? coactivates
MEF2 proteins on the PGC-1? promoter by a direct
protein–protein interaction."
"2773","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Real-time PCR
primers were designed for the PGC-1? 3' untranslated region
that allows for determination of the levels of ectopically expressed
and endogenous PGC-1?. As shown in Fig. 4B and as
expected, ectopic PGC-1? is detected only in the muscle of
transgenic mice. Strikingly, a 7-fold elevation of endogenous
PGC-1? mRNA was seen in the transgenic animals as compared
with wild-type mice (Fig. 4B). A robust increase in the transcript
levels of cytochrome c and myoglobin also was observed in the
RNA isolated from skeletal muscle of the transgenic mice,
whereas GAPDH transcript levels remained unchanged (Fig.
4B). These results indicate a regulation of PGC-1? transcription
by PGC-1? protein in an apparent autoregulatory loop."
"2774","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Expression of
myoglobin in C2C12 myotubes also required infection of both
PGC-1? and MEF2C (Fig. 5C)."
"2775","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Troponin I slow is induced after infection with virally encoded
MEF2C, and the addition of PGC-1? has no further effect (Fig.
5D). In contrast, GLUT4 transcript levels can be elevated by
PGC-1? alone, independent of MEF2C infection, consistent
with previous reports (7) (Fig. 5E)."
"2776","Handschin CRhee JLin JTarr PTSpiegelman BM","12764228","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Troponin I slow is induced after infection with virally encoded
MEF2C, and the addition of PGC-1? has no further effect (Fig.
5D). In contrast, GLUT4 transcript levels can be elevated by
PGC-1? alone, independent of MEF2C infection, consistent
with previous reports (7) (Fig. 5E)."
"2777","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:increases","false",,,"The anaphase-promoting complex (APC) or cyclosome is a ubiquitin ligase that initiates anaphase and mitotic exit. "
"2778","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:increases","false",,,"The anaphase-promoting complex (APC) or cyclosome is a ubiquitin ligase that initiates anaphase and mitotic exit. "
"2779","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"APC activation is thought to depend on APC phosphorylation and Cdc20 binding."
"2780","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"APC phosphorylation by Cdk1, but not by Plk1, is sufficient for increased Cdc20 binding and APC activation. "
"2781","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"APC phosphorylation by Cdk1, but not by Plk1, is sufficient for increased Cdc20 binding and APC activation. "
"2782","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:causesNoChange","false",,,"APC phosphorylation by Cdk1, but not by Plk1, is sufficient for increased Cdc20 binding and APC activation. "
"2783","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:causesNoChange","false",,,"APC phosphorylation by Cdk1, but not by Plk1, is sufficient for increased Cdc20 binding and APC activation. "
"2784","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:positiveCorrelation","false",,,"Cdc20 peptides were only found in mitotic APC samples, confirming that Cdc20 associates with APC in a mitosis-specific manner. "
"2785","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:positiveCorrelation","false",,,"We raised antibodies against two mitosis-specific sites on Cdc27 (phospho-S427 and phospho-T447) and one each on Apc1 (phospho-S355), Cdc16 (phospho-S558) and Cdc23 (phospho-T556). "
"2786","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:positiveCorrelation","false",,,"We raised antibodies against two mitosis-specific sites on Cdc27 (phospho-S427 and phospho-T447) and one each on Apc1 (phospho-S355), Cdc16 (phospho-S558) and Cdc23 (phospho-T556). "
"2787","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:positiveCorrelation","false",,,"We raised antibodies against two mitosis-specific sites on Cdc27 (phospho-S427 and phospho-T447) and one each on Apc1 (phospho-S355), Cdc16 (phospho-S558) and Cdc23 (phospho-T556). "
"2788","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:positiveCorrelation","false",,,"We raised antibodies against two mitosis-specific sites on Cdc27 (phospho-S427 and phospho-T447) and one each on Apc1 (phospho-S355), Cdc16 (phospho-S558) and Cdc23 (phospho-T556). "
"2789","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:positiveCorrelation","false",,,"We raised antibodies against two mitosis-specific sites on Cdc27 (phospho-S427 and phospho-T447) and one each on Apc1 (phospho-S355), Cdc16 (phospho-S558) and Cdc23 (phospho-T556). "
"2790","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"Immunopurified S-phase APC was phosphorylated in vitro using Cdk1, Plk1, or both in the presence of either non-radioactive ATP or [gamma-32P]ATP. The latter reactions were analysed by SDS–PAGE followed by silver staining and phosphorimaging (Figure 3A). Both kinases were able to phosphorylate Apc1, Cdc27, Apc5, Cdc16 and Cdc23. "
"2791","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"Immunopurified S-phase APC was phosphorylated in vitro using Cdk1, Plk1, or both in the presence of either non-radioactive ATP or [gamma-32P]ATP. The latter reactions were analysed by SDS–PAGE followed by silver staining and phosphorimaging (Figure 3A). Both kinases were able to phosphorylate Apc1, Cdc27, Apc5, Cdc16 and Cdc23. "
"2792","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"Immunopurified S-phase APC was phosphorylated in vitro using Cdk1, Plk1, or both in the presence of either non-radioactive ATP or [gamma-32P]ATP. The latter reactions were analysed by SDS–PAGE followed by silver staining and phosphorimaging (Figure 3A). Both kinases were able to phosphorylate Apc1, Cdc27, Apc5, Cdc16 and Cdc23. "
"2793","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"Immunopurified S-phase APC was phosphorylated in vitro using Cdk1, Plk1, or both in the presence of either non-radioactive ATP or [gamma-32P]ATP. The latter reactions were analysed by SDS–PAGE followed by silver staining and phosphorimaging (Figure 3A). Both kinases were able to phosphorylate Apc1, Cdc27, Apc5, Cdc16 and Cdc23. "
"2794","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"Immunopurified S-phase APC was phosphorylated in vitro using Cdk1, Plk1, or both in the presence of either non-radioactive ATP or [gamma-32P]ATP. The latter reactions were analysed by SDS–PAGE followed by silver staining and phosphorimaging (Figure 3A). Both kinases were able to phosphorylate Apc1, Cdc27, Apc5, Cdc16 and Cdc23. "
"2795","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"Immunopurified S-phase APC was phosphorylated in vitro using Cdk1, Plk1, or both in the presence of either non-radioactive ATP or [gamma-32P]ATP. The latter reactions were analysed by SDS–PAGE followed by silver staining and phosphorimaging (Figure 3A). Both kinases were able to phosphorylate Apc1, Cdc27, Apc5, Cdc16 and Cdc23. "
"2796","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"Immunopurified S-phase APC was phosphorylated in vitro using Cdk1, Plk1, or both in the presence of either non-radioactive ATP or [gamma-32P]ATP. The latter reactions were analysed by SDS–PAGE followed by silver staining and phosphorimaging (Figure 3A). Both kinases were able to phosphorylate Apc1, Cdc27, Apc5, Cdc16 and Cdc23. "
"2797","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"Immunopurified S-phase APC was phosphorylated in vitro using Cdk1, Plk1, or both in the presence of either non-radioactive ATP or [gamma-32P]ATP. The latter reactions were analysed by SDS–PAGE followed by silver staining and phosphorimaging (Figure 3A). Both kinases were able to phosphorylate Apc1, Cdc27, Apc5, Cdc16 and Cdc23. "
"2798","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"Immunopurified S-phase APC was phosphorylated in vitro using Cdk1, Plk1, or both in the presence of either non-radioactive ATP or [gamma-32P]ATP. The latter reactions were analysed by SDS–PAGE followed by silver staining and phosphorimaging (Figure 3A). Both kinases were able to phosphorylate Apc1, Cdc27, Apc5, Cdc16 and Cdc23. "
"2799","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:directlyIncreases","false",,,"Immunopurified S-phase APC was phosphorylated in vitro using Cdk1, Plk1, or both in the presence of either non-radioactive ATP or [gamma-32P]ATP. The latter reactions were analysed by SDS–PAGE followed by silver staining and phosphorimaging (Figure 3A). Both kinases were able to phosphorylate Apc1, Cdc27, Apc5, Cdc16 and Cdc23. "
"2800","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:decreases","false",,,"We recently found that HeLa cells depleted of Plk1 by this protocol enter mitosis but are then delayed in prometaphase by the spindle checkpoint."
"2801","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:increases","false",,,"We recently found that HeLa cells depleted of Plk1 by this protocol enter mitosis but are then delayed in prometaphase by the spindle checkpoint."
"2802","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:causesNoChange","false",,,"When APC was isolated from Plk1 RNAi cells or from control cells 10 h after the second thymidine release, i.e. when control cells were progressing through mitosis and when most Plk1 RNAi cells were in prometaphase, no difference in the ubiquitination activities of the APC samples could be detected, further supporting the notion that APC activation was not compromised in the Plk1 RNAi cells (Figure 7B). "
"2803","Kraft CHerzog FGieffers CMechtler KHagting APines JPeters JM","14657031","The EMBO journal","PubMed",,,"bel:causesNoChange","false",,,"These observations indicate that normal Plk1 levels are not essential for APC-mediated degradation of cyclin A. "
"2804","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:increases","false",,,"Mutations and
deletions of tumor suppressor genes, such as p53 or PTEN
(phosphatase and tensin homologue deleted on chromosome 10),
are two of the several events underlying the loss of apoptotic
pathways (4)."
"2805","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:increases","false",,,"Mutations and
deletions of tumor suppressor genes, such as p53 or PTEN
(phosphatase and tensin homologue deleted on chromosome 10),
are two of the several events underlying the loss of apoptotic
pathways (4)."
"2806","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:directlyIncreases","false",,,"The interaction of the cell survival kinase, Akt1 (5), with
the prostate apoptosis response-4 protein, Par-4 (6), results in
phosphorylation and silencing of Par-4 (7) and thus offers an
intervention target for the selective induction of apoptosis in
cancer cells."
"2807","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:directlyDecreases","false",,,"The interaction of the cell survival kinase, Akt1 (5), with
the prostate apoptosis response-4 protein, Par-4 (6), results in
phosphorylation and silencing of Par-4 (7) and thus offers an
intervention target for the selective induction of apoptosis in
cancer cells."
"2808","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Akt1 is a key cell survival protein functionally involved in
antiapoptosis in various cancers (8, 9)."
"2809","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Akt1 activity is elevated
in cancer due to the loss of PTEN tumor suppressor function"
"2810","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Fig1A, Akt1, which is activated by PI3K, plays a central role in cell survival by inactivating key agonists
of apoptosis."
"2811","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Fig1A, Akt1, which is activated by PI3K, plays a central role in cell survival by inactivating key agonists
of apoptosis."
"2812","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:increases","false",,,"Fig1A, Akt1, which is activated by PI3K, plays a central role in cell survival by inactivating key agonists
of apoptosis."
"2813","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Fig1A, Akt1, which is activated by PI3K, plays a central role in cell survival by inactivating key agonists
of apoptosis."
"2814","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Fig1A, Akt1, which is activated by PI3K, plays a central role in cell survival by inactivating key agonists
of apoptosis."
"2815","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Fig1A, Akt1, which is activated by PI3K, plays a central role in cell survival by inactivating key agonists
of apoptosis."
"2816","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Fig1A, Akt1, which is activated by PI3K, plays a central role in cell survival by inactivating key agonists
of apoptosis."
"2817","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Fig1A, Akt1, which is activated by PI3K, plays a central role in cell survival by inactivating key agonists
of apoptosis."
"2818","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:increases","false",,,"inhibition of endogenous Par-4 with antisense oligodeoxynucleotides,
a dominant-negative leucine zipper domain, or RNA
interference precludes apoptosis"
"2819","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:increases","false",,,"inhibition of endogenous Par-4 with antisense oligodeoxynucleotides,
a dominant-negative leucine zipper domain, or RNA
interference precludes apoptosis"
"2820","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Par-4 knockout mice spontaneously
develop tumors of the liver, lung, and endometrium,
exhibit prostatic intraepithelial neoplasia (PIN), and show an
increased frequency of estrogen-inducible tumors in the endometrium
and BBN-inducible tumors in the bladder (18)."
"2821","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Par-4 knockout mice spontaneously
develop tumors of the liver, lung, and endometrium,
exhibit prostatic intraepithelial neoplasia (PIN), and show an
increased frequency of estrogen-inducible tumors in the endometrium
and BBN-inducible tumors in the bladder (18)."
"2822","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Par-4 knockout mice spontaneously
develop tumors of the liver, lung, and endometrium,
exhibit prostatic intraepithelial neoplasia (PIN), and show an
increased frequency of estrogen-inducible tumors in the endometrium
and BBN-inducible tumors in the bladder (18)."
"2823","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Par-4 knockout mice spontaneously
develop tumors of the liver, lung, and endometrium,
exhibit prostatic intraepithelial neoplasia (PIN), and show an
increased frequency of estrogen-inducible tumors in the endometrium
and BBN-inducible tumors in the bladder (18)."
"2824","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:causesNoChange","false",,,"Par-4 action is not
inhibited by Bcl-2 or BclxL overexpression (19)."
"2825","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:causesNoChange","false",,,"Par-4 action is not
inhibited by Bcl-2 or BclxL overexpression (19)."
"2826","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:increases","false",,,"Importantly,
overexpression of Par-4 in prostate cancer xenografts by i.t.
injections of adenoviral Par-4, either in s.c. tumors in nude mice
or in orthotopic tumors in the prostatic milieu (6, 19), results in
apoptosis and tumor growth inhibition,"
"2827","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Importantly,
overexpression of Par-4 in prostate cancer xenografts by i.t.
injections of adenoviral Par-4, either in s.c. tumors in nude mice
or in orthotopic tumors in the prostatic milieu (6, 19), results in
apoptosis and tumor growth inhibition,"
"2828","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:directlyIncreases","false",,,"Indeed, our recent studies reveal that
binding of Akt1 to Par-4 results in both Par-4 phosphorylation and
inactivation of its proapoptotic potential (7)."
"2829","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:directlyDecreases","false",,,"Indeed, our recent studies reveal that
binding of Akt1 to Par-4 results in both Par-4 phosphorylation and
inactivation of its proapoptotic potential (7)."
"2830","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"Nuclear translocation of Par-4 is essential for the inhibition of NFKB-dependent transcriptional activity"
"2831","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:directlyIncreases","false",,,"Akt1 binding and phosphorylation of Par-4 results in 14-3-3-mediated cytoplasmic retention of Par-4 and abrogation of apoptosis."
"2832","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:directlyIncreases","false",,,"although phosphorylation of Par-4 at the T155 residue by PKA activates the Par-4 apoptotic potential in cancer cells, T155 phosphorylation does not induce apoptosis in the presence of Par-4 phosphorylation by AKT1 and cytoplasmic retention by 14-3-3 proteins."
"2833","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:increases","false",,,"although phosphorylation of Par-4 at the T155 residue by PKA activates the Par-4 apoptotic potential in cancer cells, T155 phosphorylation does not induce apoptosis in the presence of Par-4 phosphorylation by AKT1 and cytoplasmic retention by 14-3-3 proteins."
"2834","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:increases","false",,,"We recently showed that the cancer-selective proapoptotic protein Par-4 is a key target for inactivation by PI3K/Akt signaling"
"2835","Goswami ARanganathan PRangnekar VM","16540633","Cancer research","PubMed",,,"bel:decreases","false",,,"We recently showed that the cancer-selective proapoptotic protein Par-4 is a key target for inactivation by PI3K/Akt signaling"
"2836","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:directlyIncreases","false",,,"To generate mice that express
a constitutively active mutant of Hck (i.e., HckY499F),
we used gene targeting in ES cells to introduce a tyrosine
(Y499) to phenylalanine (F) substitution in exon 13 of the
endogenous hck gene."
"2837","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:increases","false",,,"the lungs of all
adult HckF/F mice (3–4 mo and older) showed areas of
atelectasis, inflammatory infiltration into the interstitium
and alveoli, and some areas of enlarged airspaces"
"2838","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:increases","false",,,"the lungs of all
adult HckF/F mice (3–4 mo and older) showed areas of
atelectasis, inflammatory infiltration into the interstitium
and alveoli, and some areas of enlarged airspaces"
"2839","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:increases","false",,,"Eosinophils represented the most prominent
cell type within the infiltrates (30 ± 9% of total
BAL-F cells in HckF/F mice versus 2 ± 1% in HckY/Y mice)."
"2840","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:increases","false",,,"The epithelium lining
conducting airways was frequently hypertrophic and many
epithelial cells were enlarged due to excessive production
and/or accumulation of mucus material (Fig. 2, c and d)."
"2841","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:increases","false",,,"lungs from HckF/F mice showed areas of
mild emphysema, as histologically evident from alveolar
enlargement with the loss of the orderly appearance of the
acinus, and signs of fibrosis characterized by deposition of
extracellular matrix in the alveolar septa (Fig. 2, e and f)."
"2842","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:increases","false",,,"lungs from HckF/F mice showed areas of
mild emphysema, as histologically evident from alveolar
enlargement with the loss of the orderly appearance of the
acinus, and signs of fibrosis characterized by deposition of
extracellular matrix in the alveolar septa (Fig. 2, e and f)."
"2843","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:increases","false",,,"BAL-F recovered from the lungs of mutant
mice revealed elevated levels of IL-5 (70 ± 27 pg/ml
in HckY/Y versus 17 ± 5 pg/ml in HckY/Y) and eotaxin
(37 ± 8 pg/ml in HckY/Y versus 23 ± 4 pg/ml in HckY/Y),
features associated with eosinophilia (28, 29)."
"2844","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:increases","false",,,"BAL-F recovered from the lungs of mutant
mice revealed elevated levels of IL-5 (70 ± 27 pg/ml
in HckY/Y versus 17 ± 5 pg/ml in HckY/Y) and eotaxin
(37 ± 8 pg/ml in HckY/Y versus 23 ± 4 pg/ml in HckY/Y),
features associated with eosinophilia (28, 29)."
"2845","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:positiveCorrelation","false",,,"BAL-F recovered from the lungs of mutant
mice revealed elevated levels of IL-5 (70 ± 27 pg/ml
in HckY/Y versus 17 ± 5 pg/ml in HckY/Y) and eotaxin
(37 ± 8 pg/ml in HckY/Y versus 23 ± 4 pg/ml in HckY/Y),
features associated with eosinophilia (28, 29)."
"2846","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:positiveCorrelation","false",,,"BAL-F recovered from the lungs of mutant
mice revealed elevated levels of IL-5 (70 ± 27 pg/ml
in HckY/Y versus 17 ± 5 pg/ml in HckY/Y) and eotaxin
(37 ± 8 pg/ml in HckY/Y versus 23 ± 4 pg/ml in HckY/Y),
features associated with eosinophilia (28, 29)."
"2847","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:increases","false",,,"Such a pulmonary
challenge with LPS elicits a rapid and transient neutrophilic
inflammatory response, followed by macrophage
invasion into the alveolar spaces (31)."
"2848","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:increases","false",,,"Such a pulmonary
challenge with LPS elicits a rapid and transient neutrophilic
inflammatory response, followed by macrophage
invasion into the alveolar spaces (31)."
"2849","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:increases","false",,,"By contrast, the
number of macrophages and eosinophils in BAL-F from
unchallenged HckF/F mice were profoundly elevated in
comparison to those detected in BAL-F from unchallenged
HckY/Y mice, with macrophages accounting for about onethird
of all cells recovered in BAL-F from HckF/F mice"
"2850","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:increases","false",,,"Collectively,
these observations suggested that monocytes and
macrophages in HckF/F mice have enhanced phagocytic activity."
"2851","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:increases","false",,,"PMNs derived from HckF/F
mice had a modestly enhanced migratory capacity when
compared with PMNs from wild-type mice (unpublished
data)."
"2852","Ernst MInglese MScholz GMHarder KWClay FJBozinovski SWaring PDarwiche RKay TSly PCollins RTurner DHibbs MLAnderson GPDunn AR","12208875","The Journal of experimental medicine","PubMed",,,"bel:increases","false",,,"BMDMs derived from HckF/F mice exhibited an
enhanced capacity to migrate when tested in in vitro
""wound-healing"" assays (unpublished data)."
"2853","Klinge CMKaur KSwanson HI","10620335","Archives of biochemistry and biophysics","PubMed",,,"bel:decreases","false",,,"In transiently transfected
MCF-7 human breast cancer cells, overexpression of
COUP-TFI inhibited TCDD-activated reporter gene
activity from the CYP1A1 promoter. TCDD inhibited
estradiol (E2)-activated reporter gene activity from a
consensus ERE and from the EREs in the pS2 and Fos
genes, and COUP-TFI did not block the antiestrogenic
activity of TCDD."
"2854","Klinge CMKaur KSwanson HI","10620335","Archives of biochemistry and biophysics","PubMed",,,"bel:increases","false",,,"In transiently transfected
MCF-7 human breast cancer cells, overexpression of
COUP-TFI inhibited TCDD-activated reporter gene
activity from the CYP1A1 promoter. TCDD inhibited
estradiol (E2)-activated reporter gene activity from a
consensus ERE and from the EREs in the pS2 and Fos
genes, and COUP-TFI did not block the antiestrogenic
activity of TCDD."
"2855","Klinge CMKaur KSwanson HI","10620335","Archives of biochemistry and biophysics","PubMed",,,"bel:increases","false",,,"Estradiol reportedly blocked TCDD-induced accumulation
of CYP1A1 mRNA and AHR-mediated activation
of the CYP1A1 gene promoter in MCF-7 cells
(32)."
"2856","Klinge CMKaur KSwanson HI","10620335","Archives of biochemistry and biophysics","PubMed",,,"bel:directlyIncreases","false",,,"Estradiol reportedly blocked TCDD-induced accumulation
of CYP1A1 mRNA and AHR-mediated activation
of the CYP1A1 gene promoter in MCF-7 cells
(32)."
"2857","Klinge CMKaur KSwanson HI","10620335","Archives of biochemistry and biophysics","PubMed",,,"bel:increases","false",,,"We examined how TCDD, alone or in combination
with E2, affected luciferase reporter gene expression
from the CYP1A1 promoter in MCF-7 cells. As anticipated,
TCDD induced a 3.5-fold induction of luciferase
activity (Fig. 7A). E2 stimulated a 2-fold induction of
luciferase activity from the CYP1A1 promoter."
"2858","Klinge CMKaur KSwanson HI","10620335","Archives of biochemistry and biophysics","PubMed",,,"bel:increases","false",,,"We examined how TCDD, alone or in combination
with E2, affected luciferase reporter gene expression
from the CYP1A1 promoter in MCF-7 cells. As anticipated,
TCDD induced a 3.5-fold induction of luciferase
activity (Fig. 7A). E2 stimulated a 2-fold induction of
luciferase activity from the CYP1A1 promoter."
"2859","Klinge CMKaur KSwanson HI","10620335","Archives of biochemistry and biophysics","PubMed",,,"bel:increases","false",,,"TCDD inhibits E2-induction of pS2, a human breast
cancer prognostic marker (47), and stimulates c-fos
expression (48)."
"2860","Klinge CMKaur KSwanson HI","10620335","Archives of biochemistry and biophysics","PubMed",,,"bel:increases","false",,,"TCDD inhibits E2-induction of pS2, a human breast
cancer prognostic marker (47), and stimulates c-fos
expression (48)."
"2861","Klinge CMKaur KSwanson HI","10620335","Archives of biochemistry and biophysics","PubMed",,,"bel:increases","false",,,"Here we tested how expression of
COUP–TFI affected TCDD activity from the natural
ERE sequences from the pS2 and c-fos promoters in
transiently transfected MCF-7 cells. E2 alone stimulated
a 1.6- to 2.1-fold induction in luciferase activity
from the pS2 ERE (Fig. 8A). 4-OHT blocked the E2
activity, indicating the specificity of the induction by
ER. TCDD alone gave a 1.4-fold induction in luciferase
activity. Cotreatment with TCDD suppressed E2-stimulated
luciferase activity. COUP–TFI inhibited both
E2- and TCDD-stimulated luciferase activity from pS2."
"2862","Klinge CMKaur KSwanson HI","10620335","Archives of biochemistry and biophysics","PubMed",,,"bel:increases","false",,,"Here we tested how expression of
COUP–TFI affected TCDD activity from the natural
ERE sequences from the pS2 and c-fos promoters in
transiently transfected MCF-7 cells. E2 alone stimulated
a 1.6- to 2.1-fold induction in luciferase activity
from the pS2 ERE (Fig. 8A). 4-OHT blocked the E2
activity, indicating the specificity of the induction by
ER. TCDD alone gave a 1.4-fold induction in luciferase
activity. Cotreatment with TCDD suppressed E2-stimulated
luciferase activity. COUP–TFI inhibited both
E2- and TCDD-stimulated luciferase activity from pS2."
"2863","Klinge CMKaur KSwanson HI","10620335","Archives of biochemistry and biophysics","PubMed",,,"bel:directlyIncreases","false",,,"Although both ERa and AHR/ARNT specifically interact
with the regulatory region of the c-fos gene, only
E2 induced reporter activity from the FOS-1211 construct
(Fig. 8B). The FOS-1211 oligomer binds ERa and AHR/ARNT in EMSA (data not shown). TCDD
suppressed the E2-stimulated luciferase activity. COUP–TFI significantly inhibited E2-stimulated luciferase
activity from FOS–1211, but had no effect in
TCDD-treated cells."
"2864","Klinge CMKaur KSwanson HI","10620335","Archives of biochemistry and biophysics","PubMed",,,"bel:increases","false",,,"Although both ERa and AHR/ARNT specifically interact
with the regulatory region of the c-fos gene, only
E2 induced reporter activity from the FOS-1211 construct
(Fig. 8B). The FOS-1211 oligomer binds ERa and AHR/ARNT in EMSA (data not shown). TCDD
suppressed the E2-stimulated luciferase activity. COUP–TFI significantly inhibited E2-stimulated luciferase
activity from FOS–1211, but had no effect in
TCDD-treated cells."
"2865","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:association","false",,,"Glycogen synthase kinase 3 (GSK-3) is implicated in multiple
biological processes including metabolism, gene expression, cell
fate determination, proliferation, and survival. GSK-3 activity is
inhibited through phosphorylation of serine 21 in GSK-3a and
serine 9 in GSK-3b."
"2866","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:association","false",,,"Glycogen synthase kinase 3 (GSK-3) is implicated in multiple
biological processes including metabolism, gene expression, cell
fate determination, proliferation, and survival. GSK-3 activity is
inhibited through phosphorylation of serine 21 in GSK-3a and
serine 9 in GSK-3b."
"2867","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyDecreases","false",,,"GSK-3 activity is
inhibited through phosphorylation of serine 21 in GSK-3a and
serine 9 in GSK-3b. These serine residues of GSK-3 have been
previously identified as targets of protein kinase B (PKByAkt), a
serineythreonine kinase located downstream of phosphatidylinositol
3-kinase."
"2868","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyDecreases","false",,,"GSK-3 activity is
inhibited through phosphorylation of serine 21 in GSK-3a and
serine 9 in GSK-3b. These serine residues of GSK-3 have been
previously identified as targets of protein kinase B (PKByAkt), a
serineythreonine kinase located downstream of phosphatidylinositol
3-kinase."
"2869","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"GSK-3 activity is
inhibited through phosphorylation of serine 21 in GSK-3a and
serine 9 in GSK-3b. These serine residues of GSK-3 have been
previously identified as targets of protein kinase B (PKByAkt), a
serineythreonine kinase located downstream of phosphatidylinositol
3-kinase."
"2870","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"GSK-3 activity is
inhibited through phosphorylation of serine 21 in GSK-3a and
serine 9 in GSK-3b. These serine residues of GSK-3 have been
previously identified as targets of protein kinase B (PKByAkt), a
serineythreonine kinase located downstream of phosphatidylinositol
3-kinase."
"2871","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyDecreases","false",,,"GSK-3 activity is
inhibited through phosphorylation of serine 21 in GSK-3a and
serine 9 in GSK-3b. These serine residues of GSK-3 have been
previously identified as targets of protein kinase B (PKByAkt), a
serineythreonine kinase located downstream of phosphatidylinositol
3-kinase."
"2872","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyDecreases","false",,,"GSK-3 activity is
inhibited through phosphorylation of serine 21 in GSK-3a and
serine 9 in GSK-3b. These serine residues of GSK-3 have been
previously identified as targets of protein kinase B (PKByAkt), a
serineythreonine kinase located downstream of phosphatidylinositol
3-kinase."
"2873","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"Here, we show that serine 21 in GSK-3a and
serine 9 in GSK-3b are also physiological substrates of cAMPdependent
protein kinase A. Protein kinase A physically associates
with, phosphorylates, and inactivates both isoforms of
GSK-3."
"2874","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"Here, we show that serine 21 in GSK-3a and
serine 9 in GSK-3b are also physiological substrates of cAMPdependent
protein kinase A. Protein kinase A physically associates
with, phosphorylates, and inactivates both isoforms of
GSK-3."
"2875","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyDecreases","false",,,"Here, we show that serine 21 in GSK-3a and
serine 9 in GSK-3b are also physiological substrates of cAMPdependent
protein kinase A. Protein kinase A physically associates
with, phosphorylates, and inactivates both isoforms of
GSK-3."
"2876","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyDecreases","false",,,"Here, we show that serine 21 in GSK-3a and
serine 9 in GSK-3b are also physiological substrates of cAMPdependent
protein kinase A. Protein kinase A physically associates
with, phosphorylates, and inactivates both isoforms of
GSK-3."
"2877","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2878","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2879","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2880","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2881","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2882","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2883","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2884","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2885","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2886","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2887","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2888","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2889","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2890","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2891","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2892","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"In Rat1, NIH 3T3, and HEK293 cells, increases in the
intracellular levels of cAMP stimulate phosphorylation of
GSK-3a and -b, as demonstrated by immunoblotting with
GSK-3 phosphorylation-specific antibodies. As shown in Fig.
1, the cell-permeable cAMP analogue 8-Br-cAMP induced a
marked increase in phosphorylation of GSK-3a and -b at
serine 21 and 9, respectively, whereas the structurally related
cGMP analogue 8-Br-cGMP had little effect. Forskolin, which
activates adenyl cyclase thus raising intracellular cAMP levels
(15), triggered a similar elevation in GSK-3 phosphorylation at
serine 21 and 9. In Rat1 cells, isoproterenol, which activates
the b-adrenergic receptor stimulating adenylate cyclase and
increasing endogenous cAMP levels (16, 17), also efficiently
stimulated GSK-3 phosphorylation at these serine sites. In
NIH 3T3 cells that contain few of the b-adrenergic receptors,
stimulation with other G-protein-coupled receptor agonists,
such as lysophosphatidic acid. also led to GSK-3 phosphorylation
(data not shown)"
"2893","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"PI3K-dependent
activation of PKB is an intermediary in the phosphorylation and
inactivation of GSK-3 induced by insulin and other growth
factors (10, 12, 14). Insulin and IGF-1 efficiently activate the
PI3K pathway in NIH 3T3 and Rat1 cells, respectively. GSK-3
phosphorylation induced by insulin and IGF-1 were eliminated
by pretreatment with the PI3K inhibitors wortmannin or
LY294002. In contrast, the effects of 8-Br-cAMP or forskolin on
GSK-3 phosphorylation in these cell lines were not altered by
inhibition of PI3K activity with wortmannin or LY294002 (Fig.
2A), excluding the possibility that PKA induces GSK-3 phosphorylation
through activation of PI3K."
"2894","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"PI3K-dependent
activation of PKB is an intermediary in the phosphorylation and
inactivation of GSK-3 induced by insulin and other growth
factors (10, 12, 14). Insulin and IGF-1 efficiently activate the
PI3K pathway in NIH 3T3 and Rat1 cells, respectively. GSK-3
phosphorylation induced by insulin and IGF-1 were eliminated
by pretreatment with the PI3K inhibitors wortmannin or
LY294002. In contrast, the effects of 8-Br-cAMP or forskolin on
GSK-3 phosphorylation in these cell lines were not altered by
inhibition of PI3K activity with wortmannin or LY294002 (Fig.
2A), excluding the possibility that PKA induces GSK-3 phosphorylation
through activation of PI3K."
"2895","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"PI3K-dependent
activation of PKB is an intermediary in the phosphorylation and
inactivation of GSK-3 induced by insulin and other growth
factors (10, 12, 14). Insulin and IGF-1 efficiently activate the
PI3K pathway in NIH 3T3 and Rat1 cells, respectively. GSK-3
phosphorylation induced by insulin and IGF-1 were eliminated
by pretreatment with the PI3K inhibitors wortmannin or
LY294002. In contrast, the effects of 8-Br-cAMP or forskolin on
GSK-3 phosphorylation in these cell lines were not altered by
inhibition of PI3K activity with wortmannin or LY294002 (Fig.
2A), excluding the possibility that PKA induces GSK-3 phosphorylation
through activation of PI3K."
"2896","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"PI3K-dependent
activation of PKB is an intermediary in the phosphorylation and
inactivation of GSK-3 induced by insulin and other growth
factors (10, 12, 14). Insulin and IGF-1 efficiently activate the
PI3K pathway in NIH 3T3 and Rat1 cells, respectively. GSK-3
phosphorylation induced by insulin and IGF-1 were eliminated
by pretreatment with the PI3K inhibitors wortmannin or
LY294002. In contrast, the effects of 8-Br-cAMP or forskolin on
GSK-3 phosphorylation in these cell lines were not altered by
inhibition of PI3K activity with wortmannin or LY294002 (Fig.
2A), excluding the possibility that PKA induces GSK-3 phosphorylation
through activation of PI3K."
"2897","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"PI3K-dependent
activation of PKB is an intermediary in the phosphorylation and
inactivation of GSK-3 induced by insulin and other growth
factors (10, 12, 14). Insulin and IGF-1 efficiently activate the
PI3K pathway in NIH 3T3 and Rat1 cells, respectively. GSK-3
phosphorylation induced by insulin and IGF-1 were eliminated
by pretreatment with the PI3K inhibitors wortmannin or
LY294002. In contrast, the effects of 8-Br-cAMP or forskolin on
GSK-3 phosphorylation in these cell lines were not altered by
inhibition of PI3K activity with wortmannin or LY294002 (Fig.
2A), excluding the possibility that PKA induces GSK-3 phosphorylation
through activation of PI3K."
"2898","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"PI3K-dependent
activation of PKB is an intermediary in the phosphorylation and
inactivation of GSK-3 induced by insulin and other growth
factors (10, 12, 14). Insulin and IGF-1 efficiently activate the
PI3K pathway in NIH 3T3 and Rat1 cells, respectively. GSK-3
phosphorylation induced by insulin and IGF-1 were eliminated
by pretreatment with the PI3K inhibitors wortmannin or
LY294002. In contrast, the effects of 8-Br-cAMP or forskolin on
GSK-3 phosphorylation in these cell lines were not altered by
inhibition of PI3K activity with wortmannin or LY294002 (Fig.
2A), excluding the possibility that PKA induces GSK-3 phosphorylation
through activation of PI3K."
"2899","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"To determine whether PKA-induced
PKB activation accounts for GSK-3 phosphorylation after treatment
with 8-Br-cAMP, forskolin, or isoproterenol, PKB phosphorylation
at serine 473 and threonine 308, which is crucial for
activation of PKB (20), was assessed. As expected, insulin and
IGF-1 strongly stimulated phosphorylation of PKB at serine 473
in NIH 3T3 or Rat1 cells (Fig. 2B). In contrast, 8-Br-cAMP,
forskolin, and isoproterenol did not significantly alter PKB
phosphorylation at serine 473 (Fig. 2B). Similar results were
obtained with a threonine 308 phosphorylation-specific antibody
(data not shown)."
"2900","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"To determine whether PKA-induced
PKB activation accounts for GSK-3 phosphorylation after treatment
with 8-Br-cAMP, forskolin, or isoproterenol, PKB phosphorylation
at serine 473 and threonine 308, which is crucial for
activation of PKB (20), was assessed. As expected, insulin and
IGF-1 strongly stimulated phosphorylation of PKB at serine 473
in NIH 3T3 or Rat1 cells (Fig. 2B). In contrast, 8-Br-cAMP,
forskolin, and isoproterenol did not significantly alter PKB
phosphorylation at serine 473 (Fig. 2B). Similar results were
obtained with a threonine 308 phosphorylation-specific antibody
(data not shown)."
"2901","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"To determine whether PKA-induced
PKB activation accounts for GSK-3 phosphorylation after treatment
with 8-Br-cAMP, forskolin, or isoproterenol, PKB phosphorylation
at serine 473 and threonine 308, which is crucial for
activation of PKB (20), was assessed. As expected, insulin and
IGF-1 strongly stimulated phosphorylation of PKB at serine 473
in NIH 3T3 or Rat1 cells (Fig. 2B). In contrast, 8-Br-cAMP,
forskolin, and isoproterenol did not significantly alter PKB
phosphorylation at serine 473 (Fig. 2B). Similar results were
obtained with a threonine 308 phosphorylation-specific antibody
(data not shown)."
"2902","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"To determine whether PKA-induced
PKB activation accounts for GSK-3 phosphorylation after treatment
with 8-Br-cAMP, forskolin, or isoproterenol, PKB phosphorylation
at serine 473 and threonine 308, which is crucial for
activation of PKB (20), was assessed. As expected, insulin and
IGF-1 strongly stimulated phosphorylation of PKB at serine 473
in NIH 3T3 or Rat1 cells (Fig. 2B). In contrast, 8-Br-cAMP,
forskolin, and isoproterenol did not significantly alter PKB
phosphorylation at serine 473 (Fig. 2B). Similar results were
obtained with a threonine 308 phosphorylation-specific antibody
(data not shown)."
"2903","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"To determine whether PKA-induced
PKB activation accounts for GSK-3 phosphorylation after treatment
with 8-Br-cAMP, forskolin, or isoproterenol, PKB phosphorylation
at serine 473 and threonine 308, which is crucial for
activation of PKB (20), was assessed. As expected, insulin and
IGF-1 strongly stimulated phosphorylation of PKB at serine 473
in NIH 3T3 or Rat1 cells (Fig. 2B). In contrast, 8-Br-cAMP,
forskolin, and isoproterenol did not significantly alter PKB
phosphorylation at serine 473 (Fig. 2B). Similar results were
obtained with a threonine 308 phosphorylation-specific antibody
(data not shown)."
"2904","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"To determine whether PKA-induced
PKB activation accounts for GSK-3 phosphorylation after treatment
with 8-Br-cAMP, forskolin, or isoproterenol, PKB phosphorylation
at serine 473 and threonine 308, which is crucial for
activation of PKB (20), was assessed. As expected, insulin and
IGF-1 strongly stimulated phosphorylation of PKB at serine 473
in NIH 3T3 or Rat1 cells (Fig. 2B). In contrast, 8-Br-cAMP,
forskolin, and isoproterenol did not significantly alter PKB
phosphorylation at serine 473 (Fig. 2B). Similar results were
obtained with a threonine 308 phosphorylation-specific antibody
(data not shown)."
"2905","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"To determine whether PKA-induced
PKB activation accounts for GSK-3 phosphorylation after treatment
with 8-Br-cAMP, forskolin, or isoproterenol, PKB phosphorylation
at serine 473 and threonine 308, which is crucial for
activation of PKB (20), was assessed. As expected, insulin and
IGF-1 strongly stimulated phosphorylation of PKB at serine 473
in NIH 3T3 or Rat1 cells (Fig. 2B). In contrast, 8-Br-cAMP,
forskolin, and isoproterenol did not significantly alter PKB
phosphorylation at serine 473 (Fig. 2B). Similar results were
obtained with a threonine 308 phosphorylation-specific antibody
(data not shown)."
"2906","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"To determine whether PKA-induced
PKB activation accounts for GSK-3 phosphorylation after treatment
with 8-Br-cAMP, forskolin, or isoproterenol, PKB phosphorylation
at serine 473 and threonine 308, which is crucial for
activation of PKB (20), was assessed. As expected, insulin and
IGF-1 strongly stimulated phosphorylation of PKB at serine 473
in NIH 3T3 or Rat1 cells (Fig. 2B). In contrast, 8-Br-cAMP,
forskolin, and isoproterenol did not significantly alter PKB
phosphorylation at serine 473 (Fig. 2B). Similar results were
obtained with a threonine 308 phosphorylation-specific antibody
(data not shown)."
"2907","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Forskolin increased PKB activity weakly in Rat1 and NIH 3T3
cells. A slightly stronger stimulation of PKB activity was seen in Rat1 cells treated with isoproterenol. However, activation of
PKB by forskolin or isoproterenol was much less than that
induced by IGF-1 or insulin (Fig. 2C)."
"2908","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Forskolin increased PKB activity weakly in Rat1 and NIH 3T3
cells. A slightly stronger stimulation of PKB activity was seen in Rat1 cells treated with isoproterenol. However, activation of
PKB by forskolin or isoproterenol was much less than that
induced by IGF-1 or insulin (Fig. 2C)."
"2909","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Forskolin increased PKB activity weakly in Rat1 and NIH 3T3
cells. A slightly stronger stimulation of PKB activity was seen in Rat1 cells treated with isoproterenol. However, activation of
PKB by forskolin or isoproterenol was much less than that
induced by IGF-1 or insulin (Fig. 2C)."
"2910","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Forskolin increased PKB activity weakly in Rat1 and NIH 3T3
cells. A slightly stronger stimulation of PKB activity was seen in Rat1 cells treated with isoproterenol. However, activation of
PKB by forskolin or isoproterenol was much less than that
induced by IGF-1 or insulin (Fig. 2C)."
"2911","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"As demonstrated in Fig. 2C,
however, 8-Br-cAMP, forskolin, or isoproterenol stimulated
phosphorylation of GSK-3a more efficiently than IGF-1 or
insulin and increased phosphorylation of GSK-3b to levels
comparable to those induced by IGF-1 or insulin."
"2912","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"As demonstrated in Fig. 2C,
however, 8-Br-cAMP, forskolin, or isoproterenol stimulated
phosphorylation of GSK-3a more efficiently than IGF-1 or
insulin and increased phosphorylation of GSK-3b to levels
comparable to those induced by IGF-1 or insulin."
"2913","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"As demonstrated in Fig. 2C,
however, 8-Br-cAMP, forskolin, or isoproterenol stimulated
phosphorylation of GSK-3a more efficiently than IGF-1 or
insulin and increased phosphorylation of GSK-3b to levels
comparable to those induced by IGF-1 or insulin."
"2914","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"As demonstrated in Fig. 2C,
however, 8-Br-cAMP, forskolin, or isoproterenol stimulated
phosphorylation of GSK-3a more efficiently than IGF-1 or
insulin and increased phosphorylation of GSK-3b to levels
comparable to those induced by IGF-1 or insulin."
"2915","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"As demonstrated in Fig. 2C,
however, 8-Br-cAMP, forskolin, or isoproterenol stimulated
phosphorylation of GSK-3a more efficiently than IGF-1 or
insulin and increased phosphorylation of GSK-3b to levels
comparable to those induced by IGF-1 or insulin."
"2916","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"As demonstrated in Fig. 2C,
however, 8-Br-cAMP, forskolin, or isoproterenol stimulated
phosphorylation of GSK-3a more efficiently than IGF-1 or
insulin and increased phosphorylation of GSK-3b to levels
comparable to those induced by IGF-1 or insulin."
"2917","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"As demonstrated in Fig. 2C,
however, 8-Br-cAMP, forskolin, or isoproterenol stimulated
phosphorylation of GSK-3a more efficiently than IGF-1 or
insulin and increased phosphorylation of GSK-3b to levels
comparable to those induced by IGF-1 or insulin."
"2918","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"As demonstrated in Fig. 2C,
however, 8-Br-cAMP, forskolin, or isoproterenol stimulated
phosphorylation of GSK-3a more efficiently than IGF-1 or
insulin and increased phosphorylation of GSK-3b to levels
comparable to those induced by IGF-1 or insulin."
"2919","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:decreases","false",,,"To determine whether the association between
GSK-3 and PKAc is regulated by cAMP levels, GSK-3b was
immunoprecipitated from HEK293 and NIH 3T3 cells treated
with or without forskolin. The level of PKAc in GSK-3b
immunoprecipitates was markedly reduced in forskolintreated
cells compared with that in unstimulated cells (Fig.
3C), suggesting that dissociation of the GSK-3b-PKAc complex
occurs after PKA activation or GSK-3 phosphorylation."
"2920","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:decreases","false",,,"To determine whether the association between
GSK-3 and PKAc is regulated by cAMP levels, GSK-3b was
immunoprecipitated from HEK293 and NIH 3T3 cells treated
with or without forskolin. The level of PKAc in GSK-3b
immunoprecipitates was markedly reduced in forskolintreated
cells compared with that in unstimulated cells (Fig.
3C), suggesting that dissociation of the GSK-3b-PKAc complex
occurs after PKA activation or GSK-3 phosphorylation."
"2921","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Transfection of PKAc, but not empty vector,
enhanced phosphorylation of cotransfected GSK-3a and -b at serine 21 and 9 in HEK293 cells (Fig. 4A)."
"2922","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:increases","false",,,"Transfection of PKAc, but not empty vector,
enhanced phosphorylation of cotransfected GSK-3a and -b at serine 21 and 9 in HEK293 cells (Fig. 4A)."
"2923","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"Consistent with this in vivo activity, PKAc enzyme efficiently
phosphorylated GSK-3a and -b at serine 21 and 9 in vitro (Fig. 4B),
which was blocked by addition of the PKA peptide inhibitor (PKI)
(26). Similar results were obtained when immunoprecipitated GSK-
3a, immunoprecipitatedHA-GSK-3b, purified GSK-3a, or recombinant
GSK-3b was used as substrate (Fig. 4B). "
"2924","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"Consistent with this in vivo activity, PKAc enzyme efficiently
phosphorylated GSK-3a and -b at serine 21 and 9 in vitro (Fig. 4B),
which was blocked by addition of the PKA peptide inhibitor (PKI)
(26). Similar results were obtained when immunoprecipitated GSK-
3a, immunoprecipitatedHA-GSK-3b, purified GSK-3a, or recombinant
GSK-3b was used as substrate (Fig. 4B). "
"2925","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyDecreases","false",,,"These in vivo and in vitro observations establish that PKA can
directly phosphorylate and inactivate GSK-3."
"2926","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyDecreases","false",,,"These in vivo and in vitro observations establish that PKA can
directly phosphorylate and inactivate GSK-3."
"2927","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:decreases","false",,,"These in vivo and in vitro observations establish that PKA can
directly phosphorylate and inactivate GSK-3."
"2928","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyDecreases","false",,,"These in vivo and in vitro observations establish that PKA can
directly phosphorylate and inactivate GSK-3."
"2929","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"BAD was originally demonstrated to be phosphorylated
at serine 136 by PKB (32, 33). However, BAD can also be
inactivated through phosphorylation of serine 112 by Rsk, which
is located downstream of mitogen-activated protein kinases
(MAPKyErk) (34–36), or alternatively by mitochondriaanchored
PKA (37). Additionally, Rsk can phosphorylate CREB
at the same serine 133 site as PKA, leading to the expression of
cAMP-responsive genes (34)."
"2930","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyDecreases","false",,,"BAD was originally demonstrated to be phosphorylated
at serine 136 by PKB (32, 33). However, BAD can also be
inactivated through phosphorylation of serine 112 by Rsk, which
is located downstream of mitogen-activated protein kinases
(MAPKyErk) (34–36), or alternatively by mitochondriaanchored
PKA (37). Additionally, Rsk can phosphorylate CREB
at the same serine 133 site as PKA, leading to the expression of
cAMP-responsive genes (34)."
"2931","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"BAD was originally demonstrated to be phosphorylated
at serine 136 by PKB (32, 33). However, BAD can also be
inactivated through phosphorylation of serine 112 by Rsk, which
is located downstream of mitogen-activated protein kinases
(MAPKyErk) (34–36), or alternatively by mitochondriaanchored
PKA (37). Additionally, Rsk can phosphorylate CREB
at the same serine 133 site as PKA, leading to the expression of
cAMP-responsive genes (34)."
"2932","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyDecreases","false",,,"BAD was originally demonstrated to be phosphorylated
at serine 136 by PKB (32, 33). However, BAD can also be
inactivated through phosphorylation of serine 112 by Rsk, which
is located downstream of mitogen-activated protein kinases
(MAPKyErk) (34–36), or alternatively by mitochondriaanchored
PKA (37). Additionally, Rsk can phosphorylate CREB
at the same serine 133 site as PKA, leading to the expression of
cAMP-responsive genes (34)."
"2933","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"BAD was originally demonstrated to be phosphorylated
at serine 136 by PKB (32, 33). However, BAD can also be
inactivated through phosphorylation of serine 112 by Rsk, which
is located downstream of mitogen-activated protein kinases
(MAPKyErk) (34–36), or alternatively by mitochondriaanchored
PKA (37). Additionally, Rsk can phosphorylate CREB
at the same serine 133 site as PKA, leading to the expression of
cAMP-responsive genes (34)."
"2934","Fang XYu SXLu YBast RCWoodgett JRMills GB","11035810","Proceedings of the National Academy of Sciences of the United States of America","PubMed",,,"bel:directlyIncreases","false",,,"BAD was originally demonstrated to be phosphorylated
at serine 136 by PKB (32, 33). However, BAD can also be
inactivated through phosphorylation of serine 112 by Rsk, which
is located downstream of mitogen-activated protein kinases
(MAPKyErk) (34–36), or alternatively by mitochondriaanchored
PKA (37). Additionally, Rsk can phosphorylate CREB
at the same serine 133 site as PKA, leading to the expression of
cAMP-responsive genes (34)."
"2935","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"VEGF is the most critical driver of
vascular formation, as it is required to initiate the
formation of immature vessels by vasculogenesis or
angiogenic sprouting."
"2936","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Ang1 and ephrinB2 are subsequently
required for further remodeling and maturation
of this initially immature vasculature notably as endothelial
cells integrate with supporting cells such as
smooth muscle cells and pericytes."
"2937","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Ang1 and ephrinB2 are subsequently
required for further remodeling and maturation
of this initially immature vasculature notably as endothelial
cells integrate with supporting cells such as
smooth muscle cells and pericytes."
"2938","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"VEGF was initially defined, characterized, and purified
for its ability to induce vascular leak and permeability
as well as for its ability to promote endothelial cell
proliferation (Ferrara, 1999)."
"2939","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"VEGFR2 is
the main receptor able to induce endothelial cell
proliferation as well as migratory and sprouting activity
and to help promote endothelial cells to form tubule-like
structures"
"2940","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"VEGFR2 is
the main receptor able to induce endothelial cell
proliferation as well as migratory and sprouting activity
and to help promote endothelial cells to form tubule-like
structures"
"2941","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"VEGFR2 is
the main receptor able to induce endothelial cell
proliferation as well as migratory and sprouting activity
and to help promote endothelial cells to form tubule-like
structures"
"2942","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Failure
of vasculogenesis is also observed in Flk-1 deficient mice
(Shalaby et al., 1995)."
"2943","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Ang1 would rather have a permissive
role by optimizing the manner by which endothelial cells
interact with each other and integrate with supporting
cells and matrix."
"2944","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Ang1 would rather have a permissive
role by optimizing the manner by which endothelial cells
interact with each other and integrate with supporting
cells and matrix."
"2945","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"recent knockout
studies have suggested key role for ephrin B2 and it
EphB4 receptor during vascular development mainly in
early angiogenic remodeling (Gerety et al., 1999)."
"2946","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"recent knockout
studies have suggested key role for ephrin B2 and it
EphB4 receptor during vascular development mainly in
early angiogenic remodeling (Gerety et al., 1999)."
"2947","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Stimuli like histamine,
atrial natriuretic factor, or thrombin, induce a rapid and
short-lived increase in vascular permeability while
others like cytokines or VEGF induce a sustained
response."
"2948","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Stimuli like histamine,
atrial natriuretic factor, or thrombin, induce a rapid and
short-lived increase in vascular permeability while
others like cytokines or VEGF induce a sustained
response."
"2949","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Stimuli like histamine,
atrial natriuretic factor, or thrombin, induce a rapid and
short-lived increase in vascular permeability while
others like cytokines or VEGF induce a sustained
response."
"2950","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Stimuli like histamine,
atrial natriuretic factor, or thrombin, induce a rapid and
short-lived increase in vascular permeability while
others like cytokines or VEGF induce a sustained
response."
"2951","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:decreases","false",,,"The major antiplatelet agents secreted by endothelial
cells are prostacyclin (PGI2) and nitric oxide (NO) (Cines
et al., 1998)."
"2952","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:decreases","false",,,"The major antiplatelet agents secreted by endothelial
cells are prostacyclin (PGI2) and nitric oxide (NO) (Cines
et al., 1998)."
"2953","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"The major antiplatelet agents secreted by endothelial
cells are prostacyclin (PGI2) and nitric oxide (NO) (Cines
et al., 1998). Both synergistically increasecAMPcontent
in platelets, hence preventing their aggregation (de
Graaf et al., 1992)."
"2954","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:decreases","false",,,"The major antiplatelet agents secreted by endothelial
cells are prostacyclin (PGI2) and nitric oxide (NO) (Cines
et al., 1998). Both synergistically increasecAMPcontent
in platelets, hence preventing their aggregation (de
Graaf et al., 1992)."
"2955","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:decreases","false",,,"The major antiplatelet agents secreted by endothelial
cells are prostacyclin (PGI2) and nitric oxide (NO) (Cines
et al., 1998). Both synergistically increasecAMPcontent
in platelets, hence preventing their aggregation (de
Graaf et al., 1992)."
"2956","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"PGI2 and NO are constitutively
released by endothelial cells but their synthesis is
increased in response to a similar range of agonists,
notably molecules involved in the coagulation process
(e.g., bradykinine and thrombin)"
"2957","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"PGI2 and NO are constitutively
released by endothelial cells but their synthesis is
increased in response to a similar range of agonists,
notably molecules involved in the coagulation process
(e.g., bradykinine and thrombin)"
"2958","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"PGI2 and NO are constitutively
released by endothelial cells but their synthesis is
increased in response to a similar range of agonists,
notably molecules involved in the coagulation process
(e.g., bradykinine and thrombin)"
"2959","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"PGI2 and NO are constitutively
released by endothelial cells but their synthesis is
increased in response to a similar range of agonists,
notably molecules involved in the coagulation process
(e.g., bradykinine and thrombin)"
"2960","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:directlyIncreases","false",,,"The protein C/protein S
pathway is initiated when thrombin interacts with the
endothelial cell receptor thrombomodulin, facilitating
activation of protein C (Sadler, 1997)."
"2961","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"The protein C/protein S
pathway is initiated when thrombin interacts with the
endothelial cell receptor thrombomodulin, facilitating
activation of protein C (Sadler, 1997)."
"2962","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:decreases","false",,,"Activated protein
C inactivates two cofactors essential for blood coagulation:
factors VIIIa and Va."
"2963","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:decreases","false",,,"Activated protein
C inactivates two cofactors essential for blood coagulation:
factors VIIIa and Va."
"2964","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Activated protein
C inactivates two cofactors essential for blood coagulation:
factors VIIIa and Va."
"2965","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Activated protein
C inactivates two cofactors essential for blood coagulation:
factors VIIIa and Va."
"2966","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:directlyIncreases","false",,,"To be effective, proteinC must
form a complex with protein S, which is synthesized by
endothelial cells (Stern et al., 1991; Esmon, 2000)."
"2967","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Complex formation between thrombin and thrombomodulin
also prevents thrombin from being able to clot
fibrinogen or to activate platelets (Esmon, 1995)."
"2968","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:directlyDecreases","false",,,"Complex formation between thrombin and thrombomodulin
also prevents thrombin from being able to clot
fibrinogen or to activate platelets (Esmon, 1995)."
"2969","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:directlyDecreases","false",,,"It must be noted that the natural
inhibitor of t-PA, plasminogen activator inhibitor type 1
(PAI-1) is also constitutively secreted by endothelial
cells."
"2970","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"The second is the von
Willebrand factor (vWF) of which endothelial cells are
the major source (Denis, 2002). vWF is constitutively
secreted into the plasma and the subendothelial matrix.
It is also stored in high amount in Weibel–Palade
bodies, which can be mobilized rapidly in response to
agonists like thrombin (van Mourik et al., 2002)."
"2971","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:directlyDecreases","false",,,"vWF binds and stabilizes coagulation factor VIII
and is a specific factor required for the binding of
platelets to exposed extracellular matrix components
when the vessel wall is damaged (Ruggeri and Preissner,
1999)."
"2972","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"vWF binds and stabilizes coagulation factor VIII
and is a specific factor required for the binding of
platelets to exposed extracellular matrix components
when the vessel wall is damaged (Ruggeri and Preissner,
1999)."
"2973","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"However, when exposed to
thrombin, cytokines, or LPS, endothelial cells synthesize
and express tissue factor at their surface (Nawroth
et al., 1986; Mackman, 1997)."
"2974","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"However, when exposed to
thrombin, cytokines, or LPS, endothelial cells synthesize
and express tissue factor at their surface (Nawroth
et al., 1986; Mackman, 1997)."
"2975","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Thrombin is the main effector protease of the
coagulation cascade. Factor Xa, activated by factor
VIIa and tissue factor, converts prothrombin to active
thrombin."
"2976","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Thrombin is the main effector protease of the
coagulation cascade. Factor Xa, activated by factor
VIIa and tissue factor, converts prothrombin to active
thrombin."
"2977","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Thrombin is the main effector protease of the
coagulation cascade. Factor Xa, activated by factor
VIIa and tissue factor, converts prothrombin to active
thrombin."
"2978","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"In
endothelial cells, thrombin causes vWF release, the
appearance of P-selectin at the plasma membrane,
production of PAF and chemokines."
"2979","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:directlyIncreases","false",,,"PAR-1,
the one present at the surface of endothelial cells, is
activated when thrombin cleaves its amino-terminal
extracellular domain (exodomain) at a specific site."
"2980","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"The NO generation by endothelial cells is constitutive
but may be enhanced by a wide variety of compounds,
including acetylcholine, angiotensin II, bradykinin,
histamine, adenine nucleotides, arachidonic acid"
"2981","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"The NO generation by endothelial cells is constitutive
but may be enhanced by a wide variety of compounds,
including acetylcholine, angiotensin II, bradykinin,
histamine, adenine nucleotides, arachidonic acid"
"2982","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"The NO generation by endothelial cells is constitutive
but may be enhanced by a wide variety of compounds,
including acetylcholine, angiotensin II, bradykinin,
histamine, adenine nucleotides, arachidonic acid"
"2983","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"The NO generation by endothelial cells is constitutive
but may be enhanced by a wide variety of compounds,
including acetylcholine, angiotensin II, bradykinin,
histamine, adenine nucleotides, arachidonic acid"
"2984","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"The NO generation by endothelial cells is constitutive
but may be enhanced by a wide variety of compounds,
including acetylcholine, angiotensin II, bradykinin,
histamine, adenine nucleotides, arachidonic acid"
"2985","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"It is
synthesized from oxygen and L-arginine by NO synthase
(NOS)."
"2986","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"EDRF diffuses to the vascular smooth
muscle cells where it stimulates soluble guanylate
cyclase, resulting in an increased formation of cyclic
GMP and subsequent relaxation (Fig. 2A) (Denninger
and Marletta, 1999)."
"2987","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"EDRF diffuses to the vascular smooth
muscle cells where it stimulates soluble guanylate
cyclase, resulting in an increased formation of cyclic
GMP and subsequent relaxation (Fig. 2A) (Denninger
and Marletta, 1999)."
"2988","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"EDRF diffuses to the vascular smooth
muscle cells where it stimulates soluble guanylate
cyclase, resulting in an increased formation of cyclic
GMP and subsequent relaxation (Fig. 2A) (Denninger
and Marletta, 1999)."
"2989","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:directlyDecreases","false",,,"infusion of a NOS
inhibitor, like L-NMMA, increases the resting blood
pressure (Fleming et al., 1996)."
"2990","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"infusion of a NOS
inhibitor, like L-NMMA, increases the resting blood
pressure (Fleming et al., 1996)."
"2991","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Endothelium generates PGI2, which relaxes the underlying
smooth muscle cells through activation of adenylate
cyclase and subsequent generation of cAMP."
"2992","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:directlyIncreases","false",,,"Endothelium generates PGI2, which relaxes the underlying
smooth muscle cells through activation of adenylate
cyclase and subsequent generation of cAMP."
"2993","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Endothelium generates PGI2, which relaxes the underlying
smooth muscle cells through activation of adenylate
cyclase and subsequent generation of cAMP."
"2994","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Endothelial cells constitutively release PGI2 (Moncada
et al., 1976) which appears to be involved in the
regulation of resting vascular tone, in addition to EDRF.
It is released in higher amount in response to ligand
binding on the cell surface such as thrombin, arachidonic
acid, histamine, serotonin"
"2995","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Endothelial cells constitutively release PGI2 (Moncada
et al., 1976) which appears to be involved in the
regulation of resting vascular tone, in addition to EDRF.
It is released in higher amount in response to ligand
binding on the cell surface such as thrombin, arachidonic
acid, histamine, serotonin"
"2996","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Endothelial cells constitutively release PGI2 (Moncada
et al., 1976) which appears to be involved in the
regulation of resting vascular tone, in addition to EDRF.
It is released in higher amount in response to ligand
binding on the cell surface such as thrombin, arachidonic
acid, histamine, serotonin"
"2997","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Endothelial cells constitutively release PGI2 (Moncada
et al., 1976) which appears to be involved in the
regulation of resting vascular tone, in addition to EDRF.
It is released in higher amount in response to ligand
binding on the cell surface such as thrombin, arachidonic
acid, histamine, serotonin"
"2998","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:directlyIncreases","false",,,"The endothelinA (ETA) receptor is situated on the
vascular smooth muscle cells and has a high affinity for
ET-1 and ET-2 but not for ET-3."
"2999","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:directlyIncreases","false",,,"The endothelinA (ETA) receptor is situated on the
vascular smooth muscle cells and has a high affinity for
ET-1 and ET-2 but not for ET-3."
"3000","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:causesNoChange","false",,,"The endothelinA (ETA) receptor is situated on the
vascular smooth muscle cells and has a high affinity for
ET-1 and ET-2 but not for ET-3."
"3001","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:directlyIncreases","false",,,"the
endothelinB (ETB) receptor is situated on the endothelial
cells and has a similar affinity for the three endothelin
isoforms."
"3002","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:directlyIncreases","false",,,"the
endothelinB (ETB) receptor is situated on the endothelial
cells and has a similar affinity for the three endothelin
isoforms."
"3003","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:directlyIncreases","false",,,"the
endothelinB (ETB) receptor is situated on the endothelial
cells and has a similar affinity for the three endothelin
isoforms."
"3004","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Binding to ETA receptor stimulated phospholipase
C initiating in turn events leading eventually
to smooth muscle cell contraction (Kedzierski and
Yanagisawa, 2001)."
"3005","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:decreases","false",,,"Binding to ETA receptor stimulated phospholipase
C initiating in turn events leading eventually
to smooth muscle cell contraction (Kedzierski and
Yanagisawa, 2001)."
"3006","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"The result of ET binding to ETB
receptor on endothelial cells is the release of EDRF/
PGI2, which opposes the vasoconstricting action of ET."
"3007","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Vasoconstricting agents like ET-1 also
exert mitogenic activity on smooth muscle cells (Alberts
et al., 1994) while EDRF and PGI2 inhibit smooth
muscle cell proliferation"
"3008","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:decreases","false",,,"Vasoconstricting agents like ET-1 also
exert mitogenic activity on smooth muscle cells (Alberts
et al., 1994) while EDRF and PGI2 inhibit smooth
muscle cell proliferation"
"3009","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:decreases","false",,,"Vasoconstricting agents like ET-1 also
exert mitogenic activity on smooth muscle cells (Alberts
et al., 1994) while EDRF and PGI2 inhibit smooth
muscle cell proliferation"
"3010","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Endothelial (eNOS)
and neuronal (nNOS) isoforms are constitutively
expressed and are activated by calmodulin/calcium."
"3011","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Endothelial (eNOS)
and neuronal (nNOS) isoforms are constitutively
expressed and are activated by calmodulin/calcium."
"3012","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Receptor-mediated agonist stimulation
(e.g., bradykinin, acetylcholine, thrombin,
histamine, . . .) leads to rapid enzyme activation by
depalmitoylation, binding to calmodulin/calcium, displacement displacement
of caveolin and release from the plasma
membrane(Govers and Rabelink, 2001; Marletta, 2001)."
"3013","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Receptor-mediated agonist stimulation
(e.g., bradykinin, acetylcholine, thrombin,
histamine, . . .) leads to rapid enzyme activation by
depalmitoylation, binding to calmodulin/calcium, displacement displacement
of caveolin and release from the plasma
membrane(Govers and Rabelink, 2001; Marletta, 2001)."
"3014","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Receptor-mediated agonist stimulation
(e.g., bradykinin, acetylcholine, thrombin,
histamine, . . .) leads to rapid enzyme activation by
depalmitoylation, binding to calmodulin/calcium, displacement displacement
of caveolin and release from the plasma
membrane(Govers and Rabelink, 2001; Marletta, 2001)."
"3015","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Receptor-mediated agonist stimulation
(e.g., bradykinin, acetylcholine, thrombin,
histamine, . . .) leads to rapid enzyme activation by
depalmitoylation, binding to calmodulin/calcium, displacement displacement
of caveolin and release from the plasma
membrane(Govers and Rabelink, 2001; Marletta, 2001)."
"3016","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"eNOS activity is also regulated at the
transcriptional level: VEGF, insulin, bFGF increase
eNOS expression while hypoxia and oxidized LDL
decrease it (Sase and Michel, 1997)."
"3017","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"eNOS activity is also regulated at the
transcriptional level: VEGF, insulin, bFGF increase
eNOS expression while hypoxia and oxidized LDL
decrease it (Sase and Michel, 1997)."
"3018","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"eNOS activity is also regulated at the
transcriptional level: VEGF, insulin, bFGF increase
eNOS expression while hypoxia and oxidized LDL
decrease it (Sase and Michel, 1997)."
"3019","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:decreases","false",,,"eNOS activity is also regulated at the
transcriptional level: VEGF, insulin, bFGF increase
eNOS expression while hypoxia and oxidized LDL
decrease it (Sase and Michel, 1997)."
"3020","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:decreases","false",,,"eNOS activity is also regulated at the
transcriptional level: VEGF, insulin, bFGF increase
eNOS expression while hypoxia and oxidized LDL
decrease it (Sase and Michel, 1997)."
"3021","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Shear stress causes rapid eNOS
activation and upregulates eNOS gene expression by
transcription activation of the eNOS promoter (Xiao
et al., 1997)."
"3022","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"the induced adherence in
inflammatory situation requires induction of L-selectin
ligand and/or of E- and P-selectins on the endothelial
surface. E-selectin is transcriptionally induced by
cytokines such as IL-1, TNF-a, or by LPS (Klein et al.,
1995; Scholz et al., 1996)."
"3023","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"the induced adherence in
inflammatory situation requires induction of L-selectin
ligand and/or of E- and P-selectins on the endothelial
surface. E-selectin is transcriptionally induced by
cytokines such as IL-1, TNF-a, or by LPS (Klein et al.,
1995; Scholz et al., 1996)."
"3024","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"the induced adherence in
inflammatory situation requires induction of L-selectin
ligand and/or of E- and P-selectins on the endothelial
surface. E-selectin is transcriptionally induced by
cytokines such as IL-1, TNF-a, or by LPS (Klein et al.,
1995; Scholz et al., 1996)."
"3025","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"In contrast, P-selectin is stored
in the membrane of storage granules, the Weibel–
Palade bodies, in endothelial cells (McEver et al., 1989).
Fusion of these granules with the plasma membrane is
rapidly stimulated by proinflammatory mediators such
as histamine and thrombin."
"3026","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"In contrast, P-selectin is stored
in the membrane of storage granules, the Weibel–
Palade bodies, in endothelial cells (McEver et al., 1989).
Fusion of these granules with the plasma membrane is
rapidly stimulated by proinflammatory mediators such
as histamine and thrombin."
"3027","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"L-selectin (constitutive rolling on endothelial cells)
and P- and/or E-selectins (inflammatory mediatorinduced
capture) work cooperatively to initiate leukocyte
migration."
"3028","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Preformed Mac-1 is stored in granules in
neutrophils and can be rapidly mobilized to the neutrophil
surface after exposure to degranulation stimuli
such as the bacterial peptide fMLP or to cytokines
(Altieri and Edgington, 1988).....This change may be induced by
phosphorylation of the cytoplasmic tail of the b subunit
(Buyon et al., 1997), possibly through a pathway
involving the small GTP-binding protein Rho, but this
is still unclear."
"3029","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:directlyIncreases","false",,,"Preformed Mac-1 is stored in granules in
neutrophils and can be rapidly mobilized to the neutrophil
surface after exposure to degranulation stimuli
such as the bacterial peptide fMLP or to cytokines
(Altieri and Edgington, 1988).....This change may be induced by
phosphorylation of the cytoplasmic tail of the b subunit
(Buyon et al., 1997), possibly through a pathway
involving the small GTP-binding protein Rho, but this
is still unclear."
"3030","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Migration of all leukocytes
depends mainly on b2 integrins (Mac-1 and LFA-1)
and on ICAM-1, their ligand on endothelial cells."
"3031","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Migration of all leukocytes
depends mainly on b2 integrins (Mac-1 and LFA-1)
and on ICAM-1, their ligand on endothelial cells."
"3032","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Specific increased
expression of glycolytic enzymes, glucose tranporter
GLUT-1, VEGF, tyrosine hydroxylase, transferrin, and
erythropoietin is observed, all proteins involved in the
adaptative response of cells to hypoxia."
"3033","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Specific increased
expression of glycolytic enzymes, glucose tranporter
GLUT-1, VEGF, tyrosine hydroxylase, transferrin, and
erythropoietin is observed, all proteins involved in the
adaptative response of cells to hypoxia."
"3034","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Specific increased
expression of glycolytic enzymes, glucose tranporter
GLUT-1, VEGF, tyrosine hydroxylase, transferrin, and
erythropoietin is observed, all proteins involved in the
adaptative response of cells to hypoxia."
"3035","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Specific increased
expression of glycolytic enzymes, glucose tranporter
GLUT-1, VEGF, tyrosine hydroxylase, transferrin, and
erythropoietin is observed, all proteins involved in the
adaptative response of cells to hypoxia."
"3036","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Numerous molecules stimulate endothelial
proliferation and migration, including VEGF, Ang1,
and bFGF."
"3037","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Numerous molecules stimulate endothelial
proliferation and migration, including VEGF, Ang1,
and bFGF."
"3038","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Numerous molecules stimulate endothelial
proliferation and migration, including VEGF, Ang1,
and bFGF."
"3039","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Numerous molecules stimulate endothelial
proliferation and migration, including VEGF, Ang1,
and bFGF."
"3040","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Numerous molecules stimulate endothelial
proliferation and migration, including VEGF, Ang1,
and bFGF."
"3041","Michiels C","12891700","Journal of cellular physiology","PubMed",,,"bel:increases","false",,,"Numerous molecules stimulate endothelial
proliferation and migration, including VEGF, Ang1,
and bFGF."
